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1S U M M A R Y
The isolation and purification o f  two major phenobarbitone-induced hepatic 
cytochromes P-450 from  male Wistar rats is described. These forms (designated 
cytochromes P-450 and P-450 B^) were extensively  characterised and
structurally and functionally compared to two other homogeneous isoenzymic forms, 
cytochromes P-452 (c lo fibrate-induced) and cytochrome P-447 (BNF-induced). 
These characterisation studies (including ca ta ly t ic , immunological, physical and 
spectral analysis) indicated that all four isoenzymes w ere  distinct, unique 
hemoproteins.
The above characterisation was extended towards the induction profiles o f 
these hemoproteins in hepatic and renal microsomes, fo llow ing single dose 
xenobiotic pretreatment. O f  primary interest was the immunoquantitation data 
which revea led  the presence o f  cytochrome P-452 as a major constitutive 
isoenzyme. This data in conjunction with the metabolic data also indicated that 
xenobiotic induction o f  cytochromes P-450 was both a spec ific  and precise event.
In order to determine the induction profile  o f  these hemoproteins fo llow ing 
xenobiotic pretreatm ent, analysis o f  the m R N A  species was also undertaken. In 
v itro  rabbit re t icu locy te  translation systems in conjunction with 
immunoprecipitation analysis (using monospecific antibodies against the spec if ic  
cytochrom e P-450) revea led  that fo llow ing phenobarbitone and 3-napthoflavone 
pretreatment the induction o f  the spec if ic  translatable m R N A  species was due to a 
d if fe rence  in the amount o f  spec if ic  m R N A  and not to a change in its 
translatability. This induction pro f i le  corresponded to that found on analysis o f  the 
holoenzyme cytochromes P-450 present within hepatic microsomes. The temporal 
aspects o f  the induction o f  the m R N A  species coding fo r  cytochrom e P-452 was not 
in agreement with the metabolic  and immunochemical data fo r  this isoenzyme in 
hepatic microsomes. This discrepancy is possibly believed to re la te  to the 
activation/repression o f  genes coding fo r  similar and related cytochrome P-452
2A  preliminary analysis o f  renal mRNA, species coding fo r  the cytochromes 
P-450 in conjunction with m etabolic  data was strongly suggestive for  there being 
d if fe ren t  modes o f  induction in the l ive r  and kidney.
isoenzymes.
I
3Cytochrom e P-450 is the terminal hemoprotein component o f  an e lectron 
transport chain ubiquitously distributed throughout living organisms and functional 
in the aerobic metabolism o f  numerous structurally unrelated compounds. These 
include drugs, carcinogens, insecticides, environmental pollutants, as w ell as a wide 
number o f  diverse endogenous compounds such as vitamin D, fa t ty  acids and steroids 
(table 1), and for  this reason a great deal o f  e f fo r t  has gone into the purification and 
characterisation o f  cytochromes P-450.
Early studies showed that d i f fe ren t  xenobiotic inducers could manipulate the 
biochemical and biophysical properties o f  the microsomal hydroxylation system 
(A lvares  et al, 1971, Conney et al. 1960), and this in conjunction with the 
remarkably broad substrate spec if ic ity ,  reg iose lec t iv ity  and s te reose lec t iv ity  o f  
cytochrom e P-450 was attributed to the ex istence o f  a number o f  distinct species o f  
the hemoprotein (Thomas e t  al. 1976, U llrich e t  al. 1977). Subsequent to these 
early studies, experim ental ev idence including sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS P .A ,G .E .), peptide mapping, amino acid 
composition and sequence determination, spectroscopy, chromatography, k inetic and 
immunological analysis, have conclusively shown that various purified cytochromes 
P-450 are distinct proteins (Lu e t  al. 1980, Guengerich et al. 1979).
This concept o f  hemoprotein m ultip lic ity  has been further extended in that it 
is now known that the metabolism o f  a wide var ie ty  o f  xenobiotics and endogenous 
substrates by these multiple forms o f  cytochrom e P-450 varies with species, sex, 
age, tissue, hormonal status and exposure o f  the animal to various fore ign 
compounds (Parke 1975). This would indicate that the d if fe ren t  cytochromes and 
there fore  their corresponding mixed function oxidase act iv it ies  (M .F .O .) are under 
d if fe ren t  genetic  control mechanisms.
Chapter 1
INTRODUCTION
Table 1.
Cytochrome P-450 Catalysed Reactions.
Reaction  Type Substrates
1. A liphatic hydroxylation Cholesterol, fa t ty  acids, pentobarbitone, 
prostaglandins, testosterone, vitamin D y
2. A rom atic  hydroxylation Aniline, Amphetamine
3. Dehalogenation Carbon tetrachloride, ch loroform , halothane,
4. Desulphuration Carbon disulphide, disulphiram,
- parathion.
5. Epoxidation Aldrin, benzo(a)pyrene, unsaturated 
fa t ty  acids, styrene.
6. Oxidative deamination Amphetamines.
7. N-dealkylation Aminopyrene, ch lorcycliz ine, 
ethylmorphiline, N -alky l amphetamines.
8. O-dealkylation Codeine, phenacetin.
9. S-dealkylation 6-methyl thiopurine.
10. N-oxidation 2-acetylaminofluorene, aniline, 
amphetamines.
11. S-oxidation Chlorpromazine.
5The bio logica l s ign if icance o f  this multiplic ity o f  cytochrom e P-450 between 
species relates to the fa c t  that the monooxygenases catalyse both activation and 
detox if icat ion  pathways fo r  a w ide var ie ty  o f  substrates, their distinct enzym atic  
properties and variable occurrences might result in marked dissimilarities in the 
pharmacology, tox ic ity  or carc inogenic ity  o f  a given compound. It is fo r  this reason 
that species d if fe rences in drug oxidations and characterisation o f  the multiple 
forms o f  cytochromes P-450 is important in order that extrapolations from  animal 
tox ic ity  testing data may serve as an indicator o f  potential tox ic ity  to man. With 
the development o f  procedures fo r  the purification o f  homogenous forms o f 
cytochrom e P-450 and reconstituted enzyme systems (Lu et  al. 1974) have o f fe red  
the possibility o f  g rea ter  detailed study o f  the more de fin it ive  roles o f  the multiple 
forms o f  cytochrom e P-450. Similarly, because o f  the absence o f  other interfer ing 
enzymes, the reconstituted enzyme system is ideal fo r  kinetic and mechanistic 
studies involving cytochrome(s) P-450. This taken in conjunction with analysis o f  
the messenger R N A  (m R N A ) species coding fo r  the distinct cytochrom e P-450 
isoenzymes, o f fe rs  an improved means o f  characterisation, with these profiles 
providing an index o f  potentia l tox ic ity .
A t  the present t ime, although the ex istence o f  multiple forms o f  cytochrome 
P-450 (as judged by the present cr iter ia  for  homogeneity ) is w e ll  documented, the 
precise number o f  d if fe ren t  forms in any given species is confusing, mainly because 
o f  the lack o f  uniformity in nomenclature amongst d if fe ren t  research groups. 
H ow ever , it is generally accepted that a conservative estim ate o f  the minimum 
number o f  forms in various microsomes ( fo r  rev iews see Lu et  al. 1980, Makowski et 
al. 1982) would be:-
a) e ight to f i f te en  forms in rat l ive r  microsomes.
b) f iv e  to six forms o f  rabbit l iver  and lung microsomes taken co l le c t iv e ly ,
o) a minimum o f  four forms in mouse l iver  microsomes.
d) an undetermined number in human l ive r  microsomes.
Further studies involving other species and tissues w ill no doubt show the 
ex istence o f  more forms. Nebert  has postulated the ex istence o f  hundreds or 
thousands o f  discrete forms o f  cy tochrom e P-450 that vary slightly from  each other 
in order to be able to e f f ic ie n t ly  metabolise the hundreds o f  substrates o f  w idely 
d if fe r ing  chemical structures (N ebert  1979). Ver if ica tion  w ill have to await a much 
grea ter  understanding o f  genetic  regulation and expression, although there is no 
doubt o f  the relationship associating genetic  variables and individual d if fe rences  in 
susceptibility to tox ic ity  and cancer, as seen in both experimental animals and 
humans (Vesell et al. 1977, N ebert  1980).
With increasing sophistication in immunological and amino acid sequencing
techniques, evidence has mounted that many o f  the multiple forms o f  cytochrom e
/
P-450 within a given species have d if fe ren t  primary and tert ia ry  structures. Such 
data (Vlasuk et al. 1982, Lev in  et  al. 1980) have indicated that these cytochromes- 
w ere  in fa c t  separate gene products and not post-translational modifications o f  a 
single gene product. Recombinant D N A  research has now shown this to be the case, 
with it becoming evident that the cytochromes P-450 are in fa c t  coded fo r  by a 
multigene complex within a given species (Atchison et al. 1983, Kumar et  al. 1983). 
Thus one should in fa c t  consider the d if fe ren t  cytochromes P-450 not as multiple 
enzyme forms but as distinct isoenzymes, because although these enzymes o ften  
catalyse the same enzym atic  reaction, they do not necessarily have similar ca ta ly t ic  
properties, being characterised by d if fe ren t  amino acid sequences and being 
immunologically distinct as a result o f  separate gene expression.
i . i  M U LT IPLE  FORMS OF R A T  H E P A T IC  M IC RO SO M AL C Y T O C H R O M E  P-450
Despite the close sim ilarities among the cytochromes P-450 in terms o f  their 
localisation, function and molecular weight range, it is becoming increasingly c lear 
that these isoenzymes are fundamently d i f fe ren t  proteins which d i f fe r  in their 
primary amino acid sequences, substrate spec if ic ity ,  immunological cross-react iv ity  
and inducibility by d i f fe ren t  xenobiotics (Ryan et  al. 1979, 1980). In general, no
7spec if ic  structural s im ilarit ies exist between the inducers o f  cytochrom e P-450 
which are responsible for the spec if ic  increase o f  a particular class o f  hemoprotein 
and hence its substrate spec if ic ity  (Snyder e t  al. 1979). This la tte r  diversity  o f  
substrate spec if ic ity  between d if fe ren t  species has been a major problem in 
adequate tox ic ity  and carc inogenic ity  screening programmes.
Accord ing to current cr iter ia  fo r  homogeneity (which includes SDS P .A .G .E ., 
ca ta ly t ic , spectral and immunological properties, sequencing o f  the N H 2- and 
COOH-term in i and pro teo ly t ic  peptide fragments o f  cytochrome P-450), eight to 
f i f te en  forms o f cytochrom e P-450 have been postulated to be present in rat hepatic 
microsomes. The amounts o f  these various isoenzymes has been shown to be a 
function o f age, sex, strain and inducer (Sato et  al. 1978, P icke tt  et al. 1981). 
Taking these variable factors into consideration, results indicate that the 
constitutive levels o f  the cytochromes P-450 and P-448 in rat l ive r  microsomes is 
very  low (less than 5% o f  the to ta l cytochrom e P-450, P icke tt  e t  al. 1981). 
Phenobarbitone and 3-methylcholanthrene induce cytochrome P-450 (15-30 fo ld ) and 
cytochrome P-448 (40 fo ld ) respec tive ly . A f t e r  phenobarbitone-induction, depending 
on the age and species o f  the animal, the phenobarbitone-induced isoenzymes 
represent 30-60% o f  the tota l m icrosomal cytochrome P-450, whereas a fte r  3- 
methylcholanthrene pretreatment cytochrome P-448 levels can be as high as 80% o f  
the tota l cytochrome P-450 population (Harada et  al. 1980). This group also showed 
that phenobarbitone pretreatment resulted in a corresponding increase in N A D P H -  
cytochrome P-450 reductase almost in parallel with that o f  to ta l microsomal 
cytochrom e P-450.
The major phenobarbitone-inducible fo rm  o f  cytochrome P-450 in rat l iver  
(designated P-450^ by some authors, Ryan et al. 1979), can also be induced by 
polychlorinated biphenyls such as A roc lo r  1254. The sub-unit molecular weight o f  
cytochrom e P-450^ ranges from  50-53K, with an absorbtion maximum o f  its reduced 
C O -d if fe ren ce  spectrum ranging from  450-451 nm. In Long-Evans rats, the N -  and 
C - terminal amino acid residues o f  cy tochrom e P-450^ are glutamic acid and serine
8respective ly  (Botelho et  al. 1979). This form  e f f ic ien t ly  catalyses the metabolism o f 
substrates such as benzphetamine, N ,N  dimethylaniline, parathion and N ,N - 
dimethylphentermine. It is also interesting to note that there is a high degree of, 
homology in the N -term inal residues o f  cytochrome P-450^ and rabbit l iver  
cytochrom e P-450 L M 2 also induced by phenobarbitone (Botelho et  al. 1979). O f the 
firs t  twenty one amino acids, fourteen common residues are found with six o f  the 
d i f fe rences being accounted fo r  by a single amino acid change and one by a double 
amino acid change in the nucleotide sequence. In addition to N -term inal homology, 
the overall amino-acid composition o f  the above 2 enzymes are very similar, and are 
in fa c t  even more c losely  re la ted in their substrate spec ific it ies  than are the three 
main forms isolated from  rat l iver  microsomes (a,b,c) a f t e r  treatm ent with 
phenobarbitone, 3-methylcholanthrene or polychlorinated biphenyls. Both enzymes 
exhibit a poor ca ta ly t ic  ac t iv ity  towards benzo(a)pyrene hydroxylation but they show 
almost absolute spec if ic ity  for  the 16a hydroxylation o f  testosterone with l it t ie  or 
no detectab le  act iv ity  for  the 6 3 or 7a hydroxylation o f  this substrate.
Despite their homology o f  N -term inal regions and sim ilarity  o f  amino-acid 
composition and ca ta ly t ic  properties, the above two proteins have d if fe ren t  amino- 
acid sequences in the C -term inal regions and do not co-e lectrophorese on SDS 
P .A .G .E . They are also immunologically non-identical (Botelho et  al. 1979), and 
since antibodies are d irected against several spatially distant sites (ep itopes) on the 
protein surface, it indicates that they have dissimilar structures.
Cytochrom e P-450^ is predominantly a low spin hemoprotein although there is 
evidence that it may contain some high-spin component. Purified  preparations 
from either phenobarbitone or A roc lo r  1254-treated rats are usually low spin 
hemoproteins (Ryan et  al. 1979).
The major 3-methylcholanthrene-induced form  in rat l iver  has been termed 
cytochrome P-450c , also induced by 3-napthoflavone, A roc lor  1254 and 3,4,5,3',5' 
pentachlorobiphenyl. Reports o f  sub-unit molecular weight o f  this cytochrome 
P-450 range from 53-56K, and its reduced CO  complex exhibits an absorbtion
9maximum o f  447 to 448 nm. In Long-Evans rats, the N - and C-term inal amino acid 
residues are isoleucine and leucine respective ly  (Botello  e t  al. 1979). Cytochrom e 
P-450c pre feren tia lly  catalyses the metabolism o f  such substrates as 
benzo(a)pyrene, 7-ethoxycoumarin, 7-ethoxyresorufin and zoxazolam ine. It also 
displays ca ta ly t ic  ac t iv ity  towards the hydroxylation o f testosterone at the 60 
position but at a much lower rate than that observed with l iver  microsomes 
suggesting that it is not the major isoenzyme responsible fo r  this hydroxylation. 
Pre lim inary work also indicated the presence o f  a second form  o f  cytochrom e P-448 
fo llow ing induction by 3,4,5,3,4,4 hexachlorobiphenyl (Kohii e t  al. 1981). This 
compound is believed to induce two forms o f  cytochrome P-448, one o f  which has 
e lectrophoretic , ca ta ly t ic  and spectral properties similar to those o f  cytochrome 
P -450c . The other form  has a sub-unit molecular weight o f  52,000, but does not 
metabolise either benzphetamine or 7-ethoxyresorufin, substrates pre ferentia lly  
metabolised by cytochromes P-450^ and P-450c respective ly .
In the rat the major fo rm  (cytochrom e P-450c ) has been shown to represent at 
least 80% o f  the to ta l po lycyc lic  aromatic hydrocarbon inducible aryl hydrocarbon 
hydroxylase (A H H ) ac t iv ity  (Thomas et al. 1981). H ow ever evidence has also been 
presented indicating the presence o f  further forms o f  cytochromes P-450 fo llow ing 
induction by TC D D  (Guenther e t  al. 1978, Chen et  al. 1982). These have been 
termed cytochromes P-^-450 and P^-450 and it has been suggested that these are 
re lated to the same species found within the mouse (Negishi e t  al. 1979). 
Cytochrom e P-^-450 is defined arbitrarily as the po lycyclic  aromatic hydrocarbon 
inducible form  most c losely  associated with aryl hydrocarbon hydroxylase act iv ity .  
Cytochrom e P^-450 is defined as the po lycyc lic  aromatic hydrocarbon inducible 
form  (when reduced and combined with carbon monoxide) having a soret peak shifted 
to approximately 448 nm. Although there was some initial sceptic ism relating to 
the existence o f  these two forms o f  cytochrom e P-450 in species other than mouse, 
data has em erged indicating that both the rat and mouse forms are immunologically 
indistinct (Chen et al. 1982).
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A  portion o f  the mouse cytochrom e P^-450 gene has been cloned and there is 
su ff ic ien t nucleotide sequence homology between the mouse structural gene and its 
m R N A  to that o f  the rat, to indicate that rat cytochrome P-450c is similar to mouse 
cytochrom e P^-450 (Tukey e t  al. 1981, Negishi e t  al. 1981). It is interesting to note 
that cytochrome P-^-450 (the form  believed  to be associated with the initiation o f  
P A H  carcinogenesis), has the highest molecular weight o f  all the cytochrome P-450 
isoenzymes induced by P A H ’s in the rat, rabbit, mouse and fish (N ebert  e t  al. 1982). 
No immunological identity is observed between the major 3-methylcholanthrene- 
induced cytochrome P-450c o f  rats and rabbits.
A  third species, cy tochrom e P-450 , has also been purified from 
phenobarbitone, 3-methylcholanthrene and A roc lo r  1254-treated rats (Ryan et  al. 
1979). It has a sub-unit molecular weight o f  48K with an absorbtion maximum o f its 
reduced CO complex at 452 nm. The hemoprotein p re feren tia lly  hydroxylates 
testosterone at the 7a position but has low ca ta ly t ic  ac t iv ity  fo r  the metabolism o f 
benzphetamine, benzo(a)pyrene and 7-ethoxycoumarin. This isoenzyme contains 
methionine as both its N -  and C -term ina l amino acids and partial sequencing o f  the 
firs t 19 amino acids o f  the N -term inal region reveals l i t t le  homology with the 
corresponding sequences o f  cytochromes P-450^ and P-450c . The substrate 
spec if ic it ies  o f  cytochromes P-450 , isolated from  A roc lo r  1254-treated rats areBjDjC
the same as the spec if ic it ies  o f  the corresponding hemoprotein isolated from 
3-methylcholanthrene or phenobarbitone treated rats.
A  further minor form , cytochrom e P-450 , has also been isolated from rats
e
treated with A roc lo r  1254 and phenobarbitone but not 3-methylcholanthrene (Ryan 
et  al. 1982). It has a minimum molecular weight o f  52,500 with an absorbtion 
maximum o f  its reduced CO complex at 450.6 nm. It has been shown to be 
immunochemically re la ted to the major phenobarbitone-induced cytochrome P-450^ 
isoenzyme. Its substrate spec i f ic i ty  is also similar to that o f  cytochrom e P-450^, 
although certain substrates such as benzphetamine, benzo(a)pyrene and 16a 
testosterone hydroxylation were metabolised at only 15-25% o f  the rate seen with
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cytochrom e P-450^. H ow ever  the metabolism o f  estradiol-173 at the 2-position was 
carried out more e f f ic ie n t ly  by cytochrom e P-45O0 than P-450^. Analysis o f  the 
peptide fragments o f  the hemoproteins fo llow ing chemical or proteo ly t ic  digestion 
(Ryan et al. 1982) as w e ll  as the gene structure (Mizukami et al. 1983) indicates that 
the two isoenzymes are very  similar but not identical.
Another cytochrom e P-450 variant, cytochrom e has been isolated
fo llow ing  induction by pregnenolone-16a-carbonitrile (Elshourbagy et al 1980). 
Animals pretreated  with this ca ta tox ic  steroid are resistant to the tox ic ity  o f  many 
drugs and xenobiotics (including CC l^ ), and are less susceptible to the formation o f  
l iver cancer by dimethylnitrosamine. It has been suggested that this might be due to 
the d if fe ren t  intra-lobuiar distribution o f  spec if ic  cytochromes P-450 and N A D P H -  
cytochrom e P-450 reductase as a consequence o f  P C N  administration (Baron at al. 
1982). It has sub-unit molecular weight o f  51K and an absorbtion maximum in its 
reduced CO d if fe rence  spectrum o f  450 nm. The purified isoenzyme has been shown 
to be distinct from  cytochromes P-450b, and P-450c with respect to exhibiting 
reduced stability  at room temperature and markedly d if fe ren t  chromatographic, 
spectral, ca ta ly t ic  and immunological properties. In addition, it also contains as 
much as f i f t y  per cent more lysine and proline residues as w e l l  as a fa r  grea ter  
amount o f  methionine residues than observed with the other two isoenzymes. In 
reconstituted enzyme systems, the purified cytochrome catalysed the N -  
demethylation o f  ethymorphine and aminopyrene but at a much slower rate than is 
seen with the original pretreated  liver  microsomes.
The presence o f  m icrosomal cytochrom e P-450p(_.^ fo llow ing  induction by 
other steroids such as dexamethasone, spironolactone and non-steroids 
(phenobarbitone) has also been demonstrated (Heuman et al. 1982). Dexamethasone 
is a potent g lucocortico id  but its inductive e f f e c t  towards cytochrom e P - A S O p ^  is 
not be lieved to be mediated by g lucocortico id  receptors, although the presence and 
involvement o f  second, low er -a f f in ity  dexamethasone receptors in l iver has been 
suggested (Heuman et  al. 1982, Ambellan et  al. 1981).
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A  unique form  o f  l iver  cytochrom e P-450 induced in rats treated  with the
methylenedioxyphenyl compound isosafrole (Dickens et al. 1978) has been purified to
apparent homogeneity (Ryan et al. 1980, Fisher et al. 1981). Isosafrole (a plant
constituent) is a known in v ivo hepatocarcinogen, and as such, may be transformed
to an ultimate carcinogen by cytochrome P-450 mediated oxygenation.
Cytochromes P-450 . have also been partia lly purified from  isosafrole treated  a,D,c
rats and these la tter  hemoproteins have the same properties as the enzymes from  
A roc lo r  1254-treated rats. The highly purified high spin hemoprotein, designated 
cytochrom e P-450^, has a sub-unit molecular weight ranging from  52-53K and a 
reduced CO complex having an absorbtion maximum at 447 nm. It is purified as an 
isosafrole m etabo lite-cy tochrom e P-450 complex, but addition o f  certa in  displacers 
such as 7-ethoxycoumarin, or benzim idazoles results in rem oval o f  most o f  the 
bound m etabolite . Cytochrom e P-450^, either before or a f t e r  rem oval o f  the 
isosafrole m etabolite , has poor ca ta ly t ic  a c t iv ity  with respect to the metabolism o f 
benzo(a)pyrene, benzphetamine, 7-ethoxycoumarin and testosterone in the 7a, 16a 
or 60 positions. The most distinguishing feature o f  cytochrome P-450^ is its high 
degree o f  spec if ic ity  fo r  isosafrole oxidation.
Cytochrom e P-45Cty has also been shown to exhibit partial immunological
identity with cytochrome P-450c . No cross reaction is evident with antibodies
prepared against cytochromes P-450g and P-450b. Peptide maps resulting from
enzym atic  or chemical c leavage  indicate that the primary structure o f  this
isoenzyme d if fe rs  from  cytochromes P-450 , (Botelho et  al. 1982).
a,o,c
During the course o f  characterisation o f  the cytochrome P-450 species induced 
by P C N , it was suggested that other forms o f  cytochrome P-450 not then 
characterised could be involved in benzo(a)pyrene metabolism since inhibition by 
antibodies to cytochromes P-450 , did not result in complete metabolic  inhibition
BjDjC
(Thomas e t  al. 1981). It was also demonstrated that high benzo(a)pyrene 
metabolising act iv ity  in P C N -trea ted  rats was insensitive to an antibody directed 
against cytochrome P-450c> Subsequent to the above observations, a low spin
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hemoprotein designated cytochrom e P-446 has been purified from  3-napthoflavone 
pretreated rat l iver (Saito e t  al. 1981). This form  o f  cytochrome has the highest 
turnover for  benzo(a)pyrene yet reported, and exhibits high act iv ity  with 
p-nitrophenotole, but has re la t iv e ly  low act iv ity  with 7-ethoxycoumarin. The 
isoenzyme was reported to have an apparent minimum molecular weight o f  53.4K 
and an absorbtion maximum in the CO reduced d if fe rence  spectrum at 446 nm. The 
amino acid composition indicates that the protein contain 35% hydrophobic residues 
and otherwise resembles that o f  most other cytochromes P-450. Subsequent work 
(Lau et al. 1982) has shown that the molecular weight o f  this cytochrome P-446 was 
in fa c t  56,500 and that it had a larger turnover number for  ethoxycoumarin than was 
previously reported (Saito et al, 1981). This turnover number was comparable to 
that obtained with cytochrom e P-450c . This has led to speculation as to whether or 
not the cytochromes P-450c and P-446 may be the same protein.
Com parative  studies have indicated that the above two cytochromes P-450 
were immunologically identical, having similar c leavage products fo llow ing 
proteolysis, identical sub-unit molecular weights and similar absorbtion maxima (Lau 
et  al. 1982 ). The only d i f fe ren ce  was their ca ta ly t ic  a c t iv ity  towards 
benzo(a)pyrene, where cytochrom e P-446 was shown to be nearly tw ice  as e f f ic ie n t  
in its hydroxylation than cytochrom e P-450c . It also appears that cytochrom e P-446 
produces higher amounts o f  the 9-hydroxy benzo(a)pyrene m etabolite . Whether this 
ca ta ly t ic  d if fe rence  is due to residual amounts o f  bound inducer or whether the two 
cytochromes are similar yet  distinct proteins can not be fully ascertained at 
present.
Gibson et al. (1982) have also purified a unique form  o f  cytochrom e P-450 
which is induced in the rat by the hypolipidaemic drug c lo fib ra te . The tota l 
cytochrom e P-450 was fract ionated  into four pools, with the first pool containing a 
cytochrom e P-450 o f  sub-unit molecular weight 51,500 and having an absorbance 
maximum in the d i f fe rence  spectrum at 451,8 nm. This fraction , designated 
cytochrom e P-452, p re feren tia lly  hydroxylated lauric acid at the 12-position, and to
14
a far lesser extent at the 11-position. It has low ca ta ly t ic  ac t iv ity  towards 
benzphetamine in direct contrast to cytochrome P-450b« The cytochrome P-450 
fract ion  2 exists as a low spin fo rm , and although less homogeneous than fraction  1, 
pre feren tia lly  hydroxylated lauric acid at the 11-position. Cytochrom e P-450 
fraction  3, exhibited only trace iaurate oxidase activ it ies , but had a rapid turnover 
rate for benzphetamine at rates comparable to cytochrome P-450b.
Comparison o f  homogeneous cytochrom e P-452 to cytochromes P-450b and 
P-447 indicated marked structural, immunological, ca ta ly t ica l and 
spectrophotom etric d if fe rences  between the 3 forms, indicating the uniqueness o f  
the cytochrome P-452 isoenzyme (Tamburini e t  al. 1984).
Although the majority o f  work on cytochromes P-450 has been carried out on 
isoenzymes induced by various xenobiotics, the purification and characterisation o f  
multiple forms o f cy tochrom e P-450 in uninduced animals has also been studied. A t  
the present time however, the relationship between these various forms is still 
unclear.
Gibson et  al. (1978) reported the partial purification o f  two forms o f 
cytochrome P-450 in high yield from  untreated rats. Cytochrom e P-450 I, had a 
reduced CO absorption spectrum at 449.5 nm, whereas cytochrome P-450 II had a 
maximum at 448.5 nm, the la tter  preparation appearing to have a sub-unit molecular 
weight o f  52K. D if fe rences  were observed in the ca ta ly t ic  ac t iv it ies  o f  . the two 
cytochromes towards severa l substrates, particularly ethylmorphine, when ac t iv ity  
was assayed in the presence o f cumene hydroperoxide as an oxidant.
Subsequent studies within the same laboratory resulted in the purification o f  
two further forms, designated RLM ^ and RLM ^, (Cheng et  al. 1982). These two 
forms have apparent minimum molecular weights o f  50 and 51K, and absorbance 
maxima in the CO reduced d i f fe rence  spectra at 449 and 451 nm respective ly . 
RLM ^ exists in a low spin form  and pre feren tia lly  hydroxylates testosterone at the 
6a and 63 positions, as w ell as catalysing the formation o f an unidentified highly
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polar m etabolite . RLlvty contains some high spin component and pre ferentia lly  
hydroxylates testosterone at the 20 and 16a positions. It also exhibits a spec if ic  
a c t iv ity  two or three times higher than RLfvty towards the metabolism o f 
benzphetamine, aminopyrene and ethylmorphine. N -term inal amino acid analysis 
indicates that the first residue o f  each form  is methionine, with the firs t four 
residues being identical fo r  both hemoproteins.
Although there is some homology between the above two forms based on the 
amino acids sequenced, they do not correspond to either cytochromes P-450b or 
P -450c . It is estimated that RLM ^ represents about 5%, and RLIvty about 6% o f  the 
constitutive isoenzymes in untreated rat l iver microsomes. Additional work 
demonstrated the ex istence o f  three further isoenzymes termed RLNtyg, RLtvty and 
R L M ^ q , characterised by monomeric molecular weights o f  49K, 51K and 53K 
respective ly  (Schenkman et al. 1982), The significance o f  these form s is unclear.
Although sex d if fe rences in cytochrom e P-450 catalysed drug and steroid 
metabolism have been known fo r  some time (Ka to  et  al. 1965, Pasleau et al. 1980), 
it is only recently  that constitutive cytochrome P-450 isoenzymes have been 
purified which show sexual d if fe ren t ia t ion  (Kamataki e t  al. 1983, MacGeoch et  al. 
1984, and Waxman 1984).
In fem ale rats a low spin constitutive form  designated cytochrome P-450 15 0 
has been isolated which was shown to have an important physiological function in 
the metabolism o f  steroids (MacGeoch et  al. 1984). Its unique ability to hydroxylate 
steroid sulphates in the 150 position accounts for the prevalence o f  15 0- 
hydroxylated sulphate metabolites o f  corticosterone in fem ale  excreta , and their 
absence in males.
The male equivalent, cytochrom e P-4502c (Waxman, 1984), is both 
ca ta ly t ica l ly  and immunologically distinct from the fem ale  form . Its ac t iv ity  is 
primarily d irected towards the endocrine regulated male spec if ic  16a-hydroxylase, 
although a paralle l induction at puberty o f  six d if fe ren t  steroid hydroxylase
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Three further isoenzymic forms have also been purified from  the hepatic 
microsomes o f  untreated and ethanol pretreated Sprague-Dawley rats (Ryan et  al. 
1984). These forms designated cytochromes P-45Q.p P-450^, and P-450^ are all
act ive  in steroid metabolism, and on the basis o f  Ouchterlony double diffusion 
analysis do not react with any o f  the already characterised inducible cytochromes 
P-450. On the basis o f  minimum molecular weight, spectral characteristics and 
ca ta ly t ic  a c t iv ity  it is highly likely that cytochrom e P-450^ corresponds to the male 
spec if ic  cytochrome P-450 purified by Kamataki e t  al. (1982), and the cytochrome 
P-450 RLM ^ form  purified by Cheng et  al. (1982).
A  summary o f  the major hepatic cytochrome P-450 isoenzymes isolated to 
date across species is given in table 1.1 which illustrates the major characteristics 
and dissimilarities o f  these isoenzymic forms with each other.
1.2 M O L E C U L A R  EVENTS F O LLO W IN G  IN D U C TIO N  OF H E P A T IC
C Y T O C H R O M E  P-450 B Y  XENQBIQTICS
1.2.1 Biosynthesis o f  Cytochrom e P-450 D irec ted  by Rat L ive r
Messenger R N A
Although the com plete  mechanism o f  hemoprotein induction has still not been 
com plete ly  elucidated, many o f  the regulatory processes involved have been 
determined. Phenobarbitone pretreatm ent o f  experimental animals results in 
hyperplasia o f  the smooth endoplasmic reticulum which results in hypertrophy o f  the 
liver, characterised by an increase o f  cytochrom e P-450 and other proteins (Orrenius 
et al. 1965, Ernster et al. (1964). These include N AD PH -cy toch rom e P-450 
reductase, epoxide hydrolase (Gonza lez  e t  al. 1981), and several cytoso lic  enzymes 
such as glutathione-S-transfergse and aldehyde dehydrogenases (Kuryama et al. 
1969). This induction (as also in the case fo r  3MC pretreatm ent) is preceded by an 
increase in the ac t iv ity  o f  the "a gg rega te "  R N A  polymerase system within the liver, 
as a result o f  an increased e f f ic ien cy  o f  the chromatin as a tem pla te  for  R N A
activities have also been observed.
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synthesis (P iper e t  al. 1968). This results in an increase in the d if fe ren t  R N A  classes 
and utilisation o f  amino acids required throughout protein synthesis (Bresnick et  al. 
1969). This inductive response can be inhibited by drugs such as actinomycin D, 
ethionine and a-aminitin (protein synthesis inhibitors), thereby suggesting that the 
inductive mode o f  action is at the le v e l  o f  transcription and/or processing o f  m R N A  
fo r  these inducers (Jacob et al, 1974). Furthermore using blockers o f  heme synthesis 
(am inotriazo le ), it was shown that the phenobarbitone-induced increase in l iver  
microsomal cytochrome P-450 was due to de novo protein synthesis which was not 
dependent upon heme synthesis, but which did require a supply o f  heme (G iger e t  al. 
1981). Phenobarbitone also leads to increased stability and processing o f  ribosomai 
R N A  precursors possibly due to decreased RNase act iv ity , Nucleocytop lasm ic 
transport o f  newly synthesised ribosomai sub-units is stimulated and is be lieved to 
be dependent on the synthesis o f  cytoplasm ic factors, possibly ribonucleoprotein 
partic les. Furthermore the increase in protein synthesis as a result o f  xenobiotic 
pretreatm ent is also be lieved  to be related to greater  m R N A  stability, possibly 
through decreased rates o f  degradation (Matsumura et  al. 1983).
Thus in considering the molecular events fo llow ing induction o f  cytochrome 
P-450, the crucial question which needs to be answered is whether the molecular 
action o f  the inducer is to enhance the expression o f  a spec ific  gene coding fo r  a 
particular cytochrom e P-450, or whether a single gene could code fo r  a number o f  
d i f fe ren t  but closely re la ted proteins by means o f  post-transcriptional control. This 
could include the regulation o f  R N A  processing control within the nucleus and the 
subsequent stability as w e ll  as translational f ide lity  o f  the m R N A  within the 
cytoplasm. In fa c t  current ev idence strongly suggests that induction fo llow ing  
xenobiotic pretreatm ent is modulated by transcriptional control o f  the spec ific  gene 
coding fo r  the particular cytochrom e P-450 isoenzyme (Tukey et  al. 1981, Hardwick 
et al. 1983). By such control, the regulation o f  spec ific  m R N A  levels  coding for the 
isoenzymic variants can be achieved.
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1.2.2 Expression o f  m R N A  A c t iv i ty  fo llow ing  Phenobarbitone and 
3-Methylcholanthrene Pre trea tm ent
Follow ing induction, analysis o f  to ta l cytoplasmic R N A  ac t iv ity  upon assaying
with an jn vitro  rabbit re t icu locy te  system was shown to increase.
Immunoprecipitation analysis with the corresponding monospecific antibody further 
substantiated this observation. These findings clearly  indicated an increase in 
m R N A  ac t iv ity  fo r  the major phenobarbitone-induced cytochrome P-450 as a result 
o f  phenobarbitone administration.
Cloning analysis fo r  the genes coding for  cytochromes P-450 coupled with
hybridisation studies has enabled the s ize o f  the corresponding R N A  species to be
determined. A  number o f  groups have subsequently determined by such means the 
size o f  the m R N A  coding for  the major phenobarbitone-induced cytochrom e P-450 
isoenzyme. This has ranged from  approximately 1.8 kb (Fujii-Kuriyama et al. 1982),
2.0 kb (Fagan et  al. 1983), and 3.8 kb (Omiecinski et al. 1983). The reason for  this 
size discrepancy is at present unclear, but is be lieved to re la te  to the fa c t  that more 
than one size m R N A  exists that would code for  similar cytochromes P-450 (Walz e t  
al. 1982^). This hypothesis is strengthened by the fa c t  that multiple size classes o f  
m R N A  are known to exist which code for  identical proteins. These include 
dihydrofolate reductase m R N A s (S e tzer  e t  al. 1980), a-amylase m R N A , 
(Hagenbuckle et al. 1981) and a-and 3-interferon m RN A s (Solymoss e t  al. 1971).
3-methylcholanthrene pretreatm ent also results in increased m R N A  act iv ity  
due to the activation  o f  the Ah locus gene which codes for a cytoso lic  receptor. 
Such an induction response includes (N ebert  e t  al 1983); (i) high a ff in ity  binding o f  
spec ific  xenobiotics to the Ah receptor; (i i )  temperature-dependent translocation o f  
the "ac t iva ted "  inducer-receptor complex into the nucleus; (i i i )  binding o f  the 
complex presumably to chromatin components; ( iv ) transcriptional activation  o f 
spec if ic  genes; (v ) maximal increases in intra-nuclear high molecular weight 
precursor m R N A  that precedes by severa l hours the maximal increases in 
cytoplasmic m R N A ; (v i )  translation o f  the m R N A  principally on membrane-bound
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polysomes; and (v i i )  increases in the spec if ic  membrane-bound proteins that r e f le c t  
enhanced spec if ic  drug-metabolising act iv it ies .
On sizing the m R N A  coding fo r  the major cytochrome P-450c isoenzyme, 
discrepancies in size (as in the case fo llow ing  phenobarbitone pre trea tm ent) were 
observed. In contrast to phenobarbitone-induction however, it appears that the 3- 
methylcholanthrene-induced cytochromes P-450 were translated from two size 
classes o f  m R N A . These have been shown to consist o f  a 2.0 and 2.7 kb m R N A  
species (Fagan et al. 1982,1983) and a 2.0 and 4.0 kb m R N A  species (Lippman 
M orv il le  et al. 1983). In mouse, two m R N A  size classes o f  2.7 and 3.5 kb have also 
been reported (Tukey et  al. 1981). Why such large m R N A  species coding for  the 
cytochromes P-450 are present is unclear, especia lly since it has been estimated 
that a m R N A  species o f  1.5 kb coding information would quite adequately translate 
into a protein o f  molecular w eigh t 50,000 (Omiecinski e t  al, 1983). Such large non­
coding regions within the m R N A  species are similarly not l im ited  just to the 
cytochrom e P-450 isoenzymic fam ily . For example, the m R N A  coding for  the 
preparathyroid hormone has been shown to be 50% non-coding (Stolarsky et al. 
1978). Whether or not this re la tes to the possibility that such large m RN A s could 
code for  a number o f  subtly heterogeneous proteins, or a lternative ly  simply code for 
longer peptides which undergo extensive proteo lyt ic  c leavage is not known and 
awaits further elucidation.
As to the size o f  the cytochrom e P-450 gene fam ily , it is currently estimated 
to consist o f  f iv e  gene clusters (N ebert  e t  al. 1985). Although a slight degree o f  
homology has been observed, the coding genes can be considered quite distinct from  
each other. The precise number o f  genes within the gene clusters coding for all the 
cytochrom e P-450 variants is not known, although values in the range o f  30-200 
genes have been suggested (N ebert  e t  al. 1985). Undoubtedly the number o f  genes 
isolated w ill increase, with it appearing to date that every  cytochrom e P-450 
protein is derived from its own gene. Whether or not this w ill be the case for  ail the 
cytochrom e P-450 isoenzymes or whether mechanisms o f d if fe ren t ia l  splicing and
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processing, gene amplification , post-transcriptional or post-translational 
m odif ication  which would allow a single cytochrom e P-450 gene to encode multiple 
protein products is not yet known. With time, further research w ill undoubtedly 
unravel the complex processes involved.
In conclusion one can state that species variation in drug metabolism can be 
rationalised by a var ie ty  o f  factors, one o f  the most important being the nature and 
amount o f  liver enzymes responsible for  the biotransformation o f  the drug or 
xenobiotic . In this respect both the involvement and multip lic ity  o f  the cytochrom e 
P-450 isoenzymes have been w ell documented. Their importance lies in their ability 
to both act iva te  and de tox i fy  drugs and xenobiotics. This d if fe ren tia t ion  causes 
major problems for both the pharmaceutical industry and the regulatory authorities, 
in that when a new drug is introduced fo r  use in man, it must f irs t  be tested in 
laboratory animals and existing methods o f  tox ic ity  testing can only extrapolate 
from  animal data and hence only indicate a potentia l tox ic ity  in man.
This problem may be overcom e on an in vitro  basis i f  the ca ta ly t ic  properties 
o f  the d if fe ren t  cytochromes P-450, which are known to be responsible for the 
activation/detoxif ication  o f  drugs could be characterised on a genetic  basis. In this 
respect, the multip lic ity  o f  cy tochrom e P-450 is w ell established, and knowledge 
relating to the regulation o f  the cytochrom e P-450 system at the levels o f  m R N A  
transcription, processing, translation and degradation is rapidly advancing. Progress 
in the study o f  gene regulation and resolution o f  specific  cytochrome P-450 gene 
structures has the potentia l to p lace the extrapolation o f  animal data to man on a 
more firm  experimental basis. Indeed this is already being done with the successful! 
isolation o f  a human cytochrom e P^-450 fu ll-length complementary D N A  clone (Jais 
e t  al. 1985). C lear ly  this is an important step forward as induction o f  cytochrome 
P^-450 has been linked to susceptibility to certa in chemically  induced cancers in 
mouse and man.
Accord ingly , identification  and characterisation o f  the cytochrom e P-450 
structural genes w ill  not only provide valuable insight into an understanding o f  the
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genetic regulation o f  drug metabolising enzyme induction, but may also aid in the 
development o f  new potentia lly  useful assays fo r  determining genetic  d if fe rences in 
individual risks o f  cancer and drug tox ic ity  in both human and animal populations.
1.3 AIMS OF THE PR ESENT INVESTIG ATIO N
The present study was centered upon the purification, characterisation and 
induction o f  the major phenobarbitone-induced cytochromes P-450. This 
characterisation and comparison was then to be extended to two other previously 
purified cytochromes P-450 (P-452 and P-447) available in this laboratory, both in a 
homogeneous state and also within the endoplasmic reticulum envrionment o f  
hepatic and renal microsomes (chapter 4).
The induction o f  these isoenzymes fo llow ing  xenobiotic pretreatm ent was to 
be investigated at both a biochemical (chapter 4) and molecular (chapter 6) leve l.  
Towards this aim intensive development o f  the in vitro translation system coupled 
with the technique fo r  immunoprecipitation analysis had to be undertaken (chapter 
5). This investigation was further extended in that the procedure fo r  the synthesis 
o f  complimentary D N A  from  purified poly (A )+ m R N A  derived from c lo f ib ra te -  
induced rat l iver was also undertaken.
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METHODS RELATING TO THE PURIFICATION A N D  
CHARACTERISATION OF C Y T O C H R O M E  P-450 ISOENZYMES
2.1 M A TE R IA LS
Sepharose 4B, DEAE sephacel, carboxymethyl sepharose C L  6B, carboxymethyl 
sephadex-C5Q, and sephadex G-100 w ere  obtained from  Pharmacia (U .K .) Ltd . 
(Hounslow, Middlesex). Acry lam ide , N ,N-m ethylene-b is-acry lam ide, sodium dodecyl 
sulphate, ammonium persulphate, coomassie brilliant blue R-250, G-250 and 
bromophenol blue were obtained from  Biorad Laboratories (W atford, Herts). 
Emulgen 911 was purchased from  K .A .O . A tlas Co. (Tokyo, Japan), and N 6 - (6 
aminohexyl) -adenosine - 2' 5' -triphosphate sepharose 4B and 2* A M P  w ere  obtained 
from  P -L  Biochemicals Inc. (M ilton Keynes, U .K .) Diaminooctane and cyanogen 
bromide were purchased from  the A ldrich Chem ical Company (Poo le , Dorset).
Sodium cholate, sodium deoxycholate, dithiothreitol, flavin  mononucleotide, 
Tris (T r izm a base), cytochrom e c, creatine phosphokinase, chymotrypsin, papain, 
bovine serum albumin, chicken egg albumin, lactic  dehydrogenase, catalase, 
N A D P H , L-a -d ilauroy l phosphatidyl choline (D LPC ),  3-napthoflavone, iauric acid, 
aminopyrine, potassium thiocyanate and diamino-benzidine chloride w ere  all 
purchased from  the Sigma Chem ical Co. Ltd . (Poo le , Dorset). Phosphorylase a and 
glutamate dehydrogenase were obtained from  the Boehringer Corporation (Lewes, 
Sussex). Staphylococcus aureus V8 protease was purchased from  Miles Laboratories 
(Slough, Berks). Sodium phenobarbitone, sucrose, ED TA , g lycine, agarose 25, 
ammonium aceta te , ammonium sulphate, sodium azide, sodium chloride, sodium 
potassium tartra te , potassium phosphate, Folin Ciocalteau phenol reagent w ere  all 
purchased from  British Drug Houses L td . (Poo le , Dorset). G lycero l was obtained 
from May and Baker Ltd. (Dagenham, Essex).
Chapter 2
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Benzphetamine was obtained from  the Upjohn Co. (Ka lamazoo, Michigan, U .S.A.), 
sodium c lo fib ra te  from  I.C.I. Pharmaceuticals (M acc les fie ld , Cheshire) and F4C - 
lauric acid from  the Radiochem ical Centre (Amersham, Bucks).
N itrocellu lose fi l te rs  (0.45 pm) were purchased from  Anderman and Co. L td . 
(Kingston Upon Thames, Surrey). A f f in i ty  purified complexes o f  peroxidase, anti- 
peroxidase complexes o f  sheep and rabbit IgG were obtained from  Nordic 
Immunology (Tilbury, The Netherlands), Control donkey sera was supplied from  the 
Guildhays animals unit (Univers ity  o f  Surrey).
A l l  other chemicals w ere  obtained as Analar grade wherever possible.
2.2 A N IM A LS
Male Wistar Albino rats o f  approximately 160g were obtained from  the 
Univers ity  o f  Surrey breeders and w ere  housed in cages with sawdust bedding, being 
allowed food (Spratts animal diet No. 1) and water ad libitum. A  tw e lve  hour light 
dark cyc le  was in operation (0700-1900 light) at 22°C  and 50% humidity.
For antibody production, male half-lop N ew  Zealand white rabbits or sheep 
were used. Rabbits were housed in the Universities animal unit and the sheep w ere  
maintained under f ie ld  conditions within the Guildhays animal farm  unit.
2.2.1 P re trea tm ent o f  Animals 
Phenobarbitone
Phenobarbitone (sodium salt) was administered orally as a 0.1% (w/v) solution 
in the drinking w ater  fo r  6 days. Norm al drinking water  was returned to the cages 
24h be fore  killing.
C lo f ib ra te
C lo fib ra te  (sodium salt) was administered as a solution in distilled water.
Rats rece ived  400 mg kg-1 by i,p. injections once daily for  3 consecutive days and 
w ere  killed 24h a fte r  the last injection.
B-Napthoflavone (BNF )
BNF induction involved i.p. injection o f  80mg/kg in 0.25 ml corn oil once each 
day fo r  3 days prior to sacr if ice . The animals were killed 24h a fte r  the last 
injection.
2.3 ISO LA TIO N  OF H E P A T IC  A N D  K ID N E Y  MICROSOMES
Tw enty  rats were used fo r  each purification o f  phenobarbitone-induced 
cytochromes P-450. The animals were killed by cerv ica l dislocation with the livers 
being rapidly excised, perfused with 0.9% (w/v) aqueous NaC l, b lotted dry and then 
weighed. A l l  subsequent steps w ere  carried out at 4 °C . The livers (averaging 
between 13-15g in w eigh t) w ere  scissor-minced and homogenised in 3 volumes (w/v) 
o f  ice-cold  0.25M sucrose using a motor driven Po tter-E lveh jem  glass te flon  
homogeniser (3 return strokes). In the case o f  kidney microsome isolation, the outer 
cutaneous membrane was firs t removed, otherwise the procedures were essentially 
identical. The homogenate was adjusted to 25% (w/v) by the addition o f  0.25M 
sucrose and centrifuged at 11,000 gav. fo r  30 mins using a 6 x 250 ml aluminium 
angle head rotor in an MSE HS 18 centrifuge . The supernatant was decanted and 
centrifuged at 105,000 gav. fo r  1 hr using a 6 x 94 ml titanium angle head rotor in a 
Beckman LK-65 re fr ige ra ted  u ltracentrifuge. The supernatant was discarded and 
the pellet resuspended in ice-co ld  50mM potassium phosphate bu ffer  pH 7.25 
containing 25% (v/v) g lycero l,  using a motor driven Po tter-E lveh jem  glass te flon  
homogeniser, to an appropriate volume o f  10 mi per gram rat l iver  (g iving a protein 
concentration o f  25-30 mg/ml). The microsomal suspension was stored at -80 °C  at 
which the cytochrome P-450 is stable fo r  severa l months.
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2.4.1 Preparation and Regeneration  o f  Column Chromatography Media
8 -A M IN Q Q C T Y L  SEPHAROSE 4B
Method o f  Synthesis
Diaminooctane was coupled to sepharose 4B utilising cyanogen bromide 
activation as described by Cuatrecasas (1970).
F inely divided cyanogen bromide (lOOg) was added with stirring to 400 ml 
(packed volume) o f  sepharose 4B present as a 1:1 suspension in distilled w ater. As 
the cyanogen bromide dissolved, the pH o f  the solution was maintained at pH 11 
with ION sodium hydroxide and the tem perature maintained at 20 °C  by adding ice . 
When the pH o f  the solution no longer showed a tendency to drop, large amounts o f  
ice w ere  added, fo l low ed  by washing under suction with 3 litres o f  50mM sodium 
carbonate/bicarbonate bu ffer  pH 10 on a sintered glass funnel as rapidly as possible. 
The act iva ted  sepharose 4B was then transferred to 400 ml o f  25% (w/v) 
diaminooctane adjusted to pH 10, and gently  stirred at 4 °C  fo r  20h. The fully 
derivatised sepharose 4B was washed on a sintered glass funnel consecutively  with 
3L o f  50mM N a^O ^/N a H C X ty  bu ffer  pH 10, distilled water  and IQOmM potassium 
phosphate bu ffer  pH 7.25 containing 20% (v/v) g lycero l, 0.7% (w/v) sodium cholate, 
Im M  dithiothreito l, Im M  E D T A , 2pM FM N, and was stored in the last bu ffer  
containing 0.02% (w/v) sodium azide at 4 °C .
Method o f  regeneration
For the most e f f e c t iv e  regeneration, it was important to elute cytochrom e 
P-450 reductase and cytochrom e b^ from  this m ateria l whilst packed in a column, 
by washing with the appropriate buffers (see purification methodology fo r  these 
enzymes). Follow ing column chromatography, the media was transferred to a 
sintered glass funnel and washed under suction consecutively with occasional 
stirring, with 2L o f  each o f  the fo llow ing  : lOOmM potassium phosphate bu ffer  pH
7.25 containing 0.4% (v/v) emulgen 911, 0.4% sodium deoxycholate; distilled water;
2.4 PURIFICATION OF MICROSOMAL ENZYMES
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10% (v/v) aqueous dioxane; distilled water ; 500mM potassium phosphate bu ffer  pH
7.25 containing 500mM potassium chloride, Im M  EDTA; distilled w ater; lOOmM 
potassium phosphate bu ffer pH 7.25 containing 0.7% (w/v) sodium cholate, Im M  
dithiothreitol, Im M  ED TA, 2pM FM N.
H Y D R Q X Y L A P A T IT E  
Preparation fo r  Chromatography
Hydroxylapatite  was routinely made in the laboratory by the method o f  Lev in  
(1962) as it was shown to possess superior chromatographic properties to the 
com m erc ia lly  available hydroxylapatite. It is prepared by dripping 0.5M di-sodium 
hydrogen orthophosphate and 0,5M calcium chloride together at a f low  rate o f  
approximately 12-15 mi/min with continual stirring. The precip itated calcium 
phosphate was allowed to se tt le  a fte r  which it was washed four times with 3L o f  
water , the precip ita te being allowed to com plete ly  sett le  between each wash. The 
prec ip ita te  was then taken up in 3L o f  w ater  to which 100ml o f  40% (w/v) sodium 
hydroxide had been added and was then boiled for  1 hour with continual stirring. 
The calcium phosphate was allowed to sediment fo r  5 mins fo llow ing which the 
turbid supernatant was rem oved by aspiration. The prec ip ita te  was then 
resuspended fo r  5 mins, with the supernatant being removed by aspiration. This last 
procedure was repeated three times. The precip ita te was then resuspended in 4L 
lOmM potassium phosphate bu ffer  pH 6.8, stirred, heated until just boiling, a llowed 
to sediment for 5 mins a fte r  which the turbid supernatant was removed. This 
procedure was repeated tw ice  with lOmM K PO ^  bu ffer  (pH 6.8), and then tw ice  with 
Im M  KPO ^ bu ffer  (pH 6.8). For each o f  the last four precipitations the boiling 
period was for f i f te en  mins. A f t e r  the last boiling preparation was com plete  the 
hydroxylapatite was resuspended in 50mM KPO ^  bu ffer  (pH 7.25) and stored at 4 °C .
For column preparation the required amount o f  hydroxylapatite was 
transferred in a 5 fo ld excess volume o f  column equilibration buffer and gently 
swirled into suspension. The hydroxylapatite was then allowed to se tt le ,  leaving a
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cloudy bu ffer  volume above containing slowly sedimenting " f ines ’1 which were 
decanted. Fresh buffer was then added and the procedure repeated four times.
The medium was discarded a fte r  use.
DEAE SEPH ACEL A N IO N IC  E X C H A N G E  MEDIUM 
Preparation fo r  Chromatography
The required amount o f  medium was transferred to a sintered glass funnel and 
washed under grav ity  with distilled w ater  to rem ove the storage solution. The 
chloride counter ion was exchanged with phosphate and the medium set to the 
co rrec t  pH by transferring to an excess volume o f  400mM potassium phosphate 
bu ffer  pH 7.25. A f t e r  12 hours, the pH was checked be fore  transferring to the 
column equilibration buffer.
Regeneration  a fte r  use
DEAE sephacel was regenerated by standing in an excess volume o f 400mM 
potassium phosphate bu ffer  pH 7.25 overnight, fo llowed by extensive washing with 
500mM NaC l and distilled w ater . The medium was stored in 400mM potassium 
phosphate bu ffer  pH 7.25, containing 20% (v/v) methanol, at 4 °C .
C A R B O X Y -M E T H Y L  5E PH AD EX - C50 C A T IO N IC  E X C H AN G E  MEDIUM
Carboxymethyl sephadex - C50 was swollen by placing in excess distilled w ater  
and heating to 90 °C  on a steam bath fo r  lh r . l g  o f  dry materia l swelled to between 
30-40 ml. The swollen materia l was transferred to an excess o f  column equilibration 
buffer prior to use. The medium was discarded a fte r  use.
C A R B O X Y -M E T H Y L  SEPHAROSE C A T IO N IC  E X C H A N G E  MEDIUM 
Preparation fo r  Chromatography
Carboxymethyl sepharose was supplied pre-swollen. The required amount o f
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medium was washed with distilled w ater  on a sintered glass funnel and transferred 
into column equilibration bu ffer  be fore  use.
Regeneration  a fte r  use
Regeneration  was achieved by standing the medium in 400mM potassium 
phosphate bu ffer  pH 7.25, fo l low ed  by washing with the same bu ffer  and distilled 
water  in a sintered glass funnel under grav ity . The medium was stored in 50mM 
potassium phosphate bu ffer  pH 7.25, containing 20% (v/v) g lycero l,  0.02% sodium 
azide at 4 °C .
SEPHADEX G-100
Sephadex G-100 was swollen in excess distilled water  by heating at 90QC for 
5h. The gel was discarded a f te r  use.
N - (6 -A M IN Q H E X Y L ) - ADENOSINE 2', 5,-D IPH O SPH ATE  SEPHAROSE 4B 
(A D P  A G AR O SE )
A D P  agarose was supplied pre-swollen and simply transferred to equilibration 
bu ffer  prior to use.
A f t e r  chromatography, the medium was washed with distilled w ater  to rem ove 
excess A M P  and stored in 20% g lycero l,  0.02% azide at 4 °C .
2.4.2 Column Pouring and Equilibration
A  small volume (1-5 m l) o f  column equilibration buffer was poured into the 
bottom o f  an assembled chromatography column o f  the required dimensions 
(Pharmacia, Sweden). The bu ffer  was partia lly  a llowed to run through the outlet tap 
to displace air trapped under the column support bed. With the ou tf low  fully closed 
and the reservoir  assembled in the pouring mode, the chromatography medium was 
care fu lly  poured into the column as a 20% (v/v) suspension with the exception o f
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sephadex G-100 which was poured as a 50% (v/v) suspension.
A f t e r  allowing the medium to se tt le  fo r  approximately 12 hours in the column, 
column packing was achieved under a constant pressure head at the f low  rate  
required during chromatography.
A l l  chromatography columns w ere  equilibrated with at least 3 volumes o f  
equilibration buffer, during which time the pH o f  the eluent was regularly 
monitored.
2.4.3 Purification  o f  Cytochrom e P-450 from  the Hepatic Microsomes
o f  Phenobarbitone - Induced Rats
A l l  operations were carried out at 0-4 °C .
Solubilisation o f  M icrosomal Proteins
Microsomal proteins w ere  solubilised with sodium cholate in the presence o f
0.1M potassium phosphate bu ffer  pH 7.25 containing 20% (v/v) g lycero l to prevent 
conversion o f  cytochrom e P-450 to cytochrom e P-420 (Lu and Coon, 1968), Im M  
dith iothreito l to keep sulphydryl groups in the reduced state, Im M  ED TA  to inhibit 
lipid peroxidation and 2pM FM N  to reverse any flavin dissociation from  N A D P H -  
cytochrom e P-450 reductase (h erea fte r  termed bu ffer  A ).  The ratio  o f  protein to 
detergent is cr it ica l in determining the recovery  o f  holo-cytochrom e P-450, with 
excess detergent leading to extensive destruction o f  cytochrome P-450. Our initial 
studies showed that solubilising microsomes at a protein concentration o f 10 mg/ml 
in the presence o f  1.4% (w/v) sodium cholate enabled us to consistently obtain 
recoveries  o f  around 90%.
The microsomes were diluted in bu ffer  A  and gassed with nitrogen for  10 
minutes with gentle stirring. Sodium cholate was then added slowly as a 21% (w/v) 
stock solution to the required concentration and solubilisation was allowed to 
proceed for  45 minutes under an atmosphere o f  nitrogen to prevent heme
31
destruction arising from  lipid peroxidation (Sato et al. 1973), be fore  centrifugation 
at 105,000g for  43 minutes using a 6 x 94 ml titanium angle head rotor in a Beckman 
L5 65 ultracentrifuge.
The supernatant containing solubilised microsomal protein was diluted with 
bu ffer  A  to a final cholate concentration o f  0.7% (w/v).
Chromatography on 8 am inooctyl sepharose 4B
The 10%  microsomal supernatant from  20 rats resulting from  the cholate 
solubilisation was applied to 2 columns o f  8-aminooctyl sepharose 4B (2.6 x 38 cm, 
Pharmacia) previously equilibrated with bu ffer  A  containing 0.7% (w/v) sodium 
cholate. Loading was carried out at a f low  rate o f  approximately 30 ml/hr and was 
allowed to continue until just over the top third o f  the column was dark red. The 
columns were then washed w ith 3 column volumes o f  bu ffer  A  containing 0.42% 
(w/v) sodium cholate to rem ove unadsorbed protein including cytochrom e P-420 and 
membrane lipids.
Elution o f  cytochrome P-450 was achieved by washing the columns with IL  o f  
bu ffer  A  containing 0.33% (w/v) sodium cholate and 0.08% (v/v) emulgen 911, 
whereupon a dark red band was seen to sharpen as it m igrated slowly down the 
column. The cytochrom e P-450 content was monitored spectrophotom etrica lly  at 
417 or 407 nm. Fractions displaying an absorbance grea ter  than 1/3 o f the peak 
value w ere  pooled and dialysed against 2 successive 3.5L volumes o f  bu ffer , 
designated buffer B, containing lOmM potassium phosphate bu ffer  (pH 7.7), O.lmM 
E D TA, 20% (v/v) g lycero l,  0.1% (v/v) emulgen 911 and 0.2% (w/v) sodium cholate, 
fo r  12h periods. The high absorbance at 280 nm o f  emulgen 911 present in all the 
subsequent buffers precluded the rapid estimation o f  the purity o f  peak cytochrom e 
P-450 from the 417 to 280 nm absorbance ratio.
DEAE Sepacel Anionic Exchange Chromatography
The pooled dialysed cytochrome P-450 was then applied to a column o f  DEAE
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sephacel (2.6 x 38 cm ) previously equilibrated with buffer B. Upon loading at a f low  
rate  o f  approximately 50ml/h, the cytochrom e P-450 was seen to bind as a tight red 
band at the top o f  the column. The column was then washed with a further 500 ml 
o f  bu ffer  B to rem ove any unadsorbed cytochrome P-450; this eluate was designated 
fraction  "A " .  Elution o f  cy tochrom e P-450 was then achieved by using a linear 0 to
0.25M N aC l gradient. The mixing flask contained IL o f  .buffer B, and the second 
flask used to form  the gradient contained IL o f  bu ffer  B to which 0.25M N aC l had 
been added. On completion o f  the gradient the elution pro f i le  was determined 
spectrophotom etrica lly  and 2 peaks, designated fraction B^ and B2 respective ly , 
were resolved. A t  this stage a third tight red band was still visible at the top o f  the 
column and this was eluted with bu ffer  B containing 0.5M NaC l. This fraction was 
designated B y  A i l  the fractions from  the column were analysed for  cytochrome 
P-450 and protein, with fractions being finally pooled according to their purity on 
SDS polyacrylamide gel electrophoresis (SDS P .A .G .E .).  Pooling o f  fractions was 
routinely carried out according to the purity o f  every  second tube.
The two fractions. B-  ^ and B2 were shown to correspond to two d if fe ren t  
cytochrom e P-450 isoenzymes requiring d if fe ren t  protocols fo r  their subsequent 
purification.
Subsequent Fractionation o f  Separate Cytochrom e P-450 Isoenzymic Forms
The B^ fraction  (o f  lower molecular weight than the B2 fract ion ) was dialysed 
against 2 successive 2.5L volumes o f  lOmM potassium phosphate buffer (pH 7.7), 
20% g lycero l,  0.2% emulgen 911, fo r  12h periods. It was then loaded onto a 
hydroxylapatite column (2.6 x 15cm) previously equilibrated with the same dialysis 
bu ffer. The column was then washed with one column volume o f  this bu ffer  a fte r  
which the cytochrome P-450 was eluted with 500 ml each o f a 10 to 200mM 
potassium phosphate (pH 7.7), 20% g lycero l,  0.2% emulgen 911, linear gradient 
bu ffer. As was the case fo r  every  column chromatographic stage, the primary 
cr iter ia  was purity and this was determined by SDS P .A .G .E . analysis o f  the elution
33
products. Follow ing this stage the isolated cytochrome P-450 phenobarbitone- 
induced isoenzyme was homogeneous, although occasionally reapplication onto 
DEAE sephacel was required in order to rem ove trace higher molecular weight 
contaminants.
The cytochrome P-450 B2 fract ion  was also dialysed against two successive 
2.5L volumes o f  lOmM potassium phosphate bu ffer  (pH 7.7), 20% g lycero l, 0.2% 
emulgen 911, fo r  12h periods* This fraction  was then reapplied to a column o f  DEAE 
sephacel (2.6 x 30 cm ) previously equilibrated with the same dialysis buffer. On 
further washing o f  the tightly  bound cytochrom e P-450 with the dialysis bu ffer  
(normally 2 column volumes) the tight red band would be seen to split into two bands 
and migrate a few  centim etres down the length o f  the column materia l. A t  this 
stage elution o f  cytochrom e P-450 was achieved by washing with the same bu ffer  in 
which the ionic strength was increased in 5mM increments up to a final 
concentration o f  35mM. The cytochrom e P-450 content o f  eluted fractions was then 
assayed and pooled as described above. The purest fractions w ere  pooled, redialysed 
against the previous lOmM KPO ^  dialysis bu ffer  and loaded onto a hydroxylapatite 
column (2,6 x 15 cm ) which had been equilibrated with the same bu ffer . The column 
was then washed with one column volume o f  this bu ffer a fte r  which the cytochrom e 
P-450 was eluted with 500 ml each o f  a 10 to 125mM potassium phosphate (pH 7.7), 
20% g lycero l,  0.2% emulgen 911, linear gradient buffer. Fractions w ere  the/i pooled 
according to their purity on SDS P .A .G .E .
R em ova l o f  non-ionic detergent (Emulgen 911)
Non-ionic detergents have been shown to a f f e c t  the spin equilibrium o f  
purified cytochromes P-450 (Hashimoto-Yutsudo et  al 1980) and their ca ta ly t ic  
properties thereby necessitating their rem oval. This was achieved in a number o f  
ways.
The pooled cytochrome P-450 was loaded d irectly  onto a small column o f  CM 
sephadex - C50 (2.6 x 4 cm ) previously equilibrated with the corresponding elution
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bu ffer  (Imai et al 1980). The cytochrom e P-450 binds as an intense red band within 
the top cen tim etre  o f  the column a fte r  which the column was rapidly washed with 
the same buffer containing zero emulgen 911 until the absorbance at 280nm in the 
eluate decreased to zero . Elution o f  the em ulgen-free protein was achieved by 
slowly eluting the column (20 ml/hr) with 325mM potassium phosphate bu ffer  (pH 
7.25) containing 20% (v/v) g lycero l.  A l l  tubes containing cytochrom e P-450 w ere  
pooled. This method enabled cytochrom e P-450 to be obtained within a suitably 
concentrated stock solution o f  between  8-10 pM with column recoveries  o f  over 
90%. H ow ever  problems w ere  encountered when this method was employed to 
rem ove detergent from  the isoenzyme pools eluted with low ionic strength (5- 
lOmM), as aggregation occurred a fte r  rem oval o f  emulgen, giving rise to low 
recoveries .
This problem was overcom e by utilising a hydroxylapatite column o f the same 
dimensions as that o f  the CM  sephadex -C50. The conditions employed w ere  the 
same fo r  both columns with the only disadvantage associated with hydroxylapatite 
usage being that o f  a slower f low  rate .
2.4.4 Purification  o f  Cytochrom es P-450 from  the Hepatic
Microsomes o f  C lo f ib ra te  and g-Napthoflavone-Induced Rats
C lo fib ra te , a potent hypolipidaemic drug induces a unique form  o f  cytochrom e 
P-450, term ed P-452 in hepatic l iver  microsomes and is o f  interest because o f  its 
high lauric acid turnover rate . The isoenzyme is purified according to the 
methodology o f  Gibson et  al. (1982) and is summarised in figure I.
For isolation o f  the major cytochrom e P-450 present in l iver  microsomes 
isolated from  0-napthofiavone (5 ,6-benzoflavone) treated animals the procedures o f  
Guengerich and Martin (1980) w ere  employed. These are summarised in figure 2.
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F I g u f o 1
Flow Chari for tha Purification ot Fouf Fraction ■ o f 
Cytochromo p-450 uolalad from tho Endop I a a m I c 
notlculum of C I o f I br o t o-1 r o n t o d Rat»
Figure 2
F l o w  C h a r t  F o r  t h o  P u r i f i c a t i o n  Ot  T w o  F r a c t l o n o  Of  
C y t o c h r o m o  P - 4 4 7  I s o l a t e d  F r o m  T h o  E n d o p l a s m i c  
R o t l c u l u m  Of  B - n a p t h o t  l o v o n o  T r o n t o d  R a t a
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Reductase (EC 1.6.2.4)
N A D P H  - cytochrom e P-450 reductase was routinely purified to 
e lectrophoretic  homogeneity utilising the method o f Yasukochi and Masters (1976), 
or by a modif ication o f  this method when isolated as a by-product from the 
purification o f  phenobarbitone-induced cytochromes P-450.
Solubilisation o f  microsomal protein and DEAE sephacel column chromatography
A ll  operations were perform ed at 0 -4°C .
The hepatic microsomes from  60 male rats, (approx. 120g wt. each), 
p retreated  with sodium phenobarbitone (0.1% (w/v) in drinking w ater  for  6 days) 
were solubilised at a concentration o f  14 mg m l-1 in lOmM Tr is -H C L  bu ffer  pH 7.25 
containing 25% (v/v) g lycero l,  O .lmM E D TA, O.lmM dithiothreitol, 0.3% (w/v) 
sodium cholate and 1% (v/v) emulgen 911 with gentle stirring for 30 minutes, 
fo l low ed  by centrifugation at 105,000 g fo r  lh  in a 6 x 94 ml titanium angle rotor 
head in a Beckman L5-65 u ltracentrifuge. The supernatant fraction  was applied to 2 
columns o f  DEAE sephacel (2.6 x 38 cm), previously equilibrated with solubilisation 
bu ffer . A f t e r  washing the columns with at least 3 column volumes o f  equilibration 
buffer, which was the same bu ffer  as the solubilisation bu ffer  excep t  that the ionic 
strength had been increased to 25mM Tr is -H C L , the cytochrome P-450 and N A D H - 
cytochrom e b^ reductase w ere  eluted by washing with the same bu ffer  in which the 
ionic strength had been further increased to 150 mM Tr is -H CL . When all the 
cytochrom e P-450 had been eluted, N AD PH -cy toch rom e P-450 reductase and 
cytochrom e b^ w ere  co-eluted in the above bu ffer  containing a 2 x I L  linear O to 
350mM potassium chloride gradient. N A D P H -cy toch rom e P-450 reductase was 
detec ted  according to its ability to reduce cytochrom e c.
Chromatography on 8-aminooctyI sepharose 4B
2.4.5 Purification of Rat Hepatic Microsomal NADPH-Cytochrome P-450
When purified as a by-product, N A D PH -cy toch rom e P-450 reductase was
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eluted from  8-aminooctyl sepharose 4B, subsequent to the rem oval o f  cytochrome P -  
450, by washing the column with 50mM potassium phosphate bu ffer  (pH 7.25) 
containing 25% (v/v) g lycero l,  0.35% (w/v) sodium cholate, 0.15% (w/v) sodium 
deoxycholate, 2 pM FM N . A l l  fractions containing N AD PH -cy toch rom e P-450 
reductase ac t iv ity  were pooled.
Chromatography on N ^- (6-aminohexyl)- adenosine 2,5'-diphosphate sepharose 4B 
(2*5* A D P  agarose)
N A D P H -cy toch rom e P-450 reductase pools, obtained either from  DEAE or 8- 
am inooctyl sepharose 4B columns, were d irectly  applied to a column o f  2'5' A D P  
agarose (1.3 x 8 cm ) previously equilibrated with the particular elution bu ffer  used 
in the previous step. Upon loading, an intense ye llow  band formed at the top (0.5 
cm ) o f  the column. When loading was completed, the column was washed with a 
minimum o f  25 column volumes o f  200mM potassium phosphate bu ffer  (pH 7.7), 
containing 25% (v/v) g lycero l,  0.1% (v/v) emulgen 911, 0.4mM E D T A  and 0.2mM 
dithiothreitol. Emulgen 911 was then rem oved from the column by washing with 
lOmM potassium phosphate bu ffer (pH 7.7), containing 25% (v/v) g lycero l,  0.02mM 
ED TA  and Q.2mM dith iothreitol until the A 2gg o f  the eluate had decreased to 
baseline, fo llowed by elution o f  the A D P  bound reductase in the same buffer 
containing 0.7mM 2 '-AM P. The N A D P H -cy toch rom e P-450 reductase in the eluate 
was monitored spectrophotom etrica lly  at 451 nm. Under these conditions, the 
protein eluted in a broader peak than i f  emulgen was present, but could be readily 
concentrated by u ltra filtra tion  to a usable stock concentration (10-20 units/ml).
Rem ova l o f  bound A M P
A M P  was routinely removed from  final reductase preparations by dialysing 
against 2 successive volumes o f  500mM potassium phosphate bu ffer  (pH 7.25), 
containing 20% (v/v) g lycero l.  This procedure resulted in e lectrophoretica lly  
homogeneous reductase preparations with emulgen 911 removed to below the leve l
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Cytochrom e t y  was also routinely purified as a by-product from  the 
purification o f  phenobarbitone - induced cytochrome P-450 according to the 
methodology o f Chiang (1981).
2.4.6 U ltra fi ltra t ion  o f  Purified  Proteins
Purified  preparations were routinely concentrated either as an integral part o f  
ongoing purifications, or to obtain proteins in usable stock concentrations.
Method
A  fresh membrane o f  the required molecular weight exclusion was placed in an 
u ltra filtration  ce l l  (Am erican  Instruments Co., U .S.A.) o f  capacity  10, 100 or 500 
ml. The chamber was fi l led  with distilled water  and the instrument attached to a 
nitrogen cylinder via a high pressure tube. By applying pressures o f  up to 30 psi, the 
water  was forced  through the membrane, displacing g lycero l contained in the pores. 
Upon emptying, the purified protein was introduced into the chamber and 
u ltra fi ltra tion  was accomplished at 30 psi. The extent o f  f i ltra t ion  was assessed by 
measuring the outflow  volume with t im e. Used membranes w ere  washed in 1M 
NaOH and stored in 20% methanol at 4 °C .
2.4.7 Storage o f  Purified  Microsomal Proteins
Purified  microsomal proteins w ere  placed in lm i  aliquots in glass f r e e ze  drying 
vials. They were then sealed with a rubber septum held in position with a crimped 
aluminium cap. The vial contents w ere  gently gassed with nitrogen using 2 fine 
syringe needles inserted into the septum to serve as a gas inlet and outlet. The 
gassed vials were then stored at -80 °C . A l l  purified proteins w ere  found to be 
stable under these conditions even a fte r  a number o f  thawing and re - freez in g  cycles.
of detection using a colourometric assay.
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2.5 S P E C T R O P H O T O M E T R Y
Spectrophotometric determinations were performed using either an Aminco 
DW2 UV-visib le split beam/dual wavelength  recording spectrophotometer, a Varian 
/Cary 219 split beam spectrophotom eter or a Pye  Unicam SP 1800 split beam 
spectrophotom eter. A l l  three instruments were equipped with a thermostated 
cu ve tte  housing. Spectral measurements were made in either the split beam mode 
(X^l = X^,) or in the duai wavelength  mode using a single cu vette  (X-3 = Simple
co lourim etric  assays were perform ed on either a Pye  Unicam SP 500, or a C ec i l  CE 
292 spectrophotom eter.
2.6 S P E C TR O PH O TO M E T R IC  E N Z Y M E  ASSAYS
2.6.1 Cytochrom e P-450
FERROUS C A R B O N  M O NO XID E AD D UCTS
I. L IVER MICROSOMES
Cytochrom e P-450 was routinely measured as the reduced carbon monoxide 
adduct (Omura and Sato, 1964). M icrosomes (1-2 mg/ml) or purified cytochrom e 
P-450 in 50mM potassium phosphate bu ffer  (pH 7.25), 20% (v/v) g lycero l was divided 
between  2 cuvettes, and a base line was recorded between 400 and 500 nm. 
Reduction o f  the fe r r ic  to ferrous form  o f  the hemoprotein was achieved by the 
addition o f  sodium dithionite to both sample and re ference  cuvettes and carbon 
monoxide (40 bubbles at approx imately 1 bubble per second) was gassed through the 
sample cuve tte  only. The spectrum was repe t it iv e ly  scanned until there was no 
further absorbance development at 450 nm. The concentration o f  cytochrome P-450
was calcu lated using the d i f fe ren ce  extinction co e f f ic ien t  (450 minus 490 nm) o f  91
1 -1 
mM cm
II. K ID N E Y  MICROSOMES
A  d if fe ren t  procedure was employed to that described fo r  l iver  microsomes, 
because kidney microsomal preparations tend to have mitochondrial contamination.
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Sodium succinate was added to the assay solution to reduce mitochondrial e lectron 
transport enzymes. N A D H  was also added to com plete ly  reduce any cytochrome ty  
present.
To 0.6 ml o f  kidney m icrosome suspension, 0.6 ml sodium succinate (100 mM) 
and 4.8 ml potassium phosphate bu ffer  (50 mM, pH 7.25 containing 20% g lycero l)  
w ere  added. 3 ml were again p ipetted into both sample and re ference  cuvettes and 
a baseline recorded. N A D H  (25 pi, 2% (w/v) solution) and a few  grains o f  sodium 
dithionite were then added to each cu vette . Again, CO was bubbled for  fo rty  
seconds into the sample cuve tte , the spectrum was reassessed and concentration 
measurements calculated as fo r  l ive r  microsomes.
Pyridine Hemochrom e Assay
This assay enables the tota l heme content o f the preparation to be determined. 
1M NaOH (1 ml) was added to 0.5 ml o f  diluted cytochrome P-450 fo llowed by the 
addition o f  60% (v/v) pyridine (2 ml). A f t e r  adjusting the volume to 6 ml with 
distilled water  and dividing between sample and re ference cuvettes, a baseline o f  
equal absorbance between 450 and 650 nm was established. A  few  grains o f  sodium 
dithionite were then added to the sample cuvette  only, and the spectrum rescanned. 
The concentration o f  pyridine hemochrome was calculated using a d if fe rence  
extinction co e f f ic ien t  (557 minus 575 nm) o f  32.4 m M "F cm 4  (Omura and Sato, 
1964a).
Cytochrom e P-450 Soret Absorbance
Cytochrom e P-450 was calcu lated from  the absolute spectrum o f  the 
hemoprotein using an extinction c o e f f ic ien t  o f  90 mM cm at 407 nm. The 
extinction co e f f ic ien t  was calculated with respect to tota l heme content determined 
from  the pyridine hemochrome measurements. 407 nm was se lected, as this 
represents the isosbestic point between low and high spin soret bands, and is 
th ere fo re  independent o f  the hemoprotein spin states.
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2.6.2 N A D P H  - Cytochrom e P-450 Reductase (E.C. 1.6.2.4.)
N A D P H  - cytochrom e c reductase ac t iv ity
Cytochrom e P-450 reductase was assayed enzym atica lly  according to the
ability o f  the protein to reduce the non-physiological acceptor cytochrom e c as
fo llows. The enzyme preparation was diluted to 2.5 ml in lOOmM Tris -HC l bu ffer
(pH 7.25) containing cytochrom e c (0.46 mg/ml). A f t e r  pre-equilibration at 25 °C
the reaction was initiated with 2% (w/v) N A D P H  in 1% sodium bicarbonate (25 pi).
The reduction o f  cytochrom e c was measured with t ime as the increase in
absorbance (550 minus 541 nm) measured in the dual wavelength mode. The
concentration o f reduced cytochrom e c formed with time was calculated using a
-1 -1
value o f  A ^ 3q nm = 19.6 mM cm for  the reduced hemoprotein. One unit o f  
a c t iv ity  was defined as 1 pmole cytochrom e c reduced per minute.
N A D P H  - cytochrom e P450 reductase absolute spectrum
The concentration o f  reductase in homogeneous preparations was determined 
from  the absolute absorbance o f  the flavin  moieties at 454 nm using an extinction 
c o e f f ic ien t  o f  21.4 mM"^ cm"^ (French and Coon 1979).
2.7 RE C O NS TITU T IO N  M E TH O D O LO G Y  FO R  A SSA Y IN G  C Y T O C H R O M E  P -450 
DEPEN D ENT MIXED F U N C T IO N  OXIDASE A C T IV IT Y  (IN  V ITR O ) USING 
PU RIF IED  RE C O N STITU TE D  PR O TE IN  COM PONENTS
The metabolism o f  model substrates by purified preparations o f  cytochrom e P -  
450 was routinely determined using the standard reconstituted system o f  Haugen et 
al (1975).
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1. L -a -d ilauroy l phosphatidyl choline (D L P C ) 300 pg/ml, probe sonicated in 
w ater.
2. Purified  cytochrom e P-450 (emulgen free ),  or microsomal samples.
3. Purified  N A D P H  - cytochrom e P-450 reductase. (Fpt)
4. Sodium deoxycholate 500 pg/ml. (DOC )
5. 400 mM Potassium phosphate bu ffer  (pH 7.25).
6. 150 mM Magnesium chloride.
7. Stock solution o f  substrate.
8. 40 mM N A D P H  in 1% sodium bicarbonate.
The components were added in the fo llow ing order on ice to obtain final 
concentrations o f
D L P C  (30 pg/ml), Cytochrom e P-450 (0.1-0.3 pM), Fpt (0.3-0.9 U/ml, DOC (50 
pg/ml), 50mM potassium phosphate bu ffer  (pH 7.25), MgCl^ (15mM), saturating 
substrate, distilled water  to the required volume (usually 1 ml).
The system was preincubated fo r  the required length o f  t ime (usually 2-3 
minutes) on a shaking water  bath set to the required temperature (usually 37 °C ) 
prior to initiation o f  the reaction by the addition o f  a final concentration o f  Im M  
N A D P H . A f t e r  allowing the reaction to proceed fo r  the required length o f  t ime the 
reaction was terminated in various ways depending upon the substrate and 
subsequent assay fo r  turnover employed. These details are given in the sections 
below.
Enzyme blank experiments where cytochrome P-450 was om itted  from  the 
complete reconstitution system w ere  run in parallel with substrate turnover 
experiments to determine the non-enzymatic rates o f  substrate turnover.
Reagents
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The standard reconstituted system described above was employed. 
Formaldehyde produced during the demethylation o f  benzphetamine was determined 
by the method o f  Nash (1953).
The reconstituted system contained 0.3 pM cytochrome P-450, 0.9 U/ml o f  
N A D P H  - cytochrome P-450 reductase and a final benzphetamine concentration o f
1.5 mM. The pre-incubation and incubation times were 2 and 3 mins respective ly . 
A f t e r  the incubation period the reaction  was terminated by the addition o f  0.5 ml o f  
ice-co ld  12.5% (w/v) tr ich loroace tic  acid (T C A )  to every  1 mi aliquot o f  the 
reconstituted system. Samples w ere  mixed and allowed to stand on ice for  5 min 
fo llow ing which they were centrifuged at 10,000 rpm fo r  10 minutes. The 
supernatant (1 ml) was then rem oved for  determination o f  formaldehyde, using the 
Nash assay.
Nash Assay
Reagent
Ammonium aceta te  (150g) was dissolved in 900 ml o f  distilled water. 
A ce ty lace ton e  (2 ml) was added and com plete ly  dissolved. The pH was adjusted to 
pH 6.0 with glacial a cet ic  acid, and the volume adjusted to IL. The reagent was 
stored at 4 °C .
Method
The supernatant from  the T C A  precipitation (1 ml) was added to Nash reagent 
(1 ml), mixed and heated in a w ater  bath at 58 °C  fo r  10 mins in the dark. A f t e r  5 
minutes cooling, the absorbance at 412 nm was recorded. A  standard curve was 
constructed using 1 ml volumes containing 0,10,20,40, 60,100,140 nmol formaldehyde 
and treated in an identical manner to the reconstituted system. Under these
2.7.1 Determination of Benzphetamine Demethylase Activity
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2.7.2 Determ ination o f Laurie A c id  Hydroxylation
The metabolism o f  ^4C-lauric acid to 12- and 11-hydroxylated products was
evaluated by t .l.c . analysis essentially as described by Parker and Orton (1980). The
1 ml incubation volume contained either cytochrom e P-450 and N A D P H  -cytochrom e
P-450 reductase at concentrations o f  0.3 pM and 0.9 units/ml respective ly  or
1 9
microsomes at a concentration o f  2 mg/assay. C-lauric acid (0.55 mM final 
concentration) was added as a methanolic solution (200 mM) and 14C-lauric acid (0.1 
pC i) was added in 10 pi o f  methanol. The pre-incubation and incubation times fo r  
the purified cytochrome P-450 isoenzymes were both 6 mins. H ow ever , fo r  l iver  and 
kidney microsomes, although the pre-incubation times remained the same, the 
incubation times were increased to 10 and 15 mins respective ly . The reactions were 
terminated by the addition o f  300 pi o f  3M HC1 to the incubation volume.
Extraction and analysis o f  hydroxylauric acid
The incubation mixtures were transferred to 15ml screw cap sovril tubes using 
ether (10ml), and then rotated end over end fo r  10 mins. A f t e r  centrifugation at 
2,000 rpm for  10 mins to c la r i fy  the phases, the upper (ether) layer (approx. 9 ml) 
was transferred to a test tube and evaporated to dryness under a steam o f  nitrogen.
Thin layer chromatography (T L C )  analysis o f  to ta l 11- and 12- hydroxylaurate
The dried ether ex tracts  were reconstituted in 60 pi o f  methanol, o f  which 20 
pi was spotted onto silica gel GE plates 250 p (Merck, 20 x 20 cm). The plates w ere  
developed in hexane: d iethyl ether: a ce t ic  acid, (70 : 20: 1.5 by vo l) with the solvent 
front being allowed to m igrate up 3/4 o f  the length o f  the plate. The rad ioactive 
areas corresponding to unmetabolised lauric acid (R f  = 0.29) and 11-and 12- 
hydroxylauric acid (R f  = 0.06) were located  by plating against Kodak CX-Industrex 
X-ray  film  fo r  3 days, a fte r  which the spots corresponding to the metabolites
conditions, 1.0 = 1?000 n moles formaldehyde.
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fo rm ed were scraped o f f ,  suspended in 5 ml CAB-O-SIL  scintillant and counted in an 
LKB  1216 Rackbeta liquid scintillation counter. The rates o f  hydroxylation w ere  
calculated from  the fract iona l conversion o f  substrate to to ta l hydroxy products 
making the estimation o f  recover ies  unnecessary.
High Perform ance liquid chromatography (H P L C ) procedure fo r  the separate 
quantification o f  11- and 12-hydroxylauric acid
The dried ether ex tracts  w ere  reconstituted in 150 pi o f  eluting solvent, w ater  
: methanol : g lac ia l a cet ic  acid (45 : 55 : 0.5 by vol.). 50-100 pi aliquots were then 
injected into the H L P C  system o f  the fo llow ing  specifications:
Column: Micropak M CH -10 (30 x 0.4 cm, Varian Associates Ltd.).
Guard Column:- Whatman column packed with CO : PE LL  ODS.
Elution o f  the products was achieved by using a linear gradient o f  w a ter  : 
methanol : g lac ia l acet ic  acid (45 : 55 : 0.5 by vo l.)  to 100% methanol over a 30 min 
period at a f low  rate o f  1.5 ml/min. A  pressure o f  350-500 psi was maintained with 
the 11- and 12-hydroxylauric acid being successively eluted fo llowed  by the 
unmetabolised lauric acid. The elution pro f i le  o f  the rad ioactive  products was 
monitored using a Berthold LB 503 H P L C  rad ioact iv ity  monitor (Laboratory  Impex 
Ltd., Middsx., U .K .) and rad ioact ive  m etabolites  were quantitated using a liquid 
scintillation technique. A lte rn a t ive ly  the D .C. output from the rad ioact iv ity  
monitor was interfaced (hexagan in ter face , IC I) with a PET 4032 m icrocomputer, 
linked to a chart recorder fo r  data analysis.
2.7.3 Determ ination o f  Ethoxyresorufin O-deethylation
The O-deethylation o f  ethoxyresorufin was routinely determined by the 
method o f  Burke et  al (1977), using the d if fe rence  in fluorescent properties o f  
ethoxyresorufin (exc itat ion  w avelength  = 456 nm, emission wavelength  = 560 nm) 
and the product resorufin (exc ita t ion  wavelength = 510 nm, emission wavelength = 
586 nm).
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The standard reconstituted system contained cytochrome P-450 and N A D P H -  
cytochrom e P-450 reductase at concentrations o f  0.3 pM and 0.5 units/ml 
respec tive ly . Ethoxyresorufin was added to a final concentration o f  50 pM in 10 pi 
o f  ethanol. The com plete  system was then transferred to a f luor im eter  cuvette  and 
placed in a thermostated cuvette  housing o f  a Perkin-Elmer MPF-3 fluorim eter, set 
at an excitation  wavelength o f  510 nm and emission wavelength o f  586 nm. A f t e r  
preincubation at 37 °C  fo r  2 min a steady base line with t ime was established. The 
reaction was initiated with a final concentration o f  Im M  N A D P H  and the production 
o f  resorufin with t ime monitored as the increase in fluorescence at 586 nm. The 
f luor im eter  was calibrated with multiples o f  10 pi o f  resorufin standard (10 pM in 
ethanol).
2.7.4 Antibody Inhibition Studies o f  C a ta ly t ic  A c t iv i ty
For the determination o f  ca ta ly t ic  ac t iv ity  o f  spec if ic  cytochrom e P-450 
isoenzymes with pre ferred  substrates the standard reconstitution systems as 
described w ere  utilised. The order o f  additions was essentially the same, excep t 
that a fte r  the addition o f  cy tochrom e P-450 and its corresponding reductase the 
mixture was allowed to equilibrate on ice fo r  5 min. A f t e r  this the spec if ic  
antibodies were added - either as sera or IgG in potassium phosphate bu ffer  (pH 7.4) 
- and preincubation was allowed to proceed at 25°C for  10 mins. The remaining 
substrates and co - fac tors  for  the spec if ic  reactions were then added and the 
reactions allowed to continue as per normal. For all analyses the corresponding 
inhibition studies were carried out with either pre-immune sera or IgG as w e ll  as 
utilising the apnropriate blanks.
2.8 D ISCONTINUOUS SODIUM D O D E C Y L  SU LPH A TE  P O L Y A C R Y L A M ID E  SLAB
GEL ELECTROPHORESIS
The method o f  Laem m ii (1970) was routinely used fo r  the assessment o f  the 
purity and molecular weight o f  l iver  and kidney microsomal proteins. The proteins
were first rendered monomeric by solubilising them with SDS in the presence o f  2- 
mercaptoethanol and then separated on polyacrylamide using a discontinuous bu ffer  
system.
Reagents
Gel monomer stock : 30% (w/v) acrylam ide (E lectran) containing 0.8% (w/v) N ,N -  
methylene-bis-acrylam ide.
Separating gel bu ffer :-  1.5M Tr is -H C l (pH 8.8) containing 0.4% (w/v) SDS.
Stacking gel bu ffer : 0.5M Tr is -H C l (pH 6.8) containing 0.4% (w/v) SDS.
E lectrode buffer : 25mM Tr is -H C l (pH 8.3) containing 192mM glycine and 0.1% (w/v) 
SDS.
Sample solubilisation bu ffer :-  62.5mM Tris -H C l (pH 6.8) containing 2.3% (w/v) SDS, 
15% (v/v) g lycero l, 5% (v/v) 2-mercaptoethanol and 0.001% (w/v) bromophenol blue. 
Ammonium persulphate 10% (w/v).
N -N -Tetram ethy lethy lened iam ine (TEMED).
M ethod:-
Electrophoresis was carried out at room temperature in either one o f  two 
ve r t ica l  slab gel assemblies. One system was laboratory manufactured in which the 
gel was contained in a glass and perspex cassette o f  internal dimensions 120 x 130 x 
15 mm. The other was a com m erc ia l ly  available LKB  2000 ver t ica l gel 
electrophoresis unit in which the internal dimensions o f  the poured gel w ere  160 x 
140 x 1.5 mm. The respective  plates w ere  stored in nitric acid and washed in 
detergent, tap water, distilled water  and acetone prior to use. The cassettes were 
assembled from the dry, dust-free plates and perspex spacers, sealed and then 
clamped in a vertica l position. The low er (separating) gel was prepared by mixing 
separating gel bu ffer  with an amount o f  gel stock to g ive  the co rrec t  running gel 
acrylam ide concentration. The volume was then adjusted with distilled w ater  and 
the polymerisation process initiated with the addition o f  TEMED and freshly
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prepared ammonium persulphate solution. This solution was then poured into the 2 
d i f fe ren t  electrophoresis cassettes to a height o f  80 and 115 mm respective ly . A  
layer o f  distilled w ater  was introduced above the gel mixture to ensure a f la t  
in ter face  between the separating and stacking gels a fte r  polymerisation. When 
polymerisation was com plete  (20-30 min), the water layer was rem oved and the 
upper (stacking) gel consisting o f a mixture o f  stacking gel bu ffer , gel stock and 
w ater - polymerisation being initiated as be fore - was poured on top o f  the 
separating gel. A  perspex comb was introduced into the stacking gel be fore  
polymerisation to form  the sample wells. A f t e r  polymerisation the bottom edge 
spacer and sample comb were rem oved and the gel slab im m ediately  placed into the 
electrophoresis tank. E lectrode bu ffer  was poured into the anode and cathode 
reservoirs with any air bubbles trapped beneath the gel combs or underneath the gel 
being removed using a syringe and fine tubing.
The samples to be analysed w ere  diluted in sample bu ffer  and placed in a 
boiling w ater  bath within a fume cupboard fo r  3 minutes. A f t e r  cooling, 5-20 pi 
aliquots were applied to the stacking gel sample wells using a Hamilton syringe. The 
amount o f  protein applied fo r  the separation o f  microsomal bands was generally  15 
pg/well fo r  20-well gels, and 80 pg/well fo r  6-well gels. The amount o f  purified 
protein applied depended upon the purity o f  the preparation. Generally  2.5 to 10 
pmol o f  cytochrom e P-450 per well w ere  applied to 20-well gels. Samples were run 
through the stacking gel under a 20 m A constant current until the bromophenol blue 
indicator entered the running gel, whereupon the current was increased to 40 m A. 
The current was switched o f f  when the indicator dye had moved to within 0.5 cm o f  
the bottom o f the gel. The gel slab holder was then removed from  the tank, the 
plates separated, and the lower running ge l cut out and removed fo r  staining.
2.8.1 Detection  o f  Proteins on Po lyacry lam ide gels
Electrophoretic  bands w ere  de tec ted  by using coomassie brillant blue R-250 as 
the protein stain.
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Staining solution:- propan-2-ol/acetic acid/water (25 : 10 : 65 by vo l.)  
containing 0.05% (w/v) coomassie brilliant blue R-250.
De-staining solution:- propan-2-ol/acetic acid/water (1 : 1 : 8 by volume). 
Method
Staining o f  protein bands was achieved by placing the gel overnight in staining 
solution. The gel background was destained by extraction with successive volumes 
o f  de-staining solution on a gently  rocking w ater  bath over a 12h period.
2.8.2 Standard protein Molecular Weight Markers used in Sodium Dodecyl Sulphate 
Po lyacry lam ide gel Electrophoresis
The fo llow ing proteins o f  known molecular weight were routinely used to 
ca librate polyacrylamide gels. Phosphorylase a (rabbit muscle Mr = 92,500), bovine 
serum albumin (Mr = 68,000), catalase (b ee f  liver, Mr = 60,000), glutamate 
dehydrogenase (bee f liver, Mr = 53,000), chicken egg albumin (Mr = 43,000), creatine 
phosphokinase (rabbit muscle, Mr = 36,000), cytochrome c (horse heart, Mr = 12,400).
The stock solution o f  standard proteins (5ml) contained lm g  o f  each protein 
made up to volume with solubilisation buffer, was stored in aliquots (0.5ml) at 
-20 °C . Be fore  use, an aliquot was diluted 1:3 and heated in a boiling w ater  bath for 
3 minutes. The volume applied was 5 pi per well fo r  20 track gels and 20pi per well 
fo r  6 track gels.
Molecular weight studies o f  the purified proteins were also perform ed using 
calibrated SDS P .A .G .E . and the degree o f  non-ideality o f  m igration o f  the 
cytochrome P-450 isoenzymes was determined according to the method o f  Fergusson 
(1964).
Reagent
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2.8.3 L im ited  Proteolys is o f  Homogeneous Cytochrom e P-450 Isoenzymes
P ro teo ly t ic  maps w ere  prepared according to the method o f  C leveland et  al 
(1977) and Koop et al (1981).
Samples o f  cytochrom e P-450 were diluted in 0.25M Tris -HC l bu ffer  (pH 6.8) 
containing 0.1% (w/v) SDS to a final concentration o f  0.33 mg/ml in 50 pi. 
Incubations were carried out at 37 °C  fo r  the required length o f  t im e a fte r  the 
addition o f  p ro teo lyt ic  enzym e and term inated by the addition o f  30 pi o f  50% (v/v) 
2-mercaptoethanol, 10% (w/v) SDS fo l low ed  by heating in a boiling w ater  bath fo r  3 
minutes. G lycero l and bromophenol blue w ere  then added to final concentrations o f  
10% (v/v) and 0.004% (w/v) respec tive ly  and 20 pi samples (3.5 pg cytochrom e P-450) 
were  submitted fo r  electrophoresis on 12.5% (w/v) polyacrylamide gels as previously 
described.
2.9 ANT ISER U M  P R O D U C T IO N
The spec if ic ity  and resolution o f  immunochemical techniques are responsible 
fo r  their increasing application to problems in biochemistry and molecular b iology 
enabling spec ific  and sensitive methods fo r  both qualitative and quantitative 
analyses o f  protein antigens to be provided. In this study antibodies have been 
raised against separate, unique, homogeneous cytochrom e P-450 isoenzymes in order 
to demonstrate: (a) immunological d if fe rences  between purified rat cytochromes 
P-450, (b) identification and analysis o f  these d if fe ren t  cytochrom e P-450 
isoenzymes fo llow ing xenobiotic induction, (c )  the presence o f  these multiple forms 
o f  cytochrom e P-450 in d i f fe ren t  tissues, (d) as a convenient and very  precise means 
o f  identify ing and isolating these d if fe ren t  multiple cytochrome P-450 isoenzymes, 
during a number o f  in v itro  experim ental procedures.
2.9.1 Preparation o f  Antigens fo r  Immunisation
Antisera was raised against a single hepatic protein antigen designated
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cytochrom e P-450 B^, fo llow ing  phenobarbitone-induction. In order to obtain as 
spec if ic  antisera as possible, the purity o f  the injected antigen is c r it ica l such that 
only entire ly  homogeneous cytochrom e P-450 fractions were employed. For the 
first immunisation 700 pg o f  the antigen was used, which was added to an equal 
volume o f  non-ulcerative Freunds com plete  adjuvant containing heat-killed BCG 
mycobacteria . The use o f  Freunds com plete  adjuvant results in a far g rea ter  
antibody response than is stimulated by antigen in a simple w ater- in -o il emulsion 
because o f  the grea ter  persistence o f  the antigenic complex within the tissues o f  the 
test animal. Similarly the presence o f  the heat-killed m ycobacteria  serve to 
stimulate the entire reticu loendothelia l system o f  the animal. The antigen-adjuvant 
emulsion is obtained by the Double-hubbed needle method firs t suggested by Berlin 
et al. (1953), which has the advantage that materials are kept ster ile  at all times, 
with there being no loss o f  materia l and that the finished emulsion can be delivered 
into one o f  the syringes involved ready fo r  immediate use. The technique employs 
two syringes which are clamped together by a double hubbed needle. The antigen 
solution is rapidly passed into the adjuvant with the mixture then being passed 
backwards and forwards between the syringes until the right viscosity is attained. 
The stability o f  the emulsion was always ascertained by placing a single drop in a 
beaker o f  cold w ater. I f  it was stable then the first droplet spreads evenly across 
the liquid surface with subsequent drops remaining on or just below the surface but 
not breaking up. I f  this was the case then immunisation was immediately  initiated.
2.9.2 Immunisation Sites, Schedules and Antiserum Processing
Fem ale N ew  Zealand white half lop rabbits were immunised intramuscularly 
and subcutaneously with 0.7 mg cytochrom e P-450 B^. Prior to immunisation 
animals w ere  bled to obtain non-immune (contro l) serum. Immunisation occurred at 
six sites intramuscularly in the legs and four sites subcutaneously in the back. A f t e r  
6 weeks, the first post-immunisation bleed was taken and the sera co llected . 
Subsequent bleeds were taken every  2 weeks with the immune response being
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conveniently estimated by immunoprecipitation analysis. An additional boost o f  700 
pg cytochrom e P-450 Ety in Freunds com plete  adjuvant was administered 12 weeks 
later with subsequent bleeds again being analysed for  highest t itres by 
immunoprecipitation analysis.
Blood was obtained by sectioning o f  the rabbit marginal ear veins, from  which 
80ml o f  blood could easily be obtained. In order to obtain a good f low  rate the ears 
w ere first swabbed with xylene (an irritant) at a position distal to the point o f  
incision, with this being removed a fterwards by washing with ethanol.
Immunisation schedule fo r  the production o f  antibodies against 
cytochrom e P-452
Antibodies to clo fibrate-induced cytochrom e P-452 w ere  raised in fem ale  
sheep fo llow ing immunisation with 600 pg o f  a highly purified e lectrophoretica lly  
homogeneous preparation o f  cy tochrom e P-452 in Freunds com plete  adjuvant. Four 
weeks later the sheep w ere  boosted with 300 pg o f  purified antigen with blood being 
co llec ted  7 days la ter from  the jugular vein. The IgG enriched fractions were 
prepared from  the sera by a combination o f  ammonium sulphate precipitations and 
DEAE cellulose chromatography a fte r  which they were concentrated to a volume o f  
70-80 mg/ml using an Amicon PM 30 membrane. Control sera and its respective  IgG 
were prepared from  the blood o f  pre-immunised sheep in the same manner.
2.9.3 Purification  o f  Immunoglobulins
Blood from  rabbits immunised w ith cytochrome P-450 B^ was obtained as 
previously described a fte r  which it was allowed to c lo t  for  a fe w  hours at room 
temperature. The sera was then carefu lly  decanted from  the c lo t and the 
immunoglobulin fraction  isolated by a m odif ication  o f the method o f  Walker and 
M ayer (1977). The sera was brought to 50% saturation with solid ammonium 
sulphate and the precip ita te  co l lec ted  by centrifugation on a MSE HS 18 centrifuge 
at 10,000 rpm for  10 min. It was then washed several times with ice cold 1.75 M
ammonium sulphate until it was white , in order to rem ove any albumin, transferrin 
and a-proteins including haptoglobin and hemeoglobin that may be present. The 
final white pe llet was then dissolved in 10 mM potassium phosphate bu ffer  (pH 7.0) 
and dialysed overnight against 5L o f  water . The subsequently precip itated 
lipoproteins were removed by centrifugation at 2,000 rpm fo r  20 min with the 
remaining supernatant being redialysed against 2 x 3L o f  10 mM potassium
phosphate bu ffer  (pH 8.0) over a period o f  16 hours. This preparation was then
loaded onto a column o f  DEAE cellulose (Whatman DE 52) previously equilibrated
with the same bu ffer  with the column then being washed with the same bu ffer  until 
all the IgG was eluted. The height o f  the column corresponded to 1ml o f  DEAE 
cellulose per 4 ml o f sera initally fractionated. Elution was measured
spectrophotom etrically  at an absorbance o f  280 nm with the protein peak being 
concentrated by u ltra filtration using an Amicon PM-30 membrane. F inally the IgG 
was dialysed against 10 mM potassium phosphate bu ffer  (pH 7.25) a fte r  which it was 
aliquoted and frozen  at -40°C .
2.10 ASSESSMENT OF A N T IB O D Y  SPE C IF IC ITY
In order to determine the spec if ic ity  o f  each antiserum severa l 
immunodiffusion and immunoelectrophoretic techniques were employed. This was 
done not only to achieve quantitative data for  spec ific  antibodies raised against the 
corresponding cytochrome P-450 antigens, but also to ensure that there were no 
artifacts  existing peculiar to any spec if ic  system which might or might not g ive 
misleading information about the m ult ispec ific ity  o f  any particular sera.
2.10.1 Quchterlony Immunodiffusion Analyses
Double-diffusion analyses as demonstrated by Ouchterlony (1967) was used to 
identify  the number o f  antigen-antibody systems between a tissue ex tract  and a 
spec if ic  antiserum.
Precoa ted  glass plates w ere  used as a base for the immunodiffusion media.
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The ( 8 x 8  cm ) plates w ere  repeatedly  washed with detergent, distilled w ater  and
ethanol. Precoating was achieved by spreading a few  ml o f  0.2% (w/v) agar, 0.1%
(w/v) thiomersal along the plate by gently  moving the edge o f  another glass plate at
a 45° angle along its surface. The agar was then dried to a fine film  in hot air from
a hair dryer. The immunodiffusion media which consisted o f  0.9% agarose 25, 80
mM NaC l, 15 mM sodium azide, IM  glycine, being adjusted to pH 7.4 with sodium
hydroxide was then gently  poured onto the glass plates on a horizontal leve ll ing
table. Fourteen ml o f  gel media was required per plate giving a ge l thickness o f  2
mm. The plates were allowed to set fo r  10 min in moisture boxes maintained damp
with a solution o f  0.1% (w/v) thiomersal in w ater . Four m il l im etre  d iam eter wells
were punched with a tem plate  resulting in a pattern o f  wells w ith center to center
distances o f  10 mm. A f t e r  fil l ing  the wells  with the appropriate proteins, the plates
were incubated at room temperature in a humid atmosphere fo r  at least 3 days.
A f t e r  this period o f  t ime any non-precipitated proteins are rem oved by washing the
plate a number o f  t imes with deproteinising solution containing 3% NaC l, 0.01%
sodium azide and 0.01% Tw een  20 with in term ittent pressings. The plates w ere
pressed by covering the gel w ith a layer o f  f i l t e r  paper (avoiding air bubbles) and a
o
2-3 cm layer o f  so ft  tissue paper. A  slight pressure o f  about 10 g/cm is sustained 
by means o f  a number o f  glass plates fo r  a period o f  30 minutes. A t  this stage the 
gel would be reduced to a thin fi lm  and would either be rewashed and pressed or else 
dried in a hot air cupboard as a prelude to staining. The number o f  washings and 
pressings would vary from  3-6 depending upon the purity and amount o f  protein 
loaded onto the gel. The plates w ere  then stained with 1.25% (w/v) coomassie 
brilliant blue R-250, 45% (v/v) 96% ethanol, 10% (v/v) acet ic  acid, in w ater  fo r  a 
period o f  10 minutes, a fte r  which they were rapidly destained in 33% (v/v) ethanol, 
13.3% (v/v) a cet ic  acid, 53.7% (v/v) water .
2.10.2 Radial Immunodiffusion
The technique o f  single radial diffusion developed by Mancini e t  al., (1965) was
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utilised in order to quantitate antigen within spec if ic  tissues.
The immunodiffusion media contained l.QM glycinfe, 0.2mM E D T A , 86mM 
sodium chloride, 15mM sodium azide, 5% glycero l, 0.9% agarose 25, 0.5% cholate, 
0.2% emulgen 911. A f t e r  melting the agarose media it is a llowed to cool to 50°C  on 
a waterbath at which point spec if ic  anti-sera is added. A f t e r  mixing, 10ml aliquots 
o f  the media are poured onto pre-heated, pre-coated ( 8 x 8  cm ) glass plates on a 
precise ly  leve l surface. A f t e r  standing at room temperature fo r  10 minutes the 
antisera-agar solution solid ifies into a gel layer o f  approximately 1.5mm thickness. 
The plates are then stored overnight at 4 °C  in a moisture chamber. Holes o f  
uniform size (2mm diam eter ) are punched into the layer and exact amounts o f 
antigen samples o f  between 1-5 pi are added using a Hamilton m icro liter  syringe. In 
the case o f  microsomes, solubilisation has to be carried out by the addition o f  lm g  
cholate, 0.2 mg emulgen 911 per mg o f  protein solubilised w ith stirring fo r  20 min on 
ice . A l l  plates had wells containing purified protein as a means o f  internal 
standard. The plates w ere  le f t  fo r  3 days fo llow ing which they were washed, 
pressed, dried, stained and destained using the same protocol and solutions as for  
ouchterlony diffusion plates.
The immunoprecipitin rings were then measured with a measuring m icroscope 
utilising a 0.1mm scale with the resulting squares o f  the diameters being plotted 
against antigen concentrations. Standard curves enabled quantitation o f spec if ic  
fractions to be subsequently made.
2.10.3 Western Blotting Analysis
This technique entails the e lectrophoretic  transfer o f  proteins from  
polyacrylamide gels to nitrocellulose sheets which are then subject to immunological 
analysis. The procedures employed were modifications o f  the basic procedures o f 
Towbin et al. (1979) and Burnette, W. (1981).
SDS - polyacrylamide gel elctrophoresis was carried out on samples to be
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analysed as previously described. The resulting gels were soaked for 45 min in 
transfer bu ffer  (20mM Tris base, 150mM glycine). This pre-transfer stage is 
included to allow any changes in the size o f  the gel due to swelling or shrinking to 
occur at this stage rather than during transfer. Actual transfer is achieved by using 
a physical assembly sandwich apparatus. In essence, a sheet o f nitrocellulose (0.45 
pm in pore s ize ) was br ie f ly  w etted  with transfer bu ffer and laid on 2 sheets o f  
Whatmann 3MM paper lying on top o f  a Scotch Brite scouring pad. The whole 
assembly is supported by a s t i f f  plastic grid. The gel to be blotted was then put on 
the nitrocellulose sheet with a further 2 sheets o f  f i l t e r  paper and a scouring pad 
being placed on top. It is important to ensure that no air bubbles are caught 
between the f i l t e r  and the gel because o f  the possibility o f  low e f f ic ien cy  transfer 
and band distortion occuring in these areas. The immobilised assembly was then 
inserted into the e lectrophoretic  transfer chamber with the nitrocellulose paper 
facing the anode. The chamber was fi l led  with transfer bu ffer  with e lectrophoretic  
transfer being achieved overnight at 5 V/cm.
For d irect visualisation o f  all proteins transferred , the nitrocellulose sheet 
could be stained for  5 mins in a solution containing 0.2% coomassie brilliant blue 
R-250, 40% methanol and 10% ace t ic  acid. Rapid destaining was accomplished in 
90% methanol, 2% acet ic  acid.
A f t e r  e lectrophoretic  transfer the nitrocellulose sheet was washed in 
phosphate bu ffered saline (PBS) containing 20% pre-immune donkey sera and 0.2% 
Triton X-100. Washing was carried out for  15 min with gentle agitation. Tw o 
further washes were then carried out as be fore  except that the control donkey sera 
concentration Mas reduced by 5% each time. A f t e r  the last PBS wash the 
nitrocellulose sheet was washed fo r  1 hr in the final wash bu ffer  (PBS containing 
10% pre-immune donkey sera, 0.2% Triton X-100) containing the primary antibody 
o f  interest. The amounts o f  primary antibody utilised varied depending on the 
experiment and spec ific  details are given in the appropriate figure legends. A f t e r  
this period, 3 further washes o f  15 min with the PBS wash buffer w ere  again carried
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out. The next wash o f  60 min consisted o f  the PBS wash bu ffer  and either the 
secondary antibody or else a horseradish peroxidase labelled antibody. I f  the firs t 
antibody was isolated from  sheep then a second sandwich antibody was required 
be fore  the horseradish peroxidase labelled double antibody. This approach gave rise 
to far g rea ter  sensitivity. Again 3 further washes in PBS wash bu ffer  o f  15 min 
duration were required fo l low ed  by a final wash in PBS alone. The nitrocellulose 
sheet was then developed in 0.1M Tris -H C l bu ffer (pH 7.5) containing 0.5 mg/ml 
diaminobenzidine chloride and 1:5,000 (30 vols). Once the desired image
intensity was observed the sheet was then rinsed in distilled w ater  which e f f e c t iv e ly  
stopped the reaction.
2.11 P R A C T IC A L  PROCEDU RES
2.11.1 Protein  Assays
Prote in  concentrations w ere  routinely determined by a modified method o f  
Low ry  et  al. (1951) using bovine serum albumin as a standard.
Reagents
2% (w/v) Sodium carbonate in 0.1M NaOH
1% (w/v) Hydrated copper sulphate
2% (w/v) Sodium potassium tartra te .
Protein  samples w ere  diluted with distilled water to g ive  appropriate 
concentrations. A  range o f  4 dilutions w ere  used in duplicate assays. The protein 
standard (20 mg/ml) was diluted in distilled water  to g ive 0, 8, 16, 24, 32, 40 
pg/assay/tube in duplicate. Copper sulphate, sodium potassium tartra te  and sodium 
carbonate/hydroxide solution were mixed sequentially to g ive  the ratio ( 1 : 1 :  100 
by vo l) im m ediately  be fore  use. The protein standards, samples and blanks (0.5ml) 
were mixed with the above reagent (2.5ml) and allowed to stand at room 
temperature fo r  10 minutes. Folin C ioca lteau  phenol reagent, diluted 1:1 with 
distilled water, was added (0.25ml) and the solutions were im mediately  vortexed.
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A f t e r  allowing to stand for  a minimum o f  30 minutes, the absorbance at 750nm was 
recorded. Most o f  the purified preparations assayed by this procedure contained 
concentrations o f  g lycero l and detergents (emulgen 911), which are known to 
in ter fe re  with the colour form ing reaction. On such occasions the presence o f  these 
compounds was compensated fo r  by appropriate additions to the standard curve. 
The ex tent o f  colour developm ent is a partial function o f  the amino acid 
composition since tyrosine residues react  w ith the Low ry  reagent.
2.11.2 Determ ination o f  Emulgen 911 D etergen t Content
The residual emulgen content o f  purified cytochrome P-450 preparations was 
routinely determined using- a general procedure fo r  the assay o f  polyethoxy non-ionic 
detergents (Goldstein and Belcher 1975).
Reagents
Ammonium cobaltoth iocyanate solution : made up as 17.8% ammonium 
thiocyanate, 2.8% (w/v) cobalt n itrate  hexahydrate stored in a polythene bottle .
Emulgen 911 standard : 2 mg/ml emulgen 911 in 50% (v/v) ethanol.
Dichloroethane.
Samples were diluted with ethanol and 50% (v/v) ethanol to g ive  an 
appropriate concentration o f  emulgen 911 in 50% (v/v) ethanol. The emulgen 911. 
standard was diluted to g ive  25, 50, 100, 200, 300 and 400 pg/assay.
Ammonium cobaltoth iocyanate (0.4ml) was added to the blanks, standards and 
samples (0.3ml), mixed, and allowed to stand at room temperature for  5 minutes, 
D ichloroethane (1.5ml) was added and the solutions w ere  vortexed fo r  2 minutes 
fo l low ed  by centrifugation at 6000 g fo r  10 minutes to c la r i fy  the phases. The upper 
aqueous phases w ere  discarded and the organic phases were scanned from  500 to 700 
nm using the reagent blank as re fe rence . The absorbance d i f fe rence  625 nm minus 
700 nm was used to construct a standard curve.
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METHODS RELATING TO THE MOLECULAR BIOLOGY OF 
C Y T O C H R O M E  P-450 ISOENZYMES
Deoxyribonucleic acid which is the genetic  materia l in eukaryotes, performs 
two functions that are basic to l i fe .  It rep licates itse lf  and it u ltim ately  directs the 
synthesis o f  all proteins. But, D N A  itse lf  is not used as a d irect tem plate for  
induced proteins, instead, it acts as the tem plate for  a corresponding R N A  molecule 
called messenger R N A  (m R N A ).  The m R N A  being a product complimentary to the 
base sequence o f  D N A  rece ives  the information for the sequence o f  the respective  
protein in the order o f  its own nucleotides and subsequently directs its synthesis by a 
process known as translation. Thus in order to study the molecular biology o f  the 
induction o f  the d i f fe ren t  cytochrom e P-450 isoenzymes the m R N A  sequences 
coding for these isoenzymes have been isolated and characterised.
3.1 M A TE R IA LS
Oligo (dT) cellulose type 7, oligo 2'-deexy-guanosine 5' triphosphate,
sodium (dGTP), 2 '-deoxythymidine 5’ triphosphate, sodium (dTTP ), 2-deoxycytid ine
5'-triphosphate, sodium (dC TP ), 2* deoxyadenosine 5'-triphosphate, disodium (dA TP ),
were obtained from  PL-B iochem icals  (Milton Keynes, U .K .). Creatine
phosphokinase, S-^  nuclease (Aspergillus o ryzae ) were obtained from  Boehringer
Mannheim (Lewes, East Sussex). Rabbit re t icu locy te  lysate (amino acid depleted,
nuclease treated ), vanadyl ribonucleoside complex, rabbit globin m R N A , E. coli
D N A  polymerase I "K len ow " fragm ent, reverse transcriptase (AM V ), cesium
chloride, formam ide (ultra-pure) w ere  obtained from Bethesda Research
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Laboratories (Glasgow, U .K .).  S-Methionine in aqueous solution containing 0.1%
2-mercaptoethanol, m ethylated protein mixture containing labelled molecular 
weight protein markers w ere  obtained from  Amersham International. These
Chapter 3
60
included myosin (Mr = 20,000), phosphorylase a, b (Mr = 92,500), bovine serum
albumin (Mr = 69,000), ovalbumin (Mr = 46,000), carbonic anhydrase (Mr = 30,000),
lysozym e (Mr = 14,300). Unlabelled amino acid mixture containing 19 o f  the 20
amino acids at a concentration o f  Im M  and 2mM dithiothreitol as an antioxidant,
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deoxyadenosine 5'- a P triphosphate, triethylammonium salt in stabilised aqueous 
solution and A m p lify  w ere  also obtained from Amersham (Bucks, U .K .). 
Guanidinium hydrochloride, o ligo (dT) cellulose, diethyl pyrocarbonate, heparin 
(porcine intestinal mucosa), 2-mercaptoethanol, lithium chloride, 
phenylmethanesulphonyl fluoride, Nonidet P-40, Triton X-100 w ere  obtained from  
Sigma Chemical Co. Ltd  (Poo le , Dorset). Whatmann GF/C f i lters  were obtained 
from  Whatmann Chem ical Separation L td . (Maidstone, Kent). Hind III D N A
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markers, Protosol, En Hance w ere  all obtained from New  England Nuclear 
(Southampton, Hants). Sucrose (RNase fr e e )  was obtained from  Cambrian Chemicals 
(Croydon, Surrey) and Pansorbin cells w ere  obtained from  Calbiochem-Behring 
Corporation (San D iego, U .S .A .). Prote in  A  agarose, sephadex G-50 and G-75 were 
obtained from  Pharmacia (U .K . )  Ltd. (Hounslow, Middx.). Boric acid, R N A  
molecular weight markers, tri-sodium c itra te ,  ethidium bromide, sodium aceta te ,  
tr ich loroacetic  acid were all obtained from  the British Drug House (Poo le , Dorset).
A l l  other chemicals used w ere  either as mentioned in chapter 2, or else o f  
Analar grade to ensure maximum purity.
3.2 A N IM A L  P R E T R E A T M E N T
Male Wistar Albino rats were obtained and maintained as previously described. 
How ever  the dcsing schedule was slightly a ltered in order to maximise the induction 
conditions for  the m R N A  levels coding fo r  the cytochrome P-450 isoenzymes.
Phenobarbitone and c lo f ib ra te  w ere  both administered as solutions in drinking 
w ater. In the case o f  phenobarbitone, animals rece ived  one i.p. injection o f  125 
mg/kg, and fo r  c lo fib ra te  one i.p. injection o f  400 mg/kg. BNF induction involved
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one i.p. injection o f 80 mg/kg in 0.25 ml o f  corn oil. A l l  animals were killed 16-18 
hr a fte r  injection by ce rv ica l  dislocation.
3.3 E X T R A C T IO N  OF T O T A L  C E L L U L A R  R N A
The major technical problem in experiments involving the isolation o f  R N A  is 
one o f  preventing R N A  hydrolysis by ribonucleases. While all the precautions taken 
throughout the nucleic acid experiments might not have always been absolutely 
necessary, it was learned by experience that extra caution • minimised the 
unexpected failure o f  some R N A  preparations, expecia lly  when these were involved 
in in v itro  translation experiments.
Inhibition o f  Ribonuclease a c t iv ity
The primary ob jec t ive  there fo re , was to denature any ribonucleases contained 
within the b io logica l materia l being excised, such that i f  there was any subsequent 
contamination it was due to exogenous ribonuclease sources. D iethyl pyrocarbonate 
is an e f f e c t iv e  inhibitor o f  ribonuclease reacting with the im idazo le nitrogens o f  
histidine residues and the free  amino groups causing subsequent loss o f  enzyme 
act iv ity .  Deionised water  was treated  with 0.1% (v/v) d iethyl pyrocarbonate with 
stirring fo r  12 hr, a fte r  which it was autoclaved tw ice  at 20 p.s.i. fo r  30 minutes. 
Following such treatm ent the w ater  was considered sterile , with such w ater  being 
used to make up all buffers, media etc . An additional measure was the addition o f  
heparin, (a sulphated polysaccharide, which is a particularly e f f e c t iv e  com pet it ive  
inhibitor o f  ribonuclease) to all media in which the tissues w ere  initially 
homogenised.
La tex  gloves were worn at all t imes in order to avoid contact between the 
experimentors fingers (a source o f  exogenous RNase contamination) and glassware 
or solutions. A ll  glassware was thoroughly washed, rinsed with deionised water  and 
then treated  at 250°C fo r  5 hours. Where applicable solutions w ere  also fi l te red
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through sterile  prerinsed 0.45 pm nitrocellulose fi lters  (M ill ipore ). During the 
synthesis o f  complimentary D N A  (cD N A )  sequences vanadyl-ribonucleoside 
complexes were employed as the most e f f e c t iv e  ribonuclease inhibitors. A l l  
experiments were carried out under the most stringent and RNase free  conditions 
possible.
Isolation o f  To ta l Cellular R N A
The method used was a m odif ication  o f the procedures o f  Chirgwin et al. 
(1.979) and Deeley  et  al. (1977).
A f t e r  killing, the livers or kidneys o f  the test animal were removed, weighed 
and then homogenised in a 7.5M guanidinium hydrochloride stock solution (pH 7.0) 
containing; 25mM Tri-sodium c itra te , lOmM 2-mercaptoethanol, 5mM dithiothreito l 
and 0.1% (v/v) Triton X-100. Pre lim inary experiments showed that optimum 
amounts o f  R N A  were isolated when a ratio o f  21 ml o f  the above guanidinium 
hydrochloride stock bu ffer  /g l iver was employed. The tissues w ere  then solubilised 
in this medium by ultraturraxing for  a fe w  minutes at maximum speed. The 
homo'genate was then cen tr i fged  at 10,000 g. av. fo r  20 minutes using a 6 x 250 ml 
aluminium angle head rotor in a MSE HS 18 centrifuge at 4 °C  in order to sediment 
any particulate m atter . The supernatant was then decanted into a flask and the 
R N A  precip itated by the addition o f  0.025 volumes (re la t ive  to the original volume 
o f  homogenisation bu ffer )  o f  1M acet ic  acid to lower the pH from  7 to 5 and 0.75 
volumes ethanol. The sample was thoroughly mixed and precipitation was allowed to 
proceed at -25 °C  overnight. N ex t  day the R N A  precip ita te was co llec ted  by 
centrifugation at 10,000 g at -10 °C  for  20 minutes with the resultant R N A  pe llet 
being again dissolved in guanidinium hydrochloride stock bu ffer  (0.5 volume o f 
original volume). R N A  was reprecip ita ted  by adding 0.025 volumes o f  1M acet ic  
acid, 0.5 volumes o f  ethanol. The solution was kept at -25 °C  fo r  12 hours and then 
centrifuged as be fore . This reprecip itation cyc le  was repeated tw ice  more with a
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further halving o f  the to ta l volume fo r  each precipitation. A f t e r  the final 
precipitation the R N A  pe lle t  was dissolved in sterile  water  and 3M sodium ace ta te  
(pH 5.5) was added to g ive a final concentration o f  0.3M. Prec ip ita tion  was initiated 
by the addition o f  2.5 volumes ethanol and storing overnight at -25°C . The R N A  
was pelleted as be fore  and the precipitation repeated. Finally the R N A  pe lle t  was 
washed once with 80% (v/v) ethanol and once with 96% (v/v) ethanol with the R N A  
being co llec ted  each time by low  spin centrifugation. The ethanol was then rem oved 
by drying under vacuum and the R N A  pe lle t  was dissolved in ster ile  w ater . The 
R N A  was stored in aliquots o f  20pl at -80°C .
Occasionally an additional purification step was used according to the 
procedure o f  Glisin, V. et al (1974) in order to ensure that the R N A  preparation had 
absolutely no D N A  contamination. This was achieved by dissolving the R N A  pe llet 
a fte r  the final guanidinium hydrochloride precipitation in lOmM Tris -H C l bu ffer  (pH 
7.5) and O.lmM E D TA . This was then gently  layered onto 1.2ml cushions o f  5.7M 
cesium chloride in 0.1M ED TA  (pH 7.5). Centrifugation was carried out in a 6 x 5 ml 
AH  650 swinging bucket rotor at 35,000 g for  12 hours at 20°C  on a Sorval 
u ltracentrifuge. Any D N A  in the preparation remains at the top o f  the cesium 
chloride cushion whereas the R N A  is pe lleted . The R N A  pe llet  is then precip itated 
with sodium aceta te  and finally washed with ethanol as be fore .
3.4 ISO LA TIO N  OF P O L Y  (A )  C O N T A IN IN G  R N A
The cr iter ia  which distinguishes the majority  o f  eukaryotic m R N A 's  from other 
cellular R N A  species is the occurrence o f  a poly (A )  segment at the 3' end o f the 
molecule. This property provides a useful means o f  isolating poly (A )  + m R N A  with 
the method o f  choice being chromatography on oligo (dT) cellulose as described by 
A v iv  and Leder  (1972).
64
Method
Loading Bu ffer: 20mM T r is -H C l  (pH 7.6), 0.5M L iC l,  Im M  E D TA , 0.1% (w/v) SDS.
Wash B u ffe r :-  20mM T r is -H C l  (pH 7.6), 0.1M L iC l,  Im M  ED TA, 0.1% (w/v) SDS. 
Elution Bu ffer :-  lOmM Tris -H C l (pH 7.5), Im M  ED TA, 0.05% (w/v) SDS.
A  6 ml oligo (dT) cellulose (Sigma Chemical Co.) column equilibrated in 
loading bu ffer  was poured into a 10 ml plastic syringe plugged with glass wool. The 
column was then washed with 5 column volumes each o f:  1. Sterile  w ater, 2. 0.1M 
NaOH, 3. 5mM ED TA , 4. S terile  w ater.
The pH o f  the column eluent is checked to ensure that it is less than pH 8 
fo llow ing which the column is equilibrated with 10 volumes o f  loading bu ffer. The 
tota l R N A  fraction  to be purified is then heated at 65°C  fo r  5 minutes, rapidly 
cooled in ice and diluted 1:1 (v/v) with 2 x loading buffer. The solution was then 
applied to the column with the eluate being again reheated at 65°C  fo r  5 minutes, 
rapidly cooled in ice and then reapplied onto the column. The subsequent eluate 
consists o f  all the unbound R N A  species lacking a polyadenylic tail. The column is 
then washed with loading bu ffer  until the A 2^g o f  the eluate is zero. It is next 
washed with wash bu ffer  so that any non-specifically  bound R N A  is also removed. 
Again, washing continues until the eluate A 2^g reading is zero. The degree o f  non­
spec if ic  binding is related to the purity o f  the oligo (dT) cellulose preparation. The 
enriched poly (A )+ m R N A  is then eluted by washing with the elution bu ffer  until the 
^260 read4n9s again reach zero .
In order to further enrich the poly (A )+ m R N A , it can be se lected  again for  
o ligo (dT) cellulose chromatography by adjusting the L iC l  concentration o f  the 
eluted m R N A  to 0.5M. The m R N A  was then heated and cooled as described 
previously and applied onto a 0.5ml high a ff in ity  oligo (dT) cellulose (type 7) column 
which had been washed and pre-equilibrated as be fore . The subsequent procedures 
for the isolation o f the enriched poly (A )+ m R N A  w ere  identical to that used in the
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f irs t column. A  solution o f  3M sodium aceta te  (pH 5.5) was added to the resulting 
poly (A )+ m R N A  eluate to a final concentration o f  0.3M and the R N A  precip itated 
by the addition o f  2.5 volumes o f  ethanol at -25 °C  fo r  12 hours. The poly (A )+ R N A  
was pe lleted by centrifugation at 10,000 g, at -10 °C  for 20 minutes a fte r  which it 
was washed once each with 80% (v/v) and 96% (v/v) ethanol. The poly (A )+ m R N A  
was then dried under vacuum, resuspended in a small volume o f  sterile  water  and 
stored in 10-20pl aliquots at -80°C .
A f t e r  completion o f  the oligo (dT ) fractionation the columns w ere  washed with 
5 column volumes each o f:
1. Water,
2. 0.1M NaOH,
3. 5mM ED TA,
4. Water.
The columns were finally  re-equilibrated with loading bu ffer  a f t e r  which they 
were stored at 4 °C  until again required.
A t  this stage the R N A  solution would routinely g ive an absorbance A 2gg : A 2gg 
nm ratio o f  between 1.8 and 2. The concentration o f  R N A  can be determined 
spectrophotom etrically  with an optical density o f  1 corresponding to 40 pg/ml R N A . 
(Maniatis e t  al 1982).
3.5 SUCROSE G R A D IE N T  F R A C T IO N A T IO N  OF P O L Y  (A ) * m R N A
Sucrose gradient centrifugation is a convenient preparative fractionation 
procedure which was used to further purify the enriched poly (A )+ m R N A  by 
fractionating the R N A  into d i f fe ren t  size classes which were then analysed to 
determine which contained the m R N A  sequences coding for  spec if ic  induced 
cytochrome P-450 isoenzymes. It was these fractions which were subsequently used 
fo r  synthesis o f  corresponding cD N A  strands. The procedure utilised was a
The gradient mixer, ce ll  tubing, eppindorf and centrifuge tubes were 
pretreated  in a 0.1% (v/v) solution o f  d iethyl pyrocarbonate in w ater  fo r  12 hours 
prior to autoclaving. A  linear 15 to 30% RNase fre e  sucrose gradient made up in 
lOmM Tris -H C l (pH 7.5), lOmM E D T A  and 0.2% (w/v) SDS was prepared in 14 mi 
Beckman SW40 centrifuge tubes. The f low  rates for  the gradients were such that 
each tube took approximately 30 minutes to f i l l ,  a fte r  which it was le f t  standing at 
room temperature for  a number o f  hours in order to rem ove any possible 
inhomogeneities within the gradient.
The R N A  to be fract ionated  was vacuum dried and then resuspended in 99% 
dimethylsulphoxide, lOmM Tr is -H C l (pH 7.5). Gentle mixing was required with it 
being possible to solubilise up to 100 pg o f  R N A  in 200 pi o f  this DMSO solution. 
The solubilised R N A  solution was then heated fo r  5 minutes at 37 °C  a fte r  which it 
was diluted 4-fold with 5mM Tr is -H C l bu ffer  (pH 7.5), Im M  E D TA , 0.5% (w/v) SDS. 
The fract ion  was mixed and then further heated fo r  1 minute at 65 °C  a fte r  which it 
was rapidly cooled in ice. The fractions were then gently layered onto the sucrose 
gradient with centrifugation being carried out at 30,000 g fo r  16 hours at 20°C  in a 
Beckman SW40 6 x 14 ml swing out rotor in the corresponding u ltracentrifuge. 
Following centrifugation the tubes w ere  removed with great care in order not to 
disturb the gradient with 0.4ml fractions being co llected  dropwise into eppindorf 
tubes by piercing the base o f  the centrifuge tube. The R N A  pro f i le  was then 
determined spectrophotom etrica lly . The R N A  was recovered  by adding 3M sodium 
ace ta te  (pH 5.5) to a final concentration o f  0.3M and precipitating with ethanol as 
already described. The R N A  pe lle t  was then washed once each with 80% (v/v) and 
96% (v/v) ethanol, vacuum dried, resuspended in a small quantity o f  w ater, a fte r  
which it was subsequently characterised.
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modification of the method of Hasletine and Baltimore (1976).
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Slab gels o f  R N A  fractions denatured by either form amide, (Maniatis e t  al 
1980) or formaldehyde, (Boedtker, 1971) w ere  routinely run to determine the 
structural in tegr ity  o f  the isolated R N A  species.
Electrophoresis o f  R N A  through gels containing formamide
The gel consisting o f  5% (w/v) acrylam ide, 1.2% (w/v) bisacrylamide, 98% (v/v) 
form am ide, 20pM N a 2HPO^, 6uM N aH 2PO^ was poured into the glass gel apparatus 
(120 x 130 x 1.5mm) as already described (section 2.8). Polymerisation was initiated 
by the addition o f  TEMED. The form am ide (ultra pure) was firs t deionised by 
passing it through a mixed bed resin (B IO -R A D  A G  501-X8) until the pH was neutral. 
The R N A  samples (5-10 pg) were dissolved in 25 pi formamide, 25% (v/v) g lycero l, 
0.01% (w/v) bromophenol blue and then incubated at 65°C  fo r  15 minutes. The gels 
w ere run at a constant vo ltage  o f  100V utilising gel bu ffer  consisting o f  0.16M 
N a 2HPO^ and 0.004M N aH 2PO^ until the dye front was within a few  centim etres o f  
the bottom o f  the gel. The gel pattern was visualised by staining with ethidium 
bromide (0.5 pg/ml) fo r  30 minutes in the dark and then viewing over a shortware 
ultra v io le t  light box.
Electrophoresis o f  R N A  through gels containing formaldehyde
1.2% (w/v) agarose gels containing 2.2M formaldehyde made up in Tris-borate 
(TBE) bu ffer  were also routinely used. TBE buffer consists o f  89mM Tris-borate, 
2mM E D T A  (pH 8.0). The samples were prepared by mixing R N A  (4.5 pi) with 10 x 
TBE bu ffer  (2.0pl), formaldehyde (3.5pl), and formamide ( lO p l)  a f te r  which they 
w ere  incubated at 65°C fo r  15 minutes. The running gel bu ffer was TBE bu ffer  and 
the gel was firs t pre-run fo r  30 minutes at 35 m A  prior to loading the samples. Four 
pi o f  gel loading bu ffer  (50% (v/v) g lycero l,  Im M  EDTA, 0.4% (w/v) bromophenol 
blue, 0*4% (w/v) xylene cyanol) was added to the R N A  sample prior to loading. Gel
3.6 GEL ELECTROPHORESIS O F  R N A
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electrophoresis apparatus and staining conditions were as for the previous gel 
system.
3.7 MESSENGER R N A  T R A N S L A T IO N
In vitro protein synthesising systems from  eukaryotic cells have been 
successfully used in studies to e lucidate the basic mechanism o f  protein synthesis 
and the identity and structure o f  the reacting components. In addition these 
systems identify  spec if ic  m R N A s enabling their properties to be studied as w e ll  as 
the properties o f  the proteins fo r  which they code by analysing their translation 
products. Furthermore, in v itro  systems which accurately  translate mammalian 
m R N A s are ex trem e ly  useful to investigate the regulation o f  m R N A  translation and 
to quantitate b io log ica lly  ac t ive  m R N A s from  whole cells or from cellular 
subfrations by their translational capacity .
3.7.1 Principles o f  the translation assay
A  number o f  in v itro  systems have now been isolated capable o f translating 
heterologous m R N A . These systems are either broken ce l l  preparations containing 
ribosomes and factors necessary fo r  protein biosynthesis or intact ce lls  which can be 
in jected with the R N A  to be tested. H ow ever  it should be noted that all these 
systems have d if fe ren t  advantages and lim itations (Shafritz 1977), there fore  it is 
important to choose the co rrec t  system most suited for ones requirements. In all 
these systems addition o f  m R N A  fractions to responsive translation systems, 
incubated in the presence o f  rad ioact ive  amino acids, w ill  synthesise a large array o f  
labelled proteins coded fo r  by the individual m RNAs. Subsequently, in order to 
monitor the translation o f  a spec if ic  m R N A  a method yielding high and consistent 
recover ies  o f  the corresponding protein from  other rad ioactive  products is required.
The most commonly utilised systems at present are as fo llows:-
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A . The Wheat Germ System (Roberts and Paterson, 1973).
B io log ica lly  a c t ive  ex tracts  o f  wheat germ have been shown to fa ith fu lly  
translate m RN A s o f  viral, plant, fungal and animal origin. Among the advantages o f  
this system are that it is easy to prepare and use, it is econom ical, and it has a 
r e la t iv e ly  low endogenous background o f  m R N A  act iv ity . Its disadvantages however 
are that its translational a c t iv ity  is low, with m R N A  molecules being translated only 
1-5 times, and that sub-optimal ion concentrations cause the production o f  
incomplete peptide fragments as a result o f  premature termination o f  protein 
synthesis with the release o f  p ep t idy l- tR N A . Longer R N A  species possibly due to a 
lack o f  normal post-translational m odif ication  o f  the polypeptides also appears to be 
particularly sensitive to this problem (Tay lor  1979).
B. The Rabbit R e t icu locy te  Lysate (Pelham and Jackson, 1976)
Its translational e f f ic ie n c y  is the highest o f  all eukaryotic systems developed 
so far and possesses the capability o f  translating m R N A  molecules more than f i f t y  
times. The inital disadvantage o f  the system was the high lev e l  o f  endogenous 
messenger ac t iv ity  (approximately 90% o f  the product represents a-and 0-globin 
chains) which acted in competition  for  the elements o f  the translation machinery 
when exogenous m R N A  was added. This problem was overcom e by preincubating the 
lysate with m icrococca l nuclease which is itse l f  inactivated a fte r  it has completed 
its task o f  destroying any endogenous m R N A  present. The system has been shown to 
translate messages coding for  proteins with molecular weights o f  up to 200,000 
daltons and has a low incidence o f  premature chain termination. A  wide var ie ty  o f  
viral, prokaryotic and eukaryotic m R N A s have been translated using this system 
(Shafritz, 1977). Its primary disadvantage is its more complex preparation and 
determination o f  optimum conditions neccessary to ensure consistent high 
perform ance.
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C. Intact Xenopus Oocytes  (Lane et al., 1971)
The injection o f  m R N A  into Xenopus oocytes to stimulate protein synthesis is 
not str ict ly  in v itro protein synthesis but it is frequently used, to achieve the same 
aims and ob jectives as in v itro  translation systems. The advantage o f  the system 
however, is that synthesis o f  heterologous protein may continue fo r  up to 2 weeks 
and that as l i t t le  as 1-10 ng o f  purified m R N A  can achieve saturation. This is close 
to the sensitivity o f  cD N A  : R N A  hybridisation. There is l i t t le  requirement fo r  
m R N A  spec if ic  factors and only slight competition between exogenous R N A  and 
endogenous R N A  unless very  high leve ls  o f  m R N A  are added. The systems 
disadvantages include; d if f icu lty  in the microinjection technique, maintaining a 
supply o f  oocytes and that as only minute quantities o f  m R N A  can be translated in a 
single egg only lim ited quantities o f  product are avilable for  analysis.
3.7.2 The Nuclease T reated  Rabbit R e t icu locy te  Lysate
Due to the very high translational ac t iv ity  and capacity  for  generating high 
molecular weight polypeptides as well as having a low incidence o f  protein 
termination, this was the in v itro  translation system o f  choice used throughout this 
study relating to cytochrome P-450 induction.
Initia lly the lysate was prepared according to the method o f  Pelham and 
Jackson (1976) but problems o f  stability  w ere  encountered a fte r  nuclease treatm ent 
even though storage was at -80°C . The lysate still showed superior protein 
translational ac t iv ity  to the com m erc ia lly  available re t icu locy te  lysate from  
Amersham International but even this was exceeded when the B RL ret icu locy te  
lysate was employed. Eventually it  was this system which was consistently 
employed because o f  the important saving in preparation time and because o f the 
reproducibility obtained in protein translation experiments.
35
The rad ioactive  amino acid employed was S-methionine because o f  its
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ava ilab il ity  at a very  high spec if ic  rad ioact iv ity  which enables a much higher 
incorporation o f  rad ioact iv ity  into protein to be obtained, even though methionine 
occurs re la t ive ly  infrequently in many proteins. Another advantage is that the 
endogenous pool size o f  methionine in the ret icu locyte  lysate is re la t iv e ly  low and 
does not greatly  dilute the added "^S-methionine.
Preparation o f  Rabbit R e t icu locy te  Lysate
Six month old N ew  Zealand white rabbits were in jected in the scru ff o f  the 
neck with 4,4 and 3 mis o f  1.25% (w/v) acetylphenyl hydrazine in w ater  fo r  3 days 
respective ly . On day 8 they were anaethetised with lignobarb and injected with
2,000 units o f  heparin into the marginal ear vein a fte r  which the animals w ere  
maximally  bled by heart puncture. This is achieved by entering the chest cav ity  just 
leve l with the elbow from  the rabbits l e f t  side and fee ling  for  the heart with the 
point o f  the needle. Once the heart has been punctured and the maximum amount o f 
blood obtained, the chest cav ity  is opened and any remaining blood is removed with 
a pasteur pipette . An average o f  80 ml blood per animal is obtained in this manner. 
The blood is f i l te red  through cheese cloth to rem ove hair and debris and is then spun 
at 2,000 rpm for 10 minutes in a 6 x 250 ml rotor in a MSE HS 18 centrifuge at 4 °C . 
The supernatant is then rem oved by aspiration and the cells suspended in buffered 
saline composed o f  0.134M N aC l, 5mM KC1, 7.5mM M gC l2 5mM D-glucose, lOmM 
HEPES (pH 7.2). The cells are spun down as be fore  with these washes being carried 
out a tota l o f  4 times. During the final wash the volume o f  cells is determined. 
A f t e r  this spin 1.5 volumes (w ith respect to the packed ce l l  vo lum e) o f  ice-cold  
distilled water, containing Im M  dith iothreitol is added to the red cells and the 
suspension thoroughly mixed. The lysate is then spun at 10,000 rpm for  10 minutes 
at 2 °C  in the MSE HS18 centrifuge a fte r  which it is f i l te red  through Nybo lt  123 
nylon mesh to prevent any glutinous stroma entering the lysate which inhibits 
protein synthesis.
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For every  10 ml o f  lysate, 0.2 ml o f  1 mM hemin, 0.1 ml o f  5 mg/ml creatine 
kinase in 50% (v/v) g lycero l, 0.1 ml o f  0.1M CaCty* and 0.1 mi o f  15,000 units/ml 
m icrococca l nuclease (staphylococcal) are added. The solution is thoroughly mixed 
and incubed at 20°C  fo r  20 minutes. The digestion is terminated by the addition o f  
0.1 ml o f  0.2M EG TA  and 60 pi o f  10 mg/ml tR N A  (ca lf  l iver ) in water . Again the 
solution is mixed a fte r  which the m icrococca l nuclease treated rabbit re t icu locy te  
lysate is aliquoted into small volumes and stored at -70°C .
3.8 PR O C E D U R E  FO R  IN V ITRO  P R O TE IN  T R A N S L A T IO N  CODED FOR 
B Y  EXOGENOUS m R N A
To ensure that a given m R N A  w ill  be e f f ic ien t ly  translated using the rabbit 
re t icu locy te  ce ll f r e e  system it is important to determine optimum values fo r  a) 
m R N A  concentration, b) length o f  incubation time, c) potassium ion concentration 
and, d) magnesium ion concentration. Also it is v ita l to ensure that no calcium is 
introduced into the lysate as this w ill  reac t iva te  the m icrococcal nuclease which 
was used to destroy the endogenous m R N A  and that the R N A  preparation to be 
translated is free  o f  any trace amounts o f  ethanol, detergent or sodium ions. Even 
residual amounts can cause inhibition o f  the translation machinery.
/
111 v ^tro translations are carried out in sterile plastic eppindorf tubes 
which are prechilled at -70 °C  fo r  severa l hours prior to the start o f  the experiment. 
The lysate is ex trem ely  sensitive to environmental conditions such that only the 
required amounts are thawed fo r  each experiment with all the additions being 
performed rapidly at 0 ° C  on ice. Typ ica l final volumes utilised fo r  translations 
varied from  5-10 pi. Prec ise measurements o f  volume were achieved with the aid o f  
graduated sterile m icro-p ippettes. The order o f  additions fo r  the translation is as 
fo llows:-
The lysate is added to the eppindorf tube to a final concentration o f 30% (v/v).
Nuclease treatment of Lysate
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A mixture o f  19 unlabelled L-amino acids which are approximately 1 mM with
respect to each amino acid is then added at a ratio o f  1 part to 15 parts o f  to ta l
lysate volume. The labelled amino acid is added, the concentration used being
dependant upon the nature o f  the experiment. I f  it was a standard translation
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experiment a concentration o f  0.5 - 0.7 pCi/pl o f  S-methionine was found to be 
su ff ic ient, but i f  it was an immunoprecipitation analysis o f  the translation products 
then this concentration had to be increased to 1 pCi/pi. The next stage is the 
addition o f  potassium ace ta te  and magnesium aceta te  ( i f  required) ions fo llowed by 
the addition o f  100 mM creatine phosphate to a final concentration o f  30 mM. A t  
this stage the lysate master mix is gently vortexed with in term itten t m icrofuging 
between mixes to ensure that all the components are thoroughly distributed. It is 
important to avoid frothing the mix, as this not only prevents good mixing but also 
results in some inhibition o f  protein synthesis through oxidation or denaturation o f  
proteins. The master mix is then fract ionated  into the appropriate number o f  tubes 
fo llow ing  which R N A  is added to the desired concentration and then sterile  w a ter  to 
the required tota l lysate volume. Thorough mixing is again achieved as be fore . The 
tubes are then removed from  the ice bath and transferred to a water bath where 
they are allowed to incubate at 30°C  fo r  90 minutes. A t  the end o f this period o f  
t ime, an aliquot (normally 1-2 pi) is removed fo r  analysis o f  incorporation o f 
labelled amino acid into protein with the remaining lysate fraction  being prepared 
d irect ly  fo r  analysis onto SDS P .A .G .E . or fo r  subsequent immunoprecipitation 
analysis. For every  translation experiment a minimum o f two controls was utilised. 
One was a zero m R N A  "blank” control, the other was the translation o f  a 
characterised m R N A  fract ion  o f  known translated ac t iv ity  in order to serve as an 
Internal standard.
Preparation o f  R N A  fo r  in v itro  Prote in  Translation
The primary means involved was that o f  heat denaturation o f  the R N A  sample
just prior to translation by incubating at 65°C  in a water bath fo r  5 minutes a fte r  
which it was rapidly cooled in ice . The R N A  fractions in any translation experiment 
were never reused in order to avoid any loss in translational ac t iv ity  as a result o f  
thawing and denaturation.
A  second procedure utilised -  although to a lesser degree because o f  the 
inherent dangers involved - was denaturation by methyl mercury hydroxide 
according to the method o f  Payvar and Schimke (1979). A  stock solution o f  1M 
methyl mercury hydroxide (a g i f t  from  Sittingbourne Research Centre ) was diluted 
to the appropriate concentration with w ater  and a equal volume added to the R N A  
sample prepared for  translation. The RNA/m ethyl mercury hydroxide mix was 
mixed as described and incubated at room temperature for  5 minutes. The treated 
R N A  was then added to the lysate master mix and the translation was allowed to 
proceed as be fore . A l l  procedures involving methyl mercury hydroxide were carried 
out in a fume cupboard with utmost caution being exercised at all times.
Assay o f  Incorporation o f  R ad ioac t iv ity  into Proteins
A f t e r  the incubation, the aliquots removed for measurement o f  incorporation 
o f  labelled amino acid into protein are de livered into 1ml o f  w ater  in 12 x 75 mm 
glass tubes with the de livery  m icrop ippette  being rinsed several times. To this is 
added 0.5 ml o f  decolourising solution containing 0.1% (w/v) DL-methionine, 5% 
(v/v) o f  30% (w/v) hydrogen peroxide (” 100 volume11) in IN  sodium hydroxide with the 
tubes then being incubated in a 60 °C  w ater  bath for  15 minutes. This deacety lates 
charged tR N A  and bleaches the red colour due to the large amounts o f  heme 
present. 2ml o£ 25% (w/v) T C A  is added to each tube with the proteins then being 
allowed to precip ita te  at 0 ° C  fo r  one hour.
The solutions are then f i l te red  through Whatmann GF/C fi lte rs  with all tubes 
being subsequently mixed with 2 x 10 ml o f  25% (w/v) T C A  and 2 x 10 ml o f  8% 
(w/v) T C A ,  with the f i lters  also being washed with the rinsings. Finally the fi lters
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are washed with 2 x 10 ml o f  96% ethanol. This last wash is important as it not only 
aids in drying the f ilters, but also rem oves a lot o f  the brown colour resulting from  
the action o f  T C A  on the heme o f  the lysate, which i f  present in large amounts acts 
as a quencher during liquid scintillation counting. The fi l te rs  are then dried, 
individually cut up into small squares and then counted in 5ml o f  liquid scintillation 
fluid.
Optimisation Conditions o f  m R N A  Translation
In order to achieve maximum translatable ac t iv ity  it is important to maintain 
optimum concentrations o f  monovalent and divalent cations fo r  the d i f fe ren t  
m RN A s tested. The type o f  ion is also important with higher rates o f  protein 
synthesis being obtained with potassium rather than sodium, and magnesium rather 
than calcium (Weber, et al. 1977). The other ion o f  the salt is also important with 
aceta te  being pre fered  to the chloride ion. This is because the high chloride 
concentrations required inhibits the binding o f  m R N A  to ribosomes in the form ation 
o f  initiation complexes, and because the use o f  acetates rather than chlorides g ives 
a much broader potassium optimum range. Accord ingly  it is important to test the 
ion concentration optima for translation o f  various m RNA 's from  d if fe ren t  sources 
in order to ensure e f f ic ie n t  and co rrec t  translation o f  the R N A .
Similarly, a concentration response curve fo r  the optimum m R N A  
concentration has also to be determined. These concentration optima vary for 
d i f fe ren t  R N A  fractions i.e. to ta l R N A ,  poly A + m R N A , polyribosomal R N A ,  and as 
such have to be determined fo r  each preparation.
The final optimisation cr iter ia  required is that o f  translational dependance 
upon t im e in order to determine how act ive  the system is under ideal conditions.
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3.9 IM M U N O P R E C IP IT A T IO N  A N A L Y S IS  OF C Y T O C H R O M E  P-450 A PO PR O TE IN S
CODED FO R  B Y  ISO LA TED  P O L Y  A+ m R N A  SEQUENCES
Although the precise mechanism o f  cytochrome P-450 induction is not 
understood studies on the subject indicate that the induction o f  these spec if ic  
isoenzymes a fte r  administration o f  certain xenobiotics to rats or m ice results from 
an increase o f  the corresponding m R N A s in the cytoplasm o f  hepatocytes. 
Accord ingly , this investigation has utilised in vitro translation studies fo llowed  by 
spec if ic  immunoprecipitation o f  the translation products in order to quantitate the 
leve l o f  functional cytochrom e P-450 m RN As in response to xenobiotic 
administration.
3.9.1 Treatm ent o f  m R N A  Coded Lysate  Translational Mix
m R N A  at spec if ic  t ime points a fte r  chemical induction was isolated and 
translated as described in sections 3.3, 3.4 and 3.8. A f t e r  this period o f  translation 
an aliquot was rem oved to determine to ta l T .C .A .  precipitable a c t iv ity  with the 
remaining fraction being utilised fo r  immunoprecipitation analysis. Experiments 
showed that the optimum lysate volume required fo r  each fraction  analysed to be 40 
pi, such that as a general indication a minimum o f  500,000 d.p.m. were present. 
Three d if fe ren t  methodologies w ere  utilised fo r  the isolation o f  the subsequent 
antigen - antibody complex, e ither by means o f  a double antibody sandwich, the use 
o f  a protein A  - sepharose slurry or fixed  Staphylococcus aureus cells. Each 
technique required d if fe ren t  modifications with each having its own corresponding 
advantages and disadvantages. Similarly even using the same technique slight 
variations had to be employed fo r  the quantitation o f  spec ific  m R N A s because o f  
the significant e f fe c ts  d i f fe ren t  detergent conditions had on the stability o f  the 
isolated antigen - antibody complexes,
3.9.2 Pre trea tm ent Stages, D etergen t Conditions and Treatm ent o f  the Isolated
Antigen - Antibody Com plexes
One o f  the major problems concerned with qualitative immunoprecipitation is
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that o f  a high background o f  non-specific precipitation. This is believed to occur 
either as a result o f  chance recognition o f  some ce ll proteins with antibodies present 
within the antisera or a lternative ly  some cellular proteins having weak but 
significant a f f in ity  fo r  similar hydrophobic regions within the immunoglobulin or 
Staphylococcus aureus molecule. Consequently d if fe ren t  techniques were shown to 
be more useful for d if fe ren t  analysis with these being utilised accordingly. For all 
the immunoprecipitation stages eppindorf tubes were used throughout to l im it 
protein adsorbtion onto their walls.
Double Antibody Immunoprecipitation
The procedure fo l low ed  was similar to those developed by Treadwell e t  al
(1980), and Fujii-Kurinyama et  al (1981).
A f t e r  translation the lysate mixes were diluted ten fo ld with phosphate 
buffered saline containing 0.01M phenylmethanesulphonyl fluoride (PM SF) and 1% 
(v/v) Triton X-100 (pH 7.6), then being m icrofuged for f i f te en  minutes in a Beckman 
Eppindorf M icrofuge to rem ove any insoluble materia l. The supernatants w ere  
rem oved to separate tubes and spec if ic  antibody directed against the antigen o f 
interest was added. Because the amount o f  antibody addition varied with d i f fe ren t  
experiments, the precise volumes utilised w ill  be documented with each experiment. 
The translation mix was then incubated at 37°C  for  one hour and then overnight at 
4 °C  with end over end rotation. N ex t  morning (usually 12-16 hours la ter) 3 pg o f 
the second antibody (donkey anti-rabbit IgG) was added and the mix was further 
incubated at 37 °C  fo r  30 minutes and then at 4 °C  with end over end rotation fo r  
four hours. The antibody spec if ity  o f  the secondary antibody was also checked by 
Ouchterlony double immunodiffusion analysis. The immunoprecipitates were 
recovered  by centrifugation in the Beckman M icrofuge at 12,000 rpm for  15 minutes 
and were then resuspended in 200 pi o f  lOmM Tris buffer (pH 7.4), 2mM ED TA , 0.1% 
(w/v) SDS. This was then gently layered on top o f  a 0.3ml cushion o f 1M sucrose,
0.5%
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(w/v) sodium deoxycholate, 0.5% (v/v) Triton X-100, lOmM unlabelled methionine. 
The initial tube was then rinsed with a further 100 pi o f  the wash bu ffer  and this 
was also gently layered on top o f  the sucrose layer. The mix was then centrifuged 
at 12,000 rpm for  15 minutes a fte r  which the supernatant was discarded with the 
immunoprecipitate being resuspended and washed through the sucrose layer as 
be fore . The pellet was then resuspended in 1ml o f  lOmM Tris bu ffer  (pH 7.4), 6mM 
ED TA  fo llow ing which it was spun down in the m icrofuge fo r  10 minutes. This final 
washing procedure was repeated a to ta l o f  three times. The resulting 
immunoprecipitate was then resuspended in 60pl o f  fluorography sample buffer, 
boiled fo r  5 minutes and then analysed on SDS P.A.G .E .
Prote in  A  aided immunoprecipitation
Prote in  A  is a single polypeptide chain o f  apparent molecular weight 41,000 
isolated from  the ce ll wall o f  Staphylococcus aureus. Its characterist ic  b io logica l 
property is its ability to interact with, and form  precip itates with, a wide var ie ty  o f  
IgG molecules (via their Fc regions) from  several species. For this type o f  
immunoprecipitation the method o f  P icke tt  e t  al. (1980) was fo llowed  with 
modifications.
A f t e r  translation the mixes were made 2% (w/v) with SDS, boiled for  three 
minutes and then diluted with 4 volumes o f  bu ffer  1 which consisted o f  2.5% (v/v) 
Triton X-100, 190mM NaC l, 5mM ED TA , 50mM Tris -HC l (pH 7.4) and 0.01M PMSF. 
The mixture was then preincubated fo r  2 hours with 10pi o f  the appropriate 
preimmune IgG and lOOpl o f  50% (v/v) protein A  slurry at room temperature with 
end over end u ta t io n  in order to decrease non spec ific  binding. The protein A  
sepharose slurry was made up in bu ffer  2 which consisted o f  150mM NaC l, 50mM 
Tris -H C l (pH 7.4), 5mM ED TA , 0.05% (v/v) Nonidet NP40 and 0.2% (w/v) sodium 
azide. The preimmune IgG/protein A  - sepharose complex was removed by 
centrifugation at 12,000 rpm fo r  15 minutes a fte r  which the required volume o f
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spec if ic  antibody was added to the decanted supernatant. Im mediate ly  fo llow ing the 
addition o f the appropriate immune IgG 150pi o f  50% (v/v) protein A  slurry was 
added with the mix then being allowed to incubate for  12-16 hours at 4 °C  with end 
over end rotation. The immune complexes bound to protein A  -sepharose were 
recovered  by centrifugation and resuspended in 200 pi o f  bu ffer  2. This was then 
layered onto a 0.3ml sucrose cushion as described previously fo r  the double antibody 
immunoprecipitation with the initial tube being rinsed with a further 100 pi o f  bu ffer  
2 which was also layered on top o f  the sucrose cushion. The washing procedure was 
then repeated as be fore  with two sucrose washes and subsequently 3 washes in lOmM 
Tr is -H C l bu ffer  (pH 7.4), 6mM E D TA . The antigen was then eluted from  the IgG by 
boiling in 60pl o f  fluorography sample bu ffer  a fte r  which the mix was centrifuged at
12,000 rpm fo r  1 minute to pe lle t  the protein A  slurry. An aliquot was rem oved to 
determine the amount o f  rad ioact iv ity  present with the supernatant containing the 
antigen o f  interest then being subjected to SDS P.A.G .E .
Staphylococcus aureus aided immunoprecipitation
The immunoprecipitation procedures utilising protein A-bearing strains o f  
Staphylococcus aureus bacteria  were modifications o f  the methods o f  Phillips e t  al.
(1981), and P icke tt  et al. (1980).
Staphylococcus aureus cells were stored in 0.5ml aliquots as a 10% (w/v) 
suspension in phosphate bu ffered  saline at -80 °C . Cells w ere  not reused a fte r  
thawing as freeze -thaw  cyc les  were shown to considerably increase the degree o f 
non spec if ic  binding. Im m ediate ly  prior to use the required amount o f  cells was 
taken and centrifuged down at 12,000 rpm for  1 minute a fte r  which they were 
resuspended and equilibrated in 1 ml o f  the extraction/washing bu ffer  (150mM NaC l, 
50mM Tr is -H C l (pH7.4), 5mM E D T A , 2mM unlabelled methionine, 0.5% (v/v) Triton 
X-100 and 0.02% (w/v) sodium azide). The cells were thoroughly resuspended in this 
bu ffer a fte r  which they were spun down as be fore . The supernatant was decanted
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and the cells were again resuspended in 1 ml o f  the above bu ffer. This procedure 
was repeated 3 times a fte r  which the cells w ere  resuspended in the same bu ffer  with 
the exception that the detergent concentration had been reduced to 0.5% (v/v) and 
unlabelled methionine was om itted . The cells were washed a further 2 times as 
be fore  a fte r  which they were resuspended in this bu ffer  to the original volume. This 
procedure serves to e lim inate fragm ented and poorly fixed staphylococci.
When using Staphylococcus aureus cells a preincubation stage was shown to be 
essential otherwise gross non spec if ic  binding was evident. Following the translation 
the mix was adjusted to 5% (w/v) SDS and then boiled fo r  3 minutes a fte r  which it 
was diluted 1:10 with the bu ffer  1 utilised during the protein A  aided 
immunoprecipitation. The mixture was then preincubated fo r  5 minutes at 30°C  
a fte r  which the cells were removed by centrifugation (5 minutes). The supernatant 
was decanted, to which was added the appropriate antibodies. This mix was then 
incubated at 30°C  fo r  1 hour and then at 4 °C  with end over end rotation for 12-16 
hours. The antigen-antibody complexes were precipitated by the addition o f  75pi o f  
prewashed Staphylococcus aureus cells fo l low ed  by a further incubation period o f  1 
hour at 4 °C  with end over end rotation. The antigen-antibody-staphyiococci 
complex was then isolated by centrifugation  in a m icrofuge (15 minutes), a f te r  
which it was thoroughly resuspended in lOmM Tris -HC l bu ffer (pH 7.4), 6mM F D T A . 
I f  the immunoprecipitation had been d irected towards the isolation o f either the 
c lo fibrate-induced cytochrom e P-452 or BNF-induced cytochrome P-447 antigens, 
then the isolated immune complexes would be washed a tota l o f  3 times in the above 
bu ffer  by means o f  resuspension and subsequent centrifugation (10 minutes) o f  the 
resulting pe llet. How ever, i f  the immunoprecipitation was d irected towards the 
isolation o f  phenobarbitone-induced cytochrom e P-450 antigens then the resulting 
immunoprecipitate complex would be layered onto a 0.3ml sucrose cushion 
containing 0.3M sucrose, 0.5% (w/v) sodium deoxycholate, 0.5% (v/v) Triton X-100 
and lOmM unlabelled methionine. The immunoprecipitates w ere  then co llec ted  by
centrifugation (10 minutes), resuspended in the lOmM Tris-HCl (pH 7.4), 6mM ED TA  
bu ffer  and then washed 3 times as be fore . A f t e r  the final wash the 
immunoprecipitated complexes were resuspended in 60 pi o f  fluorography sample 
bu ffer, boiled for  5 minutes and then centrifuged for  1 min to rem ove the residual 
Staphylococcus cells. The supernatant containing the immunoprecipitated 
translation products was then assayed for total radiolabelled amino acid 
incorporation and then analysed on SDS P .A .G .E .
3.9.3 Quantitation o f Cytochrom e P-450 apoprotein Synthesis
Quantitation o f  the immunoprecipitates resulting from  the translation 
products o f  in v itro  protein synthesis was achieved by fluorographic analysis o f  the- 
SDS polyacrylamide gels which allowed visualisation and subsequent excision o f  the 
rad ioactive  bands o f interest. Tw o d if fe ren t  methods were used o f  which the second 
was judged to be the most e f f ic ien t .
The first method utilising the digestion procedure o f  Mahin and Lo fberg  (1966) 
involves the use o f  perchloric acid and hydrogen peroxide. The ge l slice was placed 
in a 10 ml glass vial to which was added 0.2 ml o f  60% (v/v) perchloric acid fo llowed 
by 0.4 ml o f  30% (v/v) hydrogen peroxide. The vial was then capped and incubated 
at 60 °C  in a shaking water  bath for  a period o f  f iv e  hours by which t ime the gel 
slice had dissolved. The via l was allowed to cool a fter  which 10 ml o f  Econofiuor 
scintillation fluid (N ew  England Nuclear) was added with counting being carried out 
a fte r  1 hour.
In the second method the gel slice was rehydrated in a glass vial by the
addition o f  150 pi water  over a period o f f iv e  hours. To this was added 10 ml o f
Econofiuor containing 3% (v/v) Protosol (N ew  England Nuclear) with incubation at
37°C  being allowed to proceed fo r  12-16 hrs. The vials were then cooled and
subsequently counted. R ad ioac t iv ity  was monitored using an LKB  Rackbeta  liquid
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scintillation counter giving a counting e f f ic ien cy  for S o f  66%.
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3.10 F L U O R O G R A P H IC  E N H A N C IN G
The primary reason fo r  the utilisation o f  fluorographic techniques in the 
analysis o f  radiolabelled products within polyacrylamide gels is that fluorographic 
scintillators can increase sensitiv ity  in detection  by as much as 10-15 fo ld for  ^ S -  
methionine. Three fluorographic scintillators were utilised during the course o f  this 
study; sodium salicy late and the com m erc ia lly  available scintillators A m p lify  
(Amersham) and En^hance (N ew  England Nuclear). For isotope detection  Kodak X -  
Om at A R  or Kodak Industrex C X  X -ray  f i lm  was used. Fluorographic sample bu ffer  
utilised throughout the immunoprecipitation analysis consisted o f  2% (w/v) SDS, 5% 
(v/v) 2-mercaptoethanol, lOmM ED TA , 30% (v/v) g lycero l, 0.01% (w/v) bromophenol 
blue.
Fluorographic detection  o f  rad ioact iv ity  with the water  soluble fluor, sodium 
sa licy la te , was carried out according to the procedure o f  Chamberlain (1979). 
Follow ing electrophoresis the gels were f ixed  fo r  1 hour on a shaking w ater  bath in 
30% (v/v) methanol, 10% (v/v) g lac ia l a cet ic  acid and 10% (w/v) T C A .  They w ere  
then washed for  30 minutes in water  and then for  30 minutes in IM  sodium salicy late 
a fte r  which they were dried on a B io-Rad gel drier on Whatman 3MM paper and then 
plated against X -ray  film  at -70°C . The only disadvantage o f this method was that 
a slightly m ottled image o f  the rad ioact ive  bands was obtained which is be lieved to 
result from  the re f lec t ion  o f  light from  the surface o f  large crystals o f  sa licy late .
A m p li fy  was probably the safest fluorographic reagent used, being also both 
fast and convenient with it being possible to treat a gel within 2 hours on fo llow ing
3
the manufacturers instructions. H ow ever , o f  the 3 fluorographic reagents En hance 
was deemeo to be the most e f f ic ie n t  and was there fore  the most utilised despite the 
longer preparative t ime.
The polyacrylamide gels were firs t  f ixed in 30% (v/v) methanol, 10% -(v/v) 
g lac ia l acet ic  acid and 10% (w/v) T C A  for  one hour applying gentle agitation. They
were then impregnated fo r  a further hour with En^hance a fte r  which the fluor is 
precip itated by immersing the gel in w ater . The precipitation stage was carried out 
fo r  f i f t y  minutes with gentle agitation a fte r  which the gel was dried at 60-70°C on 
Whatman 3MM paper using a Bio-Rad ge l drier. The dried gel was placed against X -  
ray film  and exposed at -70 °C . Generally  an exposure period o f  2 weeks would be 
required for the analysis o f  immunoprecipitations and 1 week fo r  the analysis o f  
to ta l translation products.
3.i i  SYNTHESIS OF C O M P L IM E N T A R Y  D N A  FRO M  C LQ F IB R A T E -IN D U C E D
C Y T O C H R O M E  P-452 m R N A
The final experimental stage in this pro ject was the synthesis o f  a double 
stranded complimentary D N A  (cD N A ) sequence to the corresponding c lo fib ra te  
induced po ly (A )+m R N A . This was carried out with a primary viewpoint o f  
determining and subsequently optimising the conditions required fo r  attaining full 
length copies o f  cD N A , which would eventually be cloned and then utilised as highly 
spec if ic  hybridisation probes for  the analysis o f  the gene structure o f  the highly 
re lated cytochrome P-450 isoenzyme fam ily .
Although the enzym atic  conversion o f po ly (A )+m R N A  to double stranded 
cD N A  is now a w e l l  established procedure the task for  optimisation for  both size and 
yield is influenced by so many factors  (e.g. ribonuclease degradation, pH, 
monovalent and divalent cation concentration e tc )  that the successful isolation o f  
full length double stranded cD N A  (ds -cD N A ) becomes a complex assignment. For 
this reason no spec if ic  methodology was found to be entire ly  successful and as such 
modifications o c a var iety  o f  procedures had to be employed.
3.11.1 Synthesis o f  Single Stranded cD N A
The firs t  stage is the further enrichment o f  the m R N A  o f  interest and this is 
achieved by size fractionation  o f  the m R N A  through a sucrose gradient as described
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in section 3.5. Each fraction  o f the m R N A  is then translated in v itro  and the 
protein product o f  interest is identified by a combination o f immunoprecipitation 
and SDS polyacrylamide gei electrophoresis.
Solutions utilised
1. Reverse  transcriptase bu ffer: 500mM Tris-HCl (pH 8.3), 5GmM MgCty, and 
50mM dithiothreitol.
2. Unlabelled nucleotide (dN T P ) solution; containing G TP , C T P , and T T P  at a 
concentration o f  20mM and A T P  at a concentration o f  lOmM.
3. Oligo dt^2_Fg primer at a concentration o f  660 pg/ml in water.
4. T/E/N buffer: 20mM Tr is -H C l (pH 8.0), Im M  ED TA  and lOOmM NaC l.
5. T/E buffer: lOmM Tris -H C l (pH 8.0), Im M  ED TA
The pH o f  the reverse transcriptase bu ffer  is measured at 42 °C  because o f  the
pH variab ility  o f  Tris with temperature. The amount o f  po ly (A )+m R N A  utilised
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varied from  0.5 to 2.5 pg per assay with an optimal amount o f  50pCi o f  (a -  P ) A T P  
utilised as the labelled precursor. A l l  stock solutions, buffers and apparatus utilised 
were sterilised.
The firs t  optimisations required to be carried out, are the determination o f  the 
ratio o f  reverse transcriptase to m R N A  tem plate in order to get  maximal yield o f  
cD N A  per pg m R N A  as measured by the incorporation o f  rad ioactive  label (as 
described in section 3.12.2). The sequence o f  additions for the synthesis o f  single 
stranded cD N A  (ss cD N A ) is as fo llows:-
1.25 pi o f  stock unlabelled dNTP  solution is added to 2.5 pg o f  enriched 
c lo f ib ra te  p o ly (A )+m R N A  fo l low ed  by 50 pCi o f  (a-32p) -A T P  in a polypropylene 
eppindorf tube. The m R N A  prior to addition was heated at 65°C  for  3 minutes 
fo llow ing which it was cooled in ice. The mix was vortexed and then pe lleted by 
centrifuging for a fe w  seconds in a m icrofuge. The components w ere  then
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lyophilised in order to rem ove trace amounts o f  ethanol and possible contaminating 
trie thyl ammonium bicarbonate utilised as stabilising agents for  the radiolabel which 
would otherwise inhibit the. a c t iv ity  o f  the reverse transcriptase enzyme. F ive  pi o f  
250mM KC l, 5pl o f  reverse transcriptase bu ffer, 4ug o f oligo (dt) primer and 0 .5pi 
o f  40mM sodium pyrophosphate were then added in succession with the contents o f  
the tube again being mixed by gentle vortex ing. Avian myeloblastosis reverse 
transcriptase was then added at concentrations ranging from  0 to 100 units o f 
enzyme per pg m R N A  tem pla te . Sterile  w ater  was finally added to a final volume 
o f  25 pi a fte r  which the contents o f  the tube were mixed by gentle vortexing and 
then returned to the bottom  o f  the tube by centrifugation fo r  15 seconds in a 
m icrofuge. The mixture was then incubated at 42°C  fo r  2 hours, with aliquots being 
regularly rem oved throughout this period so that the amount o f  cD N A  being 
synthesised could be monitored. The use o f  sodium pyrophosphate as a ribonuclease 
inhibitor was shown to increase the amount o f  cD N A  synthesised in excess o f  the 
amount when vanadyl-ribonucleoside complexes were utilised as inhibitors. A f t e r  
the incubation period the reaction was extracted  with an equal volume o f 
phenol/chloroform In order to separate the proteins from  nucleic acids. The 
fractions were throughly mixed by vortex ing a fte r  which they w ere  centrifuged for  
50 seconds in a m icro fuge. The aqueous phase was then transferred to a fresh 
eppindorf tube, with the organic phase being re-extracted  with an equal volume o f  
T/E/N bu ffer . The aqueous phase was then isolated as be fore  with the two phases 
then being combined. The synthesised cD N A  was separated from the unincorporated 
dNTPs by chromatography on sephadex G-75 equilibrated in T/E/N bu ffer  by the 
procedure outlined in section 3.12.4. Fractions o f  0.2 ml w ere  co llec ted  with the 
amount o f  rad ioact iv ity  present being monitored by Cerenkov counting. Those 
fractions corresponding to ss cD N A  are pooled and to which is added one tenth 
volume o f 3M NaOH and lOmM E D T A  in order to hydrolyse the m R N A  tem plate . 
The fractions were then incubated at 68°C  fo r  1 hour a fte r  which the ss cD N A  was
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precip itated by the addition o f  3M sodium aceta te  (pH 4.7) to g ive a final 
concentration o f  0.3M fo l low ed  by the addition o f  2 volumes o f  ethanol. It is 
important to ensure that the alkali is neutralised and this is checked by spotting 
universal pH litmus paper. The ss eD N A  is allowed to precip ita te  overnight at 
-7 0 °C  fo llow ing which it is centrifuged down in a m icrofuge fo r  15 minutes at 4 °C . 
The pe lle t  is washed tw ice  in ice -co ld  70% ethanol, being pe lleted each time as 
described. Finally the ss cD N A  is lyophilised to rem ove all traces o f  the ethanol and 
is resuspended in water . The size o f  the resulting first strand cD N A  is determined 
by electrophoresis through a 1.2% alkaline agarose gel as described in section 3.12.3. 
A liquots are removed at all the relevant steps because as the spec ific  ac t iv ity  o f  the 
rad ioact ive  precursor is known this gives a means o f  estimating the yield o f  the 
reaction product.
3.11.2 Synthesis o f  Double Stranded cD N A
To 20pl o f  ss cD N A , 5pl o f  dNTP  stock is added fo llowed  by 2.5pl o f  20mM 
A T P  in order that all the dNTPs are at a final concentration o f  Im M . A  further 
25pCi o f  (a -3 2 P )-A T P  is added and the reaction mixture gently  vortexed. The 
K lenow fragm ent o f  E. co li D N A  polymerase I is added to a final concentration o f  30 
units per pg o f  initial m R N A  tem pla te with the reaction mixture then being brought 
to a to ta l volume o f  50pl with ster ile  w ater . A  further 50pl o f  2 x second strand 
buffer consisting o f  0.2M HEPES (pH 6.9), 20mM M gC l2, 5mM dithiothreito l and 
0.14M KC1 was then added. The contents o f  the tube was again mixed and brought 
to the base o f  the tube by centrifugation a fte r  which it was incubated at 15°C  fo r  
20 hours. The long incubation period is required to allow the enzyme to find the 
firs t strand cD N A  molecules with hairpin loops at their 3’ ends. The reaction is 
term inated by the addition o f  2 .0pi o f  0.5M E D TA  and the mixture is chilled on ice. 
The solution was then ex tracted  by the addition o f  100 pi phenol/chloroform as 
described previously. The two aqueous phases obtained were pooled and the ds
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cD N A  was separated from  the unincorporated nucleotides by chromatography on 
Sephadex G-50. The final ex traction  was carried out utilising T/E bu ffer  which was 
also the bu ffer  used for  the equilibration o f  the Sephadex G-50. The fractions 
containing ds cD N A  w ere  pooled, precip itated and washed as be fore . A f t e r  
lyophilisation the ds cD N A  was resuspended in 20pi water.
In an attem pt to increase the yield o f  full-length ds cD N A , the reaction 
mixture was then treated with reverse transcriptase. This is to re- in it ia te  synthesis 
at strong-stop sequences in the initial ss cD N A . To the ds cD N A , 5pl o f  1M Tris -HC l 
bu ffer  (pH 8.3), 7pl o f  1M KC1, 2pl o f  250mM MgCty, a solution o f  all four dNTPs at 
a final concentration o f  Im M , 2 pi o f  700mM 2-mercaptoethanol, 50 units o f  reverse 
transcriptase and water is added to g ive  a final volume o f  50pl. The solution was 
then mixed by gentle vortex ing, b r ie fly  m icrofuged and then incubated at 42 °C  fo r  1 
hour. The reaction is stopped by the addition o f  2.0 pi o f  0.5M E D T A  and by chilling 
the mixture on ice . Jhe sample was then extracted  with an equal volume o f  
phenol/chloroform with a second extraction  then carried out with T/E buffer. The 
aqueous phases were combined with the ds cD N A  then being separated from  the 
unincorporated nucleotides by chromatography on Sephadex G-50 as described. The 
ds cD N A  was subsequently precip ita ted  with ethanol, and washed tw ice  with ice cold 
70% ethanol, lyophilised and then resuspended in water. In order to ensure that the 
synthesis o f  the second strand was successful, the length o f  the ds cD N A  is 
visualised on an alkaline 1.4% agarose gel. As this was shown to be the case the 
experiment was term inated at this stage.
3.12 G E N E R A L  A N A L Y T IC A L  PR O CED U RES
3.12.1 Preparation o f  and Extraction with Phenol/Chloroform
One o f  the key steps in ds cD N A  preparations is the rem oval o f  utilised 
enzym es from  aqueous solutions o f  nucleic acids with a 1:1 mixture o f  
phenol/chloroform. C om m erc ia l phenol has to be further purified in order to
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rem ove contaminants that cause breakdown or cross linking o f  R N A  and D N A . This 
is achieved by redistilling phenol at 160°C to which is then added 8-hydroxyquinoline 
at a final concentration o f  0.1% (w/v). The melted phenol is then extracted  tw ice  
with an equal volume o f IM Tris bu ffer  (pH 8.0) fo llowed by a final extraction in 
0.1M Tris bu ffer  (pH 8.0), 0.2% (v/v) 2-mercaptoethanol and 0.1% (w/v) 8- 
hydroxyquinoline. The phenol is then stored in small aliquots at -40°C . Chloroform  
is defined as a mixture o f  ch loroform  : isoamyl alcohol at a ratio o f  24: 1 (v/v). This 
is stored at room temperature.
Extraction is achieved by the addition o f  an equal volume o f 1:1 (v/v) 
phenol/chloroform. The solution is thoroughly mixed until an emulsion forms at 
which stage the phases are separated by centrifugation in a m icrofuge fo r  50 
seconds. The aqueous phase is carefu lly  rem oved and transferred to a fresh 
polypropylene tube. The organic phase is then re-extracted  as be fore  with an equal 
volume o f  T/E/N or T/E bu ffer . The aqueous phases are pooled and the lower 
organic phases discarded.
3.12.2 Measurement o f  R ad ioac t iv ity  in Nucle ic  Acids by T r ich loroacet ic  
Ac id  Prec ip ita tion
An aliquot o f  labelled nucleic acid solution is added to a tube containing 200 pi 
o f  200 pg/ml salmon sperm D N A  in 20 mM E D TA. Precip ita tion  is achieved by the 
addition o f  1.75 ml o f  ice-cold  10% (w/v) T C A ,  mixing, and chilling on ice fo r  1 
hour. The precip ita te was co llec ted  by f i lter ing  through a GF/C f i l te r .  The f i l t e r  
was then rinsed tw ice  with 5 ml o f  ice-cold  10% (w/v) T C A ,  tw ice  with 5 ml 8% 
(w/v) T C A ,  tw ice  with 96% (v/v) ethanol, dried and subsequently counted.
3.12.3 Sizing o f  cD N A  in Alkaline Agarose Gels
A lkaline electrophoresis buffer: 30mM NaOH and Im M  E D TA .
Alkaline loading buffer: 50mM NaOH, Im M  ED TA, 2.5% (w/v) F ico ll (type 400) and
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A  1.2% (w/v) slurry o f  nucleic acid e lectrophoretic  grade agarose was made up 
in 50mM NaC l and Im M  ED TA . The mixture was melted on a w ater  bath, cooled to 
55°C  and then poured into the gel apparatus described in section 2.8. The gel was 
a llowed to set for  one hour a fte r  which it is covered with electrophoresis bu ffer  and 
allowed to soak fo r  a further hour. Initial migration o f  the D N A  samples into the 
gel was carried out at 25V with the vo ltage subsequently being increased to 50V. 
Electrophoresis was carried out until the dye had migrated approximately 8cm down 
the length o f  the gel. A t  the end o f  the run the gel was rem oved from its glass 
cassette , soaked in 7% (w/v) T C A  fo r  30 minutes and then dried by blotting with 
Whatmann 3MM f i l te r  paper. The gel was then covered with cling film  and plated 
against Kodak X-ray fi lm  at room temperature.
3.12.4 Sephadex Column Chromatography
The required amount o f  Sephadex G-50 or G-100 was swollen overnight in T/E
or T/E/N buffer. The slurry was then autoclaved for  15 minutes at 15-lb/square inch
on liquid cyc le , allowed to cool and stored at room temperature a fte r  a further
bu ffer  change. Columns utilised w ere  10 ml sterile , disposable, sterilin pipettes
plugged at one end with ster ile  glass wool. The sephadex was poured to a column
height o f  9 inches and was then further equilibrated with the appropriate bu ffer . In
order to fract ionate cD N A  from  unincorporated nucleotides 5pl o f  1 mg/ml (w/v)
Orange G transfer dye was added to the cD N A  solution. The tracker dye m igrates
with the unincorporated nucleotides. Fractions o f  approximately 200 pi were
co llec ted  into sterile  eppindorf tubes. It was also possible to fo l low  the progress o f
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the incorporated and unincorporated ( P ) dNTPs down the column using a hand-held 
minimonitor.
0.025% (w/v) bromocresol green.
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For the quantification o f  rad ioact iv ity  in areas o f  silica gel originating from  
T L C  plates CAB-O -S IL  was utilised. This consisted o f  4% (w/v) CAB-O -S IL , 0.5% 
(w/v) PPO  and 0.05% (w/v) dimethyl P O P O P  in scintillation grade toluene (sulphur 
fre e ) .
Routinely used standard scintillation fluid consisted o f  0.5% (w/v) PPO , 0.01% 
(w/v) dimethyl PO PO P, 33% (v/v) sym peronic-NX detergent in scintillation grade 
toluene.
3.13 SCINTILLATION FLUIDS
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PURIFICATION A N D  CHARACTERISATION OF MICROSOMAL ENZYMES
4.1 IN TR O D U C T IO N
An important feature o f  cytochrom e P-450 is the ability o f  severa l xenobiotics 
to cause the proliferation  o f  smooth endoplasmic reticulum with a concomitant 
increase in CO binding m icrosomal proteins having an absorbance maximum at or 
near 450 nm. This increase was associated with augmented drug metabolising 
a c t iv ity  and is now known to be due to induced mixed function oxidase isoenzymes. 
It is now recognised that d i f fe ren t  xenobiotics induce d if fe ren t cytochromes P-450 
and that at least 15 submembers o f  the hepatic cytochrome P-450 fam ily  exist. 
How ever  the precise mechanisms that contro l the regulation and expression o f  these 
multiple forms is far from  clear. This is partia lly  due to the fa c t  that until recently  
the ex istence o f  techniques spec if ic  enough to identify and quantitate the exact 
complement o f  cytochrome P-450 isoenzymes were just not available, let alone 
mentioning the occurrence o f  species, age, tissue d if ferences and the repressive or 
destructive e f fe c ts  o f  various exogenous chemicals.
Accord ingly , this study was in itiated with a v iew  o f  isolating the major 
phenobarbitone-induced cytochrom e P-450 isoenzyme and characterising it at both a 
b iochemical and molecular biology leve l.
Utilising protein purification procedures two major forms o f  phenobarbitone- 
induced cytochrome P-450 were isolated to e lectrophoretic  homogeneity. The study 
was expanded to include two further forms o f  e lectrophoretica lly  homogeneous 
cytochrome P-450 also purified within our laboratories, in order to study, the 
inductive heterogeneity  o f  these cytochrom e P-450's.
One o f  these forms, cytochrom e P-452, is induced fo llow ing pretreatment o f  
animals with the hypolipidaemic agent c lo f ib ra te  (ethyl 2-4-chlorophenoxy)-2~ 
methyl propanoate, (Gibson et  al., 1982). Induction resulted in significant and 
se lected  increases in cytochrome P-450 leve ls  with the cytochrome P-452 having a
Chapter 4
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high a ct iv ity  towards the to and ( to ~1) hydroxylation o f  fa t ty  acids such as lauric 
(dodecanoic) acid.
The final form  o f  cytochrom e P-450 utilised was also purified within our 
laboratory and was the major isoenzyme induced fo llow ing induction by 8-napthoflavone. 
This form  (cytochrome P-447) has a very  high ethoxyresorufin O-deethylase ac t iv ity  
and also corresponds to the major cytochrom e P-450 induced in rat l iver  fo llow ing
3-methylcholanthrene administration, sometimes termed cytochrome P-450c.
This chapter describes the purification o f  the two phenobarbitone-induced 
cytochrom e P-450 isoenzymes and the associated flavoprotein  N A D P H  cytochrom e- 
c (P-450) reductase. These purified cytochrome P-450 isoenzymes w ere  
subsequently characterised by a var ie ty  o f  c r iter ia  being compared and contrasted 
to the two other cytochromes described above. In addition a number o f  parameters 
relating to the induction o f  these spec if ic  isoenzymes fo llow ing single dose induction 
have been investigated in both hepatic and renal microsomes.
RESULTS
4.2 IN D U C T IO N  OF M IC R O S O M A L C YTO C H R O M E S  P-450 B Y  P H E N O B A R B ITO N E , 
C LO F IB R A T E  A N D  6 -N A P T H O F L A V O N E
The induction o f  microsomal cytochrom e P-450 isoenzymes was monitored by a 
var ie ty  o f  cr iter ia , one o f which was their e lectrophoretic  separation on SDS 
P .A .G .E . An example o f  this is illustrated in F ig. 4.1 which shows the 
e lectrophoretic  separation o f  m icrosomal proteins derived from  the hepatic 
microsomes o f  uninduced (contro l), phenobarbitone, c lo fib ra te  and 3~napthoflavone - 
pretreated rats. The primary region o f  interest is in the 40,000 to 60,000 molecular 
weight range where many o f  the bands observed are be lieved to represent 
cytochrome P-450 isoenzymes. The most important points to note however is that 
within this region not only are there significant dif ferences observed between the 
d if fe ren t  microsomal fractions but also in the re la tive  staining intensities o f the 
e lectrophoretic  bands. These observations suggest that pretreatm ent o f rats with
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Figure 4.1
SDS P .A .G .E . o f  the H epat ic  M icrosomal Fractions 
Isolated from Rats P re trea ted  w ith Various Inducers
10
9 2 . 5K
6 8 K 
6 0  K 
53  K 
4 3 K
3 6 K
£ 2
T rack
Number 1 2 3 4 3 6 7 0 9  10
Microsomal proteins w ere  applied in the amounts indicated within the 
brackets. In this gel 10 pmol o f  cy tochrom es P-450 B p  P-450 B p  P-447 and 20 
pmol o f  cytochrom e P-452 was added to the re levant tracks. Tracks 1, 10 contained 
0.2 pg o f each o f the standard proteins listed in section 2.8.2. M igration  was from  
top to bottom . The nature o f  the inducing agents w ere :-
T rack 2 Contro l M icrosomes (20 pg)
T rack 3 C ytochrom e P-450 B^
T rack 4 Phenobarbitone-induced microsomes (12 pg)
T rack 5 C ytochrom e P-450 B 7
T rack 6 C lo fib ra te- induced  microsomes (10 pg)
T rack 7 C ytochrom e P-452
Track 0 0-napthoflavone-induced microsomes (12 pg)
T rack 9 Cytochrom e P-447 (partia lly  purified)
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Figure 4.2
SDS P .A .G .E . o f  Phenobarbitone-induced Microsomes 
Fo llow ing D i f fe r en t  Dosing Regimens
10
6 8 K  
6 0 K  
5 3 K 
4 3 K
3 6 K
• -rto* l • v•sss*. .JTt
5* «§ * *  ***
'
T rack 
T racks
T racks
T racks
1
2, 7
3, 0
4, 9
Tracks 3, 10
T racks
: 0.2 ug o f  each o f the standard proteins.
: 12.3 and 25 pg o f  m icrosomal protein . Animals w ere
dosed ora lly  with 0.1% (w/v) phenobarbitone in their drinking 
w ater  for  4 days, on the 5th day given an i.p. dose o f  40 mg/kg 
and killed on day 6.
: 12.5 and 25 pg o f  m icrosomal protein fo llow ing  oral
dosing with 0.1% (w/v) phenobarbitone in their drinking w ater  
for two weeks.
: 12.5 and 25pg o f  m icrosomal protein fo llow ing  oral dosing
with 0.1% (w/v) phenobarbitone in their drinking w ater  for 4 
days.
: 12.5 and 25 pg o f  m icrosomal protein fo llow ing  a i.p.
dosage o f  75 mg/l<g for 4 days. K il led  on day 5.
: 5 pmol each o f  cy toch rom e P-450 and P-450 B2.
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these compounds results in a lterations in the balance o f  cytochrom e P-450 
isoenzymes in the endoplasmic reticulum o f rat liver. These changes in the hepatic 
microsomal protein content are also influenced by the mode o f  induction as shown 
in F ig. 4.2. This illustrates the e lectrophoretic  separation o f  phenobarbitone- 
induced microsomes fo llow ing four d if fe ren t  dosing regimens. The d if fe rences 
observed are shown to re la te  not to the fa c t  that d if fe ren t  proteins may be induced 
fo llow ing d if fe ren t  routes o f  dosing by the same xenobiotic, but to the re la t ive  
degree o f  induction o f  spec if ic  isoenzymes. For this reason it is important to 
maintain a standardised dosing reg im e as w ell as using purified cytochrome P-450 
hemoproteins in order to characterise microsomal induction trends by d if fe ren t  
xenobioties.
4.3 P U R IF IC A T IO N  OF M IC R O S O M A L  ENZYM ES
4.3.1 Purification o f Hepatic Microsomal Cytochrom e P-450 from 
Phenobarbitone-induced Rats
Cytochromes P-450 were purified from  male Wistar rats by a modification  o f  
the method o f Guengerich and Martin (1980). The purification protocol given in 
materia ls and methods is represented schematically in figure 4.3, and a typical 
purification result is given in table 4.1.
The recoveries  at each step were similar to those reported by other authors up 
to the DEAE sephacel chromatographic stage, a fter  which smaller yields w ere  seen 
due to subsequent subfractionations. In the purification reported (table 4.1), the 
spec ific  contents expressed as nmoles cytochrome P-450 per m illigram o f  protein 
did not always appear to increase as would be expected, for  a number o f  reasons, 
including the fa c t  that during the course o f  purification, cytochrome P-450 
undergoes heme loss to some extent, generating spectrally detectab le  apoprotein 
and decreasing the apparent purity. Also the presence o f  bu ffer components such as 
Emulgen 911 and g lycero l in samples assayed for protein content, in terfered  with 
the Lowry  protein determinations, o ften  making them unreliable.-
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In more recent purifications the purity o f  eluting fractions was subsequently 
assessed with the use o f  SDS P .A .G .E . Here all increases in purity are c lear ly  
observed at each stage o f  the purification.
Solubilisation o f  m icrosomal protein was achieved with a final concentration 
o f  1.4% (w/v) sodium cholate in the presence o f  10 mg/ml protein , fo l low ed  by 
dilution to 0.7% (w/v) cholate. This cholate concentration gave maximal recove ry  
o f  solubilised m icrosomal protein (routinely between 80-90%) with minimal 
conversion o f  cy tochrom e P-450 to P-420 as judged by pilot solubilisation studies 
utilising final cholate concentrations o f  between 0.5 to 2.0% (w/v). The inclusion o f  
the protease inhibitor PMSF (0.4mM) (Guengerich and Martin, 1980) at this stage had 
no apparent e f f e c t  upon the recover ies  at any purification stage.
F igure 4.3
F low  Chart Summarising the Purif icat ion  P ro toco l  Adopted fo r  the Fractionation 
o f  Chromatographica lly  D istinct Phenobarbitone-induced Cytochrom e P-450 Pools
The elution pro fi le  o f  cytochrom e P-450 from 8-aminooctyl sepharose 4B is 
shown in figure 4.4. Recover ies  from  this column were dependent upon the column 
batch and age. New  columns would g ive  recoveries o f  approximately 45% which 
would decrease to between 20-30% with subsequent usage. The cytochrome P-450 
pool was fre e  o f  N A D P H -cy toch rom e P-450 reductase and cytochrome b^ (which 
were subsequently eluted) but contained N AD H -cytochrom e b^ reductase act iv ity .  
The major fractions containing cytochrom e P-450 were pooled and chromatographed 
on DEAE-sephacel according to the procedures outlined in section 2.4.3. No 
significant degradation o f  cy tochrom e P-450 was observed on this column or any 
others throughout the purification. N aC l was used to form  the linear gradient. The 
elution o f  cytochrome P-450 from  DEAE-sephacel is shown in Figure 4.5A, together 
with the corresponding SDS P .A .G .E . analysis o f  the eluted fraction  (Figure 4.5B). 
The tota l yield o f  cytochrom e P-450 recovered  was routinely 50-60% fo r  this step. 
O f  this between 15-20% would represent the cytochrome P-450 B^ form  and 40-45% 
the cytochrom e P-450 B^ fo rm . H ow ever  o f  these tota l pools only a small 
proportion could be further purified because o f  contamination.
The cytochrome P-450 B^ pool contained predominant protein contamination 
o f  apparent subunits molecular weights o f  69,000, 54,000, 50,000 and 34,000. The 
proportion o f  contaminants was dependent upon the point o f  elution, with the most 
homogeneous fractions being found in the ta il region o f  the elution pro f i le . Here the 
cytochrom e P-450 B^ form  was the major protein present with none o f  the 
contamination being present in amounts grea ter  than 10%. Those fractions 
considered most homogeneous as judged by e lectrophoretic  analysis were further 
purified on hydroxylapatite in order to rem ove these contaminants. The elution o f 
the e lectrophoretica lly  homogeneous cytochrom e P-450 B^ as judged by SDS 
P .A .G .E . analysis is shown in figure 4.6. A  double peaked elution pro f i le  was 
obtained with the homogeneous protein being seen within the firs t peak. The initial 
fractions contain contaminating protein o f  apparent molecular weight 69,000 which 
gradually disappears. Towards the end o f  the peak a further contaminant appears o f
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apparent molecular weight 45,000 which runs throughout the second peak fractions. 
The cytochrome P-450 protein o f  the second peak was otherwise homogeneous. 
Those fractions considered homogeneous from  the first peak were pooled and then 
chromatographed on CM-sephadex-C50 in order to rem ove the detergent. The
spec if ic  content o f  the cytochrom e P-450 B^ isoenzyme ranged from 9 to 12 
nmol/mg.
On analysis o f the fractions obtained fo llow ing elution o f  the cytochrome 
P-450 B2 peak from  DEAE sephacel (F igure 4.5A) three distinct pools became 
evident. The initial fractions w ere  usually the least pure containing 3 major bands 
o f  apparent molecular weight 52,000, 53,000 and. 54,000. Further' minor 
contamination was seen with protein bands corresponding to apparent molecular 
weights o f  69,000, 40,000 and 34,000. The contamination seen with these minor 
forms was fa ir ly  uniform throughout the whole o f  the elution pro fi le  (see figure 
4.5B), A t  the peak o f  the elution pro f i le  the major cytochrome P-450 species was 
double-banded with these forms corresponding to the major cytochrom e P-450 B^ 
and P-450 B2 isoenzymic forms. As fo r  the cytochrome P-450 B^ proteins, the most 
homogeneous fractions were seen in the tail region o f  the elution curve with the 
degree o f  minor contamination here also being at its lowest. The very  last fractions 
contained the cytochrome P-450 B2 isoenzyme in a re la t ive ly  pure state, but with an 
underlying protein o f  apparent molecular weight o f  52,000 which could not be 
separated chromatographically. A t  this stage the most homogeneous fractions 
subsequently had to be further purified on DEAE-sephacel which normally ensured 
that homogeneous cytochrome P-450 B2 was obtained. This was achieved by 
utilising a potassium phosphate bu ffer  stepwise gradient in which the ionic strength 
was increased in 5mM increments. Homogeneous cytochrome P-450 B2 was obtained 
fo llow ing elution with 20mM potassium phosphate buffer. Subsequent elution with 
increased ionic strength buffers gave rise to a double banded cytochrome P-450 
isoenzyme fraction . This double banded fraction  could be further purified on a 
hydroxylapatite column in order to rem ove trace higher molecular weight
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Corresponding 10% SDS P .A .G .E . o f  C y tochrom e P-450 Fractions 
fo llow ing D EAE - Sephacel Chromatography
Figure 4.513
3 6 K
B 1 p e a k
s t d  5 0 5 3 5 6 5 9 6 2 6 5 6 8 7  1 7  4
9 2 . 5 K
6 8 K 
6 0 K 
5 3 K 
4 3 K
3 6 K
1 ••
—  . -,
.
B 2 p e a k
1 2. 4  K
7 7 s t d  8 0 8 3  8 6  9 2 9 5 9 8 1 0 1
The fo llow ing  volumes o f  protein w ere  loaded per track
Fractions 50 - 56 = 12 |il
59 - 06 = 10 ul
92 - 101 = 0 pi
103
9 2 . 5K
6 8 K 
6 0 K 
5 3 K 
4 3 K
3 6 K
1 2 . 4K
B 2 p e a k
1 0 5  s t d  1 2 3  1 2 9  1 3 5  1 4 1
The fo llow ing  volumes o f  protein w ere  loaded per track:
F ractions 105 - 110 = 12 pi
120 - 129 = 30 pi
132 - 141 = 35 pi
144 - 45 pi
The fractions were pooled as fo llows for  the further purification o f the cy tochrom e 
P-450 and P-450 isoenzymes.
B^ : fractions 62 - 70 
B ? : fractions 101 - 120
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Figure 4.6 Elution and SDS P .A .G .E . analysis o f  Cytochrom e P-450
from Hydroxylapatite
• 1 2 ,F r i c t i o n  v o I u m a : 5 m l  
F l o w  r a t *  : 2 5 m I / h r
00 120 180 
F r a c t i o n  N u m b t r
9 2 . 5 K
6 8 K
6 0 K
5 3 K
4 3 K
3 6 K
12.5K
( 9 % g e l )
1 6 8  1 6 0  1 5 2  1 4 4  1 3 6  1 2 8  s t d
Aliquots o f  34 pi were applied to the respective  tracks. Fractions
130-160 were pooled for chromatography on CM-sephadex-C50.
105
contamination, but it was not found possible to separate the two isoenzymic forms. 
The final stage was that o f  rem ova l o f  detergent on CM-sephadex-C50. A  SDS P .A .G .E . 
analysis and elution pro f i le  o f  the 20mM eluted cytochrome P-450 B^ fraction  is 
shown in figure 4.7.
The spec ific  content o f  the cytochrome P-450 B^ pool ranged from  12-15 
nmol/mg. These values w ere  found to be slightly higher fo r  both cytochrome P-450 
B-^  and B^ isoenzymes when the heme content was determined using the pyridine 
hemochrome assay. This d if fe rence  was believed to be due to the instability o f  this 
enzyme in the presence o f  sodium dithionite, which was used as the chemical 
reductant in the fo rm er assay system. The final preparations described above w ere  
both shown to be free  o f  Emulgen 911. The fe rr ic ,  ferrous and ferrous - carbon 
monoxide absolute spectra o f  these purified cytochrome P-450 isoenzymes are 
shown in figure 4.12A,B (section 4.4.4.).
Fraction A  isolated from  the initial DEAE sephacel column, containing all the 
unadsorbed proteins from  this column was subjected to e lectrophoretic  analysis and 
subsequently discarded. This was primarily because the fraction did not contain the 
major cytochrome P-450 forms o f  interest and because o f  its low spec ific  content.
The final fraction  isolated from  the DEAE column-designated fraction B^ -was 
shown to consist o f  a single seemingly homogeneous protein o f  apparent molecular 
weight 15,500. This information coupled with its ferrous-carbon monoxide spectra 
indicates that it is probably cytochrome b^ which was carried over from  the 
previous 8-aminooctyI sepharose 4B column.
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Figure 4.7
Elution P ro f i le  and SDS P .A .G .E . Analysis o f  Cytochrom e P-450 
Ety from DEAE-Sephacel fo llow ing Step-wise Gradient Elution
F r a c t i o n  N u m b
9 2 . 5 K
6 8 K i 
6 OK 
5 3 K 
4 3  K
>)
( 8 % g e l )
1 1 9 1 1 3 1 0 9 1 0 4 9 8 s t d
35gl aliquots were applied to the respective  tracks.
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SDS P .A .G .F . o f  Purified  Cytochrom e P-450 and P-450 Isoenzymes
Figure 4.0
9 2 . 5 K
6 8 K  
6 0 K 
5 3 K 
4 3 K
3 6 K
M
--
•
- i
;T7|
T% '
■ • CTM
•.
(99o ge l )
Tracks 1, 5 
Track 2 
Track 3 
Track 4
standard molecular w eigh t proteins.
15 pmol cy toch rom e P-450 B^.
10 pmol each o f  cy tochrom es P-450 B-, and P-450 B? 
15 pmol cytoch rom e P-450 B ? .
4.3.2 Purif icat ion  o f Ra t H epatic  N A D P H -C y to ch ro m e  P-450 Reductase
N A D P H -cy toch rom e  P-450 reductase (Fp t )  was purified according to the 
m ethodology o f  Yasukochi and Masters (1976) as described in section 2.4.5. Fpt was 
also purified by a m od if ica tion  o f  this method in which it was eluted as a by-product 
from  the 0-am inooctyl sepharose 4B column in the course o f a cy toch rom e P-450 
purification. Subsequent steps w ere  os described. Both forms o f cy tochrom e P-450, 
B^ and 3 2, could be isolated in a partia lly  purified state fo llow ing elution o f the
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solubilised m icrosomes from  DEAE-sephacel. An elution pro f i le  and the 
corresponding analysis o f  the fractions obtained throughout the Fpt purification is 
illustrated in figures 4.9A and B. The cytochrom e P-450 pools w ere  not utilised 
further however, due to the presence o f large amounts o f  cy tochrom e P-420. The 
partia lly  purified Fpt was then further purified on 2’ , 5', -ADP-sepharose 4B, 
utilising the property o f  2 '-AM P being a potent com pet it iv e  inhibitor o f  N A D P H -  
cytochrom e c reductase a c t iv ity .  A t  this stage the Fpt would normally be present in 
a homogeneous state although occasionally trace o f  a lower molecular w eigh t 
fragm ent was discernabie. This was subsequently rem oved on the final cobum n o f 
hydroxylapatite  which was used to rem ove  the detergent present and to concentrate 
the protein.
F igure 4.9A
Elution o f  Cytochrom es P-450 and Fpt from  DEAE-Sephacel
o
- 2 . 5 1
Praotlon.Numbor
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Figure 4.9B
SDS P.A.G.E. of Corresponding Fractions and Purified Fpt.
8 7 6 5 4 3 2 1
The volumes o f  each fract ion  loaded per track are indicated within brackets
Tracks 1, 8 = Standard molecular weight proteins.
2 Fraction  50 (20 ul)
3 Fraction  75 (20 pi)
4 Fraction  115 (15 pi)
5 Fraction  130 (20 pi)
6 Pooled Fpt from DEAE!-sephacel (20 pi)
7 Fpt fo llow ing chromatography on 2',5’-A D P  agarose
A purification table for a large scale Fpt preparation involving 60 rats orally 
dosed with 0.1% (w/v) phenobarbitone in drinking water  for 6 days is shown in table 
4.2. The final preparations y ielded an e lectrophore tica lly  homogeneous monomeric 
protein o f molecular weight 77,000 as judged by SDS P .A .G .E . analysis on 9% 
acrylam ide gels. A l l  preparations were free  o f  Emulgen 911, as determined by a 
co lourim etric  method.
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4.4 C H A R A C T E R IS A T IO N  OF PU RIF IED  C Y T O C H R O M E  P-450 ISOENZYMES
4.4.1 Substrate Turnover Studies
With the development o f  procedures fo r  the purification o f  homogeneous forms 
o f  cytochrom e P-450, reconstituted enzym e systems have o f fe red  the possibility o f  
g rea ter  detailed studies o f  the d if fe ren t ia l substrate spec if ic it ies  o f  cytochrome 
P-450 multiple forms. Benzphetamine, ethoxyresorufin, and lauric acid w ere  
utilised as substrates, being w idely accepted as suitable marker substrates fo r  
cytochrome P-450, P-447 and P-452 respective ly . The corresponding turnovers for  
these cytochromes P-450 are shown in table 4.3. The results revea led  clear 
d if fe rences in substrate sp ec if ic it ies  between the isoenzymes. For example, the 
cytochrom e P-450 B^ and P-450 B2 forms exhibited exceptionally  high rates o f  
benzphetamine N-demethylase ac t iv ity ,  whereas only lim ited a ct iv ity  was seen for  
the metabolism o f  lauric acid and ethoxyresorufin.
Cytochrom e P-452 displayed a marked substrate spec if ic ity  for  lauric acid. 
H P L C  analysis o f  the 11- and 12- hydroxylauric acid metabolites indicates 
pre ferentia l formation o f  12- hydroxylaurate metabolites by cytochrome P-452 
(Tamburini et al., 1984). In contrast cytochrome P-452 exhibited only trace  
turnovers with both benzphetamine and ethoxyresorufin as substrates.
In contrast, cytochrome P-447, exhibited a distinct substrate spec if ic ity  fo r  
ethoxyresorufin deethylation, an ac t iv ity  that was not shown by any o f  the other 
isoenzymes to any significant extent.
In addition to the substrates listed in table 4.3, cytochrome P-450 B2 was 
shown to be responsible fo r  the metabolism o f  1-napthol in both N A D P H  and cumene 
hydroperoxide dependent reconstitution reactions. (d’A rcy  Doherty et al. 1984) 
yielding napthoquinones and cova lently  binding species. In the presence o f  N A D P H  
the formation o f  1,4-napthoquinone (the major m etabolite ) was observed within 30 
seconds and was shown to have an almost to ta l dependence on cytochrome P-450 and 
N A D P H  cytochrome P-450 reductase. In the absence o f  N A D P H  and N A D P H -
R
ec
on
st
it
u
ti
on
 
of
 
D
ru
g 
Fa
tt
y 
Ac
id
 
O
xi
d
at
iv
e 
A
ct
iv
it
ie
s 
in 
th
e
112
i a
ro
3co
H
oLA
nP
ICL
ro
E
o
JZ
go
4-1Da
O
h
ro>
3
4-1
co
Od
E
t~io
Lu
XJ
ro
t-,
ZDCL
ro
gcz
roCO
ro
ch
0 .
ZD
Ch
O
CO
ro
A>.
X
o
X !4-JLJ
ro
c
E
CO4-J
ro
JZ
c l
n
c
roCO
oco
G*
Ch
ZD
CO
ro
COco
> .
X4-J
CD
ro
O
ECh
o
Ll.
co
X4—)
CD
E
ro
Q
CN
ro
COco»■-!
da
xoCh
XJDA
X
CD
LA
<t
I
CL
ro
Eo
Ch
X
G
O4-J
DA
u
CO
CDo
LAMD
CN
O
LA
LA
IA <
Q
CN
O
I—i
LA 
i—I
CN
JZ)
Ov X I 
• CN 
CN
CN
CD
LA
LA
LA
fA
fN
CN
C
.24-J
CLro
G
X
ro
ro
JZ
ro
EoChX
G
O4-J
>.
o
—-—Io
Ec
4-1
G
ZD
XD
CD
O
E
c
CO
CO
XJ
ro
CO
CO
roCh
CL
X
ro
CO
ro
CD
O
00
CD CN
HCU
LA LA LA <d-<P <P
Q- CL CL CL CO
c
CDcoro
Ch
CL
roCh
CD
E
CD
4-J
CODa
CO
XJ
ro4-J
D4-J
‘ coco
G
CD
Ch
ro
JZ
c
ro
co
CL
Eo
G
Chro
x
co
LA
r
CL
ro
Eo
Ch
X
G
O4-J
Da
G
O O
OO
Ov
rH
.23
ZD
X
E
CO
t-
XJo
X4-1
ro
E
ro
E
X
ZD
O♦—H
O
G
ro
X
c.2Xj
G
ro
4-Jro
XJ
ro
>
X
E
ZD
E
'c
E
rox
ro x 
I—
Da4-1
>
X
CO4->
G
CD4-J
CD
X
O
Z
<
□
z
cytochrom e P-450 reductase, 1-napthol was metabolised in a cumene hydroperoxide 
and cytochrome P-450 dependent reaction to 1,2- and 1,4-napthoquinone and 
cova lently  bound products. Glutathione and ED TA  inhibited both the N A D P H  and 
cumeme hydroperoxide formation o f  cova lently  bound products.
4.4.2 Molecular Weight Studies
Subunit Mr values o f the homogeneous cytochrome P-450 isoenzymes, P-450 
B p  P-450 B p  P-452 and P-447 were estimated from calibrated SDS P.A.G .E ., by 
plotting log^g Mr fo r  the standard proteins versus the re la t ive  mobilities (R f ) ,  as 
shown in figure 4.9A. Electrophoresis was carried out in gels o f  varying acrylamide 
concentrations from  7-12% in order to determine the degree o f  non -idea lity 'o f SDS 
P .A .G .E . in these determinations.
Accord ing to the Fergusson equation (Fergusson 1964) 
log^g R f  = - K r t  + log-^g Yo  
where K r  = retardation co e f f ic ien t  
t = acrylamide co e f f ic ien t
Y o  = re la t iv e  mobility o f  the protein - SDS complex in solution
The re la tive  mobilit ies o f  the protein standards (f igure 4,9B) and cytochrom e 
P-450 isoenzymes (figure 4.10) were p lotted against acrylamide concentration. The 
close intersection o f  all such points on the y-axis c learly  showed that the values o f 
Y o  fo r  protein standards and cytochrom e P-450 isoenzyme - SDS complexes were, 
within error the same, and there fore  independent o f  protein charge and size. This in 
turn, implies a uniform high degree o f  SDS binding and a constant ratio o f  e f f e c t iv e  
charge to fr ic t iona l co e f f ic ien t .  An analysis o f  this type was essential since certain 
hydrophobic proteins such as cytochrome oxidase (Rubin and T za g a lo f f  1973) and 
glycoproteins, bind abnormally high concentrations o f  detergent or are inherently 
highly charged, giving rise to atypica l Fergusson plots-.
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The Mr values o f  the e lectrophoretica lly  homogeneous isoenzymes analysed 
show distinct d if fe rences with the values being given in figure 4.10. These 
d i f fe rences are further emphasised when the hemoproteins are v iewed on SDS 
P .A .G .E . (f igure 4.10).
4.4.3 Peptide Mapping Studies
L im ited  proteolysis o f  cytochromes P-450 fo llowed by SDS P .A .G .E . o f  the 
resulting fragments has been used in other laboratories as a probe for  d if fe rences  in 
protein primary or possibly secondary structure (Koop et al. 1981). This technique 
was used in the present study for  the com parative analysis o f  cytochromes P-450 Ety, 
P-452 and P-447. L im ited  digestion was carried out in the presence o f  either papain 
(Papaya latex ), chymotrypsin (bovine pancrease) or S. aureus V8.
In preliminary studies, the dependence o f  the fragm entation  patterns upon 
protease concentration and incubation t ime w ere  evaluated. Protease was varied as 
fo llows: (pg  in 50 pi volume); papain (0.005-0.5), chymotrypsin (0.05-5), S. aureus 
V8 (0.125-12.5), with the incubation t ime being varied from 5 to 90 minutes fo r  each 
protease.
The conditions se lected  for  presentation (figure 4.11) were such that some 
undigested apoprotein remained to serve as a point o f  re ference  on polyacrylamide 
gels. The resulting fragmentation  patterns (figure 4.11) c learly  showed that in the 
presence o f  each protease, under similar conditions, no common fragments arising 
from  cytochromes P-450 Ety, P-452 and P-447 were observed. This strongly suggests 
that the amino acid sequences o f  these three isoenzymes are (fundamentally) 
d if fe ren t  from  each other.
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12.5% SDS - Po lyacry lam ide Gel Electrophoresis o f  Peptide Maps Resulting 
from the L im ited  Digestion o f  Cytochrom e P-447, P-450 and P-452 
in the Presence o f  Papain, Chymotrypsin and Staph, aureus V8 Protease
Fig 4.11
LIMITED PROTEOLYSIS OF P447, P450, P452
Cytochrom e P-450 isoenzymes were incubated with Staph, aureus V8 (1.25 pg for 5 
minutes), chymotrypsin (0.5 pg for  30 minutes) and papain (0.05 pg for 5 minutes). 
The amounts o f  each digested isoenzyme applied per track were; cytochrome P-450 
B2 (2 pg), cytochrom e P-447 (2 pg) and cytochrome P-452 (3.5 pg).
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As a further means o f  characterisation o f  the two isolated phenobarbitone- 
induced cytochrome P-450 isoenzymes their absolute absorbtion spectra were 
compared (figures 4.12A,B). Pr ior  to spectrophotometric determinations both 
preparations were checked to ensure freedom  from Emulgen 911 whose presence is 
capable o f  causing spectral sh ift changes. Both oxidised isoenzymic forms showed 
typical b-type cytochrom e spectra displaying a, 0 and soret bands at around 570, 
534 and 418 nm respective ly . The general shape o f  the spectrum obtained fo r  the 
oxidised hemoproteins is characterist ic  o f  low-spin hemoproteins. Although the 
d if fe rences between the two fe r r ic  isoenzymes remained subtle, there was a small 
d i f fe rence  in the 390/418 nm ratio between the two hemoproteins which could also 
r e f le c t  a dissimilarity between the spin states o f  their heme irons.
In • the reduced forms both isoenzymes exhibit a soret peak at the same 
wavelength position. The major d i f fe rence  however was that cytochrom e P-450 B^ 
exhibited a far  more intense absorbance within the a-band region and also exhibited 
a peak at 468 nm which was not ev ident within the cytochrome P-450 B2 spectrum.
This peak was also apparent fo r  cytochrom e P-450 B-  ^ when the reduced carbon 
monoxide d if fe rence  spectra was monitored. Both exhibited intense soret peaks 
within the 450 nm region. For cytochrom e P-450 B^ this was located  at 451.5 nm 
and for cytochrome P-450 B2 at 450.5 nm.
The absolute absorbtion spectrum o f  fully oxidised N AD PH -cy toch rom e P-450 
reductase is given in figure 4.13. Peaks are displayed at 380 nm and 454 nm due to 
the absorbance o f  the F A D  and FM N  prosthetic groups. The final preparations were 
fre e  o f  Emulgen 911 with preparations routinely 9*v *n9 ^280/451 ra t ' os between 
9-10.0, a value which is an agreem ent with other authors observations (French and 
Coon, 1979).
4.4.4 Spectral Characterisation
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Figure 4.12
UV/Visible Spectra o f  E lec trophore t ica lly  Homogeneous Phenobarbitone 
Induced Cytochrom e P-450 in Their Various States 
A )  Cytochrom e P-450 B^, B) Cytochrom e P-45Q'B2
* *
350 400 460 000 660 000
Wavatonoth (nm)
The spectra portrayed are o f  the oxidised ( -------- ), sodium dithionite reduced (---- ),
sodium dithionite reduced in the presence of carbon monoxide (-x-x-x-x-). The
cytochromGs P-450 concentration was 0.75 uM.
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Figure 4.13
y.Y/Visible Absorbance Spectra o f  E lectrophoretica lly  Homogeneous 
N A D P H -C y to ch ro m e  P-450 Reductase
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Metyrapone (2-m ethy i- l,2 ,d i(3  p y r id y l ) - ! -  prepananone) is commonly used as 
an inhibitor o f  some cytochrom e P-450 mediated oxidations (Jonen, H. e t  al. 1974), 
and its clin ical use in the diagnosis o f  impaired pituitary function (A C T H  re lease) is 
based on its ability to inhibit cytochrom e P-450 mediated steroid hydroxylation in 
the adrenal gland. In this study however its use is related to its ability to provide a 
spec if ic  assay for the major phenobarbitone-inducible forms o f  cytochrom e P-450.
Metyrapone reacts with the heme iron o f  ferrous cytochrome P-450, form ing a 
spectral complex with a characterist ic  peak at 446 nm. Although this ligand is not 
absolutely spec if ic  for  a single form  o f  cytochrome P-450, it is capable o f 
distinguishing between certa in cytochrom e P-450 isoenzymes. O f  the major forms 
isolated to date, only cytochrom e P-450^ and P-450e have been shown to e f f e c t iv e ly  
bind to the ligand, whereas cytochromes P-450q , P-450c and P-450^ exhibit no 
significant metyrapone spectral complex form ation (Luu-The, V. e t  al. 1980). In 
fa c t  the spec if ic ity  fo r  the phenobarbitone-induced forms o f  cytochrom e P-450 is so 
grea t that it has been used as a means o f  being able to quantitate the levels o f  this 
cytochrom e within rat l iver  m icrosomes (Mitani, F. et al. 1982).
Utilising the homogeneous isoenzymes isolated from phenobarbitone-induced 
rats -cytochromes P-450 B^ and P-450 B^ - the apparent spectral dissociation 
constants (K  ) o f  the metyrapone-reduced cytochrom e P-450 ligand complexes were 
determined (table 4.4). The data was analysed utilising a linear regression statistics 
program (Univers ity  o f  Surrey Computing Unit) by both double rec iprocal and Eadie- 
H o fstee  plot analysis. C lear d if fe rences  w ere  seen to em erge with cytochrome P -  
450 B-  ^ having a far g rea ter  a f f in ity  for  metyrapone than the cytochrom e P-450 B^ 
form . This K g value obtained was slightly lower than that obtained by other authors 
(Luu-The e t  al. 1980) but their determination was for the major phenobarbitone 
cytochrom e P-450^ fo rm  isolated from  Sprague Dawiey rats. A  K g value was also 
obtained for  phenobarbitone-induced microsomes (0,1% (w/v) Pb in drinking water, 
oral dosing for  6 days). Here , the derived K g constant was very  similar to that 
derived by other authors (Mitani, F. e t  al, 1982, Leibman, K . e t  al. 1969).
4.4.5 Substrate Binding Studies
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Apparent Dissociation Constants (K  ) fo r  Metyrapone Binding to Purified 
Cytochrom e P-450 and Phenobarbitone-induced Microsomes
Table 4.4
Because o f  the spec i f ic i ty  o f  metyrapone for  the phenobarbitone-induced 
cytochromes, its inhibitory influence upon their drug metabolising ac t iv ity  in a 
reconstituted system for  both purified isoenzymic preparations and microsomal 
fractions was determined. The turnover o f  benzphetamine was monitored in the 
presence o f  d if fe ren t  concentrations o f  metyrapone. The results (f igure 4.14) 
c lear ly  indicate the spec if ic ity  o f  metyrapone inhibition, with a corresponding 
d if fe rence  being seen in the ex tent o f inhibition as one would have expected due to 
the d i f fe rences in their K  constants.
The inhibition pro f i le  relating to benzphetamine N -dem ethylase a ct iv ity  with 
phenobarbitone-induced microsomes was also examined (table 4.5). A  temporal 
change became evident with the re la t ive  degree o f  inhibition rapidly increasing
as such undoubtedly re f le c ts  the inhibition o f  the concomitantly induced cytochrom e 
P-450 species being induced with t ime.
Cytochrom e 
P-450 B.
1
(a)
Cytochrome
P-450 B2
Phenobarbitone-
(b)
K g(pM ) 1.01 + .19 5.56 + .49 0.69 + .28
b
a
c
values represent the mean + S.D o f  9 determinations 
values represent the mean + S.D o f  6 determinations 
values represent the mean + S.D o f  12 determinations.
s
a fte r  12 hours induction. This e f f e c t  is seen to be both dose and time dependent and
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Inhibition o f  Purified  C ytochrom e P-450 and P-450 Bp Mediated 
Benzphetamine N -dem ethyla t ion  A c t iv i t y  by Metyrapone
Open bars represent P-450 B-. ac t iv it ies
JL
Figure 4.14
M o t y r a p o n o  c o n c o n t r a S l o n  On M)
Values represent the mean + S.D o f  4 determinations. For cytochrom e P-450 B^ 
and P-450 B2 the corresponding 100% a c t iv ity  values equal 275 and 223 nmol 
HCHO/nmol P-450/min respec t ive ly .
Table 4.5
Temporal Inhibition P ro f i le  o f  Metyrapone upon Phenbarbitone-
Induced Microsomes
Control 6 12 24 72
Metyrapone
Concentration
(u M )
0 0 0 0 0 0
3.7 13.7 17.3 36.6 30.8 100
18 24.9 32.5 49.3 51.3 500
35 47.8 60.9 61.1 59.1 1000
45.1 49.3 76 80 77.4 2000
Values represent tfoe rhean + S.D o f  4 determinations.
/
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The gross m ultip lic ity  o f  the M.F.O, system has resulted in there being a 
noticeab le absence o f  spec if ic  assays for  each form  o f  cytochrome P-450, which 
consequently has hindered the elucidation o f  the regulation o f  these d if fe ren t  forms 
o f  cytochrom e P-450. To overcom e this researchers have turned towards antibodies 
because being highly spec if ic  they are uniquely suited as reagents capable o f  
identify ing and discriminating between functionally related proteins such as the 
multiple forms o f  cytochrom e P-450.
The procedures utilised in the isolation and purification o f  the spec if ic  
antibody fractions is described in sections 2.9 to 2.10. I f  the antibody was required 
in a purified immunoglobulin state then salt fractionation o f  the sera fo llowed by ion 
exchange chromatography was shown to su ff ice . Using d if fe ren t  batches or types o f  
ion exchange resins did not influence the purity o f  the IgG fraction . Separation o f  
the isolated IgG into its corresponding sub-fractions was not carried out. On 
subjecting the IgG to SDS P .A .G .E . analysis two bands became evident (data not 
shown). In calibrated gels these bands w ere  shown to possess molecular weights o f  
o f  50,000 and 25,000 which correspond to the heavy and light chains o f  y  globulins 
respective ly .
4.5.1 Antibody Spec if ic ity
The most important parameter relating to any antibody is its re la t ive  degree 
o f  spec if ic ity  towards its corresponding antigen. This was routinely determined 
utilising the technique o f  double diffusion within an agarose medium as described by 
Ouchterlony (1967). The antibodies isolated (against purified cytochromes P-450 B2, 
P-452 and P-447) all gave visible precipitin bands against their corresponding 
antigens by such analysis. No d if fe rences  in immunoprecipitation were observed 
when either the corresponding sera or IgG fraction was used.
4.5 PURIFICATION A N D  C H A R A C T E R I S A TI O N  OF ANTIBODIES
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Figure 4.15 shows an analysis in which pre-immune IgG and anti-P-450 IgG 
w ere  d irected  against purified cytochrom e P-450 B2.
r
o
o o o°
O '
o
A B
Figure 4.15
Ouchterlony Double D iffusion Analysis o f  Purified Cytochrom e 
P-450 Bq Against its Corresponding Antibody and Pre-immune IgG
The centre well in A  contained 30 pg o f  pre-immune Ig G  and in B contained 
25pg anti-P-450 B2 IgG. The outside wells  in a clockwise order from  position 1 
contained 6.7, 6.7, 13.4, 13.4, 20, 20 pmoles o f  purified cy tochrom e P-450 B2 
protein.
As can be seen only a single band is obtained on reaction with its homologous 
antigen. In the contro l experim ent no precip itation reaction was observed and this 
was the case with all cy tochrom e P-450 isoenzymes analysed. To ensure the 
possibility that any possible lack o f  r ea c t iv ity  in the Ouchterlony double diffusion 
test being due to poor antigen d if fusib ility , the tests w ere  repeated both in the 
presence and absence o f  Emulgen 911 within the diffusion media. No re la t ive
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immunoprecipitation d i f fe rences were observed in either o f  the two systems, 
although the media with no detergent had a tendency to exhibit slightly less intense 
immunoprecipitation bands.
An interesting observation (figure 4.16) was that both phenobarbitone-induced 
cytochromes P-450 Ety and P-450 Ety appear to share common antigenic determinants 
in that both hemoproteins were precip itated by anti-cytochrome P-450 Ety IgG.
Figure 4.16
Ouchterlony Double Diffusion Analysis o f Highly Purified  
Cytochrom es P-450 Ety and P-450 Bq
Top centre wells contain cytochrom e P-450 B^ and bottom centre wells cytochrome 
P-450 B2 at a concentration o f  33 pmoles. Increasing amounts o f  anti-P-450 B2 
antibody were added in anti-c lockwise directions from well position 1. The same 
antibody additions were carried out in both top and bottom wells.
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Single immunoprecipitation bands were obtained in both cases and as such would 
indicate that the two forms are at least immunologically similar if  not structurally 
similar. Such cross-react iv ity  was not seen with any o f  the other antibodies (figure 
4.17). Here all the antibodies showed immunochemical identity only with their 
homologous antigens. No cross-react iv ity  was obtained between these purified 
antibodies and their heterologous antigens. This would indicate that for these major 
isoenzymic forms major structural dissimilarities exist at least within the 
framework o f antigen-antibody recognition binding sites. Further conclusions 
relating to the immunochemical relationships between these forms is not really 
possible because o f  the re la t ive  in f lex ib il ity  o f  the test system itse lf .
F igure 4.17 Ouchterlony Double Diffusion Analysis o f  Highly 
Purified  Cytochromes P-447, P-450 and P-452
Centre wells A ,B ,C ,D  contain IgG fractions corresponding to anti-P-450 B2 (9 pg), 
anti-P-447 (9 pg) and anti-P-452 (20 pg), and a mixture o f  the last 3 IgG fractions 
(equivalent amounts o f protein) respective ly . A ll  the outer wells numbered 1-6 
contain highly purified cyt . P-450 isoenzymes as fo llows; Well 1, cy t . P-450 B? (60 
pmol); Well 2, cyt. P-452 (32 pmol); Well 3, cy t . P-447 (30 pmol); Well 4, cy t . P-450 
B2 (30 pmol); Well 5, cyt. P-452 (64 pmol), and Well 6, cyt. P-447 (60 pmol).
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4.5.2 Western Blot Analysis o f  Induced H epatic  M icrosomal Fractions
The technique o f  Western b lott ing was utilised as a means o f  
immunochemical de tect ion  in order to identify  the presence o f  induced 
cytochrom es P-450 in hepatic m icrosomes with t ime. Because the secondary 
antibody was not rad iolabelled, quantitation o f  the degree o f  sp ec i f ic  induction 
was unfortunately not possible. H ow ever  the results obtained w ere  
su ff ic ien tly  visually comprehensive to indicate where induction had occurred. 
The sp ec i f ic i ty  o f  the antibodies in question was also shown w ith no cross 
reaction  being apparent within the com plem ent o f  m icrosom al proteins. 
Transfer o f  m icrosom al proteins from  the SDS po lyacry lam ide ge l to its facing 
nitrocellu lose sheet by e lec trod if fu s ion  was absolute as shown by the fo llow ing 
photograph.
A
B
1 2  3 4 4 3 2 1
Proteins visualised 
on original, dried, 
SDS P .A .G .E . gel.
Corresponding proteins 
transferred to 
nitrocellu lose.
1 = standard m icrosomal protein markers
2,3,= phenobarbitone-induced m icrosomes (25, 50 pg, respec t iv e ly )
4 = purified cy toch rom e P-450 B2 (15 pmol)
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Follow ing transfer to nitrocellulose, staining o f the original SDS P .A .G .E . gel 
did not d e tec t  the presence o f  any proteins (results not shown). The actual amounts 
o f  protein indicated in the photograph were found to be fa r  in excess o f  that 
required, due to the sensitivity  o f  this immunochemical detection  system. Routinely 
microsomal protein would be electrophoresed at concentrations o f  1-5 pg, and 
purified cytochromes P-450 at 2-4 pmol. Excess loading just resulted in a far 
g rea ter  degree o f  non- spec if ic  background binding and to a general distortion o f  the 
immunoprecipitated bands.
The induction o f  the phenobarbitone-induced cytochrom e P-450s in 
microsomes was c lear ly  t im e dependent (f igure 4.18). As the antibody raised against 
the cytochrom e P-450 fo rm  was also known to recognise the cytochrom e P-450 
form , it is interesting to note that in the control, 6 and 12 hours time periods 
fo llow ing phenobarbitone-induction only the cytochrome P-450 B2 protein was 
observed. Following this it appears that two proteins which correspond to the 
cytochrom e P-450 B^ and B2 forms were only then recognised. This was particularly 
apparent when the fractions w ere  reanalysed utilising greater amounts o f  proteins. 
Some subsequent background is seen but this is believed to be non-specific 
background binding. It has been suggested that this could be a function o f  the age o f  
the quenching pre-immune donkey sera utilised in the washing stages, especia lly 
since such binding is seen in purified isoenzyme fractions which are known to be 
e lectrophoretica lly  homogeneous. This t im e d if fe rence  between the two d if fe ren t  
isoenzymes could there fo re , ten ta t ive ly , be taken to re la te  to a d if fe ren t  induction 
control over the two forms by phenobarbitone.
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Western Blot Analysis o f  Phenobarbitone-induced H epat ic  
M icrosomes R eac ted  Aga inst A n ti-C y toch rom e P-450 B2 Antibody
A.
Figure 4.18
6 5 4 3 2 1
B.
i
7 6 5 4 3 2 1
In gel A  m icrosomal protein was 1.5 pg/track; cy tochrom e P-450 B  ^ concentration  
was 0.58 pmoles/track.
In gel B m icrosomal protein was increased to 10 pg/track and the amount o f  purified 
cytochrom e P-450 increased to 3 pmoles/track.
Track 1 = Control M icrosomes; Tracks 2,3,4,5 = 6,12,24,72 hour phenobarbitone- 
induced hepatic m icrosomes, Track 6 = cy tochrom e P-450 B^, Track  7 = cy tochrom e 
P-450 B2.
Concentration  o f  primary antibody = 80 pg/30 ml wash 
Concentration  o f secondary antibody = 30 pg/30 ml wash
In a similar experiment BNF and clo fibrate-induced microsomes were 
subjected to screening by the anti-cytochrom e P-450 B^ IgG. In both 'sets a protein 
was recognised - the intensity o f  which slightly increased with time - which 
com igrated  with the marker cytochrom e P-450 B^ isoenzyme. The conclusion 
reached was that this represented either the steady state leve l o f  this protein or 
possibly a slight increase in its induction.
When clo fibrate-induced hepatic microsomes were analysed with anti- 
cytochrome P-452 antibody a single band was visualised corresponding to authentic 
cytochrom e P-452 (figure 4.19A). Maximal amounts were seen within control, 6 and 
12 hour fractions fo llow ing induction a fte r  which an apparent steady state leve l was 
observed. How ever, as pointed out be fore , this is only a qualitative assessment 
based on visual inspection and c lear ly  quantitative methods need to be developed to 
substantiate this ten tat ive  conclusion. Renal microsomes were also analysed and 
w ere  qualita tively  shown to contain the cytochrome P-452 isoenzyme. The presence 
o f  cytochrome P-452 was also de tected  within phenobarbitone and BNF-induced 
microsomes at all t ime points, a lbeit at fa r  lower levels within the BNF-induced 
microsomes (bands very  fa int, data not shown).
BNF-induced microsomes analysed with anti-cytochrom e P-447 antibody show 
an increase in protein corresponding to homogeneous marker cytochrom e P-447 with 
time (f igure 4.22B). Maximal amounts o f  cytochrome P-447 appeared to be present 
at 24-72 hours fo llow ing dosing.
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Western B lot Analysis o f  (A )  C lo f ib ra te  Induced M icrosomes R eac ted  Aga inst 
A n t i-C y toch rom e  P-452 Antibody and (B) BNF Induced Microsomes R eac ted  Against
A n t i-C y toch rom e  P-447 Antibody.
Figure 4.19
1 2 1 1  1 0 9  8 7 6 5 4  3 2 1
Track 1 = standard molecular w e igh t  markers, Tracks 2,3,4,5,6 = contro l,  6,12,24,72 
hour c lo fib ra te - induced  hepatic m icrosom es (1 ug/track), T rack 7 = purified 
cytoch rom e P-452 (2 pmoles), Tracks 8,9,10,11,12 = contro l, 6,12,24,72 hour 
clo fib ra te - induced  renal m icrosom es (15 pg/track).
B.
6 5 4 3 2 1
Tracks 1,2,3,4,5 = control, 6,12,24,72 hour BNF-induced hepatic m icrosom es (1.5 pg 
protein ), Track 6 = purified cy toch rom e P-447 (1 pmole ).
Gel A  : primary antibody concentration  = 100 pg/30 ml wash 
Gel B: primary antibody concentration  = 80 pg/30 ml wash 
Secondary antibody concentration  fo r  both gels = 30 pg/30 ml wash.
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In reconstitution experiments, both forms o f phenobarbitone-induced 
cytochromes P-450 and P-450 B2 were previously shown to support high
benzphetamine N-demethylase a c t iv ity .  Subsequent immunological investigations 
showed that both these forms were immunologically identical when reacted against 
the anti-cytochrom e P-450 B2 antibody, and there fore  the inhibitory e f fe c ts  o f  this 
antibody on ca ta ly t ic  a c t iv ity  was investigated. No significant inhibition was 
observed with pre-immune IgG. H ow ever, d if fe rences were observed between the 2 
isoenzymic forms, with the cytochrome P-450 B2 form  being inhibited at a greater  
initial rate than the cytochrom e P-450 B^ form  (figure 4.20). In l iver  microsomes 
(phenobarbitone-induced, 12 hours), inhibition o f  benzphetamine N-demethylase 
a c t iv ity  was also evident, but was more re frac to ry  as compared to the purified 
isoenzymes (figure 4.21). This indicated that although cytochromes P-450 B-^  and 
P-450 B2 are responsible for  a substantial proportion o f  the ac t iv ity  in microsomes, 
other isoenzymic forms may also be involved in the N-demethylation. A lte rn a t ive ly  
these results may be interpreted as a result o f  incomplete antibody access to the 
membrane bound forms o f  cytochrom e P-450 B^ and P-450 B2> A t  present, the 
results do not d i f fe ren t ia te  between these two possibilities.
When the metabolism o f  lauric acid by clo fibrate-induced microsomes was 
investigated, it was found that when anti-cytochrome P-452 sera was used, an 
increase in a ct iv ity  rather than inhibition became apparent (data not shown). The 
reason for  this discrepancy is not c lear especia lly since the spec if ic ity  o f  the anti- 
P-452 antibody has been shown to be absolute. When the experiment was repeated 
using an IgG fraction  raised against cytochrome P-452 (Dr S. Bains personal 
communication) inhibition was attained. On separation o f  the m etabolites on H PLC , 
the formation o f  both the 11- and 12-hydroxy lauric acid metabolites were shown to 
be inhibited.
4.3.3 Antibody Inhibition of Cytochrome P-450 Activity
E f fe c t  o f  Varying Amounts o f  A n ti-C y toch rom e P-450 Ety Antibody on 
Benzphetamine N -dem ethylase A c t iv i t y  Catalysed by Purifed  
Cytochrom es P-450 B -^ and P-450 B^
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Figure 4.20
Values represent the mean + S.D o f  4 determinations. For cytochrom es P-450 B^ 
and P-450 the corresponding 100% a c t iv ity  values equal 265 and 212 nmol 
HCHO/nmol P-450/min respec t ive ly .
Figure 4.21
E f f e c t  o f  Varying Amounts o f  A n ti-cy tochrom e P-450 Bp Antibody on Benzphetamine 
N -dem ethylase A c t iv i t y  Cata lysed by 12 Hour Phenobarbitone-induced Microsomes
M g  I g G / n m o l  c y t o c h r o m o  P -450
Values represent the mean + S.D o f  4 determinations. For the phenobarbitone- 
induced microsomes (solubilised) 100% control a c t iv ity  equalled 15 
nmol/HCHO/nmol P-450/min.
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The 12-hydroxylation was shown to be pre ferentia lly  inhibited to 
approximately 25% o f  the original ac t iv ity ,  whereas 11- hydroxylation was less 
sensitive to anti-cytochrom e P-452 IgG with the ca ta ly t ic  a c t iv ity  being inhibited to 
only 65% o f  the original ac t iv ity .
The spec if ic ity  o f  the anti-cytochrom e P-447 antibody was also demonstrated 
by the inhibition o f  ethoxyresorufin turnover by the purified cytochrom e P-447 
isoenzyme (figure 4.22), When the spec if ic ity  o f  the antibody against hepatic BNF- 
induced microsomes (24 hours induction) was determined, the le v e l  o f  inhibition was 
not com plete , indicating that, as was the case seen for  the other microsomal 
fractions, either cross-substrate spec if ic ity  was being demonstrated by some other 
isoenzymic cytochrome P-450 form  or that antibody access to the cytochrom e was 
lim ited in the membrane fractions.
4.6 C H A R A C T E R IS A T IO N  OF M IC R O S O M A L  C Y TO C H R O M E  P-450 ISO E N ZYM E S
The hepatic m icrosomal mixed function oxidase system (M .F .O .) is 
characterised by several features which makes it unique among mammalian 
enzymes. Prim arily  these include the induction o f  multiple cytochrome P-450 
isoenzymes fo llow ing chem ical administration with many having w idely d if fe ren t  but 
broad substrate spec if ic it ies . These d i f fe rences  are dependent not only upon the 
nature o f  the inducing agent and its dose, but also, very importantly, on the sex, age 
and species o f  the animal involved. Thus it is very important that fo llow ing 
induction, one should be able to discriminate whether the levels o f  pre-existing 
M.F.O. enzymes are simply e leva ted  (possibly just with minor modifications), or 
whether novel constitutive forms are evoked to deal with the corresponding 
chemical challenge.
E f fe c t  o f  An ti-C ytochrom e P-447 Sera on Ethoxyresorufin Q -deethylase A c t iv i ty  
by Purified  Cytochrom e P-447 and BNF-induced Microsomes (24 hours)
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Figure 4.22
100% uninhibited a c t iv ity  was equal to 1.0 nmol resorufin/nmol P-450/min. Values 
represent the mean + S.D o f  three determinations.
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4.6.1 Changes in the Induction P ro f i le  o f  Hepatic and Kidney Microsomes with T im e
Animals w ere  induced with a single dose o f  phenobarbitone, c lo fib ra te  or 
B-napthoflavone as described in section 3.1.2. Hepatic microsomes were 
subsequently isolated (Section 2.3) at d i f fe ren t  time points in order to investigate 
the changes occurring within these membrane vesicles form ed from  the endoplasmic 
reticulum as a result o f  chem ical administration. This was firs tly  looked at from 
the point o f  v iew  o f  changes in the spec if ic  content o f  cy tochrom e P-450 in the 
microsomes as w ell as changes in the d if fe rence  spectra o f  the CO  complexes o f  the 
reduced cytochrome P-450. The results in table 4.6 indicate an increase in induction 
o f  cytochrom e P-450 in all the pretreated  animal groups with the absorbance change 
d if fe rence  spectra also indicating discrete but subtle changes in the cytochrome 
P-450 subpopulations. This t im e course study was also analysed on SDS P.A .G .E . 
The overa ll pattern which em erged was that fo llow ing induction, a general but 
uniform increase in m icrosomal proteins was visible with time. This coincided with 
a spec if ic  increase in the induced cytochrome P-450 variant being studied as 
monitored using the re levant purified cytochrome P-450 isoenzyme as a standard. 
H ow ever, because the analysis was s tr ic t ly  visual on SDS P .A .G .E . no quantitation as 
such is possible.
4.6.2 T im e Course Induction Pro f i les  o f  Drug Metabolising A c t iv i t y  in
Hepatic and Renal M icrosomes.
It is fortunate that the majority  o f  cytochrome P-450 isoenzymes isolated to 
date have re la t ive ly  spec if ic  marker substrates. This has made it possible to 
corre la te  the observed induction o f  drug oxidation act iv it ies  with se lec t ive  increases 
o f  m icrosomal cytochromes P-450 and thereby indicate the existence o f  multiple 
molecular species o f  cytochrom e P-450. Benzphetamine and ethoxyresorufin are 
w idely  accepted marker substrates for cytochromes P-450 and P-447 respective ly , 
and recently  lauric acid has been shown to be a suitable marker substrate for 
cytochrome P-452 (Gibson et  al. 1982). Accord ingly  the turnover rate in
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Induction o f  To ta l Cytochrom e P-450 Following Administration o f
D i f fe ren t  Xenobiotics
Table 4.6
Inducing agent 
and t ime o f 
m icrosomal isolation (hr)
Specif ic  Content 
(nmol/mg Prote in )
R e la t ive
Induction
(fo ld )
Absorbance 
^riaximun o f  
Fe -CO  complex 
o f  cytochrome P-45
Control .693 450
Phenobarbitone
6 1.40 2.02 450
12 1.50 2.16 450
24 1.89 2.73 450.2
72 1.98 2.85 450.2
C lo fib ra te
6 .826 1.19 450
12 .976 1.41 450.5
24 1.10 1.58 450.8
72 1.25 1.8 450.5
0-Napthoflavone
6 .845 1.21 450
12 1.0 1.45 449.7
24 1.05 1.52 449.5
72 1.23 1.77 448.9 v
Control .182 450.5
Phenobarbitone
6 .175 .958 450.5
12 .209 1.15 450.5
24 .31 1.71 450
72 .233 1.28 450
C lo fib ra te
6 .128 .70 450
12 .16 .871 451
24 .277 1.02 451
72 .204 1.12 451
3-Napthoflavone
6 .169 .928 449.9
12 .189 1.03 449.9
24 .216 1.18 449.5
72 .267 1.46 449.5
Values represent the mean o f  between 4 to 6 determinations + S.D from  either 2 or 3 
separate pools o f  microsomes o f  3 animals.
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microsomes for spec ific  substrates was monitored with t ime fo llow ing  induction in 
order to assess the response o f  the M .F.O . system towards these xenobiotics.
A )  Benzphetam ine-N-demethylase ac t iv ity
As expected with this marker substrate the highest ac t iv ity  observed was from  
the hepatic microsomes induced by phenobarbitone. This increase closely fo l low ed  
the Increase in spec if ic  content o f  the microsomes. Conversely c lo fibrate-induced 
microsomes appear to e f f e c t  some a f f in ity  for  this substrates turnover, a lbeit at 
lower levels . In BNF-induced microsomes this act iv ity  is decreased.
In the renal microsomes a d i f fe ren t  pattern o f  induction becomes apparent. 
There is a large increase in benzphetamine N-demethylase ac t iv ity  fo r  up to 12, 
hours fo llow ing which it begins to decline. A  similar pro fi le  is again apparent with 
respect to an increase in the m icrosomal protein levels. The ac t iv ity  o f  c lo fib ra te  
and BNF-induced renal m icrosomes was similar to that seen in the hepatic 
microsomes. The results are summarised in figure 4.23A and B.
B) Laurie Acid  hydroxylation A c t iv i t y
The tota l hydroxylation products (11- and 12- hydroxy m etabolites) o f  lauric 
acid fo llow ing xenobiotic administration were studied by means o f  t . l .c . analysis. 
Subsequently, by the use o f  H .P .L .C . it was possible to determine the degree o f  both 
the 12- and 11- hydroxyl products. The d if fe ren t  characteristics o f the two liver  
laurate hydroxylase systems have already been observed (Ellin et al. 1975) and the 
proposition put forward that separate cytochromes P-450 catalyse the two fa t ty  
acid hydroxylation reactions (i.e . the 11- and 12-hydroxylation). Indeed the 
fo llow ing results which were obtained from  the time course induction pro f i le  o f  the 
12- and 11-laurate hydroxylase a c t iv it ies  within the d if fe ren t ia l ly  induced hepatic 
and renal microsomes strongly supported the hypothesis that separate cytochromes 
mediated the two hydroxylation reactions o f  this fa t ty  acid. The overall values for  
the tota l laurate hydroxylation act iv it ies  are detailed in table 4.7. In both
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c lo fib ra te  and phenobarbitone-induced microsomes a time dependent response was 
observed, with the greatest increase being seen fo llow ing c lo fibrate-induction. Here 
a maximal increase in ac t iv ity  was observed a fter  a period o f  12 hours a fte r  which a 
decline was observed. Follow ing phenobarbitone-induction a slow but steady 
increase was observed with t ime. Treatm ent o f  rats with BNF had no stimulatory 
e f f e c t  on tota l laurate hydroxylase act iv it ies  when compared to control rats.
In the renal microsomes a d if fe ren t  pattern o f  induction appears to em erge 
with far higher levels o f  a c t iv ity  seen throughout. Here c lo fibrate- induced 
microsomes again exhibited the highest turnover act iv ity  with the levels increasing 
with time. This was also seen with the phenobarbitone-induced microsomes a lbeit at 
lower levels. Slight increases in a ct iv ity  were also observed fo llow ing B N F- 
induction.
H ow ever, the true extent o f  induction only became fully apparent when the 
proportion o f  11- and 12- hydroxylaurate metabolites were analysed (figures 4.24 
A ,B ,C ). No metabolites were form ed in the absence o f  N A D P H .
In hepatic microsomes fo llow ing  c lo fib ra te  pretreatment 12-hydroxylation o f 
lauric acid was pre feren tia lly  increased with a maximal 2.5 fo ld increase at 12 
hours. 11- hydroxylation was not a f fe c ted  to any great degree. A f t e r  12 hours a 
decrease in a ct iv ity  was observed. With the kidney microsomes a similar pre ference 
was observed with the d if fe rence  that 11-hydroxylation also increased with time but 
at a much slower rate. The increase in 12-hydroxylation o f  lauric acid fo llow ing a 
single dose was seen to continue fo r  a period up to 72 hours attaining a maximum 
leve l a fte r  24 hours.
Hepatic  microsomes from  phenobarbitone pretreated animals showed an initial 
depression o f  12-hydroxy ac t iv ity  with a slight but pre ferentia l increase in 11- 
hydroxylauric acid formation. By 72 hrs comparable ratios o f  the 11-and 12- 
metabolites became evident. In contrast the renal microsomes catalysed a
pre ferentia l increase in 12-hydroxylauric acid formation similar to that observed for
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Benzphetamine N -dem ethylase  A c t iv i t y  T im e Course P ro f i le  Follow ing 
Pre trea tm en t with D i f fe ren t  Inducers fo r  Hepatic  M icrosomes
Figure 4.23A
C L O
, PB = phenobarbitone-induced, C LO  = c lo fibrate-induced, BNF = 8-napthoflavone- 
induced. a = s ign if icantly  grea te r  than controls (p<0.001) b = (p<0.01) c = (p <0.05) 
Student's t - tes t . Each value represents the mean + S.D o f 4 determinations.
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Benzphetamine N-dem ethylase A c t iv i t y  T im e Course P ro f i le  Follow ing 
Pre trea tm en t w ith D i f fe ren t  Inducers fo r  Renal M icrosomes
Figure 4.23B
T I m  o (hours)
T ) m o  ( h o u r s )
PB = phenobarbitone-induced, C LO  = c lo fibrate-induced, BNF -  3-napthoflavone- 
induced. a = s ign if icantly  grea ter  than controls (p<0.001), b = (p<0.01), c = (p <0.05) 
Student's t - tes t . Each value represents the mean + S.D o f  4 determinations.
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R at m icrosomal lauric acid hydroxylase time course a c t iv it ie s  
fo llow ing  a single dose o f  c lo fib ra te
1. Hepatic  Microsomes
Figure 4.24A
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2. Renal M icrosomes
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Open bars represent 11- hydroxylase activities and shaded bars represent 12-
hydroxylase activities. Values represent the means + SD of three determinations.
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R at Microsomal Lauric Ac id  Hydroxylase T im e Course A c t iv i t ie s  
Follow ing a Single Dose o f  Phenobarbitone
1. Hepatic  Microsomes
Figure 4.24B
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Open bars represent 11- hydroxylase activities and shaded bars represent 12-
hydroxylase activities. Values represent the means + SD of three determinations.
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Rat m icrosomal lauric acid hydroxylase time course ac t iv it ie s  
fo llow ing  a single dose o f  B-napthoflavone
1. Hepatic  Microsomes
Figure 4.24C
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2. Renal M icrosomes
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Open bars represent 11- hydroxylase activities and shaded bars represent 12-
hydroxylase activities. Values represent the means + SD of three determinations.
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the c lo fib ra te  renal microsomes. Again, the 11-hydroxylation o f  lauric acid was also 
induced with time but to a far lesser extent.
Treatm ent o f  rats with BNF had no stimulatory e f f e c t  on either the 11-and 12- 
hydroxylase act iv it ies  within hepatic microsomes when compared to control rats. A  
general decrease with time fo r  both m etabolite  formation was observed. In the 
renal microsomes however the induction pro f i le  was similar to that fo r  the other 
two inducing agents. A  pre feren tia l increase in 12-hydroxylation was observed with 
a corresponding but much smaller increase for  the 11-hydroxy products. Although 
the general levels o f  a c t iv ity  were not significantly  higher than those seen for 
control renal microsomes, a t im e dependent response was never the less observed.
C ) 7-Ethoxyresorufin O- deethylation
The final marker substrate utilised to investigate the inducibility o f  the 
M.F.Q. system was 7- ethoxyresorufin. This is a pre ferentia l substrate for
cytochrom e P-448 type isoenzymes. The O-deethylation o f  ethoxyresorufin was 
measured as the progressive increase in fluorescence due to the formation o f  the 
product, resorufin, as shown in table 4.8. A c t iv i t y  was de tected  in both the livers 
and kidneys o f  all the animals induced, with the liver being seen to be by fa r  the 
most act ive  tissue. Follow ing both phenobarbitone and c lo fibrate-induction the 
hepatic and renal deethylation o f  ethoxyresorufin was seen to either marginally 
decline or remain at control levels . Only BNF-induction resulted in a significant 
increase in ac t iv ity  which was seen to reach a maximum at around 24 hrs fo llow ing a 
single dose in both tissues. These results, in the case o f  BNF-induction, be they 
expressed as activ ity/mg o f  m icrosomal protein or activity/nmol o f  hemoprotein 
clearly  indicate a spec if ic  increase in synthesis o f  a cytochrom e P-450 that 
catalyses the deethylation o f  ethoxyresorufin.
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4.7 IM M U N Q Q U A N T IT A T IQ N  OF C Y T O C H R O M E  P-450 ISOENZYMES FO LLO W IN G
XENOBIOTIC  IN D U C T IO N
The antibodies raised against each o f  the d if fe ren t  cytochrom e P-450 
isoenzymes have been shown to be monospecific by cr iter ia  described previously and 
there fore  may be used to quantitate the levels o f  these proteins in hepatic 
microsomes fo llow ing xenobiotic induction. How ever it should be noted that 
because cytochrom e P-450 B-^  and P-450 B2 are immunologically indistinguishable in 
Ouchterlony double diffusion analysis, immunoquantitation w ill  assay both forms. It 
is important to construct standard curves fo r  each concentration o f  antibody used 
due to the marked variation in the degree o f  immunodiffusion. An example o f  two 
such standard curves fo r  purified cytochrom e P-450 B2 is shown in figure 4.25A. 
F igure 4.25B shows the corresponding radial rings from one such analysis, c lear ly  
illustrating an increase in ring d iam eter with increasing amounts o f  antigen.
The immunochemical quantitation o f  cytochrome P-450 isoenzymes fo llow ing  • 
induction is detailed in figure 4.26, with the corresponding values expressed as a 
percentage o f  the tota l cy tochrom e P-450 population present within the liver shown 
in table 4.9. A l l  three o f  the major inducers are shown to cause an increase in the 
spec if ic  amounts o f  the re la t iv e  cytochrom e P-450 isoenzymes with time. This 
increase is especially rapid in the case o f  cytochrome P-447 isoenzyme levels within 
BNF microsomes. A t  maximal levels , phenobarbitone increased cytochrome P-450 
B^ and P-450 B2 22 fo ld; c lo f ib ra te  increased cytochrome P-452 2.13 fo ld and BNF- 
induction increased cytochrome P-447 26 fold. Following the induction o f  any major 
form  o f  cytochrome P-450 it was observed that there was a general depression in 
the induction o f  any o f the other forms which indicates the spec if ic ity  o f  each of 
the induction processes. The leve ls  o f  the cytochrome P-450 in the control, 
phenobarbitone and BNF-induced microsomes was comparable to the data obtained 
by other authors (Goldstein et  al. 1983, Thomas et al. 1983). The concentration o f 
cytochrom e P-452 is particularly interesting due to the d irect  constrast o f its 
concentration in uninduced microsomes compared to that o f  other well
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characterised forms. The fa c t  that the presence o f  cytochrome P-447 in c lo f ib ra te -  
induced microsomes was not observed is surprising as it was detec ted -a lbe it  at the 
ex trem e levels o f  detection  - by western blotting. This would suggest that although 
this isoenzyme is present in c lo fibrate-induced microsomes, its leve l is so low that it 
is below the minimum leve l  o f  immunochemical detection which can be achieved 
with this technique.
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Standard Curves for the Quantitation o f Cytochromes P-450 and 
and P-450 Bp within Hepatic  M icrosomes by Single Radial Immunodiffusion 
Utilising Anti-cy tochrom e P-450 B  ^ Antibody
Figure 4.25A
3 % sara
Figure 4.25B
pmolii cytochroma P-4 5 0 B2
track 1
track 2
track 3
Single Radial Immunodiffusion Analysis o f  Cytochrom e 
P-450 Bq Against Anti-cy tochrom e P-450 B  ^ Sera
■ : '
3  % a n t I -
- ?■ •;V < 1' ■ '
J.■ V ,  i c y t o c h r o m e
4 . . . .  I
•/'
}
i . A P -  4  5 0 B 2 
s e r a
track 4
In track 1 both rings represent 5pl o f  purified cytochrome P-450 B2 (3.35 pmol). 
Tracks 2,3,4 represent the radial rings obtained with increasing amounts o f  purified 
cytochrome P-450 B2» This relates to additions o f  0.5, 1,2,3 and 4 pi o f  purified
protein, corresponding to 0.34, 0.67, 1.34, 2.01 and 2.68 pmol cytochrom e P-450 B2 
respective ly .
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Immunochemical Quantitation o f  Cytochrom e P-450 Isoenzymes 
in Hepatic  M icrosomes fo llow ing  Treatm ent w ith D i f fe ren t  Inducers
Figure 4.26
]\  Control m icrosomes, I 1 phenobarbitone-induced microsomes,
r -71 —
//  C lo fibrate- induced microsomes, | j j j  3-napthoflavone-induced microsomes.
Values represent the mean + S.D o f  a minimum o f  6 determinations 
a = s ign if icantly  g rea ter  than controls (p<0,001) 
b = (p<.01)
c = (p<.05), Student's t-test .
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Immunochemical Quantitation o f  4 Forms o f  Cytochrom e P-450 in 
Hepatic  M icrosomes from  Male Rats Treated  with D i f fe ren t  Inducers
Percen t o f  tota l cytochrome P-450 
R a t treatm ent P-450 Unknown
B1/B2 P-452 P-447 P-450's
0 1.57 25.7 1.6 71.13
Phenobarbitone 
induced (hours)
Table 4.9
6 10.28 6.21 3.5 80.01
12 20.81 6.86 3.53 68.81
24 34.3 5.07 2.48 58.15
72 23.9 3.18 1.66 71.26
C lo fib ra te  
induced (hours)
6 8.83 27.84 N/D 63.3
12 8.09 30.74 N/D 61.17
24 8.45 42.91 N/D 48.64
72 7.36 54.72 N/D 37.92
BNF induced 
(hours)
6 4.85 4.37 33.96 56.82
12 5 3.4 35.65 6
24 4.28 2.42 40 53.3
72 3.33 2.84 42.3 51.53
N/D = not detected .
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PURIFICATION A N D  CHARACTERISATION OF NUCLEIC 
ACIDS CODING FOR C Y T O C H R O M E  P-450 ISOENZYMES
5 . !  IN TR O D U C T IO N
In the preceding chapter the isolation, purification and characterisation o f  a 
number o f  distinct cytochrom e P-450 isoenzymes was reported. In addition, 
quantitation o f  these forms in l iver  microsomes was also determined. It became 
clear that despite the close sim ilarity  o f  these proteins in terms o f their 
localisation, function and molecular weight range, that these appeared to be distinct 
isoenzymes under the functional control o f  spec ific  induction processes. 
Accord ingly , an insight into the molecular basis fo r  this multip lic ity  was sought by 
isolation and characterisation o f  the m RNA 's  coding fo r  these proteins, and by 
subsequent immunological analysis o f  the P-450 peptides synthesised from  these 
m R N A s iri v i t ro .
Messenger R N A  molecules can be considered as central components in the 
expression o f  eukaryotic structural genes. In a study designed to quantitate spec if ic  
m RN As, three experimental parameters must be considered. The first is the 
extraction  o f  intact functional R N A  containing the m R N A  o f  interest from the 
tissues in which enzym e induction is taking place. As the re la t ive  rate o f  
cytochrom e P-450 isoenzyme synthesis under maximally induced conditions seldom 
exceeds 1% o f  overall protein synthesis this is undoubtedly an important 
consideration. Secondly, the isolated R N A  sample must be capable o f  accurate 
translation in an rn vitro  protein synthesising system capable o f  using the exogenous 
m R N A  as a tem plate . F inally, the amount o f  enzyme protein synthesised in vitro in 
response to the added R N A  must be measurable in order to serve as an es tim ate o f 
the leve l  o f  translatable enzym e m R N A  contained in the R N A  ex tracted .
The results obtained w ill be described in depth in the fo llow ing chapter which 
is concerned with the induction o f  the cytochrome P-450 isoenzymes in response to
Chapter 5
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xenobiotic administration. This chapter w ill  deal with the procedures involved, and 
describe the inherent technical d if f icu lt ies  encountered in establishing the most 
suitable method for analysing the e f fe c t s  o f  xenobiotic pretreatment on the m R N A  
population within rat l iver and kidney.
5.2 P U R IF IC A T IO N  A N D  ISO LA T IO N  OF T O T A L  R A T  L IVER/KID N EY R N A
In the ce ll, R N A  exists mostly in ribonucleoprotein complexes (ribosomal 
subunits, hn RNPs (histone ribonucieoproteins) and m RNPs) which further interact 
with extraneous proteins subsequent to ce ll disruption. The essence o f  R N A  
isolation is therefore highly dependent on a protein denaturation step in conjunction 
with extensive ribonuclease inhibition. To achieve this a m odif ication  o f  the 
procedures o f  Chirgwin et  al. (1979) and D ee ley  et al. (1977) was utilised as outlined 
in section 3.3. Guanadinium hydrochloride (GHC1) extraction was favoured primarily 
because the half l i fe  o f  ribonuclease (RN ase ) is only 10 seconds in a 4M solution 
(M illar and Bolin, 1978), and also because it is a ex trem ely  strong denaturant in 
which both cationic and anionic forms o f GHC1 are potent chaotropic agents. 
Reducing agents such as 2-mercaptoethanol and dithiothreitol acting as a disulphide 
bond reductant were also included in the homogenisation mixture. Increasing the 
ratio o f  guanadinium hydrochloride stock solution (initial homogenisation volume) - 
from  16 (as recommended for  the purfication o f  pancreatic R N A )  to 22 ml per gram 
tissue considerably increased both the yield and purity o f  the final R N A  preparation 
(table 5.1). No significant d i f fe rence  was seen between the amount o f  R N A  isolated 
per gram tissue for  the d if fe ren t  inducing agents.
Table 5.1 To ta l R N A  Prepared by Guanidinium Hydrochloride
(GHC1) Fraction  o f  Rat L iver
GHC1 A verage  
(m l o f  7.5M stock 
solution/gm tissue)
R N A  yield 
l ive r  weight
Absorbance Ratio  
(mg/g l iver )
16
22
13.9
10.25
(gm)
1.35 1.75
1.913.4
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Subsequent reprecip itations in GHCl/ethanol fo llowed by sodium acetate/ethanol 
precipitations further purifies the R N A . These precipitations result in the
solubilisation and subsequent rem oval o f  all the D N A , tR N A ,  5S R N A , and
polysaccharides. The R N A  preparation was assessed for purity by means o f  an 
^260/280 r a t ‘ °  reading fo llow ing  which it would be prepared fo r  fractionation  on 
oligo (dT) cellulose. The major disadvantage o f  this isolation protocol however is 
that o f  the presence - although in the m inority - o f  the R N A  species o f  the hn R N A s  
and also the nuclear precursors o f  the cytochrom e P-450 m R N A  sequences (Taylor, 
1979). Occasionally i f  an ultra-pure R N A  was required as in the case fo r  cD N A  
synthesis, then the R N A  fraction  would be further applied to a CsC l gradient to 
ensure the rem oval o f  all D N A  sequences. Routinely values o f  > 2.0 were
obtained for such preparations.
5.2.1 Oligo (dT) Chromatography
The tota l R N A  isolated from  the previous extraction step is still grossly
contaminated with rR N A  and various nuclear RNAs, and as such, further
purification is required on oligo (dT ) cellulose. Two columns are utilised, the first 
having a binding capacity  o f  20-40 A 2gg units o f  poly (A)/gm cellulose, the second 
having a higher capacity  o f  40-60 A 26Q units/gm. The resulting poly (A )+ m R N A  
from such a purification is highly a ct ive  translationally in an in v itro  protein 
translation system.
The procedure involves heat denaturation o f  the secondary structure o f  the 
R N A  sample (65°C/5 minutes fo llowed  by rapid cooling in ice ) a fte r  which it is 
hybridised to the column at neutral pH in a high salt concentration (0.5M L iC l ) .  Any 
unbound nucleic acid is then rem oved by thorough washing in the same bu ffer . This 
tends to rem ove most o f  the poly (A ) "R N A  species. The elution is fo llowed by 
monitoring A 2^g absorbance. Some rR N A  however is still found to be bound with 
the poly (A )+ R N A  fraction  due to slight aggregation between the two forms, and 
also due to a degree o f  non-specific  binding to the column itse lf .  This can be
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rem oved by lowering the salt concentration to 0.1M. Because o f  the weak 
interactions o f  the poly (A )+ m R N A  to this spec ific  oligo (dT) column and also 
because some o f the poly (A )  segments are too short or blocked in some way, a 
proportion o f  the poly (A )+ m R N A  is always lost at each stage. Finally the poly (A )+ 
m R N A  is removed from  the column by eluting in neutral bu ffer  containing no salt.
This semi-purified poly (A )+ m R N A  preparation still has some rR N A  and tR N A  
contamination which can be rem oved by re-application on a second column o f  high 
a ff in ity  oligo (dT) cellulose (Bantle e t  al. 1975). The same column purification steps 
as be fore were used. A  representative  elution profile  obtained in the isolation o f  
poly (A )+ m R N A  sequences is given in figure 5.1 On analysis o f  the poly (A )+ m R N A  
on denaturing formaldehyde gels no significant rR N A  contamination was ev ident 
(data not shown). These poly (A )+ m R N A  preparations were capable o f  stimulating 
iin v itro  translational ac t iv ity  from  between 10 to 50 fo ld above background. 
Translational ac t iv ity  was also shown to be evident in the non-adsorbed (poly (A ) ” 
m R N A )  fractions (f igure 5.2). Immunoprecipitational analysis o f  these fractions 
showed that ac t iv ity  was also present fo r  the phenobarbitone-induced cytochromes, 
a lbeit at fa r  lower levels than that exhibited by the tota l R N A  and poly (A )+ m R N A  
fractions. This observation was also reported by Fujii-Kuriyama et al. (1981). 
Whether or not this represents poly (A )+ m R N A  sequences which had bound non- 
spec if ica l ly  and then been eluted, or else po ly (A )+ m R N A  sequences which had their 
tails removed by ribonucleases, or even nuclear precursors o f  the m R N A  sequences 
which had not ye t  becom e polyadenylated is at present unknown. H ow ever, because 
these non-adsorbed fractions represented only a small proportion o f  the m R N A  
ac t iv ity  concerned with the cytochrom e P-450 isoenzymes, compared with po ly (A )+ 
m R N A  fractions, they were not further characterised.
5.2.2 Further Fractionation o f  Isolated Po ly  (A ) * m R N A  Sequences
As a prelude to the synthesis of complimentary D N A  (cDNA) the clofibrate-
induced poly (A)+ m R N A  fraction had to be further purified by means of sucrose
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Figure 5.2
A.
B.
Translation and Immunoprecip itation o f  Fractions Obtained Fo llow ing  
O l igo (dT ) Chromatography o f  To ta l R N A  Isolated from  
Phenobarbitone-induced Animals
2 0  0 K
92.5K
6 9 K
4 6 K 
3 O K
ism
m m
5 6 7 8
A . Tracks 1 = standard molecu lar w e igh t  markers, 2 = blank (z e ro  R N A ) ,  3 = 
to ta l R N A ,  4 = 0.5M L iC l  wash (column I frac t ion  A ) ,  5 = 0.1M L iC l  wash 
(column I, fract ion  B), 6 = 0.5M L iC l  wash (column 2, frac t ion  D), 7 = 0.1M 
L iC l  wash (column 2, frac t ion  E), 8 = p o ly (A )+ m R N A  (column 2, frac t ion  F). 
A l l  fract ions w ere  translated at an R N A  concentration  o f  0.33 gg/pl.
B. The im munoprecipitation products o f  the above translated fract ions (anti- 
phenobarbitone-induced cy toch rom e P-450 IgG ) is illustrated d irec t ly  be low  
the corresponding tracks.
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gradient fractionation. G reat care has to be taken to avoid ribonuclease 
contamination, and the procedure utilised is described in section 3.5. This procedure 
is utilised to attain an enrichment o f  the m R N A  o f  interest in order to bring the 
m R N A  within cloning range. The u ltimate aim is to be able to reduce the cD N A  
library to a manageable number o f  clones which can then be screened individually. 
The procedure involved in this fractionation  was essentially the size fractionation o f 
m R N A  species. These were then translated in a in vitro translation system and 
subsequently immunoprecipitated against the anti-cytochrome P-452 antibody. 
Those fractions which gave positive results were pooled and used in the synthesis o f 
the corresponding cD N A .
The c lo fib ra te  poly (A )+ m R N A  was solubilised in 99% DMSO, 10 mM Tr is -H CL 
(pH7.5) and then heated be fo re  being layered on top o f the sucrose gradient. It was 
found that no more than 300 pg m R N A  could be fractionated through a single 
gradient otherwise aggregation tended to occur. A verage  values fo r  the recovery  o f  
to ta l R N A  within this range was in the region o f  70%. The separation o f  the m R N A  
species was monitored spectrophotom etrica lly  with the fractions containing R N A  
being precip itated by the addition o f  sodium acetate/ethanol. Because o f  the very 
low amounts o f  R N A  present within these fractions, not all o f  the R N A  was 
recovered  and losses o f  approximately 10% w ere  routine. The pro f i le  o f  the sucrose 
gradient separation is shown in figure 5.3A. The poly (A )+ m R N A  was seen to still 
contain a fa ir  proportion o f  rR N A  (28s) despite 2 oligo (dT) cyc les (data not shown). 
On translation o f  the R N A  containing fractions, maximal a c t iv ity  was seen 
predominantly in the 18s region, with the ac t iv ity  fo r  cytochrome P-452 being found 
in the peak o f  this area (f igure 5.3B). Those fractions which displayed ac t iv ity  fo r  
cytochrom e P-452 fo llow ing  immunoprecipitation analyses were pooled and 
concentrated by sodium acetate/ethanol precipitation. This pool was shown to 
correspond to less than 1% o f  the tota l fractionated  poly (A )+ m R N A . The ^260/280 
ratio o f  the enriched fract ion  was always above two indicating the absence o f  any 
significant contaminating protein.
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5.3 O PT IM ISA TIO N  OF R IB O N U C LE IC  A C ID  T R A N S L A T IO N A L  A C T IV IT Y  IN THE
RABB IT  R E T IC U L O C Y T E  L Y S A T E  SYSTEM .
Throughout the period o f  this study 3 d if fe ren t  in vitro  translation systems 
w ere  utilised with the most successful and u ltimate ly  adopted system being the 
com m erc ia l ly  available nuclease treated  lysate from  Bethesda Research L im ited  
(B .R .L .).  O f  the two others, one was purchased from  Amersham International and 
the other prepared in the laboratory. The main cr iter ia  for any translation system 
are low leve ls  o f  endogenous m R N A , the requirement for  low concentrations o f 
radiolabelled amino acid and most importantly , e f f ic ien t ,  co rrec t  and reproducible 
translation o f added m R N A . Unfortunately , the 2 la tter  systems mentioned w ere  
not able to satis fy  these cr iter ia .
The major problem associated with the lysate from  Amersham International 
was that o f  a generally  low stimulatory translational ac t iv ity .  Translational a c t iv ity  
was in general about 5-10 fo ld above background with a number o f  d i f fe ren t  m R N A  
preparations. In contrast translation with B.R.L.'s lysate fo r  the same m R N A  
preparations would result in 20 fo ld  increases in act iv ity . These values could also be 
attained with the home-made lysate preparation, but the major problem found here 
was that o f  nuclease contamination. With fresh lysate batches high levels o f  
translational a c t iv ity  w ere  obtainable which unfortunately diminished with t ime, 
such that within 4-6 weeks o f  preparation, translational a c t iv ity  was down to 
approx imately twenty percent o f  the starting a ct iv ity .  This was undoubtedly 
associated with the release o f  the m icrococca l nuclease initially used to destroy all 
the endogenous R N A  present. The nuclease is subsequently inactivated with EG TA . 
This decrease in translational a c t iv i ty  is there fo re  most likely to be due to either 
the E G T A  dissociating i ts e l f  from  the nuclease with t ime, or a lternative ly  residual 
calcium interacting with the E G T A  which would again result in nuclease activation .
O f  primary importance is the optimisation o f ion concentrations within the 
lysate mix to attain maximum act iv ity .  These optimisation conditions were shown 
to s ignificantly  vary fo r  both o f  the com m erc ia l lysate preparations re f lec t in g  
variations in the indigenous proportions o f  the ions within their respective  systems.
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When d if fe ren t  R N A  fractions w ere  translated, i.e. rabbit globin m R N A , rat l iver  
m R N A , the conditions required fo r  optimal ac t iv ity  were not found to s ign if icantly  
d i f fe r .  The fo llow ing results, unless otherwise specified , re la te  to the use o f  the
B .R .L . lysate.
5.3.1 Salt Concentrations
Changes in the ion concentration were shown to significantly  influence the
degree o f  a c t iv ity  obtained with the translation system using rat l ive r  R N A  (figure
5.4). With K +, the optimal concentration was within the region o f  80mM, and for  
2+
Mg about Im M  which is the residual leve l  found within the system. Increasing the 
M g2+ concentration resulted in inhibition o f  translational a c t iv ity .  As these 
conditions were shown to be optimal fo r  the translation o f  the rat l iver  R N A  
fractions isolated throughout the study, they were maintained throughout the rest o f 
the translation experiments.
It was not possible to compare the ion concentration optima between d if fe ren t
lysate systems. Generally , these are between 75-150mM fo r  K  and between l-2m M  
2+
fo r  Mg . Although some o f  this variation could be attributed to d if fe ren t  
requirements being needed fo r  d i f fe ren t  m R N A s this is undoubtedly not the major 
cause. For example i f  the same m R N A  fractions were translated with the
Amersham ret icu locy te  lysate system to ta lly  d if fe ren t  ion optima w ere  required. In
+ 2+ this case, fo r  K  this was in the region o f  135-I40mM and for  Mg approximately
1.6mM. Such variations emphasise the need for such standardisation experiments in
order to ensure maximal translation o f  all the R N A  species present.
5.3.2.E f f e c t  o f  m R N A  Concentration on In V itro  Protein Synthesis
The concentration o f  nucleic acid assayed varied with the purity o f  the m R N A  
preparation. Generally, any preparation with ^ g g ^ g g  values o f  less than 1.8 were 
not capable o f  high translational a c t iv ity .  Optimisation o f  the amount o f  R N A  to be 
translated is also important, as inhibition would be seen to result in incorporation by 
the re t icu locy te  lysate system at high concentrations. This is be lieved  to re la te  to
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blocking o f  the ribosomal binding sites as well as com petition  fo r  the various 
in it ia to r/e f fec to r  factors required throughout protein synthesis. A  third fa c to r  to 
be considered would also have to be the increased presence o f  possible inhibitors in 
the R N A  fraction  itse lf , such that w herever possible, the tota l amount o f  R N A  
introduced into the re t icu locy te  system would not rise above 10% o f  the tota l 
volume. Optimisation profiles fo r  both to ta l R N A  and poly (A )+ m R N A  are shown in 
figure 5.5. Increasing the amounts o f  R N A  resulted in a linear increase in 
translational ac t iv ity  up to a point o f  saturation. Low er amounts o f  poly (A )+ 
m R N A  were required in comparable translation a ct iv ity  experiments to to ta l R N A ,  
with this being d irectly  re la ted  to the purity o f  the R N A  fraction  itse lf .
It was also possible to enhance the e f f ic ien cy  o f  translation by a number o f  heat 
denaturation steps o f  the R N A  fract ion  im m ediately  prior to translation. 
E f fe c t iv e ly  this reduces the leve l  o f  aggregation by disrupting the secondary 
structure o f  the R N A  molecules thereby obtaining a more accurate measure o f 
m R N A  act iv ity .  This was achieved by heat denaturation at 65°C  fo r  15 minutes in a 
w ater  bath or else by the addition o f  methyl mercury hydroxide (Payvar  and 
Schimke, 1979) as outlined in section 3.8. These authors reported on the e f fe c t s  o f  
methyl mercury enhancement o f  translation and transcription o f  ovalbumin and 
conalbumin m RN As. The e f f e c t  appears to be m R N A  spec if ic  with reported 
increases o f  6-10 fo ld and 2.5 fo ld being obtained respective ly . This is be lieved to 
result from  an improvement o f  initiation, elongation and termination o f  the m R N A  
or possibly inhibition o f  degradation. Most certainly, in this study, treatm ent o f  
phenobarbitone-induced poly (A )+ m R N A  was a f fe c ted  by methyl mercury 
denaturation with this resulting in the grea test  means o f translational stimulation 
(table 5.2). A c t iv i t y  was almost double that obtained from  the standard means o f 
heat denaturation (heating at 65°C/5 min, and then rapid cooling in ice ) but 
u ltim ate ly  this method was not utilised because o f the inherent health dangers o f 
using this tox ic  chem ical. When the translational products were analysed on SDS 
P .A .G .E . by fluorography, no d if fe rences  w ere  observed between the polypeptides 
generated by either o f  the two procedures (data not shown).
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Figure 5.4
(A )
Optim isation o f  m R N A  Translation 
A )  Potassium A c e ta te  B) Magnesium A c e ta te
Final i F  concontntlon (mM)
(B)
Final M g  c o n c e n t r a t i o n  ( m M )
R at l ive r  poly (A )  m R N A  was translated at a concentration o f  0.037 jjg/pi utilising
35 2+
0.5 pCi S-methionine/pl. In experim ent A ,  Mg concentration was O.BmM. In
experim ent B, K  concentration  was 80mM. In both A  and B, the assay mixtures
w ere  incubated at 30 °C  fo r  90 minutes. For both experiments values represent the
average o f  two separate determinations.
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Table 5.2
The E f fe c t  o f  D i f fe ren t  Denaturation Procedures on the Translation
o f  Po ly  (A )+m R N A  In Vitro
3 5
m R N A  fract ion  S-Methionine Fold enhancement
pretreatm ent incorporation
cpm/pi
None 3,359
Heat denaturation 4,338 1.29
Methyl mercury
hydroxide ( Im M ) 7,162 2.13
Phenobarbitone-induced poly (A )+ m R N A  was translated at a concentration o f  0.03 
pg/pl using "^S-methionine (0.5 pCi/pl) as the rad ioactive tracer fo r  90 mins in the 
iri v itro  translation system. Values represent the means from  a minimum o f two 
determinations.
5.3.3 T im e Course fo r  Translation o f  D i f fe ren t  m RN As
Characterisation o f  the in v itro  re t icu locy te  lysate system indicated that at 
optimal conditions a linear increase in translational ac t iv ity  with t im e was observed 
(f igu re 5.5). Accord ing ly  all translations w ere  carried out fo r  (a period o f )  90 
minutes to ensure maximal translation o f  all available m R N A  species. This is 
especia lly re levant in the case where high molecular weight polypeptides are being 
synthesised, as ribosomes require approximately 30-40 minutes to assemble a 
polypeptide o f  250,000 daltons, such that a high percentage o f  the ribosomes would 
stil l be carrying uncompleted chains a fte r  1 hour. One o f  the features o f  the lysate 
is that it  tends to stop initiating new chains be fore  it loses the ability to e longate 
and com plete  chains which have already started, so that longer incubation times 
predispose to higher yields o f  fu ll length translation products. The in vitro  
translation was carried out at 30° (and not 37°C ), fo r  at 37°C  although the initial 
reaction is faster  there is g rea ter  tendency fo r  the system to shut down earlier, 
resulting in the synthesis o f  only low molecular weight polypeptides. In addition i f
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the m R N A  has become contaminated by ribonucleases or proteases, incubation at 
30 °C  reduces the risk o f  degradation.
33In the analysis o f  translation products, S-methionine was utilised at a
concentration o f  0.5-0.75 pCi/pl. In the case o f  immunoprecipitation analysis, this
was increased to 1.0 pCi/pl in order to increase sensitivity o f  analysis. Although
grea ter  stimulation could have been attained by increasing further the amount o f
radiolabel this was not carried out because o f  the expense o f  the compound. The
35only disadvantage with using S-methionine as a label is the occasional presence o f
a non-specific background polypeptide band which has an apparent molecular weight
o f approximately 48,000. The presence o f  this band was a nuisance as it can
in ter fe re  with the interpretation o f  ge l patterns when the added m R N A  translation
products have molecular weights in the region o f  50,000 (the cytochrom e P-450
region). The precise reason fo r  its presence is unknown but was de fin ite ly  related to
the age o f  the rad ioact ive  amino acid precursor as it was never observed with fresh 
35
batches o f  S-methionine. One suggestion is that it arises from a tRNA-dependant 
but ribosome - independent addition o f  methionine to a pre-existing protein and that 
its appearance can be circumvented by storing the "^S-methionine in 50mM tric ine 
(pH7.4) (N .E .N . technical bulletin). Here however, problems are also encountered in 
that the long-term  stability  o f  the label within this medium is diminished.
5.3.4 Fluorographic Analysis o f  Translation Products
On analysis o f  in v itro  translation products by SDS P .A .G .E . it was found that
35
weak 3-particles such as those em itted  by S are adsorbed within the gel itse lf , and 
as such are recorded in e ff ic ien t ly  by f i lm . This adsorbtion can be overcom e by 
impregnating the sample w ith a sc intil la tor to achieve maximum contact between 
the isotope and the sc intilla tor. In this way even weak emissions can transfer their 
energy to sc intilla tor molecules which can em it  ultra v io le t  light. Provided the 
sample is translucent and colourless, the light can travel further than the original 3- 
partic le to form  an image on the adjacent f i lm . This process is called fluorography.
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The use o f  such scintillators has to be looked at not only from  the point o f  
v iew  o f  e f f ic ien cy  but also cos t-e f fe c t iv en ess  with the three d i f fe ren t  types utilised 
all having their own corresponding advantages as well as disadvantages. Procedures 
for  their use are as described in section 3.10.
The most sa t is factory  sc intilla tor utilised was En^hance which provided not 
only a corresponding increase in sensitiv ity  but also gave c lear, precise and 
de f in it ive  images o f  the polypeptide bands which had been translated. Exposure to 
X -ray  fi lm  was carried out at -70 °C  because at this temperature, increased light 
production from  the fluor and increased sensitivity o f  the X-ray  f i lm  to low 
intensities o f  light dram atica lly  increases resolution (Luthi and Waser, 1965). In 
addition the duration o f  exposure was an important fa c to r  w ith corresponding 
increases in t ime resulting in increased image resolution. This is quite fo rce fu l ly  
illustrated in figure 5.6 where the translation products from  globin m R N A  and R N A  
from  control, phenobarbitone and c lo fibrate-induced rats are shown. Illustrations A  
and B show the respective  products o f  both tota l R N A  and poly (A )+ m R N A  d irected 
translations fo llow ing 1 weeks exposure against X -ray  f i lm . Illustration C (to ta l 
R N A )  and D (poly A + m R N A )  show the same fractions but a fte r  two weeks exposure. 
Correspondingly when just the analysis o f  to ta l translation products was required a 
period o f  1 weeks exposure against fi lm  was utilised. In the case o f 
immunoprecipitation analysis this was increased to 2 weeks, not only to g e t  be tter  
resolution o f  the immunoprecipitated product but also to ensure that no other cross 
recognition had occurred between the antibody and heterologous translation 
products.
Sodium salicy late (Chamberlain, 1979) was also used as a fluorographic 
enhancer but generally this was not found satis factory  because o f  poor resolution 
due to mottled images. This made individual band analysis more d if f icu lt  such that 
its use was lim ited only to those experiments where this was not a major fa c to r  o f  
concern. A m p li fy  (Amersham International) was also used with its advantages being 
its sa fe ty  (non-DMSO based) and the speed o f  application. Qualita t ive ly  however it
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was not judged as e f f ic ie n t  as En^hance which u ltimate ly  became the fluorographic 
sc intilla tor o f  choice.
5.4 USE OF IM M U N O AD S O R B E N T  C O M PLEXE S IN T R A N S L A T IO N A L
IM M U N O P R E C IP IT A T IO N  A N A L Y S IS
Quantitation o f the m R N A  species coding fo r  spec ific  cytochromes P-450 can 
be achieved by the immunoprecipitation o f  their corresponding translation products. 
It is there fore  very  important not only to obtain total immunoprecipitation o f  the 
spec if ic  cytochrome P-450 but also to be able to accurately  quantitate it.
5.4.1 Spec if ic ity  o f  Immunoadsorbent Complexes in Translational 
Immunoprecipitation Analysis
In the course o f  developing an assay fo r  spec ific  protein synthesis within m 
vitro  rabbit re t icu locy te  lysate translation systems three d i f fe ren t  
immunoprecipitation procedures w ere  investigated (section 3.9). Essentially the 
immunoprecipitation o f  antigens involves two main steps. First, spec if ic  antibody is 
added to a detergen t-trea ted  ce ll lysate containing the radiolabelled antigen. Nex t , 
the complexes o f  labelled antigen or antibody are bound with a second agent that 
provides su ff ic ien t mass to fa c i l i ta te  precipitation . The size o f  this prec ip ita te  can 
be further enhanced by the addition of. cold carrier antigen. Traditionally  this 
second agent has been anti-immunoglobulin antibody directed against the first 
antibody but a lternative approaches now include the use o f  chem ica lly  fixed, protein 
A  bearing strains o f  Staphylococcus aureus bacteria  (Kessler, 1975) which have an 
ex trem e ly  high a ff in ity  fo r  IgG.
In the analysis o f  the double antibody technique phenobarbitone IgG (spec if ic  
against cytochrom e P-450 forms B^ and B ^  was directed against the translation 
products coded fo r  by phenobarbitone-induced po ly (A )+ m R N A  fractions. The 
experimental procedure could be considered a success in that immunoprecipitation
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was apparent with there being minimal non-specific background. On analysis o f  the
immunoprecipitated products by gel electrophoresis three major bands were seen in
the cytochrom e P-450 region fo l low ed  by two further bands at approximately 50K
and 25K respec tive ly . These last 2 bands are be lieved to correspond to the heavy
and light chains o f  the precip itating IgG, where because there was such an excess o f 
35antibody, some S label may have been trapped within the immune complexes 
themselves.
The addition o f  PMSF (0.01M) - a protease inhibitor - in the washing 
procedures had no e f f e c t  on the appearance o f  these bands, indicating that their 
presence was not a result o f  p ro teo ly t ic  or other degradative influences. To  a 
certain  exten t, the presence o f  these bands could be sign if icantly  reduced by 
increasing the detergent concentration in the final washing steps but this also 
resulted in a concomitant reduction in the intensity o f  the immunoprecipitated 
polypeptide. The final and possibly major drawback seen with this system was that 
because analysis is perform ed by gel electrophoresis the large amount o f 
precip itating IgG utilised results in gross protein overloading and distortion o f  
resolution within the region o f  the IgG chains. This makes the quantifiable analysis 
o f  immunoprecipitated polypeptides both d if f icu lt  and not wholly reliab le . To a 
certain extent this could be circum vented, but this required that quantitative 
antigen recoveries  be sacr if ic ied  in order to obtain low er leve ls  o f  background 
rad ioact iv ity . These drawbacks necessitated a d if fe ren t  immunoprecipitation 
method to be developed. Towards this end the use o f  S. aureus ghosts and protein A  
were investigated.
The advantage o f  protein A  usage is its high binding sp ec i f ic i ty  to the F c 
regions o f  many IgG subclasses (Goding, 1978). It behaves as an immunoadsorbent 
possessing a high adsorbtion capacity  and rapid binding which permits the spec if ic  
recovery  o f  antigen from  ce ll  lysates simply by centrifugation . D if fe ren t ia l  
separation o f  the protein A  fractions from  the antigen/antibody complexes can then 
be obtained by heat denaturation and chemical reduction just prior to
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In both S. aureus ce l l  and protein A  aided immunoprecipitations, a pre- 
precip itation reaction as w e ll  as a number o f  subsequent washing cycles w ere  found 
to be essential in order to rem ove m ater ia l within the lysate ex trac t  which could 
bind non-specif ica lly  to immunoglobulins or staphylococci. I f  this was not carried 
out, a high background o f  non spec if ic  bands was observed. The amount o f  proteins 
which w ere  adsorbed in this way was quite considerable (f igure 5.7A) and consisted 
primarily o f  lower molecular weight proteins (<50K). This la tte r  ge l illustrates the 
pre-clearing prec ip ita te  obtained with pre-immune IgG and prote in -A  sepharose 
slurry. The major band visible at 50K represents the heavy chain o f  IgG. No major 
proteins appear to be adsorbed in the cytochrom e P-450 region.
I f  the lysate supernatant was also assayed fo llow ing  spec if ic  IgG 
immunoprecipitation with immune antibodies, then again no major peptides are 
visible within this region, indicating the spec if ic ity  by which the corresponding 
antigenic determinants are rem oved by this procedure (f igure 5.7B). When S. aureus 
cells w ere  used in the preclearing step the addition o f  pre-immune IgG was shown 
not to be required with su ff ic ien t adsorbtion being obtained by the cells alone. 
There was some variation in the proteins adsorbed, although again they were 
primarily o f  low molecular w eight. When the pre-clearing fractions obtained using 
either S. aureus cells or pre-immune IgG - protein A  sepharose slurry were analysed 
by immunoprecipitation no ev idence o f  cytochrom e P-450 presence was seen to be 
evident (figure 5.8).
The antigen-antibody complexes were still contaminated with a fa ir  degree o f  
non-specific background proteins and their rem oval necessitated further 
resuspension and centrifugation  through a detergent containing wash bu ffer. This 
was especia lly  true in the analysis o f  the phenobarbitone-induced cytochrom e P-450 
isoenzymes where an additional centrifugation step through a 0.3M 
sucrose/detergent cushion was an absolute necessity. The sucrose supernatant
electrophoresis.
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Figure 5.7A F luorographic Analysis o f  Preclear inq
Fractions fo l low ing  in v itro  Translation
2 0 0 K  
9 2 .  5 K  
6 9 K
4 6  K 
3 OK
Prec lea r ing  was ach ieved using 
pre-immune IgG with protein 
A  sepharose slurry.
1 2 3 4  5 6
Figure 5.7B Fluorographic Analysis o f  in v itro  Translation
Mix fo l low ing  Antibody Immunoprecip itation
4 B k  >
Track 1 = standard, Track 2 = 
prec leared  fract ion  from  zero  
m R N A  blank, Tracks 3-7 = 
p rec leared  fractions from  
phenobarbitone poly ( A ) + 
m R N A  translations.
A l l  tracks represent the supernatant from  an i_n v itro  translation mix coded for  by 
phenobarbitone-induced poly ( A ) + m R N A  fo l low ing  immunoprecipitation w ith anti- 
phenobarbitone-induced cy toch rom e P-450 antibody.
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fractions fo llow ing such centrifugation  w ere  also immunoprecipitated against the 
anti-phenobarbitone-induced cy tochrom e P-450 antibody. No precipitation was 
ev ident indicating no dissociation o f  the antigen from the immunoprecipitation 
complex throughout this step. This rigorous washing procedure was only required in 
the analysis o f  the phenobarbitone-induced cytochromes P-450. I f  cytochrom e P- 
452 (and to a lesser ex tent cytochrom e P-447) immunoprecipitated polypeptides 
were  subjected to this washing procedure then complete disruption o f  the antigen- 
antibody complex was obtained with the immunoprecipitation not succeeding. 
Gentle washing with a non-detergent bu ffer  was su ff ic ient fo r  rem oving any non- 
spec if ica l ly  bound proteins.
The e f fe c t s  o f  the addition o f  cold carr ier  antigen to the 'm v itro  translated 
polypeptide mix just prior to immunoprecipitation with an aim to increase the yields 
was also investigated (f igure 5.9). Increasing the amount o f  antibody itse lf  
increased the amount o f  immunoprecipitated cytochrome P-450. H ow ever  addition 
o f  cold homogeneous cytochrom e P-450 B2 resulted in lower amounts o f  the 
polypeptide being prec ip ita ted . Undoubtedly com pet it ive  binding between the 
translated polypeptides and the cold protein was the major fa c to r ,  and as such this 
aspect o f  immunoprecipitation was not pursued any further.
On translation o f  c lo f ib ra te  and BNF-induced R N A  preparations, 
immunoprecipitation analysis o f  the translation products indicated the presence o f  a 
single polypeptide band which was shown to co -m igra te  with the corresponding 
homogeneous cytochrom e P-450 when analyzed by SDS P .A .G .E . This was not the 
case however with immunoprecipitated phenobarbitone-induced cytochrom e P-450 
isoenzymes fa llow ing translation o f  the corresponding R N A  fraction . H ere  a group 
o f  3-4 proteins were immunoprecipitated, two o f  which corresponded to the B^ and 
B 2 cy tochrom e P-450 forms. The same pattern was observed when either S. aureus 
cells or protein A  sepharose was used to pull down the antigen-antibody complex. 
O f this group o f  precip ita ted  polypeptides, the fourth (being the lowest having an 
apparent molecular weight o f  50,000) was eventually shown to be an a r t i fa c t  as a
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Figure 5.8 Analysis and Im munoprecip itation  o f  5. aureus
C e l l  and Pre-im m une Antibody-pro te in  A  Sepharose A ided  
P rec lea r inq  Fractions
 ^ ^  ^  ^ ^ ' mRNA. Tracks 3,4 il lustra te
‘ ' ' the precleared  proteins rem oved
1 2 3 4  5 6 7 8 9  1 0
by protein A  w ith corresponding 
immunoprecipitations by immune antibody shown in tracks 5,6. Tracks 7,8 represent 
5. aureus prec leared  fractions w ith  imm unoprecipitation analysis shown in tracks 
9,10.
Figure 5.9 The E f f e c t  o f  C arr ie r  P ro te in  on the Immunoprecip itation 
o f  Phenobarbitone-induced C ytoch rom e P-450 Isoenzymes
2 0 0 K  
9 2 . 5 K  
6 9 K
4 6 K 
3 0 K
1 2 3 4 5 6
Track 1 = standard molecu lar 
w eigh t proteins, Tracks 2-6 
represent the im m unoprec ip itated  
translation products o f  phenobarbitone 
-induced poly (A )+ m R N A .
Track 2 = im m unoprec ip itated  w ith 
pre-immune IgG. Tracks 3,5 
imm unoprecip itated w ith 50pg 
and tracks 4,6 w ith  400pg o f 
an ti-cy tochrom e P-450 B^/B? 
antibody. 0.5 and 5pg o f  
purified cy toch rom e P-450 B ? 
w ere  added to the fractions
analysed in tracks 5,6 
respec t ive ly .
t
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non-specific binding. Its presence was shown to be dependent not only upon the 
result o f  amount o f  precip itating matrix utilised but also upon the degree o f
washing o f  the immunoprecipitated complex. It was fo r  this reason that the final
sucrose/detergent wash o f the isolated phenobarbitone d irected R N A  precip ita te
was carried out. This is illustrated in figure 5.10 which illustrates the e f f e c t  o f
increasing background with increasing amounts o f  immunoprecipitating S. aureus
cells. No precipitation is observed fo r  the preclearing stage, or with S. aureus cells
alone, as w e ll  as with control pre-immune IgG on the tota l translation products.
Tw o major proteins are immunoprecipitated whereas a third underlying protein is
seen to becom e evident when g rea ter  amounts o f  S. aureus cells are used to bring
down the antigen-antibody complex.
The sensitivity  o f  antigen detect ion  by immunoprecipitation is there fore  
lim ited by such background rad ioact iv ity . The primary cause is believed  to be 
various polypeptides primarily in the form  o f  glycolip ids associating non-specif ica lly  
with the immunoprecipitates (Kessler, 1981). Most certainly throughout the course 
o f  this study, it was observed that S. aureus cells - despite being stored at -70 °C  and 
washed prior to use to rem ove any dead cells - had an increased tendency to bind 
such "st icky proteins" with time. Thus a balance always had to be maintained 
between the possibility o f  a low intrinsic background and the sensit iv ity  o f  antigen 
detection  attainable.
5.4.2 Quantitation o f  Antibody Concentrations Required fo r  Optimum
Immunoprecipitation o f  Cytochrom e P-450 Apoproteins.
The final parameter which had to be determined fo r  each antibody was the 
optimal concentration required fo r  antigen isolation. This varied between the 
d i f fe ren t  antibodies and although a molar excess o f  antibody to antigen was always 
used care also had to be exercised to ensure that subsequent resolution on SDS 
P .A .G .E . was not a f fe c ted .  To overcom e the possibility that not all the antibody 
spec ified  antigen was being ex tracted , immunoprecipitations w ere  carried out
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Figure 5.10 Analysis o f  5. aureus A ided Immunoprecip itation
o f  Phenobarbitone-induced Po ly  (A )+ m R N A  D irec ted  Translation
2 0 0 K  
9 2 . 5 K  
6 9 K
4 6 K
3 0 K
7 6 5 4  3 2 1
Track 1 = standard m olecular w e igh t  proteins
Phenobarbitone-induced poly (A )+ m R N A  was translated and * subsequently 
im m unoprecip itated under a va r ie ty  o f  conditions.
Track 2 : im m unoprecipitation w ith  pre-immune IgG.
Track 3 : prec ip ita tion  w ith  S. aureus ce lls  alone (no antibody)
Track 4 : Immunoprecip itation o f  p rec ip ita te  from  preclearing stage w ith  20pg an ti­
cy toch rom e P-450 antibody and lOOpl S. aureus cells.
Tracks 5,6,7, : Immunoprecip itation w ith 20pg an ti-cy tochrom e P-450 antibody 
utilising 20, 80 and 200pi o f  S. aureus respec t ive ly  to bind the antigen/antibody 
m atrix .
(S. aureus ce lls  w ere  prewashed and used as a 10% (w/v) suspension)
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sequentially such that a minimum o f  two immunoprecipitations w ere  employed. The 
m ajority  o f  any antigen present would be extracted  fo llow ing  the firs t  
immunoprecipitation, with the remainder being removed in the second. Subsequent 
immunoprecipitations occasionally indicated the presence o f  further antigen, but 
this was rare and the amounts neglig ib le (f igure 5.11). Subsequent isolations were 
shown to result in increased background which relates to the S. aureus cells 
themselves. No d if fe rences  were observed in the immunoprecipitation o f 
polypeptides when either S. aureus cells or protein A  was used as the immunological 
matrix.
Both unfractionated antisera and IgG w ere  used fo r  antigen recovery . Apart 
from  the fa c t  that the IgG fractions could be used at fa r  lower concentrations no 
spec if ic  d if fe rences were observed throughout the immunoprecipitation procedure 
(data not shown). A  slightly higher le v e l  o f  background rad ioact iv ity  was observed 
with whole antisera but. this was countered by the more stringent washing 
procedures.
With anti-cytochrom e P-452 antibody the optimal amount o f  antibody was 
approx imately in the range 250-500 pg anti-sera per fraction  immunoprecipitated 
(f igure 5.12), although as l i t t le  as 10 pg antisera was su ff ic ien t to pull down the 
antigen. In the case o f  the antibody against the phenobarbitone-induced 
cytochrom es P-450, maximal e f f ic ie n c y  o f  immunoprecipitation was seen with 20 pg 
IgG (data not shown). For this antibody fraction  immunoprecipitation was attainable 
with as l i t t le  as 0.01 pg indicating its high spec if ic ity  fo r  these forms. For the 
immunoprecipitation o f  BNF-induced polypeptides an anti-sera fract ion  was utilised 
at a concentration o f  500 pg/assay (data not shown).
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Figure 5.11 To ta l A n tigen ic  Im munoprecip itation o f  C y tochrom e P-452
from  C lo f ib ra te  T im e Course D irec ted  m R N A  in v itro  Translated Fractions
2 0 0 K  
9 2 . 5 K  
6 9 K
4 6 K
3 0 K
1 2 6 7 1 2 3 4  5 6 7
2 0 0 K
9 2 . 5 K  
6 9 K
4 6 K
V
3 0 K
C lo f ib ra te  tota l R N A  was isolated at 6,12,24,72 hours fo l low ing  induction, 
translated, and subsequently im m unoprecip itated against an ti-cy tochrom e P-452 
antibody (tracks 4,5,6,7). Tracks 1 = standard molecular w eigh t proteins, 2 = zero  
m R N A  blank, 3 = 72 hour c lo f ib ra te  R N A  immunoprecip itated against pre-immune 
IgG. Four consecutive, identica l immunoprecipitations w ere  then carried out on the 
same fractions with the products then being analysed on SDS P .A .G .E . (illustrations 
A ,B ,C ,D ).
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Figure 5.12 Determination of the Antibody Titre of Unfractionated Sera
in the Immunoprecipitation of C y t o c h r o m e  P-452 C o d e d  for by Clofibrate 
-induced Poly (A)+ m R N A  Within an in vitro Translation System.
200K
92. 5K 
69K
46K
30K
1 2 3 4  5 6 7  8 9
Track 1 = standard molecular weight proteins.
Track 2 = zero m R N A  blank.
Track 3 = p r e - im mu ne IgG immunoprecipitation (500pg).
Tracks 4-9 = immunoprecipitations with increased amounts of anti-P452 antibody 
utilising 1,10,100,250,500 and 1,000 pg/track respectively.
(from the original X-ray film, immunoprecipitation is evident from a concentration 
of 10 pg anti-P-452 antibody. Clofibrate poly (A)+ m R N A  w a s  isolated following
18.5 hours induction, and translated at a concentration of 0.037 pg/pl, 1.0 pCi ^ S -  
methionine/pi).
Antibody Concentration (pg)
1 10 100 250 500
Percentage cytochrome P-452 
immunoprecipitated of total 
translation products.
0.28 .041 .072 .089 .040
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Ail samples to be analysed by S D S  P.A.G.E. analysis were boiled in sample 
buffer containing S D S  and 2-mercaptoethanol reductant for 5 minutes. This 
effectively elutes any bound protein from the staphylococci so that only the 
immunoprecipitated peptides were analysed. If the resulting staphylococci pellet 
following such treatment w a s  resuspended in buffer, recounted and analysed on S D S  
P.A.G.E. no trace of immunoprecipitated protein was evident, indicating that the 
separation of bound protein to S. aureus cells wa s absolute.
Quantitation of the immunoprecipitated complex was achieved by excising the 
region within the gel containing the immunoprecipitated protein. The gel slice was 
then rehydrated and the corresponding radioactivity leached out of the gel matrix by 
m e a n s  of a gel solubiliser (Protosol, section 3.9.3). A  corresponding area of the gel 
(within the 50-55,000 migratory molecular weight region) in which no radioactivity 
w a s  present was also excised with every analysis, to serve as a blank control of 
background counts. Typically values for such blanks would be in the region of 1-200 
counts/minute with this value being subtracted from all the immunoprecipitation 
obtained data. The manufacturers (NEN) estimate that greater than 8 0 %  recovery 
of radioactivity from gel slices is obtained with this protocol utilising Protosol.
5.5 S Y N T H E S I S  Q F  T H E  C O M P L I M E N T A R Y  D N A  ( c D N A )  F R O M  P U R I F I E D
P O L Y  (A)+ m R N A  D E R I V E D  F R O M  C L O F I B R A T E - I N D U C E D  R A T  L I V E R
Poly (A)+ m R N A  w a s  isolated from rat liver by oligo (dT) chromatography 
undergoing subsequent fractionation on a linear sucrose gradient as described earlier 
in this chapter. This is to r e m o v e  other R N A  sequences present especially r R N A .  
Subsequent immunoprecipitation results in even further purification of the m R N A  
such that the final preparation wa s highly enriched for the clofibrate poly (A)+ 
m R N A  sequence.
Because of the importance of c D N A ,  considerable effort has gone into defining 
conditions which optimise its synthesis. Unfortunately amongst all the different 
laboratories employing this technique no standardised procedure appears to be
183
available, no doubt reflecting the fact that different m R N A s  are copied into D N A  
with different efficiencies. As such, the optimisation for the yield of c D N A  from an 
R N A  must be established for each analysis. In this section such optimisation for the 
synthesis of c D N A  to clofibrate-induced m R N A  is described.
5.5.1 First Strand Synthesis
The ultimate aim of this work wa s to determine those conditions required in 
order to get ma xi ma l c D N A  yield and length, which would subsequently be used in 
cloning experiments. The first and most important parameter to be considered is 
that of the use of reverse transcriptase (RT). The ratio of reverse transcriptase to 
m R N A  template as well as the time of incubation was found to be critical, as was 
the presence of different R N a s e  inhibitors. Although the Avian myeloblastosis virus 
R T  is supplied in a highly purified state inhibitors of R N a s e  are still required. Both 
vanadyl-ribonucleoside complexes and sodium pyrophosphate were employed and 
shown to be effective in preventing the degradation of the m R N A  template. To 
begin transcription of its template, R T  requires an oligonucleotide primer with a 
free 3'-OH group. This w a s  provided by using short oligo (dT) molecules 12-18 
nucleotides in length which bind to the 3' end of the poly (A)+ m R N A .  O n  
subsequent initiation of the c D N A  synthesis reaction the ratio of R T / p g  R N A  could 
then be determined. In this case an o p t i m u m  time period of 90 minutes utilising 50 
units R T / p g  R N A  w a s  used (table 5.3).
Because the amounts of c D N A  synthesised are so small (<1 pg) great care has 
to be taken to ensure all losses from the subsequent manipulations are kept to a 
m i n i m u m .  This is especially true in the case of sephadex chromatography and 
phenol extraction. The sephadex column is used to r e mo ve all the unincorporated 
dNTP's. The elution profile is visualised as 2 peaks, the first, representing the ss 
c D N A ,  the second being by far the largest, the remaining unincorporated 
nucleotides. Here a large column (10-12 inches, sephadex G-75) was shown to be a 
necessity as anything smaller resulted in poor separation. The phenol extractions
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were carried out in the presence of 8-hydroxyquinoline which is a potent R N a s e  
inhibitor. O n  analysis of the organic phase following phenol extraction no ss c D N A  
w a s  shown to be present. The ss c D N A  is then ethanol precipitated, and sized on a 
alkaline agarose gel. A  s m ea r of radioactivity w a s  observed (figure 5.13) ranging in 
size up to the largest species in the R N A  preparation, indicating successful c D N A  
synthesis. For the clofibrate poly (A)+ m R N A ,  the yield of the first strand reverse 
transciptase reaction w a s  generally between 2 5 - 5 0 %  of the weight of the poly (A)+ 
R N A  added, with the product having an approximate size of six to eight hundred 
base pairs. This is illustrated in the following autoradiograph of a 1.2% alkaline 
agarose gel in which 2 fractions of ss c D N A  from different preparations are 
analysed.
prep. 1 prep. 2
ss c D N A  fractions.
(conditions of isolation were as previously described).
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As indicated on the gel, reproducibility of synthesis of c D N A  strands was 
obtained. The fractions were then utilised for the synthesis of the corresponding 
second strand.
5.5.2 Synthesis of Double Stranded c D N A  (ds c D N A ) .
As before, the extent of ds c D N A  synthesis can be monitored either by 
measuring the incorporation of label into T C A  precipitable material or else by 
monitoring its decrease in electrophoretic mobility.
Essentially the ss c D N A  is suspended in a buffered synthesis media (section
3.12.1) containing the K l e n o w  fragment of E. coli D N A  polymerase I (30 units per 
original pg R N A ) .  The reaction mix is incubated at 1 5 ° C  for 20 hrs. It is essential 
to ensure that the Kl en ow fragment concentration does not exceed 10-15% of the 
total reaction mix, otherwise synthesis can be inhibited by the glycerol and 
phosphate present within the storage buffer. The reaction temperature is kept low 
to minimise the possibility of D N A  synthesising back upon itself, with the long time 
period allowing the e n z y m e  to find the first strand c D N A  molecules with hairpin 
loops at their 31 ends. This is because it is believed that these structures are both 
unstable and transient with the e n z y m e s  having to wait for and catch molecules in 
this unlikely configuration in order to begin synthesis of the second D N A  strand 
(Maniatis et al. 1982). It is also advantageous to use the K l e n o w  cleavage fragment 
of D N A  polymerase I rather than D N A  polymerase I itself because of the formers 
lack of 5’ to 3’ exonuclease activity. Both possess 3' to 5’ nuclease activity essential 
for generating a suitable hairpin primer.
At this stage however, the length of the ds c D N A  sequence is still unlikely to 
be complete because of the presence of strong-stop sequences in the c D N A  which 
cause incompleted sequences within the synthesised second strand. To a certain 
extent this can be over co me by the subsequent use of reverse transcriptase which 
responds to different sequences than the K l en ow polymerase. As such, a greater 
yield of full-length ds c D N A  can be obtained. This is visualised in figure 5.13 which
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Figure 5.13 Optimisation of the Conditions Required for
the Synthesis of Full Length ds cD N A '
2 . 2 . .  
2. 1 Kb
w ,
Track 1 = ss c D N A  (600 c p m )
2 = ds c D N A  following K l e n o w  fragment addition (700 c p m )
3 = ds c D N A  following R T  synthesis (1,350 c p m )
4 = Total ds c D N A  (4700 c p m )
Analysis wa s  carried out on a 1 . 2% alkaline agarose gel. T h e  gel w a s  exposed to X -  
ray film for 12 hours prior to developing.
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shows the changes in size, as judged by electrophoretic mobility, of the ds c D N A  
following synthesis from the ss c D N A  as obtained using the aforementioned 
techniques.
That the synthesis of the second strand w a s  successful is s h ow n in the 
following figure 5.14 which c o mp ar es ss and ds c D N A  on a 1.4% alkaline agarose gel. 
The length of the ds c D N A  on the basis of the gel w a s  seen to be approximately 
double that of the first strand with the size distribution of the ds c D N A  being in the 
region of 1,200 to 1,500 base pairs. This is a result of the first and second strands 
being covalently joined by the hairpin loop which is subsequently cleaved with 
nuclease.
Figure 5.14
Size Distribution of ss and ds c D N A  C o mp li me nt ar y 
to Clofibrate-induced Poly (A)+ m R N A .
2 . 2
2. 1 k b I
1 2  3
Tracks 1,2 represent the ss cDNA derived from clofibrate-induced poly (A)+ mRNA, 
Track 3 represents the corresponding ds cDNA sequence.
189
Having prepared the ds c D N A  the next stage would be the digestion of the 
hairpin loop by nuclease activity followed by the generation of cohesive ends of 
the ds c D N A  for ultimate insertion into a cloning vector. H o w e v e r  it wa s decided to 
terminate the study at this point for a n u m b e r  of reasons. Firstly, by this stage 
experimental time remaining wa s a critical factor such that cloning analysis would 
just not have been possible. Secondly the direct objective of this study had only 
been the development and optimisation of methods for the synthesis of ds c D N A  
which would eventually be used for cloning analysis.
5.6 D I S C U S S I O N
The primary aim of this chapter wa s to describe the methods developed and 
the results obtained in the course of characterising the R N A  species coding for 
cytochromes P-450.
The first objective therefore wa s the isolation of R N A  in an undegraded and
-5active form. A  typical m a m m a l i a n  cell contains about 10 pg of R N A  of which 80- 
8 5 %  is ribosomai (chiefly 28s, 18s and 5s) with a further 1 0 -1 5% consisting of a 
variety of low molecular weight species (tRNAs, hn R N A s  etc). In contrast, the 
m R N A  only m a k e s  up between 1 - 5 %  of the total R N A  and as it is this form which is 
directly responsible for the assembly of amino acids into proteins a high yield is 
preferable. The success of the extraction, is ultimately governed by the degree of 
ribonuclease activity and as such the use of guanidinium hydrochloride wa s judged to 
be the most efficient m e a n s  of isolating functional m R N A .  The use of phenolic 
solvents to extract poly (A) containing R N A  wa s not undertaken because of the 
greater potential for loss of the poly (A) tail from the R N A  species during 
extraction (Perry et al, 1972). Animals were not starved prior to death. This was 
primarily because starvation has been reported to result in significant release of 
polyribosomes from the endoplasmic reticulum into the cytoplasm (Yap et al, 1978) 
but also because of the concomitant changes in glycogen, lipoprotein and hormonal 
levels. It wa s found to be critical to excise and homogenise the tissues with G H C 1
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as rapidly as possible as any delay resulted in accompanying R N A  degradation. 
Subsequent GHCl/ethanol reprecipitations, were followed by 3 M  sodium 
acetate/ethanol precipitation and resulted in a successful deproteinisation of the 
R N A  complex as judged by A  260/280 ra^ os* The R N A  wa s occasionally further 
purified on CsCl gradients, although at this stage occasional problems of 
aggregation were encountered. This could be avoided to a large extent by heat 
denaturation of the secondary structure of the R N A  prior to centrifugation. The 
precise reason for this is not k n o w n  but is believed to relate to the interactions of 
the adenine-uracil rich regions of the molecules involved (Glisin et al. 1974). 
Further purification of the R N A  wa s still required and this was achieved by two 
cycles of oligo (dT) chromatography. Th e resulting poly (A)+ m R N A  fractions were 
shown to be translationally active and only minimally contaminated with 28s 
ribosomal R N A .
It is of interest to note that all of the poly (A)" containing fractions isolated 
from the oligo (dT) purification of phenobarbitone-induced m R N A  displayed not only 
total translational activity, but also activity coding for the phenobarbitone-induced 
cytochromes P-450. Undoubtedly this is representative of both competitive 
chromatographic binding and w e a k  interactions of the R N A  species for the oligo (dT) 
itself, as well as s o m e  m R N A  chains having such short poly (A) segments that they 
are just not able to bind to the oligo (dT) adsorbent. In addition because the total 
R N A  represents both nuclear and cytoplasmic species the poly (A)~ fractions could 
conceivably contain R N A  species not yet capped with a polyadenylate tail awaiting 
transfer across the nuclear m e m b r a n e .  Indeed, although the precise role of the poly 
A  tail has still not been elucidated, it is k n o w n  to confer resistance for the m R N A  
species against degradation during such transfer, although the tail itself has been 
shown not to be required for the efficiency of m R N A  species promoting total 
polypeptide synthesis (Brawerman, G. 1981). Finally this could also be a result of 
ribonuclease action against the completed m R N A  sequences but this is less likely 
due to the presence of R N a s e  inhibitors throughout all the stages involved in the
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Translation of the purified poly (A)+ m R N A  sequences allows elucidation of 
the correspondingly coded polypeptides. These in vitro translation systems are 
highly prone to external influences (eg R N a s e  contamination) however, and as such 
optimisation of the correct conditions for efficient, reproducible activity must be 
carried out. Excluding the possibility of R N a s e  contamination, the most important 
parameters are those of energy requirement and salt concentration. The energy 
requirement is over co me by supplementing the system with an excess of creatine 
phosphate to catalyse the A D P  — > A T P  reaction. (All told, it takes the equivalent 
of four high energy phosphate groups split to m a k e  one phosphate bond, half of this 
total being required to charge t R N A  with amino acids, the other half being used for 
reactions occurring on the ribosome). The salt optimisation within the translation 
system is similarly an important factor. This is particularly important because 
minor variations from the o p t i m u m  ion concentration can result in an increased 
missense error frequency (Pettersson et al. 1980) and in extreme cases total 
inhibition.
As only very small quantities of protein are produced by in vitro translation of 
m R N A s ,  with it being extremely rare to be able to detect any corresponding 
biological activity it is therefore essential that an amino acid of very high specific 
activity is utilised. The label chosen w a s  ^^5-methionine, which although not the 
most predominant amino acid present within the amino acid composition of 
cytochromes P-450 does not present any problems in terms of overall incorporation 
into the synthesised polypeptides. This is because, (A) the label is always utilised in 
excess, (B) the methionine content of all the cytochromes P-450 sequenced to date 
is very similar (table 5.4).
extraction of poly (A)+ m R N A .
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Comparison of Methionine A m i n o  Acid Composition of Different
Cytochromes P-450.
Species and N u m b e r  of Methionine
form. residues per molecule
Rat/Hepatic 
P-450b 11
P-450d 8
Rabbit/Hepatic 
P-450 L M 2 8
Rat/Mitochondrial 
P-450 (SCC) 13
P-450 (113) 13
Rat/adrenal cortex 
P-450 (C-21) 11
P-450 (17a,lyase) 8
The final constraint of the translation system which has to be considered is 
that of the assumption that all the m R N A  species coding for their respective 
proteins are being translated with the s a m e  efficiency. This is very important 
because analysis of the translation products reveals the nature of the m R N A  and the 
relative quantity of any particular kind of m R N A .  Such translational competition 
has been reported in the synthesis of the liver proteins hemopexin, ferritin and 
albumin as analysed by quantitative immunoprecipitation of the corresponding 
m R N A  coded translation products (Kaempfer et al. 1983). Here the relative 
translation yield of these proteins changed as a function of the a m o u n t  of m R N A  
present, revealing the existence of translational competition between individual 
species of m R N A  from the liver. Analysis indicated that this wa s due to
competitive binding by the different R N A  species towards an initiation factor 
(eIF-2). This functions in the indispensible role of binding the M e t - t R N A - e l F
a
complex to 40s ribosomal subunits during initiation, as well as possessing m R N A
Table 5.4
Reference
Fujii-Kuryama et al. (1982) 
Kawajiri et ai. (1984)
Tarr et al. (1983)
Ogishima et al. (1983)
ii
ii
i i
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binding properties and being able to recognise the ribosome binding site sequences in 
m R N A .  K a e m p f e r  et al (1983) further suggested that a relationship exists between 
the competitive strength of a given m R N A  species and the degree of differentiation 
accompanying expression of the gene that encodes it. Whether or not this is the 
case for the translation of all m R N A  species in vivo is not known, but should still be 
taken into consideration w h e n  analysing m R N A  coded in vitro translated products.
The immunological characterisation of peptides synthesised by different 
cytochrome P-450 m R N A s  has enabled the relationship between these proteins and 
their m R N A s  as well as their subsequent characterisation to be undertaken. This 
relationship is based upon the recognition that specific antibodies have for distinct 
antigenic determinants. As such, a n u m b e r  of criteria have to be followed to ensure 
that the immunoprecipitated product is indeed a cytochrome P-450 including:
1. R N A  extracted from a different source (i.e. globin m R N A ) ,  which does not 
synthesise cytochrome P-450, does not stimulate amino acid incorporation into 
a peptide that is immunoprecipitable.
2. The immunoprecipitated material is the s a m e  size as the corresponding 
authentic ho mogenous cytochrome P-450.
3. The immunoprecipitated material is specific for anti-cytochrome P-450 
antibody. This critera wa s fulfilled by immunoprecipitating the translation 
products of phenobarbitone coding poly (A)+ m R N A  with anti-albumin IgG and 
a h u m a n  y-globulin fraction (isolated from m y  o w n  sera). In both cases (data 
not shown) there w a s  no evidence of any immunoprecipitated radioactivity. 
H o w e v e r  w h e n  the total in vitro translation products from differently induced 
m R N A  fractions were immunoprecipitated with different anti-cytochromes 
P-450 antibodies s o m e  cross reaction might be expected. This is because the 
cytochromes P-450 have m a n y  structural and functional characteristics in 
c o m m o n ,  possibly including their substrate specificities, their h e m e  binding 
sites and their binding sites for N A D P H - c y t o c h r o m e  P-450 reductase. As 
such, it would be feasible to expect certain peptides having s o m e  antigenic
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features in c o m m o n ,  even though they are distinct peptides derived from 
different m R N A s .  This subject is discussed in detail in the fallowing two 
chapters.
The final analysis to be discussed here is that of the synthesis of c D N A  to 
clofibrate-induced poly (A)+ m R N A .  The ultimate advantage of such a c D N A  probe 
is that it can be used to quantitate the absolute levels of the corresponding m R N A  
within control or drug-induced animals. The first step in the isolation of a ds c D N A  
w a s  that of enriching the m R N A  population coding for cytochrome P-452. This was 
achieved by fractionation on a sucrose gradient where despite 2 passes through oligo 
(dT) cellulose considerable r N R A  contamination wa s evident. O n  
immunoprecipitation of the 18s fraction, only a very small percentage was shown to 
have activity coding for cytochrome P-452. It wa s this fraction which wa s used as a 
template for c D N A  synthesis. A  ss c D N A  molecule of approximately 600-800 bp 
w a s  synthesised whose size w a s  doubled on synthesis of the second strand. Although 
reports (Payvar et al. 1979) have shown that fuller length transcripts can be 
obtained by first denaturing the m R N A  with methyl mercury hydroxide this wa s not 
carried out. The length of the ds c D N A  is relatively small but then again it is not 
k n o w n  w h at size fragments would be obtained following nuclease digestion. 
Generally, reported values of c D N A  sizes coding for the cytochromes P-450 range 
from 200-2000 bp. (Philips et al. (1983), Fujii-Kuriyama et al. (1981). Also on 
cloning it would be unlikely that a full length c D N A  insert coding for cytochrome 
P-452 would be obtained. A m o n g s t  other things this is because 15-20 nucleotides 
corresponding to the extreme 5’-terminal region of the m R N A  are invariably lost 
w h e n  the hairpin loop is digested with nuclease. At present, no full length c D N A  
copy for any cytochrome P-450 isoenzyme has yet been isolated, with the 
elucidation for the gene structure of those cytochromes P-450 n o w  determined being 
achieved by overlapping c D N A  sequences (Mizukami et al. 1983).
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I N D U C T I O N  O F  C Y T O C H R O M E  P-450 I S O E N Z Y M E S  
IN R E S P O N S E  T O  X E N O B I O T I C  A D M I N I S T R A T I O N .
6.1 I N T R O D U C T I O N
In chapter 4, the induction and characterisation of hepatic microsomal 
cytochrome P-450 isoenzymes wa s undertaken. Moreover, this analysis was 
extended so that the s a m e  parameters were also investigated for specific purified 
cytochromes P-450. The results clearly indicated differences amongst the 
isoenzymic population on the basis of spectrophotometric and physical properties, 
peptide patterns generated by partial proteolysis, immunological reactivities and 
substrate specificity. Consequently the study wa s expanded towards the analysis of 
the m R N A  fractions coding for the cytochromes P-450, in order to analyse what 
degree of coordinate induction exists in male Wistar rats following induction by a 
single dose of xenobiotic.
Such elucidation of the molecular events leading to an accumulation of 
cytochromes P-450 wa s achieved by using the techniques of in vitro translation with 
subsequent immunoprecipitation of the translated proteins. In this w a y  it was 
possible to quantitate the level of functional cytochrome P-450 m R N A  in response 
to single dose induction with time. Similar analysis of the induction of different 
cytochromes P-450 have been carried out by other research groups, but generally 
the results obtained exhibit significant variation concerning the time of m a x i m u m  
m R N A  level and the extent of m R N A  increase. Undoubtedly these differences are a 
reflection of different dosing regimens, species and strain differences and m e a n s  of 
quantitation of the m R N A  itself. This study hopes to circumvent s o m e  of these 
problems by standardising (as far as possible) the protocol for such quantitation 
following induction for all three inducers previously described in one rat strain.
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following Pretreatment with Phenobarbitone
Total R N A  fractions were isolated at times 0,6,12,24 and 72 hours following 
induction. These fractions were subsequently translated in vitro and the 
corresponding polypeptides analysed on S D S  P.A.G.E. (figure 6.1). Analysis of the 
translation products of these differentially induced m R N A  fractions indicated clear 
variations in the polypeptides synthesised. However, qualitative visualisation of 
specific individual polypeptides with time wa s m o r e  difficult. This wa s primarily a 
reflection of length of exposure of the S D S  polyacrylamide gel against X-ray film, 
but also of the m a n y  translated products present (figure 5.6).
Fluorographic analysis of the translation of phenobarbitone-induced, co mpared 
to uninduced (zero time point) m R N A  fractions, indicated prominent differences in 
polypeptides synthesised with apparent molecular weights in the region of 25 - 30K, 
52 - 55K, 60K, and 7 7 K  with time (figure 6.1A). This in itself is not really surprising 
considering the potent inductive effect of barbiturates upon integral m e m b r a n e  
proteins of the endoplasmic reticulum. Phenobarbitone itself is k n o w n  to be 
responsible not only for the induction of specific cytochromes P-450, but also of 
N A D P H - c y t o c h r o m e  P-450 reductase (Hardwick et al. 1983), glutathione-S- 
transferases (Pickett et al. 1982) and epoxide hydrolase (Pickett et al. 1981). The 
lower molecular weight polypeptide bands visualised are believed to represent the 
glutathione-S-transferase subunits. Here an increase in intensity of the polypeptide 
bands is seen with time with the lower molecular weight bands (25-30K) being the 
most markedly enhanced. The origin of the 6 0 K  band is unknown.
The above data is consistent with the previously determined phenobarbitone 
time course induction of glutathione-S-transferase B (Pickett et al. 1982). These 
workers showed that this particular isoenzymes exists as a heterodimer comprised 
of a Y a  subunit (M.W. approximately 27l<) and a Y c  subunit (M.W. approximately 
29.5K). Translatable hepatic glutathione-S-transferase B  m R N A  levels were shown 
to be maximally induced at 16 to 24 hours after a single injection of phenobarbitone
6.1.1 Time Course Induction Profile of Hepatic m R N A
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to rats, with the Y a  subunit being markedly enhanced in comparison to the Y c  
subunit.
The translated polypeptides in the molecular weight region of 52-55K 
represent the major phenobarbitone-induced cytochromes P-450. Within this area 2 
bands are seen in the translation products of uninduced m R N A ,  with this n u m b e r  
increasing to 3 possibly 4 polypeptides, by 24 hours following phenobarbitone
induction. A  subsequent decrease in the intensity of the synthesised polypeptides is
seen thereafter. A  similar, although m u c h  less intense pattern of induction is seen 
with the 7 7 K  molecular weight polypeptide. This is believed to represent the 
corresponding N A D P H - c y t o c h r o m e  P-450 reductase protein as it migrates in the 
s a m e  position with the purified protein on S D S  P.A.G.E. (data not shown).
6.1.2 T i m e  Course Induction Profile of Hepatic m R N A  following
Clofibrate Pretreatment
Analysis of the clofibrate time course translation products (figure 6.IB) 
revealed an overall similar but not identical c o m p l e m e n t  of synthesised 
polypeptides. The presence of the proposed glutathiane-S-transferase subunits was 
observed but at intensities not rising above that seen in the uninduced m R N A  
fraction, suggesting that no induction had occurred. The 6 0 K  polypeptide seen 
following 12 and 24 hours phenobarbitone-induction was not observed in any of the 
clofibrate time course fractions. C y t o c h r o m e  P-450 isoenzyme induction was
evident amongst the polypeptides of apparent M . W .  51-55K. B e tw ee n 3-5
polypeptides are maximally induced within this region above basal levels, although 
as before visual qualification is difficult because of the extremely close proximity 
of these proteins.
6.1.3 T i m e  Course Induction Profile of Hepatic m R N A  following B N F  pretreatment
BNF-pretreatment increased the translation of a polypeptide of apparent M . W .  
55K, which corresponds to the major BNF-inducible cytochrome P-447 isoenzyme
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isolated as described previously. A  rapid induction of this isoenzymes level is seen 
within 6 hours of dosing with optimal levels being attained at approximately 12 
hours, after which a decline is observed (figure 6.2). Within the cytochrome P-450 
molecular weight region only one other polypeptide is visualised with an 
approximate molecular weight of 52K. The level of this polypeptide is seen to 
steadily decrease with time following dosing but at different rates than that 
observed for the cytochrome P-447 isoenzyme following BNF-pretreatment. This 
would appear to indicate that the m R N A s  for these 2 polypeptides were under s o m e  
different form of temporal control. A  decrease in the intensity of polypeptide bands 
believed to represent the glutathione-S-transferase subunits w a s  also evident 
following BNF-pretreatment.
6.2 T I M E  C O U R S E  I M M U N O P R E C I P I T A T I O N  A N A L Y S I S  O F  H E P A T I C  m R N A  
T R A N S L A T I O N S  F O L L O W I N G  P H E N O B A R B I T O N E  P R E T R E A T M E N T
Quantitation of the expression of m R N A s  coding for the cytochromes P-450 
w a s  achieved by their translation and subsequent immunoprecipitation. 
Fluorographic analysis enabled detection of the immunoprecipitated peptides to be 
made, which could then be extracted and quantitated. It should be noted that for 
such analysis the fluorographic exposure is far longer than required for total 
translation products, and as such in certain gels minor immunoreactive species m a y  
be visible. These are believed to represent non-specific background binding and are 
not a reflection upon antigen-antibody specificity.
Figure 6.3 shows the polypeptides immunoprecipitated by anti-cytochrome 
P-450 B 2 IgG from the translation products of phenobarbitone-induced rat liver 
fractions. That the specificity of the antibody in the immunoprecipitation of these 
isoenzymes was absolute wa s confirmed by binding competition analysis with 
unlabelled purified cytochrome P-450 B 2 (section 5.4.1). The radioactivity 
contained in the immunoprecipitated peptides was lowered as larger quantities of
200
Figure 6.2 Fluorographic Analysis of m R N A  Fractions following
Single D o se B-napthoflavone Pretreatment
200k
92.5k
69k
46k
30k
1 2 3 4 5 6
Tracks 1 = standard molecular weight proteins, 2 = zero m R N A  blank, 3,4,5,6 = 
m R N A  fractions isolated following 6,12,24 and 72 hours B N F - p r et re at me nt 
respectively.
All fractions were translated at a m R N A  concentration of 0.156 pg/pl with 
approximately 3.5 x 10^ acid precipitable c p m  being loaded per track for S D S  
P.A.G.E. analysis.
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Table 6.1 Induction of Ra t Liver C y t o c h r o m e  P-450 t y / B p m R N A  by 
Phenobarbitone following Single-dose Pretreatment
Percentage of translatable m R N A
activity immunoprecipitated with Increase
anti-cytochrome P-450 Ety/Ety (fold)
antibody (a)
0 0.034 1.0
6 0.0504 1.48
12 0.113 3.32
24 0.245 7.2
72 0.205 6.02
Conditions for quantitation are as described in figure 6.3.
(a) - determined by dividing total immunoprecipitated activity (cpm) by the total 
am ou nt of acid precipitable activity utilised in each immunoprecipitation analysis.
Treatment
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unlabelled cytochrome P-450 w a s  added (figure 5.9). This result confirmed the 
specificity of the immunoprecipitation reaction, and excluded significant non­
specific adsorption of radioactivity on the immunoprecipitate.
At present, no inductive quantitation of the m R N A  species coding for 
cytochromes P-450 in Wistar rats has been undertaken, thereby making comparison 
to other results impossible.
F r o m  the data obtained in this study, phenobarbitone pretreatment of Wistar 
rats resulted in a ma xi ma l increase in the m R N A ' s  coding for cytochromes P-450 
B 1/B2 at 24 hours. At this point a 7 fold induction wa s evident with this level 
subsequently declining with time (table 6.1). A  total of 3 peptides are 
immunoprecipitated, and as far as it is possible to qualitatively ascertain from S D S  
P.A.G.E. analysis it appears that they are equally induced with time. All three 
proteins are evident at 6 hours following pretreatment (bands very faintly 
discernable on photograph) with the upper two bands being believed to represent 
cytochromes P-450 B-  ^and B ^  These immunoprecipitated polypeptides co-migrate 
with their homogeneous counterparts w h e n  analysed on S D S  P.A.G.E. (data not 
shown). The third band possibly represents the product of a constitutive cytochrome 
P-450 m R N A  and this will be discussed in the following chapter. It should also be 
noted that the presence of this latter protein wa s not detected in phenobarbitone- 
induced microsomal fractions w h e n  analysed by Western blotting.
The need to do multiple immunoprecipitations of the in vitro translation 
products should also be stressed (figure 6.3B), otherwise erroneous values in the 
quantitation of m R N A ’s could result due to incomplete polypeptide determination.
6.2.1 T i m e  Course Immunoprecipitation analysis of hepatic m R N A
following clofibrate pretreatment
The molecular pattern for clofibrate induction appears to be of a different 
nature to that observed following phenobarbitone and BNF-pretreatment. In the
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latter cases pretreatment stimulates the synthesis of corresponding m R N A ' s  with a 
concomitant increase in protein synthesis. In the case of clofibrate pretreatment 
however, an initial drop in the level of m R N A  activity coding for cytochrome P-452 
is observed which does not regain basal levels until 24 hours following pretreatment. 
Even at 72 hours the level of coding cytochrome P-452 m R N A  is only just slightly 
increased (figure 6.4). This is in direct contrast to the data obtained following 
single radial immunoquantitation of hepatic microsomes (table 4.11), which showed 
that despite the fact that cytochrome P-452 is present within uninduced hepatocytes 
at extremely high levels, a linear increase in the level of this cytochrome is 
observed with time (2 fold increase at 72 hours) upon pretreatment. This 
immunologically derived quantitative data however, does not correlate with the 
metabolic activity data of these microsomal fractions. In the case of lauric acid 
hydroxylation - a preferential substrate of cytochrome P-452 - an increase in 
metabolic activity is seen to increase only for a 12 hour period following 
pretreatment, after which a steady decline is observed.
O n e  important consideration was to ensure that the immunoprecipitated 
peptide from the translation products of clofibrate-induced R N A  fractions wa s the 
s a m e  as that obtained upon immunoprecipitation of uninduced R N A .  Separate 
analysis, in which the immunoprecipitated products from clofibrate and uninduced 
R N A  fractions were comp ar ed to the unlabelled cytochrome P-452 isoenzyme by 
migration on S D S  P.A.G.E., indicated that this appeared to be the case. H o w e v e r  
w h e n  these immunoprecipitated products were analysed side by side on S D S  P.A.G.E. 
(figure 6.5A), and also upon combination within the s a m e  track (figure 6.5B), this 
indication b e c a m e  slightly m o r e  tentative. The S D S  P.A.G.E. data indicates that 
there is a possibility that in fact the two immunoprecipitated polypeptides are 
separate isoenzymes of nearly identical molecular weight, both being recognised by 
the anti-cytochrome P-452 antibody. A t  this point it should be stressed that the 
data from which this conclusion is derived from is not specific enough to be able to 
definitely say whether this is or is not the case. Its inclusion is important however,
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because of the contrasting parameters which have already been observed during the 
induction process by clofibrate. Whether or not these factors are indicative of 
subtle heterogeneic changes within the cytochrome P-450 subpopulation is not 
known. All these factors will be brought together and discussed in detail in the 
following discussion chapter.
6.2.2 T i m e  Course Immunoprecipitation Analysis of Hepatic m R N A  following
B-napthofiavone Pretreatment
Following B N F  pretreatment an extremely rapid induction of m R N A  activity 
coding for the major inducible B N F  cytochrome P-450 is observed. Increased m R N A  
synthesis could be demonstrated as early as six hours after B N F  administration with 
a m a x i m u m  increase at between 12-16 hours (figure 6.6). Immunoprecipitation of 
the jn vitro translation products of the time course m R N A  fractions indicates the 
presence of one major protein which comigrates in S D S  P.A.G.E. with the 
corresponding homogeneous protein purified from BNF-pretreated rats (data not 
shown). A  second polypeptide of approximate molecular weight 7 0 K  is also 
immunoprecipitated by the anti-cytochrome P-447 antibody. Its induction appears 
to be independant and opposite to that of the m R N A  coding for cytochrome P-447 
(table 6.2). Induction of this peptide wa s seen to decrease w h e n  there wa s an 
accompanying increase in cytochrome P-447 m R N A  activity and vice versa.
Visualisation of the immunoprecipitated cytochrome P-447 from uninduced 
m R N A  translation products wa s not possible even with the aid of fluorography. 
Quantitation wa s achieved by excising the region of the S D S  polyacrylamide gel 
which corresponded to the area of immunoprecipitation, as determined by using 
purified unlabelled cytochrome P-447 as a marker. Quantitation of the m R N A  
activity coding for the higher molecular weight polypeptide within uninduced R N A  
was not determined. The significance or identification of this protein is not known.
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6.3 A N A L Y S I S  O F  D I F F E R E N T I A L L Y - I N D U C E D  m R N A  S E Q U E N C E S  C O D I N G  F O R  
S P E C I F I C  C Y T O C H R O M E S  P-450 W I T H I N  T H E  L I V E R  F O L L O W I N G  P R E T R E A T M E N T  
B Y  D I F F E R E N T  X E N O B I O T I C S
In the previous section quantitation of induced m R N A  coding for distinct 
cytochromes P-450 following xenobiotic administration was determined. Induction 
by these comp ou nd s resulted in an increase (with time) of polypeptides synthesised 
which were recognised by corresponding antibodies raised against these forms. N o  
immunoprecipitation was observed with pre-immune IgG or formalised Staph, aureus 
cells (Fagan et al. 1983). The specificity of the antibody directed i m m u n o ­
precipitation of differentially induced m R N A  in vitro translation products was 
extremely high as shown in figure 6.7 A,B,C. The first illustration shows the total 
acid-precipitated protein - which would include traces of Staph, aureus cells, sera, 
non-specifically bound proteins etc. - analysed on S D S  P.A.G.E. for subsequent 
fluorographic analysis. The second illustration portrays the corresponding 
immunoprecipitated polypeptides, with their relative position in the original gel 
being shown last. The reasoning that the immunoprecipitated polypeptides represent 
the corresponding homoge ne ou s proteins is based on several experimental factors. 
Firstly their co-migration wa s indistinguishable in electrophoretic mobility from 
corresponding purified cytochromes P-450 on S D S  P.A.G.E. analysis (data not 
shown). Secondly the polypeptide is quantitatively re mo ve d from the translation 
products by precipitation with the corresponding antibody and finally, because the 
addition of an excess of non-radioactive purified cytochrome P-450 blocks only the 
immunoprecipitation of the corresponding radiolabelled protein.
This section is directed towards extending this analysis in order to determine 
whether or not the administration of a specific xenobiotic which is k n o w n  to induce 
a cytochrome P-450 isoenzyme, also induces other m R N A  species coding for other 
distinct cytochromes P-450. In these analysis, all the poly (A)+ m R N A  fractions 
were isolated at 16 hours following xenobiotic pretreatment. Less stringent 
detergent washing procedures of the immunoprecipitated complex were employed to
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Figure 6.7C
200K
92.5K 
6 9K
4 6 K
3 O K
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Figure 6.7C illustrates the position of the immunoprecipitated peptides (figure 6.7B) 
in relation to the total acid - precipitable translation products (figure 6.7A), thereby 
illustrating the specificity of both the antibodies and technique in question.
Track 1 = standard moelcular weight proteins; track 2 = zero m R N A  blank, tracks,
3,4 and 5 are representative of the translation products of uninduced m R N A  
immunoprecipitated with anti-cytochromes P-450 B ^ / B 2 , P-447 and P-452 antibodies 
respectively; tracks 6,7 and 8 are representative of the translation products of 
clofibrate-induced m R N A  immunoprecipitated with anti-cytochromes P-450 B 4/ B 2 ,
P-447 and P-452 antibodies respectively,
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maximise the degree of immunoprecipitation. In s o m e  cases this resulted in an 
increase in background non-specific binding.
6.3.1 Uninduced Poly (A)+ m R N A
Primary immunoprecipitation analysis of uninduced poly (A)+ m R N A  
translation products with antibodies directed against cytochromes P-450 
P-452 and P-447 is shown in figure 6.8A. Only one peptide is immunoprecipitated, 
of approximate M . W .  51,000, with the anti-cytochrome P-452 antibody. N o  visual 
immunoprecipitate was observed with the anti-cytochrome P-447 antibody. 
Occasionally the antibody directed against the phenobarbitone-induced cytochromes 
P-450 B j / B2 immunoprecipitated a peptide with an approximate molecular weight in 
the region of 48-50K (figure 6.8B). Subsequent analysis indicated that the 
immunoprecipitation of this peptide amongst different m R N A  fractions translated 
was only associated with the cytochrome P-450 B ^ / B2 antibody. Its presence was 
shown to relate to the fact that the strict detergent washing protocol for the 
S. aureus/antigen/antibody complex which was found necessary for the i m m u n o ­
precipitation of the cytochrome P-450 B j / B2 phenobarbitone peptides wa s not 
employed (section 3.9). If such washing procedures were utilised then the presence 
of this band wa s not apparent, indicating that it is highly likely that the presence of 
this peptide is the result of non-specific binding.
Because no visual immunoprecipitation was observed for peptides 
corresponding to cytochromes P-447 and P-450 B-^/B2 this is indicative that either 
there is no m R N A  present coding for these cytochromes P-450 within uninduced 
hepatic m R N A  or alternatively that the amounts are to low for detection by this 
technique. Quantitation of the basal levels of these cytochromes P-450 was 
achieved by excising that portion of the S D S  P.A.G.E. gel which corresponded to the 
unlabelled purified protein. This is in agreement with data obtained by other 
workers (Phillips et al. 1981, Gozukara et al. 1984). (N.B. a background gel slice
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count is determined and subtracted from all quantitations). Secondary 
immunoprecipitation of the s a m e  fractions with the corresponding antibodies showed 
further cytochrome P-452 immunoprecipitation (figure 6.8B). As before, the 
presence of any immunoprecipitated cytochrome P-447 was not detected.
6.3.2 Clofibrate-induced Poly (A)+ m R N A
Clofibrate induction is seen to maximally express the cytochrome P-452 
peptide, as was also identified in the uninduced m R N A  translation (figures 6.8A,B; 
6.9). • N o  immunoprecipitable activity is seen with the anti-cytochrome P-447 
antibody. As before the anti-cytochrome P-450 B ^ / B2 antibody recognises the 5 0 K  
peptide.
It is apparent from the results obtained from this analysis that the induction of 
cytochrome P-452 is relatively unique as comp ar ed to that of the other cytochromes 
P-450 investigated. O n  clofibrate pretreatment, only the m R N A  coding for this 
peptide is expressed with the level of m R N A  coding for the other cytochromes 
P-450 remaining at or near that seen in the uninduced state. This would suggest - 
making the assumption that all m R N A s  are being equally translated - that the genes 
transcribing for these particular isoenzymes are not being activated. Analysis of 
the m R N A  population following phenobarbitone and BNF-pretreatment however, 
still shows the presence of actively translating m R N A  species coding for 
cytochrome P-452 (figure 6.9). At 16 hours, relative to the uninduced m R N A  level 
coding for cytochrome P-452 a corresponding decrease of 12 and 71 per cent was 
seen for this m R N A  in phenobarbitone and BNF-induced fractions respectively. 
These differences would again suggest subtle differences in genetic control.
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Figure 6.9
Immunoprecipitation Analysis of the Translation Products 
of Uninduced, Phenobarbitone, Clofibrate and B-napthoflavone- 
Induced Poly (A)+ m R N A  by Anti-Cytochromes P-450 B ^/ B ^ and
P-452 Antibody
2 OO K
92. 5K 
69K
46K
3 OK
Tracks 1 = standard molecular weight proteins, 2 = zero m R N A  blank. The following 
tracks represent the immunoprecipitated products coded for by:-
3.7 = uninduced poly (A)+ m R N A
4.9 = phenobarbitone-induced poly (A)+ m R N A
5.8 = clofibrate-induced poly (A)+ m R N A
6.10 = BNF-induced poly (A)+ m R N A .
Immunoprecipitations were carried out with anti-cytochrome P-450 B ^ / B2 antibody 
for fractions in tracks 3-6, and with anti-cytochrome P-452 antibody for fractions in 
tracks 7-10. Poly (A)+ m R N A  wa s translated at a concentration of 0.037 ug/pi.
216
6.3.3 Phenobarbitone-induced Poly (A)+ m R N A
Following phenobarbitone-induction, immunoprecipitation analysis of the 
translation products shows the presence of 3-4 polypeptide bands w h e n  reacted 
against anti-cytochrome P-450 B j / B2 antibody. The lowest band (the 5 0 K  protein) 
wa s believed to result from the non-specific adsorption of the protein onto the 
immunoprecipitation complex, as its presence was easily r e mo ve d by a detergent 
wash. The 2 upper bands represent the cytochrome P-450 B^ and B 2 isoenzymes 
with the cytochrome P-450 B^ peptide being immunoprecipitated to the greatest 
extent (figure 6.10). The nature of the lower band - which has a molecular weight of 
approximately 50-51,000 - and which wa s shown to be present in all the R N A  
fractions isolated for the determination of the phenobarbitone m R N A  time course 
induction profile, is unclear (figure 6.9) although the tenous possibility that this 
represents cytochrome P-452 cannot be entirely discounted (figures 6.10, 6.11A,B).
The fact that immunoprecipitation of the m R N A  fractions isolated at 16 hours 
following phenobarbitone pretreatment with anti-cytochrome P-452 antibody, should 
reveal the presence of actively translating m R N A  coding for cytochrome P-452, is 
not in itself surprising. This is for a n u m b e r  of reasons. First, data obtained during 
this study showed that cytochrome P-452 wa s immunologically detectable at high 
levels in an uninduced state, and even though phenobarbitone-induction resulted in a 
decrease of these levels, they were still detectable 72 hrs after single dose 
pretreatment (table 4.10, 4.11). This w a s  also manifested in the metabolic activity 
profile of the induced microsomal fractions. This would suggest that phenobarbitone 
exerts an influence at the cytochrome P-452 g e n o m e  level, in that although it does 
not appear to totally repress the gene coding for cytochrome P-452 it certainly 
possesses a modulatory role.
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Figure 6.10 Immunoprecipitation Analysis of the In Vitro
Translation Products of Liver Poly (A)+ m R N A  Isolated from 
Phenobarbitone-treated Animals
200K
92. 5K 
6 9 K
4 6 K 
30 K
1 2 3 4 5 6
Tracks 1 = standard molecular weight proteins, 2 = zero m R N A  blank, 3,4,5,6 = 
phenobarbitone-induced poly (A)+ m R N A  immunoprecipitated with p r e - i m m u n e  IgG, 
anti-cytochromes P-450 B ^ / B ^  P-452 and P-447 antibody respectively. 
Poly(A)+ m R N A  wa s translated at a concentration of 0.037 ug/pl with 
immunoprecipitation being achieved with Staphylococcus aureus cells.
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Sequential Immunoprecipitation Analysis of Liver Poly (A)+ 
m R N A  following Phenobarbitone and Clofibrate-induction
Figure 6.11A
2 OOK
92.5K 
6 9 K
4 6 K
3 OK
f t
Minimal washing of the immunoprecipitated complexes (figure 6.11A,B) w a s  carried 
out in order to get ma x i m a l  visualisation of precipitated proteins. Track 1 = 
standard molecular weight proteins; tracks 2,3 = immunoprecipitated products from 
phenobarbitone-induced poly (A)+ reacted against cytochrome P-450 B^ /B ^ antibody; 
track 4 = immunoprecipitated products from phenobarbitone-induced poly (A)+ 
m R N A  reacted against anti-cytochrome P-452 antibody. The immunoprecipitated 
products visualised in this gel (figure 6.11A) are derived from the first antibody 
immunoprecipitation of the m R N A  fraction concerned.
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Sequential Immunoprecipitation Analysis of Liver Poly (A)+ m R N A  
following Phenobarbitone and Clofibrate-induction
Figure 6.11B
200k
92.5k
69k
46k
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1 2 3 4  5 6  7 8
The immunoprecipitated products visualised in this gel (figure 6.11B), unless 
otherwise indicated, are derived from secondary, identical antibody 
immunoprecipitations of the fractions concerned. Track 1 = standard molecular 
weight proteins. Track 2 = zero m R N A  blank. Track 3 = immunoprecipitated 
products from phenobarbitone-induced m R N A  reacted against anti-cytochrome 
P-452 antibody (corresponds to second immunoprecipitation of track 4 fraction, 
figure 6.11A). Tracks 4,6,0 represent the secondary immunoprecipitation products 
of phenobarbitone-induced m R N A  reacted against anti-cytochrome P-450 B ^ / 32 
antibody (tracks 6,8 represent the secondary immunoprecipitated products of tracks 
2,3, figure 6.11A). Track 5 (first immunoprecipitation), track 8 (second 
immunoprecipitation of m R N A  fraction utilising track 5 of this assay), represent the
immunoprecipitation products from clofibrate-induced mRNA reacted against anti- 
cytochrome P-452 antibody.
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The possibility that this peptide represents cytochrome P-452 is based on its 
migration within S D S  P.A.G.E. in comparison to immunoprecipitated cytochrome 
P-452 from both phenobarbitone and clofibrate-induced R N A  fractions (figures 
6.11A,B). As such this experimental observation must be regarded as tenous and will 
be amplified upon in the following discussion chapter.
6.3.4 3-napthoflavone Induced Poly (A)+ m R N A
Analysis of the immunoprecipitation products derived from BNF-induced 
m R N A  fractions indicates the presence of translatable m R N A  with the capability of 
expressing all four forms of cytochromes P-450 analysed (figure 6.12). The peptides 
corresponding to cytochromes P-450 B a n d  P-450 B ^  are just visible in figure 6.12, 
with there also being precipitated a m u c h  larger am ou nt of the 5 0 K  peptide. With 
anti-cytochrome P-447 antibody, 2 peptides are precipitated with the lower one 
corresponding to the cytochrome P-447 isoenzyme.
6.3.5 Expression of Hepatic m R N A  Sequences Coding for Specific
Cytochromes P-450 Subsequent to Xenobiotic Induction
With the development of the in vitro translation system in conjunction with 
immunoprecipitation utilising cytochrome P-450 specific antibodies, it has been 
possible to measure the levels of translatable cytochrome P-450 m R N A s  and thereby 
characterise the temporal induction profile by phenobarbitone, clofibrate and 
3-napthoflavone in Wistar rats.
The data determined from the last part of this study detailing the levels of 
m R N A  coding for the specific cytochromes P-450 as well as the overall fold 
increases of the m R N A  over that seen In the uninduced state is given in table 6.3.
This data, in conjunction with the immunological and metabolic data obtained 
from the analysis of the pretreated microsomal fractions (chapter 4) will be 
analysed together, in detail, in the following discussion chapter.
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Separate Immunoprecipitation Analysis of Liver Poly (A)+ m R N A  
following Single Do se 6-napthoflavone Pretreatment
Figure 6.12
200k
92.5k
69k
\
46k
30k
Track 1 = standard molecular weight proteins, 2 = zero m R N A  blank. T h e  following 
tracks represent 0-napthoflavone poly (A)+ m R N A  fractions separately 
immunoprecipitated against p r e - i m m u n e  (track 3), anti-cytochrome P-450 Ety/Ety 
(track 4), anti-cytochrome P-452 (track 5) and anti-cytochrome P-447 (track 6) 
antibodies respectively. BNF-poly (A)+ m R N A  w a s  translated at a concentration of 
0.037 pg/pl.
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6.4 Inductive Response of Kidney m R N A  Populations following Specific
C y t o c h r o m e  P-450 Inducer Administration
Preliminary investigation into the inductive response of m R N A  species coding 
for cytochromes P-450 in the kidney wa s also carried out. S o m e  caution has to be 
shown in the analysis of the experimental data as it was found that the amounts of 
translational activity (in terms of acid-precipitable cpm) significantly affected the 
extent of peptide immunoprecipitation. This wa s due in part to the relatively low 
amounts of translational c p m  utilised per fraction per assay (1-5 x 10*9 as comp ar ed 
to the amounts used in the immunoprecipitation of liver m R N A  fractions (0.5 - 1.5 x 
10^ cpm). This wa s not believed to affect the immunoprecipitation of the 
cytochrome P-450 species preferentially expressed, but only those in which the level 
of expression is very low.
Figure 6.13 shows the translation products of total R N A  isolated from rat liver 
and kidney pretreated with clofibrate for 16 hours. Full length peptides are 
visualised within the range of the S D S  polyacrylamide gel indicating functional 
translational integrity of the isolated m R N A .
O n  immunoprecipitation of the translation products (2 x 10^ c p m) in uninduced 
R N A  by p r e i m m u n e  and anti-cytochromes P-450 B ^ /E ^ j P-452 and P-447 the major 
peptide precipitated throughout wa s the 5 0 K  protein. Only anti-cytochrome P-452 
precipitated any other peptide which could be visualised, with this corresponding to 
cytochrome P-452. Even here, the image obtained was extremely faint (data not 
shown). Quantitation as such, in order to assess the basel levels of any possible 
precipitated peptide was achieved by excising that area of the gel corresponding to 
the ho mo ge no us protein. The results of all the data, expressed as an an increase 
(fold) of m R N A  over uninduced levels, found with the kidney m R N A  species upon 
induction is shown in table 6.4.
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Figure 6.13 Fluorographic Analysis of In Vitro Translation Products 
from Liver and Kidney Total R N A  Isolated from 
Clofibrate-pretreated Animals
Tracks 1 = standard molecular weight proteins, 2 = zero m R N A  blank, 3 = total liver 
R N A ,  4 = total kidney R N A .  Total R N A  fractions were translated at a 
concentration of 0.156 pg/pl.
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W h e n  kidney R N A  isolated from clofibrate-pretreated animals was subjected 
to immunoprecipitational analysis (1 x 10^ cpm), only the cytochrome P-452 peptide 
w a s  precipitated (by anti-cytochrome P-452 antibody). This precipitated peptide 
comigrated with the corresponding precipitated peptide from liver R N A  of 
clofibrate-pretreated animals, (figure 6.14A). H o w e v e r  on increasing the n u m b e r  of 
translational counts for immunoprecipitation (4 x 10 cpm) the presence of both 
cytochrome P-450 Ety and cytochrome P-447 could be detected w h e n  precipitated 
with the specific antibodies (figure 6.14B). The second precipitation also pulled 
d o w n  the 5 0 K  protein which had not been observed in the first precipitation analysis. 
The presence of cytochrome P-450 B 2 upon immunoprecipitation with the antibody 
directed against the phenobarbitone-induced isoenzymes was not visualised. With 
anti-cytochrome P-447 antibody, the upper 7 0 K  fragment which wa s seen upon the 
immunoprecipitation of cytochrome P-447 coding m R N A  in liver, wa s also apparent.
Sequential immunoprecipitation of kidney R N A  following phenobarbitone- 
induction wa s also undertaken (figure 6.15). The 5 0 K  band was immunoprecipitated 
by all the antibodies utilised, including pr e-immune antisera, further suggesting that 
this does indeed represent a non-specifically adsorbed protein. N o  
immunoprecipitation wa s observed with the anti-cytochrome P-4-50 B 2 antibody 
although this could be a reflection of the counts utilised in the translation assay (2 x 
10 ). Anti-cytochrome P-452 antibody however, immunoprecipitated the 
cytochrome P-452 peptide indicating the presence of the m R N A  coding for this 
isoenzyme in kidney following phenobarbitone-induction. The fact that this peptide 
w a s immunoprecipitated in contrast to the other isoenzymes, would also suggest 
that this is the predominant cytochrome P-450 isoenzyme present in this induced 
state.
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Table 6.4
Increase in m R N A  Induction over Uninduced Levels Coding for 
Cytochromes P-450 in Kidney R N A  following Xenobiotic Pretreatment
Kidney R N A  Isolated
from animals pretreated Cytochromes C y t o c h r o m e  C y t o c h r o m e
with:- P-450 B 1/ B2 P-452 P-447
Clofibrate 0.62 0.7 0.58
Phenobarbitone 2.3 1.03 0.39
Increase (fold) relates to relative increase in m R N A  levels comp ar ed to those in 
the uninduced state.
Although only the presence of cytochrome P-450 B-  ^wa s detected following 
immunoprecipitation with anti-cytochrome P-452 on clofibrate kidney R N A ,  the 
presence of the cytochrome P-450 B 2 form cannot be precluded.
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Immunoprecipitation Analysis of Kidney Total 
R N A  Fractions Isolated from Wistar Rats following Single 
Dose Clofibrate Pretreatment
Figure 6.14A
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In this assay the relative translational activity (cpm) per fraction 
approximated 1 x 10^ cpm.
Tracks 1 = standard molecular weight proteins, track 2 = zero m R N A  blank, 
track 3 = clofibrate-induced hepatic poly (A)+ m R N A  immunoprecipitated 
against anti-cytochrome P-452 antibody. Tracks 4,5,6,7 represent the 
separate translation products of clofibrate total kidney R N A  fractions 
immunoprecipitated against p r e - i m m u n e  (track 4), anti-cytohrome P-450 
B 3/B2 (track 5), anti-cytochrome P-452 (track 6), and anti-cytochrome P-447 
(track 7) antibodies respectively.
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Immunoprecipitation Analysis of Kidney Total 
R N A  Fractions Isolated from Wistar Rats following Single Dose 
Clofibrate Pretreatment
Figure 6.14B
200k
92.5k
69k
46k
30k
For this assay the relative translational activity (cpm) per fraction w a s  
increased to approximately 4 x 10^ cp m.
Track 1 = standard molecular weight proteins, Track 2 = zero m R N A  blank. 
Tracks 3,4,5 represent the separate translation products of clofibrate total 
kidney R N A  fractions immunoprecipitated against anti-cytochromes P-450 
B^/B^ (track 3), anti-cytochromes P-452 (track 4) and anti-cytochrome P-447 
(track 5) antibodies respectively. Total R N A  fractions utilised in both assays 
(figures 6.14A,B) were isolated at 16 hours following clofibrate pretreatment.
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Figure 6.15
Immunoprecipitation Analysis of Kidney R N A  Isolated from 
Phenobarbitone-induced Wistar Rats with Pre-immune, Anti- 
C y t o c h r o m e  P-450 Ety/Ety, P-452 and P-447 Antibodies
200K 
92.5K 
69K
4 6 K 
3 O K
u.mr -vu-m.
1 2 3 4 5 6
Track 1 = standard molecular weight proteins, track 2 = zero m R N A  blank. 
Tracks 3,4,5,6 represent the separate translation products of phenobarbitone- 
induced (16 hours) total kidney R N A  fractions immunoprecipitated against 
p r e i m m u n e  (track 3), anti-cytochrome P-450 Ety/B2 (track 4), anti-cytochrome 
P-452 (track 5), and anti-cytochrome P-447 (track 6) antibodies respectively.
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Chapter 7
DISCUSSION
The cytochrome P-450 mediated mixed-function monooxygenases of liver and 
kidney microsomal m e m b r a n e s  are of central importance in the metabolism of a 
wide variety of endogenous and exogenous compounds. Our research groups interest 
has evolved from initial studies on the contribution of these distinct inducible 
cytochrome P-450 isoenzymes towards drug metabolism to an overall analysis of the 
biochemistry and biophysics of purified cytochrome P-450 catalysis. The study was 
initiated with a viewpoint to developing a purification protocol for the major 
phenobarbitone-inducible form(s) of cytochrome P-450. These isoenzymes were to 
be characterised and then contrasted to the already purified cytochrome P-450 
isoenzymes (P-452 and P-447) available in this laboratory, with emphasis being 
placed on their mode(s) of induction. The resultant data obtained for both the 
development of the techniques utilised and the results relating to the induction and 
characterisation of these isoenzymes, wa s presented in the last three chapters. 
Accordingly the aim of this chapter is to analyse the complete data set in an 
attempt to provide a greater understanding of the processes involved in cytochrome 
P-450 induction.
7.1 P H E N O B A R B I T O N E  I N D U C T I O N
In recent years the molecular biology of cytochrome P-450 induction has been 
extensively studied, and evidence suggests that the major influence of 
phenobarbitone induction is to a u gm en t transcription of specific genes (Gonzalez et 
al. 1982). To date, a n u m b e r  of distinct phenobarbitone-induced hepatic 
cytochromes P-450 have been isolated from Sprague-Dawley rats ( W a x m a n  et al.
1982), Long-Evans rats (Ryan et al. 1982) and Wistar rats (this study). These 
purified hemoproteins can be distinguished from each other by minor structural 
differences although they share several c o m m o n  properties. The presence of these
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isoenzymes - in unique combinations - is n o w  k n o w n  to be a characteristic of 
different strains and colonies of rats (Vlasuk et al. 1982). The two major forms 
isolated-designated cytochromes P-450b and P-450g (Ryan et al. 1982) - have n o w  
undergone successful cloning analysis such that the primary structure of these 
cytochromes P-450 has been elucidated (Fujii-Kuriyama et al. 1982, Y u a n  et al. 
1983).
The cytochrome P-450^ gene w a s  shown to span at least 1 3 K b  pairs and 
contain at least 9 exons separated by 8 introns. Except for the ninth exon (568-569 
base pairs), all the exons are m o r e  or less similar in size, varying from 150 bp for 
the third exon to 201 bp for the first one. The sizes of the intron sequences are 
m u c h  m o r e  variable, ranging from 0.3 to 3.2 Kb. Comparison to the cytochrome 
P-450^ c D N A  clone indicated only 40 base substitutions in a sequence of 
approximately 1,900 bases, with 15 of t h e m  resulting in 14 amino-acid replacements. 
These replacements occurred in relatively limited regions of the gene sequences 
with most being found within exons 6,7,8 and 9 (Mizukami et al. 1983). Most of the 
amino acid replacements between the two isoenzymes were relatively conservative 
changes although four of the substitutions were thought likely to contribute either 
to structural changes or to charge differences between the two isoenzymes 
(Mizukami et al. 1983). Further analysis of the rat g e n o m e  has suggested the 
presence of a further four genes or gene-like sequences which hybridise to 
phenobarbitone-induced cytochrome P-450 c D N A .  The significance of these 
sequences is unknown. N o  protein product has been isolated from any of these 
sequences and they m a y  in fact be pseudogene's (Mizukami et al. 1983).
Also of interest is the fact that the genes coding for these isoenzymes encode 
a cysteine-rich containing tridecapeptide segment which has also been observed in 
two dissimilar forms of rabbit cytochrome P-450 and a bacterial cytochrome 
P-450 c g m  of Ps eudomonas putida (Ozols et al. 1981, Fujii-Kuriyama et al. 1982). 
One of the rabbit liver cytochromes P-450 was a constitutive form (LM~3b), the 
other, a form induced by phenobarbitone (LM-2). Although a tempting speculation,
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it is not possible to say at present whether or not compatible genes for 
corresponding cytochromes P-450 exist across species.
Cy tochromes P-450 Ety and P-450 Ety were purified from the hepatic 
microsomes of phenobarbitone-induced Wistar rats in the current study. O n  
extensive characterisation they were shown to be distinct isoenzymes (chapter 4) 
although still possessing m a n y  similar properties suggestive of cytochromes P-450b 
and P-450^ isolated from other rat strains. H o w e v e r  despite m u c h  compelling 
evidence these forms can not be conclusively shown to represent the aforementioned 
forms although the slight variations observed could be explained in terms of 
microheterogeneity across species (Vlasuk et al. 1982). A m o n g s t  the most important 
evidence for this degree of homology was that obtained from immunological studies. 
The antibodies utilised throughout this work had been extensively characterised and 
shown to be highly specific, therefore uniquely suited as probes to identify and 
discriminate between the functionally similar proteins such as the cytochrome P-450 
isoenzymes. N o n e  of the antibodies prepared against the corresponding purified 
cytochromes P-450 cross-reacted with their heterologous antigens, with the only 
cross reactivity being seen between the cytochrome P-450 Ety and P-450 Ety forms. 
Both these findings are in agreement with the results obtained by other research 
groups involved in the purification of cytochromes P-450^ and P-45O0 from other 
strains of rat (Ryan et al. 1982). Ouchterlony double diffusion analysis (figure 4.19) 
indicates that the cytochromes are immunochemically identical as determined by 
the lack of spurs at the junction of the immunoprecipitin bands. Both isoenzymes 
also form a line of identity with liver microsomes of rats treated with 
phenobarbitone. This cross specificity curtailed any individual quantitation of the 
specific phenobarbitone-induced isoenzymes by immunological means. This antibody 
specificity wa s also apparent in the antibody inhibition studies which were set up 
with a view to determining the contributions of these two isoenzymes to the 
benzphetamine N-demethylase activities of phenobarbitone-induced microsomes. 
Using the purified proteins it b e c a m e  apparent that at low antibody concentrations
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the cytchrome P-450 B 2 hemoprotein was preferentially inhibited (30% of control 
activity as comp ar ed to 5 0 %  for the cytochrome P-450 B ^  form). This degree of 
inhibition however decreased with increasing antibody concentration such that equal 
rates of inhibition were observed for both isoenzymes. At this antibody level (5mg 
IgG/nmol P-450) approximately 20 per cent of control activity is observed, and the 
earlier differences thought to relate to the specificity of antibody binding to the 
corresponding antigenic epitope. In phenobarbitone-induced microsomes only fifty 
per cent inhibition could be observed at comparable antibody concentrations. This 
low degree of inhibition - considering that the antibody is k n o w n  to recognise both 
phenobarbitone-induced isoenzymes which have a very high activity for 
benzphetamine turnover (table 4.6) - could reflect insufficient access to the antigen 
within the endoplasmic reticulum by the antibody. Alternatively, also far m o r e  
likely is that this is indicative of the presence of other forms of cytochrome P-450 
which also possess this ability for this substrates turnover. This antibody cross­
specificity for the two phenobarbitone-induced isoenzymes has to date been found 
in all the different rat strains from which these isoenzymes have been purified.
Another similarity which these two cytochrome P-450 isoenzymes (B^ and B /  
have in c o m m o n  with the phenobarbitone-induced isoenzymes from other strains is 
that of their interaction with metyrapone. It is n o w  k n o w n  that the selectivity of 
metyrapone in binding to hemoproteins parallels its selective inhibitory action on 
those monooxygenase activities which are phenobarbitone-inducible. Of the purified 
hemoproteins analysed, only the cytochromes P-450^ and P-450g (this includes any 
microheterogeneous isoenzyme variation) have been shown to effectively bind this 
ligand (Luu-The et al. 1980). Values obtained for the apparent spectral dissociation 
constant (Ks) for the major purified cytochrome P-450 form have ranged from 1.09,
1.2 to 1.8 p M  in Holtzman, Long-Evans and Sprague-Dawley strains respectively 
(Ryan et al. 1982a, Luu-The et al. 1980). In this study utilising Wistar rats a Ks 
value of 1.01 p M  was reported for the major cytochrome P-450 Bj form which is 
comparable to the above reported values. H o w e v e r  for the cytochrome P-450 B 2
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form a far lower value was obtained (K = 5.56), suggesting differences in the active 
site of the two hemoproteins, resulting in a decreased affinity for ligand binding. 
W h e n  phenobarbitone-induced microsomes were analysed a Ks value of 0.69 p M  was 
determined which is similar to that determined for phenobarbitone-induced 
microsomes isolated from Sprague-Dawley rats (K = 0.6 pM, Mitani et al. 1982). 
A n  inhibition profile of phenobarbitone-induced microsomes isolated at different 
time points was also carried out. Ma xi ma l inhibition was seen at a period of 24 
hours following pretreatment at which point one also observes ma xi ma l induction of 
the phenobarbitone-induced cytochromes P-450.
However, despite these various parameters suggesting that cytochrome P-450 
B^ represents P-450^ and cytochrome P-450 B 2 represents P-450e s o m e  anomalies in 
characterisation have been shown to exist. These relate to the cytochrome P-450 
B 2 form, with the first relating to its apparent sub-unit molecular weight. In this 
study the size of cytochrome P-450 B 2 wa s shown to be 2000 K  larger than the 
corresponding P-450 B-^ form. In other strains the relative differences in size only 
tend to differ by about 500 K  (Ryan et al. 1982). These differences could simply be 
the result of anomalous behaviour on S D S  P.AG.E. with such difficulties associated 
with this isoenzyme having already been reported (Levin et al. 1984). The second 
difference wa s that of catalytic activity in that cytochrome P-450g has been 
reported to exhibit only 15-20 per cent of the activity of cytochrome P-450^ (Ryan 
et al. 1982). For the isoenzymes isolated from Wistar rats a level of 80 per cent 
activity is attained. Whether these differences are simply due to a
microheterogeneous variation across different strains or alternatively whether or 
not these proteins do in fact represent distinct and unrelated isoenzymes cannot be 
fully ascertained at present.
The molecular me chanisms governing, phenobarbitone-induction of cytochrome 
P-450 is still not fully understood (Rees, D., 1979) although it has been suggested 
that activation of gene transcription plays an important role (Hardwick et al. 1983). 
This conclusion is based on the observations that m R N A s  coding for epoxide
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hydratase, N A D P H - c y t o c h r o m e  P-450 reductase and cytochrome P-450^ are rapidly 
elevated after xenobiotic pretreatment (Gonzalez et ah 1981) and that this 
elevation is blocked by the R N A  synthesis chain terminator 3'-deoxyadenosine. In 
addition, prior to the appearance of elevated levels of the major phenobarbitone- 
induced cytochromne P-450^ m R N A  in the cytoplasm, a m a r k e d  increase in 
intranuclear pre m R N A  species is noted (Gonzalez et ah 1982). After 
phenobarbitone-pretreatment, the cytochrome P-450^ gene wa s transcriptionally 
activated within 60 min, with ma xi ma l transcription (23 fold) being attained at 3 
hours after dosing. The corresponding increase in cytochrome P-450^ observed 
paralleled the appearance of increased m R N A  within the cytoplasm. The 
transcription of the gene continues for a period of up to 24 hours, at which time 
point a 14 fold increase in activity over basal levels is still observed (Hardwick et ah
1983).
In this study, analysis of the jn vitro translation products of isolated hepatic 
m R N A  sequences at different time points, indicated that phenobarbitone-induction 
(and clofibrate and 8-napthofiavone) did not s e e m  to significantly alter the template 
activity of total liver m R N A .  This is in agreement with other studies (Phillips et ah
1981), although selective specific increases in the level of translatable m R N A  for 
several polypeptides is apparent. The quantitation for the expression of these 
different m R N A s  w a s  determined by immunoprecipitation analysis. This technique 
has been shown to accurately reflect the increase of induction of m R N A s  in that 
comparable results have been obtained utilising techniques in which analysis is both 
at the R N A  and D N A  level (table 7.1).
Immunoprecipitation analysis of these time course fractions indicated that 
ma xi ma l induction of the m R N A s  coding for the cytochromes P-450 Ety/Ety occurred 
at 24 hours following single dose phenobarbitone-pretreatment. With pretreated 
Sprague-Dawley rats comparable values of between 16-24 hours have also been 
reported (Dubois et al, 1981, Gozukara et al. 1984). With Wistar rats, 
immunoprecipitation analysis indicated that three polypeptides were recognised by
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the anti-cytochrome P-450 Ety antibody. Th e lowest band which wa s induced to the 
least extent - possibly represents a constitutive from of cytochrome P-450, with the 
upper 2 bands representing cytochromes P-450 Ety and P-450 Ety respectively. The 
reasoning behind this conclusion is that this lower band represents a constitutive 
cytochrome P-450 form - possibly cytochrome P-452 - is only based upon co- 
migratory evidence within S D S  P.A.G.E. (figure 6.10), and as such has to be 
considered speculative. Its presence is difficult to explain however, in that although 
clearly evident at the induced m R N A  level, it is not recognised by the s a m e  
antibody in the microsomal fractions following phenobarbitone pretreatment upon 
Western blot analysis. This cannot simply relate to its relatively low level of 
induction - as judged by the fact that its presence was only seen during a first 
immunoprecipitation analysis (figures 6.11A,B) - in that the sensitivity of Western 
blot analysis against microsomal fractions is extremely high.
Alternatively, it m a y  simply represent another m e m b e r  of the phenobarbitone- 
induced cytochrome P-450 isoenzyme family possessing similar epitopic 
determinants (such as seen for the cytochromes P-450 B^/Tty) which ma ke s it 
accessible to recognition by the anti-cytochrome P-450 B^ antibody. The fact that 
its presence is not seen in the microsomal fractions after induction and Western 
blotting analysis could be explained in a n u m b e r  of ways. Analysis of the Nhty- 
terminal residue of cytochrome P~450b (Haugen et al. 1982, H e i n e m a n n  et al. 1983) 
has shown it to be rich in methionine, and as this was the radioactively labelled 
amino acid utilised during the translation experiments one would expect the 
corresponding radiolabelled apoprotein to be easily detected after 
immunoprecipitation and fluorographic analysis. O n e  possibility therefore, could be 
that removal of the transient signal sequence from the translated apoprotein occurs, 
which is essential for the co-translational insertion of the cytochrome P-450 into 
the endoplasmic reticulum (Bar-Nun et al. 1980). This transient signal sequence 
present in a vast n u m b e r  of nascent secretory peptides tends to be rich in 
hydrophobic amino acid residues and is located usually at the Nl-ty-terminal end
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(Blobel et al. 1975). Its removal - possibly by s o m e  form of proteolytic degradation 
process - would result in the particular isoenzyme not being able to insert itself into 
the endoplasmic reticulum environment required for its activity. Subsequent 
breakdown within the cytoplasm would then occur. Alternatively, it could be that 
there is an absence of a signal recognition particle which is a ribonucleoprotein 
complex required in addition to the transient signal sequence for the co- 
translational insertion of the cytochrome P-450 into microsomal m e m b r a n e s  (Walter 
et al. 1984). The importance of such a complex has been demonstrated for the co- 
translational insertion of the major phenobarbitone-inducible form of rabbit liver 
microsomal cytochrome P-450 into heterologous microsomal m e m b r a n e s  (Sakagucki 
et al. 1984). A  final possibility could also be that the insertion of the cytochrome P- 
450 isoenzyme into' the endoplasmic reticulum results in the blocking of the 
isoenzymes antigen binding site(s) which is being recognised by the anti-cytochrome 
P-450 B 2 antibody.
Monitoring the time course of m R N A  induction coding for the phenobarbitone- 
induced isoenzymes shows an identical profile to that of the immunochemically 
quantitated isoenzymic levels (figure 7.1). In both cases ma xi ma l induction is 
attained at 24 hours following pretreatment, at which stage a gradual decline is 
observed. This induction was reflected within microsomes by a corresponding 
increase in benzphetamine N-demethylase activity which is a preferential substrate 
for the phenobarbitone-induced cytochrome P-450 isoenzymes. Immuno ch em ic al 
quantitation of these isoenzymes indicates an extremely rapid induction with time 
with the levels attained being similar to those found within other rat strains upon 
induction. Following pretreatment, a greater than 6-fold increase in m R N A  
translation is observed within 6 hours. This rapid rise (table 4.10) coupled with the 
data n o w  k n o w n  about the rapid increase in transcription of specific cytochrome 
P-450 genes (Hardwick et al. 1983) followed by translation of the induced m R N A ' s  
(table 6.2) is strongly indicative of a inducer-receptor complex being associated with 
phenobarbitone-induction. However, no hard evidence has em er ge d to support this
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At present there is no available me th od to differentiate quantitatively the 
level of cytochrome P-450^ in rat liver microsomes from that of cytochrome P- 
450e< Western blotting analysis (figure 4.21) suggests that at basal levels, the 
cytochrome P-450 Ety form is the major isoenzyme present, with equal levels of the 
isoenzymes only being seen at between 6-12 hours following pretreatment. A t  this 
onwards point qualitative visualisation suggests that the cytochrome P-450 Ety 
isoenzyme is the major form present. This is in contrast to the observed induction 
of these isoenzymes within rat liver microsomes of Sprague-Dawley rats. Here it 
has been suggested (Vlasuk et al. 1982) - on the basis of S D S  P.A.G.E. analysis -that 
regardless of changes in the absolute level, the ratio of these two isoenzymes 
remains relatively constant. It is striking though, that these two isoenzymes of 
apparent im mu no ch em ic al identity, peptide mapping patterns and amino-acid 
sequences, still appear to be synthesised from independent m R N A  molecules, not 
appearing to undergo significant post-translational modifications being expressed as 
co-dominant alleles as determined from mating experiments (Walz et al. 1982, 
1982a).
Monitoring the metabolic activity of the microsomal fractions shows an initial 
drop in benzphetamine turnover activity up to 6 hours, with the turnover only 
increasing above basal levels after this period of time. This difference suggests that 
the association of h e m e  with the apoprotein m a y  be a rate-limiting event, a 
conclusion also speculated upon by other research groups (Dubois et al. 1979). The 
continuing increase in specific content (24 to 72 hours) as comp ar ed to a gradual 
decline in the level of immunologically detectable cytochrome P-450 (radial 
immunodiffusion) and m R N A  levels probably reflects the continued induction of 
other M.F.O. en zy me s (Gozukara et al. 1984). The fact that there is still an 
increase in metabolic activity at 72 hours despite the decrease in m R N A  levels, and 
to a certain extent immunologically detectable cytochrome P-450 Ety/Ety (figure
7.1), is believed to relate to the in vivo turnover of both the apoprotein and h e m e
concept (Poland et al. 1981).
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Figure 7.1
The Induction of Hepatic Cytoch ro me s P-450 B ^/B^ 
following Single-dose Phenobarbitone Pretreatment
(A) represents increase (fold) of immunoprecipitable m R N A  activity coding for 
cytochromes P-450 B^/B^.
(B) represents increase (fold) of cytochromes P-450 B 3/B2 in phenobarbitone- 
induced microsomes as determined by single radial immunodiffusion assay.
(C) represents increase (fold) in benzphetamine N-demethylase activity within 
phenobarbitone-induced microsomes.
All values represent increases above basal levels. (Data from chapters 4 and 6).
241
moieties of the cytochrome P-450 isoenzymes, as well as the contribution of other 
cytochromes P-450 towards benzphetamine demethylation. The turnover of hepatic 
cytochromes P-450^ and P-450e within Long-Evans rats has been shown to 
correspond to half lives of 37 and 28 hours for the apoprotein and h e m e  moieties 
respectively (Parkinson et al. 1983). The involvement of other isoenzymic 
cytochromes P-450 in benzphetamine turnover has already been shown both by the 
antibody-inhibition data (section 4.5.3) as well as reconstitution analysis with the 
purified cytochrome P-450 isoenzymes (table 4.6).
The inhibition data showed that the cytochromes P-450 were responsible
for an important part of the benzphetamine N-demethylase activity in 
phenobarbitone-treated rat microsomal fractions, but that there were also other 
isoenzymic forms present with the potential for such activity. This is in contrast to 
studies in Long Evans rats where 1 0 0 %  inhibition of benzphetamine N-demethylase 
activity wa s obtained with the anti-cytochrome P-450^ antibody (Thomas et al. 
1976). The precise reason for this discrepancy is unclear, but is not believed to 
relate to non-antibody specificity especially since other homogeneous cytochromes 
P-450 were also shown to possess this metabolising activity (table 4.6), albeit at far 
lower amounts.
Interestingly, on the basis of the single radial immunodiffusion and metabolism 
data (chapter 4), it is possible to conclude that phenobarbitone acts not only at the 
molecular level for the genes coding for cytochromes P-450 B^/B^, but also has the 
capability for regulating other cytochrome P-450 isoenzymic gene activity (figure
7.2). Analysis of the m R N A  sequences within animals pretreated for 16 hours with 
phenobarbitone (table 6.5) indicates that the m R N A  sequences coding for 
cytochrome P-452 remain at or near basal levels, whereas those coding for 
cytochrome P-447 have undergone a 2-fold increase. These results however, are not 
entirely consistent with the metabolic and immunochemical quantitation data 
(figure 7.2) suggesting that other regulatory mechanisms m a y  be involved.
The level of immunoquantitatable cytochrome P-452 is seen to rapidly
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diminish (24% of basal levels following 6 hours pretreatment), and although a slight 
increase is observed at 12 hours the isoenzymic levels further decrease after this 
period. C y t o c h r o m e  P-452 is preferentially induced following clofibrate 
pretreatment, and has been shown to be involved in the to and ( w -l)-hydraxylation 
of saturated fatty acids such as lauric acid within the liver (Gibson et al. 1982). 
Purified cytochrome P-452 preferentially hydroxylates lauric acid at the (12-) 
position. The presence of cytochrome P-452 within the c o m p l e m e n t  of m R N A  
species induced by phenobarbitone-pretreatment has also been conclusively shown 
for the first time by immunoprecipitation analysis (figure 6.9). H o w e v e r  despite the 
fact that there is a relative decrease in immunologically detectable cytochrome 
P-452, there is a corresponding increase in total 11- and 12-lauric acid 
hydroxylation activity with time (figure 7.2). This would strongly support the 
hypothesis put forward that separate cytochromes P-450 catalyse the two fatty 
acid-hydroxylation reactions in liver microsomes (Bjorkhem et al. 1970, Okita et al. 
1980).
Phenobarbitone-induction results in a ma xi ma l 1.5 fold increase in 11- and 12- 
hydroxylation of lauric acid, a value in agreement with other authors (Orton et al.
1982). H P L C  analysis (figure 4.11B) indicated that following pretreatment with 
phenobarbitone there was a decrease in 12-hydroxylaurate production and a 
preferential increase in 11-hydroxylation for a period up to 24 hours. This is also in 
agreement with other studies, which have shown that phenobarbitone causes a small 
but preferential increase in 11-hydroxylauric formation (Orton et al. 1982). By 72 
hours however, this product ratio was reversed in that metabolism was 
preferentially occurring at the 12-hydroxy position. This reversibility further lends 
credence to the belief that two different isoenzymes are induced, with both being 
under independent genetic control.
Phenobarbitone does not appear to exert any specific effect on the gene 
coding for cytochrome P-447. Although a slight increase in the expression of its 
corresponding m R N A  w a s  observed, the relative immunologically detectable 
proportion of the isoenzyme stayed at basal levels. S o m e  metabolic activity (figure
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7.2) was observed but this decreased with time and is more likely to be a reflection  
of cross-substrate specificity amongst different isoenzymes.
In conclusion, it was demonstrated in this study that the purified cytochrome 
P-450 preparation from male Wistar rats is comprised of two major polypeptides. 
Immunoprecipitational analysis of the induced mRNA species corroborates this 
finding and further suggests the possible presence of one other minor form of 
phenobarbitone-induced cytochrome P-450. The levels of mRNA coding for these 
phenobarbitone-induced isoenzymes represent 0.034% of the total hepatic poly (A)+ 
RNA isolated from control animals. This is in close agreement to the levels 
(0.029%) found in male Sprague-Dawley rats (Shephard et al. 1982). A fter induction 
the two predominant cytochrome P-450 isoenzymes become major microsomal 
polypeptides. This is further corroborated by metabolic and immunological data. 
All three polypeptides are the products of distinct mRNAs. These mRNAs are at 
very low levels in untreated rats but accumulate rapidly in response to the acute 
administration of phenobarbitone.
This data is consistent with the studies of Adesrv^j et al. (1981) and Phillips et 
al. (1985). These groups utilised cDNA clones to quantitate the level of cytochrome 
P-450 mRNA as a function of phenobarbitone-induction. The induction of the 
phenobarbitone isoenzymes was shown to be mediated by an induction of the specific 
mRNAs, with this being accounted for almost entirely by an increase in the 
transcription of the phenobarbitone cytochrome P-450 genes.
7.2 CLOFIBRATE IND U C TIO N
Clofibrate has been administered to human patients as a hypolipidaemic agent, 
although its precise mechanism of action still remains unknown. Within rats it has 
been shown to cause hepatomegaly and marked proliferation of peroxisomes in liver 
cells (Moody et al. 1978). The peroxisomal proliferation is almost always associated 
with an increase in peroxisomal enzyme activities including the fa tty  acid B- 
oxidation system (Reddy et al. 1984), as well as increasing a number of mixed
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function oxidase enzyme activities (Orton et al. 1982). O f these, the major 
cytochrome P-450 isoenzyme induced appears to represent a form termed 
cytochrome P-452 (Gibson et al. 1982). This form has since been extensively 
characterised and shown to be representative of a unique cytochrome P-450  
isoenzyme (Tamburini et al. 1984). Evidence obtained in this laboratory is also 
highly suggestive that cytochrome P-452 represents a constitutive cytochrome 
P-450 isoenzyme, and that many hypolipidaemic agents function as inducers of 
constitutive hemoprotein isoenzymes.
Although considerable understanding of the action of clofibrate at a 
biochemical level has now been attained (Cohen et al. 1981, Reddy et al. 1984), very 
little  or no work has been carried out at the molecular level.
The induction profile following clofibrate pretreatment was the most complex 
of the three xenobiotic inducers studied. This was primarily because the molecular 
pattern appears to be of a different nature to that observed following 
phenobarbitone and BNF-pretreatm ent. In these latter cases pretreatm ent was 
shown to stimulate the synthesis of corresponding mRNAs with a concomitant 
increase in protein synthesis. In the case of clofibrate-induction however, an initial 
decrease in the level of mRNA coding for cytochrome P-452 was observed 
concomitant with an increase in both immunologically detectable cytochrome P-452 
and an increase in lauric acid hydroxylation (figure 7.3).
Single radial immunoquantitation (table 4.11) showed that the basal levels of 
cytochrome P-452 in hepatic microsomes was high (25% of total cytochrome P-450). 
Upon clofibrate-induction a 2-fold increase in cytochrome P-452 was seen. This 
high level of cytochrome P-452 in uninduced microsomes is in direct contrast to the 
amounts of other well characterised isoenzymic forms, and for this reason is 
believed to represent a constitutive form. For example, cytochromes P-450j:)j P- 
450 and cytochrome P-450 only occur to the extent of approximately 1-2% in
8 C
uninduced microsomes (Thomas et al. 1983), with these levels being increased to 
55% and 71% respectively of the total cytochrome P-450 population upon
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Figure 7.3 Induction of Hepatic Cytochrome P-452 following
Single Dose C lofibrate Pretreatm ent
A) Represents increase (fold) of immunoprecipitable m RNA translational
activ ity  coding for cytochrome P-452.
B) Represents increase (fold) of cytochrome P-452 within clofibrate induced
microsomes as determined by single radial immunodiffusion assay.
C) Represents increase (fold) in total 11- and 12- lauric acid hydroxylation
activ ity  in clofibrate-induced microsomes.
A ll values represent increases above basal levels. (Data is from pertinent result
sections, chapters 4 and 6).
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corresponding xenobiotic induction. That this immunoquantitation is an accurate 
reflection, is based entirely upon the specificity of the antibody utilised. The 
specificity is believed to be absolute however; not only on the basis of Ouchterlony 
analysis and the presence of single radial immunodiffusion rings, but also from the 
data obtained from Western blot analysis of the induced microsomal fractions. In a 
different study (Bains et al. 1985) clofibrate induction (clofibrate was administered 
as 0.4% (w/w) of standard powdered laboratory diet for 14 days) was also shown to 
induce similar levels of the cytochrome P-452 isoenzyme (57% of the total 
cytochrome P-452). Comparable values to this study were also observed within 
uninduced hepatic microsomes.
This induction however was not correlated to a corresponding increase in 
lauric acid hydroxylation activity (figure 7.2). An initial rapid increase was seen 
which subsequently declined at between 12-24 hours following pretreatm ent. A 
maximal 2.5 fold increase in activ ity  was seen, which is comparable to the levels 
observed within the aforementioned study also using Wistar rats (Bains et al. 1985). 
The time differences observed with respect to the amount of immunologically 
detectable isoenzyme and metabolic activity between the two studies are believed 
to relate entirely to the different dosing regimens utilised and therefore
bioavailability of the drug.
The discrepancy arises from the fact that a fall in metabolising activity is
observed at a time when the immunologically detectable levels of cytochrome P-452
are rising. The reason for this contradiction is at present unknown.
That clofibrate pretreatm ent resulted in the induction of a specific isoenzyme 
was also conclusively shown by analysis of the hydroxylated lauric acid metabolites 
by HPLC (figure 4.11A), This showed that the increase was due to specific induction 
of the 12-hydroxylase, with the 11-hydroxylase activity not being significantly
affected at all. This constrasts with phenobarbitone (figure 4.11B) which was shown 
to cause an initial small, but preferential increase of 11-hydroxylase activ ity .
It should also be mentioned that recent work carried out in this laboratory in
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fact suggests that lauric acid serves only as a model substrate for a physiologically 
more relevant endogenous substrate. This is based on the observation that only 
trace amounts of this fa tty  acid are found in hepatic microsomal membranes, and 
also because of the ability of cytochrome P-452 to metabolise arachidonic acid 
(Bains et al. 1985). Absolute inhibition of this activity can be obtained with the 
anti-cytochrome P-452 antibody.
A further puzzling observation was that of the temporal expression of the 
mRNA sequences coding for cytochrome P-452 on induction. An apparently 
different trend of induction to that expected is again observed (figure 7.2). An 
in itial drop in mRNA activ ity  coding for the induced cytochrome P-452 isoenzyme is 
seen which continues for a period of 12 hours, following which the levels begin to 
rise. A t 72 hours following pretreatm ent the mRNA levels are only just above those 
present in the uninduced state. This drop in activity would appear to suggest either 
a repressive or some form of modulatory mechanism operating on the gene coding 
for the cytochrome P-452 isoenzyme, or possibly even the switching on of a 
different gene altogether. I t  has also been speculated that hypolipidaemics exert 
their inductive effect by binding to a cellular receptor protein (Lalwani et al. 1983), 
in a manner analogous to that seen with the Ah locus (Nebert et al. 1981). As yet 
however, this work has not been corroborated and further study in this area is 
required.
These contrasting parameters make it d ifficu lt to specify the precise nature of 
clofibrate induction. One possible explanation which encompasses all the data, is 
indicative of a subtle heterogeneity occurring within the cytochrome P-450 sub­
population, as follows.
The analysis of clofibrate-induced mRNA isolated at 16 hours following 
pretreatm ent indicated a substantially lowered level of expression for the 
cytochrome P-452 mRNA (60%) as compared to that observed in uninduced mRNA  
species. That one does not see a large increase in the level of mRNA expressed 
upon induction need not necessarily be surprising. Firstly, this is because of the high
level of this mRNA being present in the uninduced state (table 6.5) which no doubt is 
representative of the very high constitutive levels of cytochrome P-452. Secondly, 
upon induction a maximal 2-fold increase only, is seen for the cytochrome P-452 
isoenzyme and as such this increase could be more related to an increased 
processing and/or stabilisation of the mRNA itself. The actual mechanism(s) 
remains to be determined.
Upon translation and subsequent immunoprecipitation of uninduced and 
clofibrate pretreated (16 hours) mRNA fractions, a single polypeptide band was 
observed which appeared to migrate with authentic unlabelled cytochrome P-452 on 
analysis on SDS P.A.G.E. (figure 6.5A). However if the two immunoprecipitates
were combined and analysed together on SDS P.A.G.E. then the possible presence of
two polypeptides stacked immediately on top of each other was just discernable 
(figure 6.5B). This discrepancy is based upon a tentative observation especially 
because the differences in size between these two possibly immunoprecipitated 
polypeptides is so small. If  one accepts that this is not an a rtifac t however, then 
the SDS P.A.G.E. analysis indicates that the polypeptide visualised upon 
immunoprecipitation of the uninduced mRNA fraction represents the top band (i.e. 
higher molecular weight), and the lower polypeptide represents the induced 
polypeptide.
A possible explanation for this observation is that the polypeptide which is 
visualised within the uninduced mRNA state represents the precursor form of 
cytochrome P-452 with the mature form only being expressed upon induction. A 
number of workers have shown that certain proteins are synthesised as precursor
forms (table 7.2) although this does not extend to other enzymes of drug
metabolism, including certain cytochrome P-450 isoenzymes (Bresnick et al. 1981), 
NADPH-cytochrome P-450 reductase (Gonzalez et al. 1980), epoxide hydratase 
(Gonzalez et al. 1980a), and the glutathione-5-transferases (Pickett et al. 1982). 
These la tter workers have shown that the above proteins are synthesised as the 
complete, mature polypeptide.The only problem with this supposition however, 
would be the extremely short length of the precursor segment.
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Table 7.2
Monomeric Molecular Weights of the Precursor and Mature Forms of
Protein Mature Precursor Precursor
Cytochrome P-450 ' see 49K 54.5K 5.5K
Cytochrome P -4 5 0 ^ ^ 48K 53.5K 5.5K
Adrenodoxin 12K 19K 7.OK
Adrenodoxin reductase 51.IK 53.4K 2.3K
Cytochrome P-448 53K 59K 6. OK
Reference
Dubois et al. 1981
Kramer et al. 1982 
Kramer et al. 1982 
Kramer et al. 1982 
Kumar et al. 1980
A more likely explanation is that some different form of control over gene 
activ ity  is emerging following induction. This could involve a decrease in expression 
of the cytochrome P-452 gene in uninduced animals with a concomitant increase in 
activity of a highly related gene coding for a similar cytochrome P-452. Certainly  
from the results presented, a decrease in mRNA activity is observed followed by a 
subsequent increase after 12 hours. This data taken in conjunction with the 
induction metabolism profile (figure 7.3) would support this hypothesis. If this is 
indeed the case then the fact that the anti-cytochrome P-452 antibody recognises 
both related isoenzymes is also not surprising (consider the antibody recognition for 
cytochromes P-450 B j/E ^ ). The fact that one does not get a decrease in total 
cytochrome P-452 level (with respect to the single radial immunodiffusion data and 
increase in microsomal specific content with time) could also be explained by a 
corresponding balance between the levels of the constitutive and induced isoenzymic 
form.
The possibility of such a regulatory role over gene activ ity  is now emerging 
(Mizuno et al. 1984), with it appearing that short RNA molecules made when one 
gene is active having the capability of binding to a mRNA of a different but
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intim ately linked gene thereby modulating its activity (Simons et al. 1983). In this 
manner the activity of any one gene is capable of increasing or decreasing the 
protein production of another.
From the immunological and metabolic data, it also becomes apparent that 
clofibrate functions as a highly specific inducing agent, not acting at the genome 
level coding for the phenobarbitone or BNF-induced cytochrome P-450 isoenzymes 
(figures 7.4). Although there is immunological evidence for the increased presence 
of cytochromes P-450 B j/B 2 above uninduced levels (table 4J/1) upon clofibrate 
pretreatm ent, this is not coupled to an increase in benzphetamine N-demethylase 
activ ity . Similarly upon immunoprecipitation of clofibrate induced mRNA (16 hours 
pretreatm ent) no evidence of expression for the phenobarbitone-induced isoenzymes 
was found. In the case of cytochrome P-447 no evidence for immunological 
presence was found within clofibrate microsomes. This corresponded to the 
metabolic turnover of 7-ethoxyresorufin which stayed at or near basal levels (figure 
7.4).
This specificity of clofibrate for the induction of cytochrome P-452 has also 
been suggested across other species and strains by means of hybridisation 
techniques. Stupans et al. (1984) have presented data which indicates that there is 
no cross-hybridisation between clofibrate-induced mRNA and either mouse D2 strain 
cytochrome P-450b cDNA or mouse cytochrome P^-450 cDNA clones. A t the level 
of hybridisation stringency utilised in the Northern analysis, there was no cross- 
hybridisation between the phenobarbitone-induced mouse or Sprague-Dawley rat 
cytochrome P-450^ and the cytochrome P^-450 cDNA probe. This was also the case 
when hybridisation was carried out between the 3-methylcholanthrene-induced 
mouse or rat cytochrome P^-450 and the cytochrome P-450b cDNA probe.
The same results were obtained when total liver poly (A)+ from clofibrate- 
induced Wistar rats (this study) was analysed with a probe coding for the major 
BNF-induced cytochrome P-450 (Phillips, I. 1984, personal communication).
In conclusion, with the data obtained throughout this study it is not possible to
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precisely define the mode of induction mediated by clofibrate-pretreatm ent. The 
specificity of clofibrate induction for cytochrome P-452 was also determined, and 
this coupled with the hybridisation data discussed above, strongly suggests that 
clofibrate pretreatm ent involves activation of cytochrome P-450 gene(s) not 
present in the multigene families induced by either phenobarbitone or the polycyclic 
aromatic compounds.
7.3 B-NAPTHQFLAVQNE IN DUC TIO N
The induction of drug metabolising enzymes by foreign chemicals such as 
3-methylcholanthrene (3MC), 3-napthoflavone and TCDD has been extensively 
studied within the mouse and is now known to be controlled by the Ah locus (Nebert 
et al. 1981). The induction response is the result of an increase in several gene 
products associated with the metabolism of drugs and carcinogens chemically 
related in structure to the inducers. These gene products include cytochromes 
P^-450 (Negishi et al. 1979), P2~450 (Ohyama et al. 1984), P^-450 (Negishi et al.
1979) and UDP-glucuronosyltransferase (Owens, I. 1977). The presence of such a 
cytosolic high affin ity  Ah receptor has been shown to be strain specific (Hannan et 
al. 1981) with inheritance of this, receptor following Mendeiian genetics (Nebert et 
al. 1981).
Within a number of different rat strains pretreatment with 3MC has been 
shown to result in the induction of three separate cytochrome P-450 isoenzymes, 
termed P-450^, P-450c and P-450^ (Ryan et al. 1979, 1980). Of these forms, the 
major cytochrome P-450 isoenzyme is the P-450c form with this being shown to 
correspond to the same major isoenzyme induced upon pretreatm ent with B- 
napthoflavone. (Lau et al. 1982).
Following the chromatographic purification of microsomes isolated from BNF- 
pretreated Wistar rats a single major isoenzyme corresponding to the major 
isoenzymic cytochrome P-450c form found in Sprague-Dawley rats was isolated. 
Immunological characterisation (figure 4.20) indicated that there was no cross- 
reactivity between this form and the other cytochrome P-450 isoenzymes analysed.
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The Induction of Hepatic Cytochrome P-447 following 
Single Dose (3-napthoflavone Pretreatm ent
Figure 7.5
(A) represents increase (fold) of immunoprecipitable mRNA translatable activ ity  
coding for cytochrome P-447.
(B) represents increase (fold) of cytochrome P-447 within 8-napthoflavone- 
induced microsomes as determined by single radial immunodiffusion assay.
(C) represents increase (fold) in 7-ethoxyresorufin activ ity  within 8-napthoflavone 
induced microsomes.
All values represent increases above basal levels. (Data is from pertinent result 
sections, chapters 4 and 6).
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This is in agreement with other authors who have also shown no immunological 
cross-reactivity amongst the major homogeneous cytochrome P-450 isoenzymes 
purified to date (Thomas et al. 1981).
Analysis of the Wistar ra t microsomal fractions following single dose 
pretreatment indicated an increase in microsomal specific content with time (table
4.3). This also manifested itself in the qualitative visualisation of cytochrome P-447 
within microsomes as visualised by Western blotting (figure 4.22B), and also by 
quantitative determination carried out by single radial immunodiffusion analysis 
(table 4.10). With respect to the Western blotting analysis one major band was 
visualised which was shown to correspond to the authentic cytochrome P-447 
isoenzyme. A similar pattern was obtained upon immunoprecipitation of mRNA  
fractions isolated at d ifferent time points following BNF pretreatment (figure 6.12). 
This is in contrast to the results obtained by other workers who have been studying' 
similar parameters in different rat strains. Immunoprecipitation analysis of mRNA  
fractions from 3M C-pretreated animals with anti-cytochrome P-450c antibody, has 
revealed the presence of two polypeptides within both Sprague-Dawley and Long- 
Evans rat strains. (Fagan et al. 1983, Lippman-Morville et al. 1983). The upper 
higher molecular weight polypeptide was shown to correspond to cytochrome P-450c 
and the lower polypeptide to cytochrome P-450^ which is also the major isoenzymic 
form induced following isosafrole pretreatm ent (Ryan et al. 1980). The reason for 
this cross-reactivity is the sharing of common antigenic determinants, although both 
isoenzymes can be distinguished on the basis of spectral properties, catalytic  
activities and the N - and C -term inal amino acid sequences (Reik et al. 1982). The 
complete nucleotide sequences for the 3MC-inducible cytochrome P-450^ (Sogawa 
et al. 1984) and P-450^ (Kawajiri et al. 1984) genes have been determined and 
although similarities exist, the genes cannot be considered identical.
This would suggest that the mode of induction by 3MC and BNF is different 
either at the strain level or alternatively at the level of immunological identity 
between the two isoenzymes. Analysis of the total translation products of the
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mRNA fractions isolated at d ifferent time points (figure 6.2) indicated the presence 
of an induced polypeptide with time of approximate molecular weight 52K. On the 
basis of mobility upon SDS P.A.G.E. this could represent cytochrome P-450^. A 
further factor also to be considered is the dosing regimen. It  has been reported that 
on consecutive dosing the ratio of cytochrome P-450c to cytochrome P-450^ is far 
greater than obtained on single dosing (Yabusaki et al. 1984). Possibly within Wistar 
rats the expression of the mRNA for cytochrome P-450d is much lower than that 
seen within other rat strains. A t the moment the available data is not sufficient to 
rule out or support any of these possibilities.
In the present study, subsequent to BNF pretreatment, a rapid induction in the 
expression of the mRNA coding for cytochrome P-447 was observed. This 
expression was observable as early as 6 hours following pretreatment attaining a 
maximum at between 12-16 hours (figure 7.5). A fter this period the mRNA coding 
for cytochrome P-447 was seen to diminish, although at 72 hours following dosing 
was still higher than that seen in uninduced animals. This time period for maximal 
induction is in agreement with other authors who have shown that in Sprague- 
Dawley pretreated animals (both 3MC and BNF pretreated), the corresponding 
optimal increases were at 15 hours (Bresnick et al. 1981) and 16 hours (Dubois et al.
1980) respectively.
Previous work (Kumar et al. 1980) has suggested that cytochrome P-450c is 
first synthesised as a precursor molecule with a molecular weight 6000 greater than 
the mature protein. This study using the jn vitro translation system assay was 
unable to confirm the existence of a precursor segment of the size suggested, and it 
would appear that the cytochrome P-447 protein was synthesised in the mature 
form. Evidence amongst different strains has been presented both for (Fagan et al. 
1983), and against (Bresnick et al. 1981) the presence of this precursor segment.
Coupled with the rapid induction of the mRNA coding species is a rapid 
increase in the rate of metabolism of the substrate 7-ethoxyresorufin. A maximum 
is achieved at 24 hours post- dosing with the levels decreasing thereafter in line
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with the decrease in mRNA levels (figure 7.5). On immunological quantitation an 
even greater increase is seen in the level of immunologically detectable cytochrome 
P-447 with levels 25 fold over that seen in uninduced animals being observed. This 
immunochemical induction profile is similar to that observed in Sprague-Dawley rats 
(Harada et al. 1981), except that at the maximally determined levels the percentage 
of cytochrome P-447 of total cytochrome P-450 present within the hepatic 
microsomes of Wistar rats was approximately 40-50% of that seen in pretreated 
Sprague-Dawley animals (Harada et al. 1981, Goldstein et al. 1984). One possible 
reason for this discrepancy could be that with Sprague-Dawley pretreated animals 
the anti-cytochrome P-450c antibody recognises both the P-450c and P-450^ 
isoenzymes (Reik et al. 1982), which according to the results from this study does 
not appear to be the case in Wistar rats. This possibility is further strengthened by 
the fact that the ratio of the contents of cytochromes P-450c and P-450^ in BNF 
pretreated Sprague-Dawley rats is about 3:1 (Thomas et al. 1983). Taking this value 
into consideration would therefore suggest that the degree of induction of 
cytochrome P-447 would then be approximately the same across the two strains.
The fact that this was indeed the major cytochrome P-447 peptide induced was 
also ascertained by means of antibody inhibition analysis (figure 4.23). Comparable 
values for the inhibition of ethoxyresorufin O-deethylase activity was obtained 
within a reconstituted enzyme system utilising both the purified protein and 
microsomal fractions.
It  was also interesting to note how quickly mRNA coding for cytochrome 
P-450 following BNF pretreatm ent was expressed. This was attained at 
approximately 12 hours following dosing and contrasts sharply to the comparable 
time period following phenobarbitone pretreatm ent. This difference could possibly 
relate to the e ffect of various xenobiotics upon the integrity of RNA polymerases 
which are essential components in the transcription of mRNA. 3MC pretreatment 
was shown to increase RNA polymerase I and II activity by 70% and 3Q% 
respectively, resulting in increased transcription of both ribosomal and mRNA
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molecules (Liberator et al. 1981). Phenobarbitone on the other hand, exerted no 
e ffec t on either RNA polymerase I or II activity (Liberator et al. 1981). This factor 
is probably fundamental in explaining the differences observed in time for maximal 
induction by the two xenobiotics. Inhibitors of RNA synthesis or RNA polymerase 
activity totally prevent the induction of cytochrome P-450 mediated reactions 
(Cutroneo et al. 1973, Jacob et al. 1974).
Evidence was also presented (figure 7.6) that BNF also exerted an e ffect on 
the genes expressing cytochromes P-450 Ety/Ety and P-452. Immunological 
quantitation of BNF pretreated microsomes showed the presence of slightly elevated 
levels of cytochromes P-450 Ety/Ity above that seen within the uninduced state. 
These levels decreased with tim e, ranging from 2-3% of the total cytochrome P-450 
population. Similar values as high as 5% have been reported within Sprague-Dawley 
rats pretreated with 3MC (Harada et al . 1981). The presence of these isoenzymes 
could also be detected in BNF pretreated microsomes by means of Western blotting, 
although visualisation was at the minimum level of detection. There was no 
increase in benzphetamine N-demethylase activity above basal levels indicating the 
lack of inducibility of metabolically active cytochromes P-450 B ^ / B y  The reason 
for the discrepancy between the presence of actively metabolising holoenzyme and 
immunologically detectable protein is unclear, although the possibility that the 
antibody is recognising some other form of cytochrome P-450 cannot be discounted. 
Analysis of the mRNA species coding for the phenobarbitone-induced isoenzymes 
indicates that there is a 53% drop in activ ity  relative to the uninduced state 
following BNF pretreatm ent (16 hours). This is in very close agreement with that 
observed in Sprague-Dawley rats where the level was shown to be decreased by 55% 
upon BNF pretreatm ent (Phillips et al. 1983a). These results in the Wistar rats 
would therefore concur with previous findings in the Sprague-Dawley rat (Phillips et 
al. 1983a). These results also indicated that the decrease in specific phenobarbitone 
cytochrome P-450 upon BNF pretreatm ent was not the result of passive dilution 
effects as a result of microsomal membrane proliferation but more
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The effect of 3-napthoflavone upon the cytochrome P-452 gene is even more
pronounced in that almost complete repression is observed. Immunological
$
quantitation reveals that the cytochrome P-452 isoenzyme is decreased by up to 
90% of its level as compared to its uninduced state. This corresponds to a 65% 
decrease in the cytochrome P-452 mRNA activity following 3-napthoflavone 
pretreatm ent. Although some lauric acid hydroxylase activ ity  is still observed 
following pretreatment (figure 7.6), HPLC analyses indicates that this is primarily
11-hydroxylase activ ity . Hydroxylation at the 12-position is depressed to the 
greatest extent (figure 4.11C). This would be expected, as it has already been shown 
(chapter 4) that hydroxylation at the 11- position is primarily attributed to 
phenobarbitone-type isoenzymic activity and hydroxylation at the 12- position as a 
result of clofibrate-induced cytochrome P-452 activity. This suggests that the 
lauric acid hydroxylation activ ity  observed within BNF pretreated microsomes is 
therefore possibly being mediated by the cytochrome P-450 Bh/B 2 isoenzymes still 
present - albeit at very low levels - within the microsomal membranes.
In summary, it has been shown that BNF pretreatment of Wistar rats results 
in a very rapid increase in expression of mRNA molecules coding for cytochrome 
P-447. This is concomitantly reflected in an increase in metabolic activity  
(ethoxyresorufin O-deethylase) and immunologically detectable protein. Despite the 
overall increase of total cytochrome P-450 within the liver microsomal membranes 
however, 3-napthoflavone was shown to decrease the amounts of both cytochromes 
P-450 B^/B2 and P-452 as well as their corresponding translatable mRNAs. The 
gene(s) coding for cytochrome P-452 appeared to be affected to the greatest extent. 
This indicates that induction of cytochromes P-450 by xenobiotics is not an 
indiscriminate process, but involves both the expression and repression of gene 
activity for various cytochrome P-450 variants.
directly due to an effect at the specific gene level.
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XENOBIOTIC PRETREATMENT
Whereas cytochrome P-450 dependent monooxygenases in liver microsomes 
have been extensively studied, only a lim ited amount of information is available 
from kidney microsomes. Homogeneous cytochrome P-450 has been isolated from  
the pig kidney cortex and shown to be active in the 11- and 12- hydroxylation of 
prostaglandins A^, E^ and lauric acid (Okita et al. 1981). Two other forms have 
been purified (Ogita et al. 1982) - and a further form speculated upon (Kusunose et 
al. 1981) - from the kidneys of New Zealand white rabbits. Within this species 
pretreatm ent with 3MC (Ogita et al. 1982) resulted in the isolation of one form  
active in the 11- and 12-hydroxylation of fa tty  acids and the other in the 
preferential hydroxylation of benzo(a)pyrene. In both species, the cytochrome P-450 
was primarily distributed within the proximal tubule (Masters et al. 1981; Endou, 
1983). Additional work utilising rat kidney microsomes (Sprague Dawley) has also 
led to the suggestion that the kidney cytochrome P-450 system has a very high 
substrate specificity which is primarily directed towards fa tty  acid hydroxylation 
(Ellin et al. 1972, 1975).
Single-dose clofibrate pretreatm ent resulted in an in itial decrease, followed by 
an increase attaining a maximum at 24 hours, of specific microsomal content (table
4.3). This pattern was also reflected in Western blot analysis with anti-cytochrome 
P-452 antibody of the pretreated renal microsomal fractions (figure 4.22A). Here a 
single polypeptide band was visualised which was shown to co-migrate on SDS 
P.A.G.E. with homogenous hepatic cytochrome P-452. Catalytic analysis of total 
lauric acid metabolites showed a linear increase with time, with this being further 
evidence for cytochrome P-452 induction. HPLC analysis (figure 4.11A) of the 
metabolites indicated that activity was preferentially at the 12-position although 
lower levels of activity were also seen at the 11-position. It is interesting to note 
that 11-hydroxylation was linear in activ ity  with time, whereas 12-hydroxylation 
began to very slowly decrease a fte r 24 hours. This change which is reflected in the
7.4 INDUCTION OF R E N A L  C Y T O C H R O M E S  P-450 F O L L O W I N G
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12- to 11-hydroxylation ratios (table 7.3) could suggest that two hydroxylases were 
involved. This is in contrast to the observed effects of Sprague-Dawley rats where 
it is believed that only one hydroxylase is present (Ellin et al. 1975).
Table 7.3
The E ffect of Xenobiotic Pretreatm ent Upon Renal Lauric Acid 
Metabolites Hydroxylation Ratios
Pretreatm ent Clofibrate Phenobarbitone 3-napthoflavone
time (hours) pretreatment pretreatment pretreatment
0 3.04 3.04 3.04
6 2.55 2.88 3.34
12 3.14 3.12 3.3
24 3.77 3.37 3
72 3.25 4 3.15
Other differences between the two species are also apparent. Firstly in 
Sprague-Dawley rats the cytochrome P-450 hemoprotein population involved in 
laurate oxidation has an absorption peak in the CO-complexed form at 453-454 nm 
(Ellin et al. 1972). Within uninduced Wistar rats this value is 450.5 nm which 
increases to 451 nm upon clofibrate pretreatm ent. Secondly, using lauric acid as a 
substrate, the ratio between the 12- and 11-hydroxylated products was 
approximately 2:1 (Ellin et ai. 1973), whereas in Wistar rats this value was closer to 
3:1. The final difference relates to the overall levels of lauric acid turnover. With 
Sprague-Dawley rats (Jakobsson et al. 1970, Ellin et al. 1973) the level of lauric acid 
hydroxylation approximated that seen with the liver. Within Wistar rats however a 
20-30 fold higher level of overall activ ity  was observed (nmol product/nmol 
P-450/m in). This difference was not related to the dietary state of the animals as 
the animals were not starved prior to death, an event known to increase the level of 
fa tty  acid hydroxylation activ ity  (Ellin et al. 1971).
i
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On the basis of metabolic activity reconstitution experiments, clofibrate  
pretreatm ent did not appear to induce either cytochromes P-450 Ety/Ety or P-447 in 
terms of the metabolic turnover of benzphetamine and 7-ethoxyresorufin. This was 
also proved by immunoprecipitation analysis of renal mRNA species isolated at 16 
hours following clofibrate pretreatm ent. Similarly the levels of mRNA coding for 
cytochromes P-450 Ety/Ety and P-447 (table 6.6) were shown to be depressed as 
compared to basal levels. Despite this, visual precipitation of these peptides was 
still possible (figure 6.14B) which is to an extent surprising as this was not seen to 
be the case on analysis of the hepatic mRNA complement following clofibrate  
pretreatm ent. The reason for this difference is unclear but may be representative 
of a different mode of induction between the two organs.
On quantitating the mRNA levels coding for cytochrome P-452 these were 
seen to be just lower than those observed within the liver. Because of the very high 
lauric acid hydroxylation rates observed within the kidney this could suggest that a 
for more effic ient expression, or alternatively an increase in the stability of the 
cytochrome P-452 coding mRNA population is apparent. Unfortunately the 
available data is not sufficient to discriminate between these possibilities.
Phenobarbitone pretreatm ent resulted in the induction of cytochrome P-450 
as determined by Western blot analysis and in a increase in benzphetamine N- 
demethylase activity with tim e. It  is not possible to conclude from the results of 
this study whether or not there is any cytochrome P-450 B2 present within renal 
microsomes or alternatively whether it is present in such low amounts that the 
techniques utilised are not sufficiently sensitive. Immunoprecipitation of mRNA  
directed translation products indicated that a 2.3 fold increase in its mRNA coding 
complement for this isoenzyme occurred. This is approximately half the level 
observed within the hepatic complement at 16 hours dosing. As the values observed 
for benzphetamine N-demethylase activ ity  are similar to that seen within the liver, 
then the possibility exists that the cytochrome P-450 B^ coding mRNA is being 
influenced in the same manner as that seen for the clofibrate mRNA.
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Immunoprecipitation analysis of the mRNA complement clearly indicated the 
presence of cytochrome P-452. Quantitation of these levels indicated that they 
were approximately the same as that seen within the uninduced state, which is a 
similar finding to that observed within the hepatic mRNA complement. This 
increase was also reflected in an increased level of lauric acid hydroxylation with 
the 12-hydroxylase being preferentially expressed (table 7.3, figure 4.11B). It  should 
be noted here that with hepatic microsomes the 11-hydroxylase is primarily induced. 
This increase in induced renal lauric acid hydroxylase activity is again different to 
that observed in Sprague-Dawley rats (Jakobsson et al. 1970), where no measurable 
effects on either the cytochrome P-454 level or w-oxidation activity was observed. 
This difference is believed to relate to the involvement of the induced cytochrome 
P-452 - as is seen within the liver - and not due to any of the induced 
phenobarbitone isoenzymes. The fact that a linear increase in 12-hydroxylation with 
time is observed however, in contrast to clofibrate pretreatment where maximal 
activ ity  occurs at 24 hours post-dosing, cannot preclude the possibility that other 
forms of cytochrome P-450 are involved.
No expression of the cytochrome P-447 gene is indicated, in that both the 
levels of mRNA coding for cytochrome P-447 and the rate of metabolic turnover of 
7-ethoxyresorufin are decreased by 60%.
Only lim ited analysis was carried out upon the effects of 3-napthoflavone 
induction upon renal microsomes. Upon single-dose pret;reatment a very rapid 
increase in the turnover of 7-ethoxyresorufin O-deethylase activity was observed 
with this attaining a maximum at 24 hours. The rate of cytochrome P-447 induction 
was much higher within the renal than hepatic microsomal complement, although 
the maximal rate (9 fold) and trend of induction were the same in both cases.
The presence of cytochrome P-452 could also be detected within the BNF- 
induced microsomes by Western blot analysis. This was also reflected in a slight 
increase in 12-hydroxylase activ ity  (table 7.3, figure 4.11C). The levels of 
cytochrome P-452 coding mRNA within the total RNA complement induced by 3-
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napthoflavone was not determined. However the lim ited increase in lauric acid 
hydroxylation would suggest that as within the liver, B-napthoflavone acts to repress 
cytochrome P-452 gene activ ity . As no activity towards the demethylation of 
benzphetamine was observed a similar premise can be applied towards the 
cytochrome P-450 Ety/Ety gene.
From the lim ited results obtained upon analysis of the renal fractions, one can 
conclude that clear differences emerge between the mode of xenobiotic induction in 
the liver and the kidney as well as across strains (Wistar and Sprague-Dawley rats). 
Cytochrome P-452 appears to be present in all of the xenobiotically pretreated  
microsomal fractions suggesting that as within the liver it is present in high levels 
as a constitutive form. Pretreatm ent resulted in the specific induction of 
corresponding cytochrome P-450 isoenzymes which was reflected in increases in the 
metabolism of marker substrates. This is in contrast to the Sprague-Dawley strain 
(Hodgson et al. 1980) where the kidney cytochromes P-450 were shown to be 
relatively inactive in xenobiotic oxidation.
The fact that such high levels of UJ -hydroxylation are observed lends support 
to previous observations that renal cytochrome P-450 mixed function oxidase 
activity is directed towards the W - and (id-l)-hydroxylation of fa tty  acids.
The evidence presented also strongly suggests that only one hydroxylase is 
induced, with this being preferentially stimulated by all the xenobiotics studied. 
This cannot be considered absolute however as the relative rates of induction of 
both hydroxylases was shown to d iffer with time upon clofibrate pretreatm ent. The 
precise reason for this is unclear, but could possibly be explained by the 
consideration that the constitutive renal cytochrome P-452 form is preferentially  
responsible for the (J -hydroxylation of fa tty  acids. On pretreatm ent with 
clofibrate, this activ ity  is enhanced with a further isoenzymic variant of 
cytochrome P-452 catalysing the (U -l)-hydroxylation of fa tty  acids also being 
induced.
266
In the last few years tremendous progress in the understanding of gene 
structure and gene expression with its concomitant regulation of the drug 
metabolising enzymes has been achieved. It  is anticipitated that this progress will 
continue, and that the techniques of molecular biology w ill be increasingly used to 
probe the existence and induction of the isoenzymic groups involved in xenobiotic 
biotransformation in experimental animals.
With a view to this study the intriguing pattern of the clofibrate-induced  
cytochrome P-450 isoenzyme merits further study. This is further justified by the 
indication that it is present as a major constitutive isoenzymic form with a wider 
substrate activity than previously thought. Although its induction parameters were 
analysed, questions still remain, and the next stage should be directed towards the 
cloning analysis of the cytochrome P-452 isoenzyme(s). At the same time 
immunoquantitation in parallel with metabolic activity profiles for this isoenzyme 
should also be investigated within other organs (especially the kidney).
The ultimate gaol of any such study should be the eventual isolation of well 
characterised cDNA animal probes directed against the different cytochromes P-450 
in order to type human liver. This w ill provide a far more detailed understanding of 
the drug-metabolising enzymes within humans, such that animal experimentation 
data could provide a more accurate prediction of potential toxicity of any compound 
within man.
This could be achieved by the isolation and subsequent characterisation of 
highly purified drug metabolising enzymes. The subsequent preparation of 
monospecific antibodies against these variants could then be used to immuno- 
quantitate these forms amongst different species, including man. In conjunction 
with these studies, molecular biology techniques could be utilised in order to enrich 
for the specific mRNAs from animal livers from various sources in order to 
construct the corresponding cDNAs. These would be utilised to identify the gene
Suggestions for Further Work
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structure coding for these isoenzymes , which could then be compared and 
contrasted to that present within the human genome.
Aside from the greater understanding of genetic regulation upon xenobiotic 
pretreatm ent which would be attained, the possibility of improved 
clinical/toxicological diagnosis has to be considered. Indeed such genetic 
characterisation could well result in it being possible to predict clinically, 
individuals who are at increased risk for developing certain types of chemically 
induced cancers or who would suffer deleterious effects after certain forms of drug 
therapy due to a patients underlying pharmogenetic disorder.
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